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Abstract 
NaV1.1 is a voltage-gated sodium channel encoded by the gene SCN1A. Mutations in 
SCN1A cause dominantly inherited epilepsy syndromes in humans and NaV1.1 is an 
important target of several anti-epileptic drugs (AEDs). A common polymorphism in this 
gene has been shown to alter the expression of two splice variants of the channel, NaV1.1-
5N (containing exon 5N) and NaV1.1-5A (containing exon 5A). Although the splicing is 
highly conserved and the polymorphism that modifies it has been associated with altered 
AED dosage, the functional impact of the splicing on NaV1.1 is unknown.  
This project used whole cell voltage clamp of heterologously-expressed NaV1.1-5A and 5N 
to compare the intrinsic properties of the splice variants, their modulation by AEDs, their 
interaction with a published epilepsy mutation (R1648H), their modulation by G-proteins 
and how they responded to co-expression of sodium channel β subunits. 
The main finding was that, although when recorded at physiological temperatures the splice 
variants produced macroscopic currents that were similar for many parameters, they 
differed in the rate at which they recovered from inactivation, with NaV1.1-5N recovering 
more rapidly than NaV1.1-5A. This difference in recovery was conferred by a single amino 
acid substitution that is conserved in several sodium channels that are alternatively spliced 
at this site, and the difference was obscured in the presence of the common AED, 
phenytoin. Inclusion of the mutation R1648H also eradicated the difference by 
disproportionately slowing the recovery of NaV1.1-5N. Although several other subtle 
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differences were seen, no consistent differences were found in interactions between the 
splice variants and G-proteins or β subunits. By converging on a single parameter, recovery 
from inactivation, the data presented here suggest this parameter is modulated by splicing, 
and may play a role in development and treatment of seizures. 
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Chapter 1: Introduction 
Overview of introduction 
Ion channels are pore-forming proteins that permit the movement of ions across cell 
membranes and are involved in a wide range of physiological roles. Voltage-gated sodium 
channels (VGSCs) are responsible for generating and propagating action potentials in 
electrically excitable cells (Catterall 1995). Genes encoding ion channels, including 
VGSCs, undergo extensive alternative splicing (Blencowe 2006). SCN1A, the gene that 
encodes the α subunit of the VGSC designated NaV1.1 is alternatively spliced at exon 5. 
SCN1A contains two copies of exon 5, denoted 5N and 5A. The two alternative splice 
variants encode channels that differ near one of the segments of the ion channel thought to 
be important for voltage-sensing. Sodium channels are tightly regulated, consequently even 
subtle effects of alternative splicing on channel gating may have important consequences 
for neuronal behaviour. Through NaV1.1, this project focuses on the interaction between 
three broad fields: Biophysics and structure of VGSCs; the contribution of VGSCs to 
development and treatment of epilepsy, and the impact of alternative splicing on channel 
behaviour. In order to provide background for each of these broad themes, the introduction 
will be in four parts: 
Part 1 reviews what is known about VGSCs, with an emphasis on explaining what 
outstanding questions this work sets out to resolve. 
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Part 2 gives a history of the study and treatment of epilepsy, focusing on the role of 
sodium channels as a drug target and a possible aggravating cause. 
Part 3 provides a brief introduction to alternative splicing, but focuses on the problem of 
attributing specific functions to highly-conserved but nearly identical variants of proteins 
and channels. 
Part 4 is an overview of the factors that are known to modulate sodium channels which 
were probed in this report, including: G-proteins, temperature, and intracellular ions. 
Aim of study 
There were several aims to this thesis: both practical and biological. The basic goal was to 
functionally characterize transiently transfected NaV1.1-5A and NaV1.1-5N channels in 
HEK 293 cells using whole-cell patch clamp.  Ideally experiments would have been 
conducted in neuronal model and not a heterologous cell line. Within the limits of using 
HEK 293 cells there was a continuous aim to implement accurate biological conditions. 
This is reflected in using different intracellular anions and performing experiments at 
physiological temperatures.  Using molecular biology and electrophysiological techniques 
different neuronal models were also contemplated.   
Once the methodological aims were fulfilled one endeavour was to investigate the potential 
impact of NaV1.1 splicing on the development and treatment of epilepsy. In parallel, a 
broader aim, to examine channel modulation by auxiliary β subunits and G-proteins, was 
undertaken using the methods previously mentioned.   
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1.1.1 Original characterization and cloning of VGSCs 
The first VGSC was purified from rat brain in the early 1980s (Hartshorne & Catterall, 
1981; Hartshorne & Catterall, 1984; Messner & Catterall, 1985). Early on, VGSCs were 
shown to comprise a hetero-oligomeric polypeptide comprising a functional channel-
forming α unit (Goldin et al., 1986) associated with one or more modulatory β subunits: a 
non-covalently attached β1 subunit and a disulphide-linked β2 subunit. More recently, three 
other human β subunit isoforms have been cloned which will be discussed later (section 
1.1.9). The α subunits of VGSCs are encoded by a family of ten similar genes (Goldin 
2001; Table 1.1).  Generally the type of VGSC, designated NaV1.x (where x = 1 to 9) is 
specified by the α subunits (encoded by SCNnA, n = 1 – 5, or 8 – 11). The presence of β 
subunits is implicit in the channel protein complex but usually not designated. The 
variations between the α subunits result in distinct currents. When modulated by 
combinations of β subunits and the resulting VGSCs confer specific physiological 
properties relevant to the tissue in which they are expressed (Goldin 2001). This importance 
of narrow control of VGSC properties is highlighted by diseases termed „channelopathies‟.  
These can be caused by mutations in individual VGSC genes that mainly affect the organ 
where the α subunit is most important (Kullmann 2002).  In fact, given the paucity of 
specific toxins or pharmacological labels, much of what is known about the functional roles 
of the different VGSCs has come from characterization of the distinct channelopathies 
caused by mutations in the different VGSC genes. 
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Table 1.1: NaV channels CNS, Central nervous system; IC50 half maximal inhibitory concentration; OMIM Online Mendelian 
Inheritance in Man; PNS, Peripheral nervous system; TTX, Tetrodotoxin; STX, Saxitoxin; Va, half maximal conductance 
(Catterall et al.,2005; Chahine et al.,2005; Noda 2006; Brakenbury & Isom, 2008). 
Channel 
Gene 
name 
Chromosomal 
location 
Full length 
amino acid 
size 
Tissue 
localization 
TTX/ST
X(IC50) 
Va (mV) Associated human pathophysiology 
OMIM 
number 
NaV1.1 SCN1A 2q24.3 2009 
CNS, PNS, 
heart 
10 nM -33 Epilepsy, migraine, autism 182389 
NaV1.2 SCN2A 2q2a23-24 2005 CNS 10 nM -24 Epilepsy 182390 
NaV1.3 SCN3A 2q24 1951 CNS, heart ~15 nM -23 to -26 Epilepsy 182391 
NaV1.4 SCN4A 17q23-25 1836 Skeletal muscle ~25 nM -26 to -30 Hyperkalemic periodic paralysis, paramyotonia congenita 603967 
NaV1.5 SCN5A 3p21 2016 Heart, CNS ~6 μM -27 
Long QT syndrome, Brugada syndrome, progressive heart block, 
idiopathic ventricular fibrillation, congenital sick sinus syndrome, 
dilated cardiomyopathy 
600163 
NaV1.6 SCN8A 12q13 1980 
CNS, PNS, 
heart, glia, 
nodes of 
Ranvier 
~6 nM -17 to -40 Mental retardation, pancerebellar atrophy, and ataxia 600702 
NaV1.7 SCN9A 2q24 1977 
PNS, Schwann 
cells 
~25 nM -31 to -45 
Primary Erythermalgia, Channelopathy-Associated Insensitivity to 
Pain, Paroxysmal Extreme Pain Disorder, Epilepsy 
603415 
NaV1.8 SCN10A 3p22-24 1957 PNS >100 μM -16 to -21 Undetermined 604427 
NaV1.9 SCN11A 3p21-24 1792 PNS 1 μM -47 to -60 Undetermined 604385 
Nax SCN6A/7A 2q21-23 1682 
Heart, uterus, 
glia, PNS 
smooth muscle 
<1 μM 
Voltage,salt 
sensitive 
Undetermined 182392 
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Table 1.2 NaV β subunits (Catterall et al.,2005; Chahine et al.,2005; Noda 2006; Brakenbury & Isom, 2008 abbreviations same 
as Table 1.1) 
Channel 
Gene 
name 
Chromosomal 
location 
Full length 
amino acid size 
Tissue localization 
TTX/ST
X(IC50) 
Va 
(mV) 
Associated human 
pathophysiology 
OMIM 
number 
β1 SCN1B 19q13 218 
Heart, skeletal 
muscle, CNS, glial 
cells, PNS 
- - 
Epilepsy, Brugada syndrome, 
cardiac conduction defect, 
cancer 
600235 
β2 SCN2B 11q22 186 CNS, PNS - - 
Altered pain response, seizure  
susceptibility, Multiple 
Sclerosis 
601327 
β3 SCN3B 11q23.3 215 
CNS, adrenal gland, 
kidney, PNS 
- - Brugada syndrome, Cancer 608214 
β4 SCN4B 11q23 228 
Heart, skeletal 
muscle, 
- - 
Long QT syndrome, 
Huntington‟s disease 
608256 
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1.1.2 NaV1.1 
Mutations within SCN1A cause central nervous system (CNS) channelopathies ranging 
from febrile convulsions and epilepsy to migraine (Dichgans et al., 2005; Ragsdale 2008). 
SCN1A is located on human chromosome 2q24.3 (Escayg et al., 2000) and encodes a large 
(223 kDa) protein. Original immunohistological work indicated that NaV1.1 was primarily 
localized to the somata and dendrites of neurons within broad brain regions including the 
brainstem, substantia, cerebellum and hippocampus (Westernbroek et al., 1992; Gong et 
al., 1999). One of the challenges of localizing NaV1.1 is the high identity between VGSC 
subunits.  Functional work in a SCN1A knockout mouse model indicated that NaV1.1 was 
predominant in inhibitory interneurons although no immunohistochemical paper had 
indicated this localization (Westernbroek et al., 1992; Gong et al., 1999; Yu et al., 2006). 
In response to the data from the mouse model, and in spite of significant early work looking 
at the distribution of these channels, a subsequent immunohistochemical and in situ study 
re-assessed the localization of NaV1.1 with a view to determining whether the channels 
were predominantly interneuronal.  Ogiwara and colleagues (2007) demonstrated that 
NaV1.1 was expressed in rat caudal brain regions, namely the thalamus, superior colliculus, 
inferior colliculus, pons, medulla, deep cerebellar nuclei and spinal cord. Expression 
signals were less intense in the hippocampus, cerebral cortex, and cerebellum. The authors 
verified their immunohistochemistry by using three distinct NaV1.1 antibodies and 
comparing expression to brain slices of NaV1.1 null mice (Ogiwara et al., 2007). Further 
inspection corroborated the functional data from the knockout mice and showed that 
NaV1.1 was localized to the axon initial segments (AISs), axons and somata of 
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Parvalbumin-positive interneurons in the immature neocortex and hippocampus (Ogiwara 
et al. 2007).  
Within cerebellar white matter, the corpus callosum and ﬁmbria Ogiwara and colleagues 
identified NaV1.1 channels in the nodes of Ranvier.  A later immunocytochemistry study 
supported these findings in the cerebellum but in not the latter two brain regions (Duflocq 
et al., 2008).  NaV1.1 was also identified in both the nodes of Ranvier and AIS of neurons 
within similar mouse brain regions described by Ogiwara et al. (2007). These 
inconsistencies highlight the continuing difficulties in accurate NaV1.1 immunostaining. 
However, NaV1.1 expression was comparable in both studies (Ogiwara et al., 2007; 
Duflocq et al., 2008). In the spinal cord Duflocq et al. (2008) identified three populations 
of nodes: NaV1.1 predominant, NaV1.6 predominant or those expressing a mixed population 
of both channels. Within NaV1.1 specific nodes, a higher concentration of channels were 
clustered near the soma. Unlike NaV1.6 specific nodes, channels were more evenly 
distributed throughout the AIS. In the third, „mixed‟ node population, NaV1.6 expression 
complemented NaV1.1 localization whereby NaV1.6 channels were more highly expressed 
in the distal AIS Duflocq et al. (2008). This regional localization implicates NaV1.1 in 
action potential generation and propagation in GABAergic interneurons perhaps with 
specific firing properties that are dependant on VGSC background (Duflocq et al., 2008).   
1.1.3 Structure of VGSC α subunits 
The α subunits of VGSCs have a highly conserved structure that is organized into four 
homologous domains (I – IV) that are connected by cytoplasmic linkers. Each domain 
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contains six transmembrane segments (S1 to S6; Figure 1.1 A).  The C and N termini are 
intracellular.  The S4 segments act as the voltage sensors and a membrane-associated loop 
between segments S5 and S6 in each domain determines ion conductance and acts as the 
selectivity filter (Guy and Seetharamulu, 1986). The tertiary structure of sodium channels 
remains ambiguous. X-ray crystallography of potassium channels imply that some 
segments are within the membrane and cryo-electron microscopy studies by Sato and 
colleagues (2001) suggest that the channel is bell-shaped and vertically traversed by a 
cross-shaped pore that allows the permeation of Na
+
 ions (Figure 1.1 B). Many studies have 
linked the different regions of the α subunits to the VGSC functions that underlie action 
potentials. Different regions of the peptide, even in some cases individual amino acids, 
have been shown to contribute to gating, permeation and inactivation of the channels.  
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Figure 1.1: Putative topology and three dimensional structure of a VGSC. A. The membrane topology of the α and β 
subunits. B. The proposed three dimensional structure of a VGSC. Sodium ion channels are postulated to enter and exit via four 
holes located on the extracellular and intracellular faces respectively. Two smaller peripheral channels that run parallel either 
side to the main pore are hypothesized to create a hydrophilic environment important for voltage sensing. PKC, Protein kinase C; 
PKA, protein kinase A. Picture and text redrawn from Cusdin et al., 2008; Sato et al., 2001 and www.wikipedia.com 
A 
B 
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1.1.4 Structural elements underlying channel gating 
At the onset of an action potential sodium channels move from a closed to an open, 
conducting state. VGSCs are activated, or „gated‟, by membrane depolarization. The most 
recognized model of how they detect and respond to membrane depolarization is the sliding 
helix model. According to this model, within the voltage sensing S4 helices, there are 
positive arginine or lysine residues at every third position that lie between 
hydrophobic/non-polar residues and respond to changes in voltage across the membrane 
(Hille 2001). At rest, ion pairs formed between these charged residues and with 
neighbouring segments lock in the S4 segment. A depolarisation of the membrane potential 
causes each S4 segment to „screw‟ outwards in the extracellular direction through an 
aqueous environment called the „canaliculus‟ (Sands et al., 2005).  The motion causes the 
cationic residues to move from a „water pocket facing position‟ to a more external position 
(Sands et al., 2005). This movement is thought to generate a conformational change of the 
S5 helices within the channel pore to shift it from a closed to an open state where its ion 
conductance is zero or maximal, respectively.  
1.1.5 Structural elements underlying channel permeation 
Tetrodoxin (TTX) is a sodium channel blocker that binds to and occludes the outer pore of 
most neuronal VGSCs. Mutagenesis studies investigating which specific amino acids bind 
to TTX revealed that the S5-S6 linker of each domain contributed to the pore, which 
consisted of inner (DEKA) and outer (EEDD) negatively charged rings of amino acids 
(Catterall 2005; Noda et al., 1989; Terlau et al., 1991). Mutations within the inner ring 
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were shown to alter single-channel conductance and ion-selectivity (Pusch et al. 1991; 
Heinemann et al., 1992b). 
1.1.6 Inactivation of VGSCs 
There are several VGSC inactivation states divided into fast and slow categories. The fast 
mode of inactivation, which is better understood than slow inactivation, occurs briefly (<1 
msec) after channel opening, and blocks Na
+
 ions permeating through the pore. At 
repolarising potentials, channels remain in a refractory, inactivated state, inhibiting ion flux 
until their recovery at hyperpolarised resting membrane levels.  Fast inactivation occurs via 
a „hinged lid‟ mechanism. The cytoplasmic linker between domains III and IV contains an 
inactivation particle consisting of three adjacent amino acids: isoleucine, phenylalanine and 
methionine. In the inactivated state this triad, presented via the reminder of the rigid loop, 
acts as a latch that docks within the intracellular pore through hydrophobic interactions 
(West et al., 1992). Several amino acids lining the mouth of the pore form the receptor for 
the inactivation gate and the whole complex is stabilized by the proximal part of the c-
terminus (Lerche et al., 1997; McPhee et al., 1998; Motoike et al., 2004; Smith & Goldin, 
1997; Figure 1.2). The time course of inactivation helps to regulate the frequency at which 
neurons can fire. Fast inactivation is voltage-dependent and triggered by the movement of 
the voltage sensor during channel activation. The voltage sensor in the fourth domain plays 
a pivotal role in this process (Chen et al., 1996). 
Slow inactivation of VGSCs is less understood and remains ill defined in the literature 
(Ulbricht 2005).  „Slowly‟ inactivating currents can take seconds to shut down (Taddese & 
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Bean 2002; Ptak et al., 2005). „Non-inactivating‟ describes currents that do not inactivate 
on any time scale. For the purpose of this report these two types of current will be 
considered distinct. The mechanism behind and structural basis of „slowly‟ inactivating 
currents are not fully understood, but are thought to involve different structural components 
to those for fast inactivation. Slow inactivation does not occur in conditions which can 
induce transient current inactivation (Clay 2003) and in heterologous systems expressing 
brain sodium channels prolonged or repetitive depolarisations are used to reveal slow 
inactivation (Toib et al., 1998). It is hypothesized that during this type of inactivation the 
pore undergoes a conformational change, which may restrict ion flow (Ong et al., 2000; 
Struyk & Cannon 2002).  
 
 
Figure 1.2: Amino acids involved in VGSC inactivation The residues that interact with 
the isoleucine, phenylalanine, methionine (IFM) motif in fast inactivation are shown as 
orange circles. Residues thought to be involved in slow inactivation are shown as green 
diamonds (Redrawn from Goldin 2003).  
1.1.7 The Persistent Sodium Current 
A „non-inactivating‟ or „persistent‟ sodium current (INaP; Figure 1.3) is present in almost 
all mammalian neurons and it is likely to be an intrinsic component of transient sodium 
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currents (Bean 2007). Of the different types of sodium current, the basis of INap is least 
understood, but several mechanisms have been proposed, including: increased pore open-
time, change in activation/inactivation voltage dependence, any of which may be associated 
with altered channel phosphorylation (Stafstrom 2007). Although INaP only accounts for 1-
3% of the peak inward sodium current, it can substantially alter the firing characteristics of 
healthy brain cells (Cummins et al., 1994; Fan et al., 1994; Wu et al., 2005; Zeng et al., 
2005).  For example, in many neurons, the dominant form of INaP has approximately a 10 
mV more negative activation threshold than the transient sodium current (Alzheimer et al., 
1993). In some preparations INaP was observed to activate at very hyperpolarized 
potentials, between -85 and – 90 mV (Huang & Trussell, 2008). INap activation at more 
negative potentials allows the non-inactivating current to amplify dendritic excitatory 
postsynaptic potentials (EPSPs) as well as subthreshold stimulations at the AIS and 
proximal axon (Astman et al., 2006; Schwindt & Crill, 1995). On hyperpolarisation INaP is 
partly inactivated resulting in a large decrease of inward sodium current which is 
comparable to an increase in outward current (Vervaeke et al., 2006). In this way 
afterhyperpolarizations (AHP) are augmented and it is postulated that this causes 
transiently-gated sodium channels to recover from fast inactivation more rapidly, which can 
lead to increased spike frequency (Vervaeke et al., 2006). Additionally, persistent current 
influences the „intrinsic electrical properties of neurons‟ (Vervaeke et al., 2006), and can 
drive membrane potential oscillations (Jahnsen & Llinas 1984a; Agrawal et al., 2001).  
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Figure 1.3: The persistent sodium current Superimposition of typical whole cell sodium 
current (black trace) and sodium current with an abnormally large persistent component 
(green trace). Taken from Ragsdale 2008. 
 
Not all persistent currents are generated equally, and for electrophysiologists the definition 
of INap is somewhat blurred. For example, INap recorded from heterologously expressed 
VGSCs, including NaV1.1, and cultured neurons have been reported to activate between -60 
to +20 mV (Ptak et al., 2005; Aman et al., 2009). The window current predicted to peak at -
50 mV (Crill 1996) describes the overlap of the transient sodium current activation and 
inactivation curves;  wherein a proportion of sodium channels continue to open while 
others begin to inactivate (Crill 1996), in this window currents would be expected to 
„persist‟ during longer voltage-steps. In fact, the commonly used Horn-Vandenberg- 
Bezanilla INa gating model predicts a sustained current at voltages positive to – 60 mV, 
which some argue may account for in vitro „persistent‟ currents (Horn & Vandenberg 1984; 
Vandenberg & Bezanilla 1991; Clay 2003).  However, Sun and colleagues (2007) 
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demonstrated that NaV1.3 macroscopic currents recorded from transfected HEK cells 
demonstrated significant INaP that was not carried by the window current, suggesting a 
different mechanism may underlie this current. Unfortunately, until a drug that specifically 
blocks INaP is found, the mechanistic discrepancies of slow inactivation, non-inactivating 
and persistent currents are unlikely to be resolved.  
1.1.8 Persistent sodium currents in disease 
The characteristics of persistent currents enhance abnormal biophysical mechanisms, 
mainly by generating increased neuronal excitability (Kohling 2002). It also thought to 
have functional importance for epileptogenesis, that is, the development to the state of 
epilepsy (Scharfman 2007).  The mechanisms of epileptogenesis are complicated and often 
paradoxical. However, a fundamental principle is an imbalance between excitation and 
inhibition (McCormick & Contreras, 2001). Seizures are thought to arise from the 
simultaneous occurrence of high-frequency firing, often referred to as „hyperexcitability‟, 
and with the „hypersynchronization of neuronal populations‟ (Bromfield et al., 2006).  
There are physiological controls of hyperexcitability, but as highlighted by persistent 
current, there are also factors that can promote increased neuronal firing. When 
preventative mechanisms against excessive activity break down or mechanisms that 
facilitate excitation are over activated, pathological activity arises (Scharfman 2007).  
A relatively small increase (~2%) in INaP would change spike initiation and promote 
repetitive firing (Kuo et al., 2006). In seizure-prone areas including the hippocampus, 
entorhinal cortex and neocortex INaP has been shown to amplify remote dendritic signals. 
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(Schwindt et al., 1993; Lipowsky et al., 1996; Magistretti et al., 1999; Köhling, 2002). This 
boosts current flow along neuronal dendrites to higher levels to that attained by solitary 
stimulations and therefore, contributes to pathological firing (Köhling, 2002).  Likewise, 
the neuronal networks to which these cells belong can be paced by INaP regulated 
oscillations promoting epileptogenesis (Köhling, 2002). More specifically, INaP is able to 
maintain the characteristic tonic discharging of layer III entorhinal neurons via spike AHP 
amplification. In temporal lobe epilepsy, these cells deteriorate rapidly because of their 
high activity levels. This disrupts neuronal rhythmicity and exacerbates abnormal firing 
(Dickson et al., 1997). Burst discharges are speculated to initiate irregular synchronous 
excitations (Köhling, 2002) and in vitro studies suggest that this activity is dependent on 
INaP (Franceschetti et al., 1995). In some epilepsy models persistent currents have been 
shown to underlie epilepform activity, namely, paroxysmal depolarization shifts (Segal et 
al., 1994; Bromfield et al., 2003). However, without specific antagonists the contribution of 
persistent sodium currents is difficult to disentangle from the contributions of transient 
currents. 
1.1.9 A select overview of proteins that interact with VGSCs 
After translation, nascent VGSCs interact with a variety of proteins (Figure 1.4) that are 
involved in their trafficking and maturation into functional channels (Shao et al., 2009). For 
example, ankyrins are scaffolding proteins that bind to the second intracellular loop of 
neuronal VGSCs and cluster channels at the nodes of Ranvier (Garrido et al., 2003; Jenkins 
& Bennett 2003: Duflocq et al., 2008). In contrast, the adaptor protein papin binds to 
discrete domains within the same region as ankryin and is involved in retention and 
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internalization of VGSCs (Shao et al., 2009).  Protein kinases (PK) are enzymes that 
control protein activity by adding phosphate groups to serine, threonine, or tyrosine 
residues (Lodish et al., 2000). Isoforms of PKA and PKC differentiately modulate the 
trafficking and biophysical properties of VGSCs.  Phosphorylation of NaV1.1 and NaV1.7 
by PKA reduces sodium currents and through a similar mechanism, PKC attenuates NaV1.2 
and NaV1.5 currents (Bartschat & Rhodes 1995; Carr et al., 2003; Tateyama et al., 2003; 
Chen et al., 2006). However, kinases have been reported to increase currents of other 
members of the VGSC family (Brackenbury & Djamgoz 2006). This may result from 
indirect kinase-protein interactions with A-kinase anchoring proteins (AKAP), which are 
involved in ion channel trafficking (Tibbs et al., 1998; Shao et al., 2009). Calmodulin, a 
calcium-binding protein, binds to motifs within the c-terminal tails of skeletal and neuronal 
VGSCs and has been shown to alter gating in a calcium-dependant manner (Herzog et al., 
2003). Targeted degradation of NaV1.1 and other VGSCs is likely to be mediated by a 
member of the ubiquitin family, Nedd4-2, which also binds to domains within the c-
terminal tail of these channels (Fotia et al., 2004).  
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Figure 1.4 Schematic of protein interactions with VGSCs. Calmodulin hinders PKC 
action by binding to its substrates (dashed arrow). p11, Calcium binding protein; fyn, 
tyrosine kinase protooncogene; FHF1B, fibroblast growth factor; Nedd 4-2, ubiquitin 
ligase; AKAP15/18, Protein kinase; MAPK, Mitogen activated protein kinase. Redrawn 
from Shao et al. 2009. 
1.1.10 Accessory β subunits  
The α subunit is sufficient for channel function, pharmacology, and appears to determine 
channel distribution, consequently the channel name NaV1.n is linked only to the identity of 
the α subunit, but combinations of β subunit isoforms affect the expression level, voltage 
dependence and gating kinetics of the channels and are essential for proper channel 
function (Isom 2001). However, β subunits may not always be present. During early 
development VGSC α subunits are not bound to β subunits (Scheinmann et al., 1989). 
Moreover, β1 (Ellerkmann et al., 2003), β2 (Gastaldi et al., 1998) and β3 (Gorter et al., 
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2006) are transiently down regulated in experimental models of epilepsy and/or epilepsy. It 
is not currently known what the consequences of β subunit downregulation are for VGSC 
function, or whether different VGSC types are differentially modulated by assembly with 
different β subunit partners. 
There are five human β subunit isoforms reported and based on sequence similarity these 
are separated into two groups: β1, β1b, β3 and β2, β4 (Morgan et al., 2000; Qu et al., 2001; 
Yu et al., 2003). The two groups associate with the α subunit differently: β1, β1b and β3 
attach through non-covalent bonds while β2 and β4 link with the extracellular domain via 
disulphide bonds. In vivo, the expression of β subunits frequently overlaps but it is 
complementary in some regions. The α subunit associates with one β1, β1b or β3 together 
with one β2 or β4 (Morgan et al., 2000; Yu et al., 2003). All β subunits are single 
transmembrane domain proteins. Their extracellular amino-terminus contains a single 
immunoglobulin (Ig) domain and it is within this region that the β1 subunit is thought to 
interact with extracellular protrusions between S5-S6 of domains I and IV in skeletal and 
brain α subunits (Makita et al., 1996). The short intracellular c-terminal also interacts with 
α subunits. The impact of the β subunits on channel kinetics is highly dependent on cell 
background (Isom 2001). The detailed overview below focuses on the findings with the 
most-investigated β1 subunit, and only summarises recent findings concerning the other β 
subunits. 
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1.1.11 β1 
Early patch-clamping studies investigating the effect of these auxiliary subunits on channel 
kinetics centred on NaV1.2. NaV1.1 recombinant channels were initially too difficult to 
engineer (Alekov et al., 2001). Subsequent investigations have demonstrated that the two 
VGSC homologs undergo similar modulation.  Initial electrophysiological studies were 
carried out using Xenopus oocytes. One advantageous feature of these cells is their low 
expression levels of endogenous multimeric channels (Avanzini et al., 2007). In this 
expression system the VGSC α subunit, when expressed on its own, displayed a „slow 
gating mode‟.  Co-expression of β1 induced a faster gating mode, that is, the rates of 
channel activation and inactivation were increased. Moreover β1 increased peak sodium 
currents and produced a hyperpolarizing shift in the voltage dependence of inactivation 
(Isom et al., 1992; Patton et al., 1994). A decade later, similar effects were observed from 
recordings with rat NaV1.1 (Spampanato et al., 2001; 2003). However, a comparable 
NaV1.2 study using CHO cells indicated that when expressed alone in these cells the α 
subunit did not have the „slow gating mode‟ seen in oocytes; it activated and inactivated 
quickly. Northern blot analysis confirmed that there were no endogenous β subunits in 
these cells. Further experiments indicated that co-expression with β1 increased α subunit 
expression levels and the voltage dependence of inactivation was shifted to more negative 
potentials (Isom et al., 1995). Conversely, when these experiments were repeated in HEK 
293 cells the voltage dependence of activation and inactivation were shifted to more 
positive potentials. It is clear that within different cell lines β1 and the α subunit can have 
different interactions, possibly due to distinctive posttranslational modifications or 
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interactions with cell-specific endogenous proteins giving rise to different channel 
properties (Toib et al.,1998; Qu et al.,2001; Meadows et al., 2002; Xu et al., 2007). 
What is the true modulatory effect of β1? This remains unclear but further insights are 
given by mutations within its Ig loop and from animal knockout studies. The integrity of 
the tertiary structure of the Ig loop of β1 is dependent on a disulphide bridge between 
cysteines 40 and 121. A change in the second cysteine to a neutral amino acid (C121W) in 
human SCN1B was the first mutation identified as causing a childhood febrile epilepsy 
syndrome (Wallace et al., 1998). Three further mutations located in this domain have been 
identified and result in the same phenotype (Scheffer et al., 2007). Electrophysiological 
studies in mammalian cells, investigating the functional effects of C121W, suggest that the 
alterations in VGSC function are subtle. For instance, the frequency-dependent rundown of 
NaV1.2 and NaV1.3 channels was reduced (Meadows et al., 2003). The authors 
hypothesized that external disruption like fever, together with these slight functional 
changes, may be sufficient to break down normal channel regulation. A second amino acid 
of β1, R85, is a hotspot with two alternative mutations: R85C and R85H. Although no 
functional investigations have revealed the effects of these mutations, this amino acid lies 
close to modulatory glycosylation sites and therefore may alter channel glycosylation, 
which may alter channel gating.   
An investigation by Chen and colleagues (2004) demonstrated that homozygous knockout 
β1 mice are ataxic, suffer spontaneous seizures, slow growth and die within three weeks of 
birth. These mice displayed disrupted axo-glial junctions, which were thought to contribute 
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to their axonal slowed conduction in the CNS and suggested the β1 isoform is essential for 
the structural integrity and functioning of myelinated axons. Surprisingly, and in contrast to 
the heterologous expression data, the absence of β1 in a mixed population of hippocampal 
neurons did not change sodium current activation or inactivation.   
1.1.12 β1B 
β1 and its splice variant β1B share an identical extracellular domain encoded by exons 1-3. 
β1B contains a novel c-terminal that is encoded by the part incorporation of intron 3 before 
an in-frame stop codon (Qin et al., 2003). Electrophysiological studies in oocytes 
demonstrated that the human β1B subunit increased peak sodium current when co-
expressed with NaV1.2 but channel gating was not significantly changed. The investigators 
suggested that this increase may be due to several factors including an increase of the open 
probability of the channel (Qin et al., 2003). What this study does highlight is that the c-
terminal is important in either channel conductance or trafficking but further studies in 
neuronal models are needed to clarify its precise modulatory nature.  
1.1.13 β2 
Electrophysiological studies in HEK 293 cells and β2 null mice suggest this subunit can 
cause a positive shift in the voltage dependence of inactivation and increases CNS sodium 
current amplitude (Qu et al., 2001; Chen et al., 2002). The latter is thought to reflect β2 
increasing the density of α subunits at the cell surface.  To date no mutations in the β2 
subunit gene are known to give rise to epilepsy (Ito et al., 2006). Additionally, β2 knockout 
mice develop normally but demonstrate an increased susceptibility to pilocarpine-induced 
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seizures suggesting these subunits may play a role in suppressing seizures (Chen et al., 
2002).  
1.1.14 β3 
β3 and β1 share a high sequence similarity in their extracellular domains (Stevens et al., 
2001). Due to their similar functional effects and expression patterns it is generally 
accepted that these two subunits complement each other in vivo (Morgan et al., 2000; 
Stevens et al., 2001; Qu et al., 2001). However, mutagenesis studies showed that the 
differential phosphorylation of an intracellular serine residue present in β3 but not β1 
altered NaV1.2 voltage dependency of inactivation and recovery from inactivation (Merrick 
et al., 2010). Moreover, a recent electrophysiological study of β3 null mice demonstrated 
that these rodents had aberrant heart conduction properties but no abnormal neurological 
phenotype was reported (Hakim et al., 2010), suggesting that β1 may play a more 
prominent role in the CNS. 
1.1.15 β4 
To date, no functional data on β4 knockout mice have been published. The first functional 
investigations into β4 suggested its effects were not unique, for instance, co-expression of 
NaV1.2 and β4 in HEK 293 cells resulted in a negative shift in the voltage dependence of 
activation (Yu et al., 2003). In similar conditions a comparable effect was observed for 
NaV1.1 channels (Akam et al., 2009). However, a later study by Grieco et al. (2005) 
revealed that the cytoplasmic tail of the β4 was the molecular basis of resurgent sodium 
currents in Purkinje neurons. In these cells, NaV1.6 channels undergo normal gating 
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kinetics but on repolarisation, as the channels recover from inactivation, a smaller transient 
inward current is recorded that quickly deactivates. The β4 intracellular tail has an unusual 
row of positive charged amino acids along with hydrophobic residues that could convey the 
correct properties of a pore „blocker‟, that is, it would be voltage dependent and may 
unbind slowly enough at more negative potentials to produce the kinetics demonstrated by 
the resurgent current (Bean 2005). Therefore, modulation by β4 may have important 
consequences in controlling repetitive firing in the nervous system. This may be channel-
specific, cell-specific or both as this β4 modulation was not reproduced in HEK cells 
expressing NaV1.1 channels (Akam et al., 2009). Akam et al. demonstrated that β4 
promoted NaV1.1 derived persistent currents, which were masked by co-expression β1 
subunits. Chimeric and mutagenesis experiments showed that the extracellular domain of 
β1 subunits regulated NaV1.1 INaP and suggests that β1 and β4 may have opposing effects 
on the gating and kinetics of NaV1.1 (Akam et al., 2009).  
1.1.16 Proposed alternative functions of β subunits  
Evidence suggests that β subunits are involved in modulating the trafficking of VGSC α 
subunits to the surface membrane. In embryonic rat neurons β2 subunits retrieved neuronal 
α subunits from intracellular pools and inserted channels into the membrane (Schmidt et al., 
1985). This effect is observed in multiple cell types; even down to Xenopus oocytes where 
it was shown that the microvillus surface areas of these cells were significantly increased 
upon co-injection with rNaV1.2 and β2 compared to oocytes injected with only α or both α 
and β1 subunits (Isom et al., 1995b). The authors surmised that this resulted from increased 
α subunit cell surface expression through αβ2 interactions (Isom et al., 1995b). More 
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recently, Rusconi and colleagues (2007) demonstrated that all four β subunits partially 
rescued a trafficking-defective NaV1.1 GEFS+ mutant α subunit expressed in HEK cells. In 
these experiments, the β1 subunits exerted the greatest affect. Mutagenesis studies have 
demonstrated that both extra- and intracellular regions of β1 are important for increased 
mutant α subunit cell-surface expression (Rusconi et al., 2007). This auxiliary subunit may 
play a non-redundant role in NaV1.1 trafficking because the function of one folding-
defective NaV1.1 channel was only restored by β1 (Rusconi et al., 2009). β subunits are 
also involved in trafficking of PNS VGSCs. For instance, the first intracellular loop of 
NaV1.8 contains the endoplasmic reticulum (ER) retention motif RRR (Zhang et al., 2008). 
Both NaV1.1 and NaV1.5 channels have similar motifs in the same region. Using cell-
surface biotinylation and immunoblotting techniques Zhang and colleagues (2008) showed 
that c-terminal tail of β3 masked the retention motif within heterologously expressed 
NaV1.8 channels. This allowed the primary subunits to be trafficked to the cell surface, an 
effect not observed with co-expression of homologous β1 subunits.  
The extracellular immunoglobulin (Ig) domains of β subunits are structurally homologous 
to the cell adhesion molecules (CAMs) contactin (β2, β4; Isom et al., 1995a) and myelin Po 
(β1, β3; McComerick et al., 1998; Morgan et al., 2000). Through this domain β1 subunits 
interact with several adhesion molecules, including tenascin-R and neuronal cell adhesion 
molecules (NrCAMs), and play a role in neuronal migration and pathfinding (Srinivasan et 
al., 1998). BACE, the protease that produces β-amyloid, cleaves the extracellular domain of 
β subunits (Kim et al., 2007; Miyazaki et al., 2007). The soluble Ig fragments produced by 
this cleavage modulate cell adhesion and migration (Brackenbury & Isom 2008). β1 subunit 
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Ig domains interact homophilically, and, with the receptor protein tyrosine phosphatase, β 
subunits recruit ankyrin proteins to their intracellular tails (McEwen et al., 2004). Ankyrin 
binds to the cytoskeleton, enabling VGSC localization to the nodes of Ranvier for example, 
or in the absence of α subunits, mediates neurite extension at the growth cone (Malhotra et 
al., 2002; Brackenbury et al., 2008). β subunits have numerous binding partners that are 
involved in regulating similar cellular processes. The various types of dysfunction 
associated with loss of VGSC β subunits suggests they are vital to CNS development and 
maintenance and are not simply auxiliary to α subunits (Brackenbury & Isom 2008).  
Although their modulatory effects in the literature are contradictory, β subunits can 
substantially affect the behaviour of different α subunits. One purpose of this study is to 
determine whether channels containing exon 5N (NaV1.1-5N) interact with different 
combinations of β subunits in the same manner as those containing exon 5A (NaV1.1-5A). 
1.2.1 A selected overview of the historical and social impact of inherited epilepsies 
„Epilepsy‟ is derived from the Greek word epilambanein, which means „to seize‟ or „to 
attack‟ (Gross 1992). Amongst the bizarre etiologies and treatments reported through more 
than a millennium of history, one idea has remained consistent: that epilepsy is inheritable. 
Around 400 B.C. this was first recorded in a Hippocratic text The Sacred Disease, later 
noted by renaissance physicians and robustly documented in the modern age (Gross 1992).  
Unfortunately, people affected with epilepsies, both genetic and symptomatic, did and 
continue to face discrimination. Early 20
th
 century eugenicists in New Jersey, USA, 
considered affected families as an „epileptic menace‟ and argued the disorder predisposed 
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patients to commit „brutal crimes‟ (Hermann 2010). Villages were designed to detain 
„epileptics‟ who were involuntary sterilized under a law created in 1911. This was revoked 
two years later for humanitarian reasons (Hermann 2010). Decades later, Shoffner et al., 
(1990) were the first to identify a mutation in mitochondrial DNA that caused a generalized 
epilepsy (see Table 1.2). Within the last 20 years hundreds of epilepsy causing mutations in 
the human genome, including in VGSC genes, have been identified. Yet despite advances 
in the understanding and treatment of this disorder, today in some countries in Asia 
epilepsy is a lawful reason to stop or annul marriages (WHO 2010).  Laws that prevented 
people with epilepsy marrying in the UK and USA were abolished in the 1970s and 80s 
(WHO 2010). In this context of isolationism, it is ironic that so much of our understanding 
of the brain is derived from studies of epileptic patients. Indeed, modern research, including 
this investigation of SCN1A, attempts to interpret how genetics change the presentation, 
progression and treatment of epilepsy. This may also further our understanding of healthy 
brain function, but it would be impossible without the involvement of families with 
inherited forms of epilepsy.     
1.2.2 Classification of seizures  
Today stigma about people with epilepsy still remains and may harm their employment 
opportunities, health or life insurance and ability to gain access to a driving license (WHO, 
2010). Clinicians are cautious of these socio-economical impacts and distinguish between 
individuals have experienced a single epileptic seizure and patients suffering from epilepsy 
(Fisher et al., 2005). In 2005, The International League Against Epilepsy (ILAE) and the 
International Bureau for Epilepsy (IBE) defined epileptic seizures as: “A transient 
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occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal 
activity in the brain” (Fisher et al., 2005). The mode of onset of seizures is widely 
categorized as Generalized or Focal (Berg et al., 2010) and the categories are detailed in 
Table 1.2. Definitions in the recent consensus report by the ILAE„s Commission on 
Classification and Terminology (Berg et al., 2010) of each seizure sub-type relevant to this 
study are described later in the text. Broadly, generalized seizures initiate in either cortical 
or subcortical regions and quickly spread throughout bilateral networks (Berg et al., 2010). 
Generalised seizures do not repeatedly localize to the same region (Berg et al., 2010).  
Focal seizures are identified as more consistent in their origin and propagation between 
ictal events. Seizures are more likely to start in a subcortical region within one hemisphere, 
either in a distinct or broad area and in general propagate within the same cerebral half but 
can spread to the contralateral side (Berg et al., 2010).  
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Table 1.3: ILAE classification of seizures (Berg et al., 2010) 
I Generalized seizures   
   Tonic-clonic (in any combination) 
   Absence   
    Typical  
    Atypical  
    Absence with special features: 
     Myoclonic absence 
     Eyelid myoclonia 
   Myoclonic   
    Myoclonic   
    Myoclonic atonic  
    Myoclonic tonic  
   Clonic   
   Tonic   
    Atonic     
II 
Focal 
seizures     
III Unknown     
    Epileptic spasms   
1.2.3 Epilepsy syndromes 
The ILAE and IBE define epilepsy as “a disorder of the brain characterized by an 
enduring predisposition to generate epileptic seizures and by the neurobiological, 
cognitive, psychological, and social consequences of this condition. The definition of 
epilepsy requires the occurrence of at least one epileptic seizure” (Fisher et al., 2005). In 
Europe, the prevalence of epilepsy in 2004 was 4.3–7.8 per 1,000 but the proportion 
contributed by genetic disease was unknown (Pugliatti et al., 2007). A dramatic change in 
epilepsy classification has occurred in the past year, reflecting the evolving nature of 
understanding of this disorder. Therefore these descriptions may not match with previous 
idiopathic, symptomatic and cryptogenic categories familiar to the reader (Berg et al., 
2010). Syndromes are often characterized by seizure presentation, age of onset, 
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electroencephalogram (EEG) findings, various hallmarks from Magnetic Resonance 
Imaging (MRI) or X-ray computed tomography (CT) scans and genetics (Brodie & French, 
2000). Epilepsy is now grouped and defined into the following categories (ILAE and IBE, 
Berg et al., 2010): 
1. Genetic: genetic aberrations are known to be the primary cause of seizures proved 
by “diagnostic tests” and the seizures are the “core symptom of the disorder” (ILAE 
and IBE, Berg et al., 2010). 
2. Structural/metabolic: “there is a distinct other structural or metabolic condition or 
disease that has been demonstrated to be associated with a substantially increased 
risk of developing epilepsy” (ILAE and IBE, Berg et al., 2010). Examples of 
structural conditions are given as: “Stroke, trauma and infection”. The authors also 
recognize that metabolic conditions may have a genetic origin, but seizures result 
from a secondary effect caused by the primary disorder. For example, genetic 
mutations that hinder cortical development, thereby provoking seizures, would be 
categorized as structural/metabolic rather than genetic (ILAE and IBE, Berg et al., 
2010). 
3. Unknown cause: the etiology is unidentified (ILAE and IBE, Berg et al., 2010). 
1.2.4 Diagnosis of epilepsy 
It is thought that 50 % of epilepsies result from genetic abnormalities (Pal et al., 2010) in 
either single or multiple autosomal, X-linked or mitochondrial genes (Stafstrom 2009). 
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Before a genetic evaluation is made of a patient with epilepsy, initial assessments are 
carried out (Pal et al., 2010). These include reviewing patient‟s medical records, their 
family medical history, EEG and imaging assessments. If genetic causality is suspected, 
genomic DNA can be obtained from patient blood, muscle or skin (Pal et al., 2010). There 
are several genetic analysis methods available to the investigator. As previously mentioned, 
before genetic markers were developed, family, or more specifically, twin studies provided 
information into the genetic causes of epilepsy and these studies are still used today 
(Sugawara et al., 2002). For example, twins are chosen from a family where affected 
members with epilepsy are suspected of harbouring a mutation. Investigators compare 
concordance or discordance, that is, the presence or absence of the same trait between 
monozygotic and dizygotic twins.  The former are thought to share all their alleles while the 
latter only half. Alleles are alternative DNA sequences of a gene that are located at specific 
locations on particular chromosomes. It is considered, therefore, that discordance between 
monozygotic, not dizygotic twins is solely due to environmental factors. This was thought 
to allow the assessment of both genetic and environmental contributions to the development 
of epilepsy (Greenberg et al., 2007). Today, genetic markers are favoured, however, as 
these studies make two false assumptions: that twins share exact environments and genetic 
and environmental factors are independent of one another (Greenberg et al., 2007).  
The chromosomal location, 2q21-q33, of SCN1A was first identified in 1999, by Baulac 
and colleagues using linkage analysis, an approach that takes advantage of recombination 
and is effective in family studies. Recombination is the process through which maternal and 
paternal chromosomes exchange DNA sequences during meiosis. The greater the distance 
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between two DNA sequences the more likely the exchange. Genetic markers, usually single 
nucleotide polymorphisms (SNPs), are at specific locations along chromosomes and can be 
mapped. By convention, a SNP is a variation of a single nucleotide that occurs in more than 
1% of the population (in contrast to mutations which can also be single nucleotide 
variations, but occur in much less than 1% of the population). The more distant the marker 
is from the disease gene, the more likely that recombination will occur between the marker 
and the gene. However, if a marker is close to the disease gene it is less likely to 
recombine, often co-segregates, and is linked to the affected gene. These linked markers 
give an indication of the location of the disease gene. Although the location of SCN1A is 
now known, in 15 % of patients with these childhood epilepsy disorders the genetic origin 
is unknown, so this analysis remains useful (Escagy & Goldin, 2010).  
A similar principle to that of linkage studies applies to association analyses that compare 
the frequencies of DNA variants, usually SNPs, among unrelated patient and control 
chromosomal DNA (Altshuler et al., 2008). This allows the geneticist to determine if a 
marker or markers are „associated‟ with an augmented risk of a disease, and thereby may 
help identify more than one disease gene (Altshuler et al., 2008). These studies are possible 
because humans have limited genetic deviations throughout continental populations 
(Altshuler et al., 2008). Association analysis can be used to directly identify candidate 
genes or expand linkage study data. Specific association studies involving SCN1A will be 
discussed in detail later.  
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Mutational analysis looks for specific mutations in candidate genes that have been 
identified by linkage and/or association studies. In earlier reports for example of SCN1A, 
standard Polymerase Chain Reaction (PCR) techniques, that use primers that hybridize to 
coding and non-coding regions of the gene were used to detect point mutations (Claes et 
al., 2003; Wallace et al., 2003; Nabbout et al., 2003; Harkin 2007). Multiplex Ligation-
dependent Probe Amplification (MLPA) is an adapted PCR technique developed in 2002 
by Schouten and colleagues that can detect genomic rearrangements. Primers are designed 
to amplify a specific length of DNA. Primers are split into two oligonucleotides and 
forward probes are fluorescently labelled. If the two adjacent target sequences are present, 
the primers will anneal and during PCR a ligase enzyme will join the two probes together. 
The greater number of probe-DNA hybridizations and probe coupling indicates duplicated 
regions or increased gene copies. If a sequence is absent the probe will not contribute to the 
fluorescence intensity. The fluorescence from each amplicon from patient and control 
samples are detected and compared. The relative differences in the peaks of fluorescence 
between the two groups, indicates the presence and level of sequence duplications or 
deletions (Schouten et al., 2002; Marini et al., 2007; Wang et al., 2008). Additionally, 
genomic deletions can be confirmed by fluorescent in-situ hybridization (Wang et al., 
2008).  
1.2.5 SCN1A and epilepsy 
Genetic tests have detected nearly 700 mutations in SCN1A that cause a range of infantile 
epileptic encephalopathies with varying phenotypic severities, for brevity only a few will 
be discussed (Mulley et al., 2005; Harkin et al., 2007, Table 1.3, Figure 1.5).   
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Phenotypically, the most acute syndrome is called Severe Myoclonic Epilepsy of Infancy 
(SMEI), which was first described by Dravet in 1978 and therefore, is also called Dravet 
Syndrome.   At about 6 months children will have their first epileptic seizure, that maybe 
generalized or focal, which is triggered by fever or an increase in body temperature. Within 
their first year of life these seizures may continue monthly, precipitated by fever (Scheffer 
et al., 2009). For the next three years children exhibit myoclonic (synchronized muscle 
jerks); complex partial (consciousness is changed or lost) and absence seizures (glazed 
staring with eye twitches) and may become ataxic. Their EEGs may be normal during this 
period and their seizures may not subside or may even be exacerbated on antiepileptic drug 
(AED) administration (Guerrini et al., 1998). At around one year of age children can begin 
to regress intellectually, and into adulthood are likely to have severe intellectual disabilities 
(Jansen et al., 2006). Post infancy, brain MRI scans may show slight cerebral atrophy. 
Another two syndromes have been classified that are variations on this phenotype, one 
being „Borderline Dravet syndrome‟ (SMEB) which describes patients who may not exhibit 
myoclonic seizures or despite severe seizures may be cognitively normal as an adult. 
Another variation of SMEI is „Intractable childhood epilepsy with generalized tonic-clonic 
seizures‟ (ICE-GTE) where children do not exhibit strict myoclonic, complex partial or 
absence seizures but generalized tonic-clonic seizures, namely, convulsions (GTCS). The 
latter presents as an initial tonic phase of stiffening of the skeletal muscles causing the child 
to fall and also lose consciousness. Subsequently, a clonic jerking of the extremities phase 
begins, which may involve drooling, strong jaw contractions or bladder or bowel 
incontinence. 
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Figure 1.5 Spectrum of phenotypes associated with SCN1A abnormalities 
 
A less severe phenotype is Myoclonic-astatic epilepsy (MAE, Figure 1.5). Two thirds of 
infants with this syndrome will develop afebrile GTCS and another third febrile seizures, 
between 1-5 years of age. Children will develop generalized seizures, including myoclonic, 
absence and atonic (spontaneous loss of postural tone and change or loss of consciousness) 
and can develop intellectual disabilities (Scheffer et al., 2005).  
Genetic (formally Generalized) epilepsy with febrile seizures plus (GEFS+) describes a 
milder sub-spectrum of familial epilepsy syndromes (Figure 1.5). The most frequent are 
Febrile seizures (FS). These are convulsions that occur in infants between the ages of 6 
months to 6 years when their body temperatures rise above 38
o
C.  The next most common 
sub-syndrome is Febrile seizures plus (FS+; Figure 1.5), where as well as febrile seizures, 
patients have afebrile GTCS. These may continue beyond 6 years of age after their febrile 
seizures have abated (Scheffer et al., 2005). Both of these sub-syndromes can be associated 
with other seizure types depicted in Figure 1.5, but also with temporal lobe seizures that 
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can follow either FS or FS+ (Wallace et al., 2002). Frontal lobe epilepsy has also been 
associated with one GEFS+ family (Baulac et al., 1999). 
1.2.6 GEFS+ is also caused by other ion channel related genes 
Mutations in SCN1A account for the majority cases of GEFS+ epilepsy syndromes but 
aberrations in other genes also cause similar epilepsy syndromes (Reid et al., 2009). These 
will be described using the OMIM categories, although the reader should note that for some 
there is little evidence. Because mutations in these other genes can produce phenocopies of 
GEFS+ mutations in SCN1A they may provide insight into the mechanism and pathways 
involved in developing the disease. GEFS+ is subdivided into genetic types denoted by a 
number, representing the chronological order of mutation identification in each disease 
gene (OMIM 604233). For GEFS+ Type 4 and 6 (OMIM 609800 & 612279 respectively) 
the specific syndrome -causing genes are unknown but the chromosomal loci have been 
mapped to Type 4: 2p24 and Type 6: 8p23-p21 (Audenaert et al., 2005; Baulac et al., 
2008). The vast majority of epilepsy mutations, including those found in SCN1A, are 
inherited in a heterozygous manner, that is, only one allele is affected. Therefore, the 
mutation either causes a dominant effect or loss-of-function of the protein causing 
haploinsufficiency (Reid et al., 2009).  
1.2.7 GEFS+ type 1 SCN1B  
A mutation in SCN1B, the gene that codes for β1 subunit was the first gene to be identified 
to cause GEFS+ (GEFS+ Type 1). It was discovered using linkage and PCR analysis of 
nearly 400 members of a Tasmanian family that had mixed phenotypes, including FS, FS+ 
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and MAE (Wallace et al., 1998). The mutation, C121W, disrupts a highly conserved 
cysteine residue thought to be essential for maintaining the tertiary structure of β1 
extracellular loop. Subsequent missense and in-frame deletion mutations in the extracellular 
region have been indentified in other GEFS+ patients with heterogeneous phenotypes 
including R85C, R85H, I70_E74del and V138I (Wallace et al.,1998; Wallace et al.,2002; 
Audenaert et al.,2003; Scheffer et al.,2007; Orrico et al.,2009). This implies that the β1 
extracellular domain is vital to healthy neuronal function. Electrophysiological reports into 
the effects of these mutations on VGSCs as discussed fully later earlier, these β1 mutations 
either altered channel slow inactivation or resulted in complete loss of β1 subunit function 
(Patino et al., 2009).  The importance of β1 extracellular loop is supported by a SMEI 
causing mutation, R125C, located within this region. It is the only known homozygous 
recessive GEFS+ mutation and results in loss of β1 function at the cell surface (Patino et 
al., 2009). Moreover, the only identified mutation located outside β1 extracellular region, 
K208I, found within the transmembrane domain, caused a mild FS phenotype in an Italian 
patient (Orrico et al., 2009).  
1.2.8 GEFS+ type 3 GABRG2 
The third gene found to cause GEFS+ (Type 3) was GABRG2, the gene that encodes the 
GABAA γ2 subunit. The GABAA is a multi-subunit channel complex of which α1β2γ2 is 
the most common in the brain. GABAA receptors are ligand-gated ion channels that 
outwardly conduct chloride, hyperpolarizing the membrane, and are involved in rapid 
synaptic that is phasic, inhibition. The γ2 subunit has four transmembrane domains: M1-
M4. A missense mutation in the extracellular loop connecting M2-M3, K289M, was found 
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in a GEFS+ French pedigree (Baulac et al., 2001). Similar to patients harbouring SCN1A 
and SCN1B mutations this family also demonstrated phenotypic heterozygosity ranging 
from mild FS to severe afebrile convulsions (Baulac et al., 2001). Two-electrode voltage 
clamp studies of α1β2γ2K289M channels expressed in Xenopus oocytes demonstrated a 
reduction in chloride conductance upon micromolar GABA application compared to wild-
type channels (Baulac et al., 2001). These data were the first to indicate that a dysfunction 
in inhibitory signalling may be the underlying cause of GEFS+. A reduction in IGABA 
amplitude caused by γ2K289M was contradicted by later electrophysiological reports using 
fibroblasts and hippocampal neurons transfected with mutant channels (Bianchi et al., 
2002; Eugene et al., 2007). These reports showed that α1β2γ2K289M channels had faster 
deinactivation rates predicting a reduced duration of Inhibitory Postsynaptic Inhibitory 
Potentials (IPSPs) and in turn neuronal inhibition.  
Subsequent GABRG2 mutations have been identified and support this hypothesis. For 
example, Q351X was discovered in an Australian family whose members displayed the full 
spectrum of GEFS+ syndromes. Q351X introduces a stop codon within the cytoplasmic 
loop connecting M3 and M4 (Harkin et al., 2002), truncating the subunit at M3. 
Immunofluorescence studies in HEK cells showed that α1β2γ2Q351X channels were retained 
in the ER and failed to reach the cell membrane (Harkin et al., 2002). In regions specific to 
α1β2γ2, the authors surmised that this mutation would lead to a loss of neuronal inhibition 
by GABA.  
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Most thoroughly investigated is a third missense mutation in the N terminus of γ2 mutation 
R43Q. Originally found in another large Australian pedigree, relatives were affected with a 
range of epilepsy syndromes including GEFS+ and SMEI, but also childhood absence and 
temporal lobe epilepsies (Wallace et al., 2001a). Investigations in Xenopus oocytes and 
transfected fibroblasts revealed that γ2R43Q reduced benzodiazepine sensitivity (Bianchi et 
al., 2002; Bower et al., 2002). Benzodiazepines bind to specific sites on γ2 subunits and 
enhance chloride conductance (Kucken et al., 2000). These drugs are often used to treat 
anxiety, but also are effective in preventing febrile seizures (Wallace et al., 2001a). It is 
hypothesized that poorly understood endogenous benzodiazepine-like compounds, namely 
endozepines, can prevent fever-induced seizures (Wallace et al., 2001a). α1β2γ2R43Q 
channels showed reduced IGABA amplitudes (Bianchi et al.,2002) likely to result from 
abnormal subunit assembly and trafficking and in turn GABAA membrane expression 
(Sancar & Czajkowski, 2004). Mutagenesis studies performed by Hales and colleagues 
(2005) demonstrated that the R43 residue was essential for correct inter-subunit interface 
configurations and surmised that γ2R43Q containing channels would lead to smaller IPSP 
amplitudes. Indeed, somatosensory cortical neurons from heterozygous knock-in mice 
harbouring the γ2R43Q mutation had significantly diminished subunit expression and IPSP 
currents (Tan et al., 2007). Surprisingly, this model recapitulates absence-seizures not 
GEFS+ phenotypes and suggests other factors, perhaps genetic, influence epileptic 
phenotypes in rodents; and also that impaired inhibition may be a common etiology for 
different epilepsy syndromes (Tan et al., 2007). Chiu et al., (2008) engineered an inducible 
mouse model that allowed γ2R43Q expression to be switched on, within forebrain neurons, at 
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specific intervals during development. Their main finding was that mice induced at three 
weeks were more resistant to pharmacologically induced seizures compared with mice that 
expressed γ2R43Q from birth. The authors surmised that GABAA channel abnormalities early 
during development may affect neuronal network formation, structure and excitability 
determining seizure vulnerability in later life and could partly explain why GABRG2 
mutations are associated with childhood epilepsy syndromes (Chiu et al., 2008).  
1.2.9 GEFS+ Type 5 GABRD 
A mutation in another GABAA subunit gene, GABRD, which encodes for the δ subunit is 
categorized into the fifth GEFS+ type.  GABAA δ subunit containing receptors are located 
extra- or peri-synaptically (Reid et al., 2009) and respond to diffuse, submicromolecular 
concentrations of GABA. Unlike γ2 proteins, δ subunits mediate tonic inhibition, which 
describes a sustained activation of GABAA receptors present in the extracellular space 
(Richerson 2004). Its function is not clear but it is thought to modulate neuronal coding and 
firing patterns (Hausser & Clark, 1997) and decrease amplitude and length of excitatory 
synaptic events, reducing the likelihood of firing (Feng et al.,2006). Dibbens et al. (2004) 
identified a mutation in the N-terminal, extracellular region of δ subunit, E177A, in only 
two members of a small GEFS+ family; therefore its link to epilepsy is disputed. 
Nonetheless immunoblotting and electrophysiological analyses of δE177A combined with 
physiological significant subunits α4 and β2 in HEK cells, revealed the mutation reduced δ 
subunit cell surface expression and altered channel gating. For example, GABA-mediated 
α4β2δE177A current amplitudes and desensitization were reduced and single channel analysis 
demonstrated that mean opening times of δE177A containing channels were significantly 
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decreased (Feng et al., 2006). These data reiterate that an impairment of inhibition, either 
phasic or tonic, contributes to the varying epileptic phenotype of GEFS+ patients.  
1.2.10 GEFS+ Type 7 SCN9A 
The last GEFS+ category, Type 7, is associated with mutations in the sodium channel gene 
SCN9A. This codes for NaV1.7 and as previously described is considered a „peripheral‟ 
VGSC and is highly expressed in Dorsal Root Ganglion cells, sympathetic neurons, 
Schwann cells and neuroendocrine cells (Catterall et al., 2005). Most mutations in SCN9A 
cause pain disorders including autosomal dominant primary erythermalgia (episodic 
burning pain in feet and lower legs initiated by exercise and warmth; OMIM 133020), 
autosomal paroxysmal extreme pain disorder (attacks of extreme pain in the rectal, ocular, 
and mandibular areas; PEPD; OMIM 167400) and autosomal recessive channelopathy 
associated insensitivity to pain (indifference to pain; OMIM 243000). A single-cell-reverse 
transcription-polymerase chain reaction (SC-RT-PCR) study confirmed that SCN9A is 
expressed in immature rat hippocampal pyramidal cells (Mechaly et al., 2005). Singh et al. 
(2009) identified seven missense mutations distributed throughout the intra- and 
extracellular loops of NaV1.7 in GEFS+ patients with either a Caucasian or Hispanic 
background.  A large American family harboured a mutation located in the first 
intracellular loop, N641Y. Again, the members in this family demonstrated a broad range 
of GEFS+ syndromes including FS and MAE. To further understand the pathological 
mechanism of this mutation the authors engineered a SCN9A
N641Y 
knock-in mouse model. 
Heterozygous and homozygous mice did not exhibit spontaneous seizures but demonstrate 
lowered electroconvulsive seizure thresholds (Singh et al., 2009). The paper did not 
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analyze the biophysical properties of mutant channels in different cell backgrounds, and it 
remains undetermined whether GABAergic neurons up-regulate NaV1.7 and directly 
modulate inhibitory signalling. The vulnerability of SCN9A
N641Y 
mice to thermally-induced 
seizures was also not investigated. Additionally heterozygous missense mutations in similar 
regions of NaV1.7 cause PEPD (Fertleman et al., 2006), but the authors failed to address 
why these patients only had an epileptic and/or PEPD phenotype.  
 
Figure 1.6 Mutations in VGSC β1, GABAA and NaV1.7 genes that are associated with 
GEFS+. SMEI causing mutations are shown in red and milder phenotype causing 
mutations in yellow. 
1.2.11 Unclassified GEFS+ genes 
Two other genes have been linked to GEFS+ but have not been officially classified. A 
nonsense mutation in a third sodium channel gene SCN2A has been identified in only one 
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Japanese patient who suffered with febrile and afebrile seizures (Sugawara et al., 2001). 
SCN2A codes for NaV1.2 that is expressed in glutamatergic cells (Planells-Cases et al., 
2000) and suggests that disrupted excitability in these cells could also lead to 
hypersynchronized networks. However, currently most mutations in SCN2A lead to milder 
phenotypes of benign familial infantile convulsions (BFIC, OMIM 607745), and no other 
patient with GEFS+ like consequences of mutations in SCN2A has been described since 
2001, suggesting this is a very rare cause of the disorder.   
A second unclassified gene is the newly described triple proline deletion (delPPP) in the 
Hyperpolarisation-activated cyclic nucleotide-gated ion channel: HCN2 found in 6 
unrelated Australians with GEFS+ (Dibbens et al., 2010). Half presented with FS and 
another half with MAE. Upon hyperpolarisation HCN2 coded channels carry a „funny‟ 
inward mixed cation, denoted If that slowly depolarizes the membrane to less negative 
potentials and is responsible for the creation of neuronal pacemaking potentials in the 
thalamus and cerebellum (Luthi & McCormick, 1998). Voltage-clamp experiments using 
Xenopus oocytes demonstrated that HCN2delPPP channels caused a small increase If that in 
vivo would cause a depolarization of the membrane (Dibbens et al., 2010). If is also gated 
by cyclic adenosine monophosphate (cAMP) and increases the activity of these channels. 
The delPPP is close to the cAMP binding domain, but forskolin, an activator of cAMP, in 
Xenopus oocytes had no effect on If derived from this mutant (Dibbens et al., 2010). HCN2 
is transcribed in both GABAergic and glutamatergic cells and an increase in depolarization 
may enhance inhibitory and excitatory signalling. Moreover, either an increase or a 
decrease in HCN channel function can result in hyperexcitability (Dibbens et al., 2010). 
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Therefore, the pathological mechanism of this GEFS+ associated mutation remains 
undetermined. 
1.2.12 Genotype phenotype relationships for mutations in SCN1A 
Table 1.3 shows an overview of published SCN1A mutations up until July 2010 (University 
of Antwerp, http://www.molgen.ua.ac.be/SCN1A. Mutations/Statistics/Mutations.cfm). 90 
% of genomic rearrangements mutations in the coding sequence of SCN1A cause SMEI and 
approximately 5 % of coding missense mutations cause GEFS+ (Type 2). 29 mutations 
throughout intronic regions of SCN1A are reported to cause more severe clinical 
presentations including SMEI (Claes et al., 2001; Nabbout et al., 2003; Mancardi et al., 
2006; Harkin et al., 2007; Marini et al., 2007). Less information is available about intronic 
mutations because it is uncommon for diagnostic laboratories to sequence non-coding 
regions (Catterall et al., 2010).  The literature assumes that SCN1A mutations that cause 
more severe phenotypes like SMEI result from NaV1.1 loss of function. This theory is not 
unfounded: half of mutations truncate the beginning of the channel, hypothesized to cause 
aberrant channel trafficking, biophysical properties and interactions with other proteins: 
rendering NaV1.1 non-functional (Catterall et al., 2010; Escagy & Goldin, 2010) 
Additionally, SCN1A partial deletions and deletions have only been reported in SMEI 
patients (see Table 1.3). However, a recent case report of a GEFS+ Chinese patient 
harbouring a stop mutation in the first intracellular loop of NaV1.1 questions this 
assumption (Yu et al., 2006). The mutation in this adolescent had arisen de novo, that is, it 
was not inherited. This is also unusual for a GEFS+ causing mutation. Conversely, the 
majority of SMEI mutations are de novo and analysis of 44 Caucasian SMEI patients 
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revealed that three-quarters of non-inherited SCN1A mutations originated from the paternal 
chromosome (Heron et al., 2010).  The authors surmised this was caused by an increased 
rate of mitosis during spermatogenesis compared to oogenesis increasing the likelihood of 
replication errors (Heron et al., 2010). A small percentage of SMEI mutations can also arise 
from somatic or germline mosaicism. This has reported in patients with Mediterranean, 
Roma/Gypsy and Japenese genetic backgrounds (Depienne et al., 2006; Gennaro et al., 
2006; Morimoto et al., 2006; Azmanov et al., 2010). However, understanding the etiology 
of SMEI is complicated. In 2009 Marini and colleagues, using MLPA, described three 
SMEI patients with amplifications and/or duplications in SCN1A. The last exon, exon 26, 
was particularly affected: amplified (multiple copies) in one individual and duplicated (two 
copies) in another, suggesting that increased gene number copy is also pathogenic.  
1.2.13 Other genes providing phenocopies of SCN1A mutations  
PCDH19 codes for a subtype of protocadherins, which are the calcium dependent cell-cell 
adhesion molecules, and is expressed in the cortex and hippocampus (Dibbens et al., 2008; 
Depienne et al., 2009; Jamal et al., 2010). In one report only female carriers heterozygous 
for mutations in this X-linked gene exhibit a SMEI-like epilepsy syndrome (Dibbens et al., 
2008). However, in a later study by Depienne et al. (2009) a male patient with a deletion of 
the gene also presented with the same phenotype. The authors surmised that epilepsy was 
caused by „cellular interference‟. Heterozygous females and males with a deletion of the 
gene within their sole X chromosome would have tissue mosaicism, that is, two populations 
of cells either mutant or wild-type that may interfere with cell-cell communication 
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(Depienne et al., 2009). Males with mutations in PCDH19 possess a homogeneous 
population of cells and therefore do not develop epilepsy (Depienne et al., 2009).    
.  
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Table 1.4 Overview of published SCN1A mutations CFE: cryptogenic focal epilepsy; CGE: cryptogenic generalized epilepsy; 
FHM: familial hemiplegic migraine; FS: febrile seizures; FS+: febrile seizures plus; GEFS+: generalized epilepsy with febrile 
seizures plus; ICEGTC: intractable childhood epilepsy with generalized tonic-clonic seizures; IS: infantile spasms; LGS: 
Lennox-Gastaut syndrome; MAE: myoclonic-astatic epilepsy; PE: partial epilepsy; PS: Panayiotopoulos syndrome; SIGEI: 
severe idiopathic generalized epilepsy of infancy; SIMFE: severe infantile multifocal epilepsy; SMEI: severe myoclonic epilepsy 
of infancy; SMEB: borderline SMEI; TLE: temporal lobe epilepsy. (Taken up to date on 23.07.10 from 
http://www.molgen.ua.ac.be/SCN1AMutations/Statistics/Mutations.cfm) 
Epilepsy  syndrome Severe   Other Mild     
              
  
SMEI, 
SMEB, 
Dravet 
syndrome 
ICEGTC, SIGEI, 
SIMFE, MAE, 
MAE&GEFS+ 
IS, LGS, 
CGE, 
CFE, 
SGE 
GEFS+, FS+, 
PE&FS+, 
TLE&FS 
FHM, 
PS Total 
Point Mutations             
translation initiation mutation 1         1 
Splice donor mutation 41 1 1 1   44 
Splice acceptor mutation 23         23 
silent mutation 2         2 
nonsense mutation 135         135 
Missense mutation 246 14 9 28 7 304 
in-frame deletion mutation 14         14 
frameshift mutation 119 3 1 0   123 
complex mutation 1 1       2 
Total 582 19 11 29 7 648 
Genomic rearrangments             
Translocation (rearrangements of regions 
between chromosomes) 1         1 
partial/whole gene duplication mutation    1     1 
partial/whole gene deletion mutation 42         42 
partial/whole gene amplification mutation 3         3 
Total 46 0 1 0 0 47 
Total SCN1A mutations 628 19 12 29 7 695 
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1.2.14 Mouse models of SMEI 
The following sections (1.2.14-1.2.19) will summarize the findings from studies involving 
rodent models of SMEI and GEFS+. Emphasis will be placed on the GEFS+ mutation 
investigated in this study, R1648H. These reports reveal the possible effects of a loss or 
predicted disruption of NaV1.1 function would have on neuronal function and possible 
factors that may influence the epilepsy phenotype.  
A breakthrough in understanding the pathological mechanisms of loss of NaV1.1 function 
was achieved by a study by Yu and colleagues (2006) that investigated NaV1.1 null mice.  
They disrupted the coding sequence of exon 26 in SCN1A in different strains of mice, 
preventing the expression of the channel in vivo, which was confirmed by southern blot 
analysis. The mice developed an ataxic and epileptic phenotype, in which the latter was 
dependent on genetic background in heterozygotes. For example, regardless of strain 
SCN1A
-/-
 mice developed severe seizures on P9 and postnatally did not survive beyond two 
weeks, confirming that NaV1.1 is essential for normal brain function.  Heterozygous mice 
exhibited a delayed decline, had spontaneous seizures and sporadic deaths beginning after 
P21. Interestingly, in one mouse strain at postnatal week 12, approximately 80% mice died 
spontaneously post-seizure, compared to around 20%, in another strain at the same time 
point. These data were consistent with another NaV1.1 null mouse model. Ogiwara et al. 
(2007) introduced a truncation mutation in the mouse SCN1A gene. R1407X has been 
identified in three unrelated SMEI patients (Ogiwara et al., 2007) and causes a complete 
loss of NaV1.1 function (Sugawara et al., 2003). Ataxic SCN1A
RX/RX 
mice developed 
spontaneous seizures at a similar developmental stage to the Yu et al. model. Again 
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heterozygotes suffered from spontaneous seizures approximately three weeks after birth 
and their lifespans were dependant on genetic background.   These studies strongly indicate 
that genetic modifiers, discussed in detail later, may influence the phenotype of affected 
SMEI patients.  
Later, Oakley et al. (2009) investigated whether age and elevated temperatures affected the 
epileptic presentation of the original SCN1A mutant mouse model. The strain in which the 
SCN1A
+/-
 phenotype demonstrated greater penetrance was used to assess these factors. 
Seizures were induced by increasing core body temperature by a minimum of 1.5
o
C in 
month-old heterozygous mice; their wild-type counterparts were unaffected. Furthermore, 
mutant mice at P20-P22 and P30-P46 were more susceptible to temperature-induced 
seizures, compared to younger, P17-18, heterozygous mice which remained resistant.  At 
higher temperatures the former age-groups exhibited myoclonic seizures followed by 
generalized seizures that increased in duration, spike frequency, racine score and spike 
number in the older P30-P46 set (Oakley et al., 2009). In addition, the temperature at which 
seizures were induced was dramatically reduced in the latter compared to P20-22 animals 
and spontaneous seizures were only observed in mice older than P32. Indeed, at 
physiological temperatures interictal EEG spike activity, indicative of spontaneous seizure 
susceptibility (Oakley et al., 2009), was recorded in mice only more than a month old. This 
implies that at biological temperatures the more immature nervous systems of SMEI mice 
were better adapted to perturbations in neuronal excitability, and network vulnerabilities 
caused by SCN1A haploinsufficiency were only exposed at higher temperatures. 
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Electrophysiological findings in the original study indicate that these perturbations are 
likely to affect inhibitory signalling (Yu et al., 2006).  
Macroscopic currents from cultured hippocampal cells from SCN1A
-/-
 and SCN1A
+/-
 mice 
showed that a decrease in NaV1.1 expression was correlated with a reduction in current 
density from GABAergic interneurons. Reduced sodium currents were not observed in 
excitatory pyramidal cells and NaV1.1 channel gating was unaffected by cell type. These 
findings were corroborated in SCN1A
RX
 inhibitory cortical neurons (Ogiwara et al., 2007). 
Kalme et al. (2007) using the Yu et al. mouse model demonstrated that peak, persistent and 
resurgent currents were reduced in inhibitory cerebellar purkinje neurons from NaV1.1 null 
mice. Voltage dependencies of activation and inactivation were also unaltered in this cell 
type. Current clamp experiments demonstrated that the excitability of cortical, hippocampal 
and Purkinje inhibitory neurons was reduced in NaV1.1 mutant mice (Yu et al., 2006; 
Kalme et al., 2007; Ogiwara et al., 2007). For example, compared to healthy and SCN1A
+/-
 
neurons the number of action potentials of hippocampal and pyramidal GABAergic cells 
from homozygous mice was reduced over a broad range of current injections: 20 – 100 pA. 
A comparable number of spikes were observed in wild-type and heterozygous hippocampal 
cells at low level depolarizing injections.  However, at current pulses higher than 60 pA 
SCN1A
+/-
 interneurons failed to maintain high frequency firing (Yu et al., 2006), unlike 
SCN1A
+/-
 pyramidal neurons that consistently fired at lower rates compared to wild-type 
interneurons (Kalme et al., 2007). In both hippocampal and cerebellar cells of NaV1.1 
mutant mice the threshold potential was unchanged suggesting that NaV1.1 is likely to play 
an essential role in establishing firing frequencies of inhibitory cells.  This was emphasized 
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by analysis of P14 mutant mice; a compensatory upregulation of NaV1.3 and an increase in 
NaV1.6 activity were observed in hippocampal and Purkinje neurons respectively.  The 
authors surmise that a feedback control system within neurons attempts counteract the 
decrease in cellular excitability, but is insufficient to establish normal neuronal firing rates 
(Yu et al., 2006; Kalme et al.,2007).  
1.2.15 Mouse models of GEFS+   
There are fewer mutations described that are linked to GEFS+ than to SMEI, however, 
since some of these GEFS+ mutations have been identified in large pedigrees with variable 
penetrance and severity, there is extensive interest in investigating how the mutations alter 
neuronal behaviour, and what possible genetic backgrounds can modify this behaviour. To 
date, the most extensively studied mutation associated with GEFS+ is the R1648H mutation 
first described by Baulac et al. in 1999.  
1.2.16 The original NaV1.1-R1648H pedigree 
GEFS+ mutations are distributed throughout the channel and thought to result in NaV1.1 
dysfunction and a milder GEFS+ phenotype (Ragsdale 2008). NaV1.1-R1648H was one of 
the first identified missense mutations to cause GEFS+ (Figure 1.7; Baulac et al., 1999; 
Escagy et al., 2000). Analysis of four generations from a French family revealed that all 
affected members were heterozygous for the mutation. Moreover, the phenotypic variation 
between the relatives was striking. Some were mildly affected, for example patient II-1 at 
60 years suffered from two spontaneous seizures without a previous history of epilepsy and 
was seizure free for a further 10 years (Baulac et al.,1999). Not all patients suffered with 
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febrile seizures at a young age, for instance patients II-1, II-2, II-3 and III-5. Others only 
suffered with febrile seizures but did not go on to develop generalized epilepsy, for 
example patient III-8 suffered with numerous febrile seizures only until the age of 7. Two 
siblings had particularly severe phenotypes, patients IV-5 and 6. Both exhibited febrile 
seizures that continued into late childhood/early adulthood as general tonic clonic seizures. 
There was also a huge variation in patient AED treatment, which is depicted in Figure 1.7. 
Unfortunately the authors did not specify which drugs were used for treatment. Nonetheless 
a wide variability in treatment efficacy is apparent. Some members of the family from 
different generations were successfully treated with AEDs, others controlled their seizures 
with mono- or polytherapy, and one patient, IV-5, was pharmacoresistent.  Why are there 
large deviations R1648H patient phenotypes and drug treatment? As previously described 
this paradigm is not unique to this SCN1A mutation. In the past ten years extensive 
electrophysiological research into NaV1.1-R1648H has tried to answer these questions. 
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Figure 1.7 Partial pedigree of a French family with R1648H mutation. Family 
members are all heterozygous for the mutation but exhibit varied phenotypes and respond 
differently to AEDS.  
1.2.17 Functional consequences of R1648H in NaV1.1 channels expressed in 
heterologous cells 
The consequences of this mutation are strikingly different depending on the cell 
background. The first functional characterisation of NaV1.1-R1648H channels was 
performed in Xenopus oocytes using the rat ortholog of NaV1.1. This study found that in the 
absence of β subunits R1648H increased channel recovery from inactivation and decreased 
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frequency dependence of inactivation, predicting an increased neuronal excitability 
(Spampanato et al., 2001). However, it is not clear that these effects will be conserved in 
the human ortholog of NaV1.1 expressed in cells of human origin.  
In tsA201 cells (a cell line derived from the HEK line) a different gain of function effect 
was observed: an increase in persistent current. The authors co-expressed the human 
NaV1.1-R1648H with β1 and β2 and argued that their conditions revealed more accurate 
functional defects responsible for GEFS+ compared to the seminal study in oocytes (Lossin 
et al., 2002). Although the cell background is more similar to neurons the presence of β 
subunits may have masked some effects of this mutation. In humans it is unknown when 
during development β subunits are associated with α subunits. This is particularly relevant 
for NaV1.1-R1648H as 10 of 14 affected members of the R1648H family had childhood, or 
developmentally regulated seizures (Baulac et al., 1999). A second complication to 
assuming the β subunits are constitutively incorporated in all VGSCs is that in experimental 
epilepsy and/or following seizures β1, β2, and β3 are all at least transiently down-regulated 
(Ellerkmann et al., 2003; Gastaldi et al., 1998; Gorter et al., 2006). This down regulation 
implies that patient seizure history may affect their β subunit expression and in turn alter 
mutant channel behaviour. Nonetheless, single channel recordings by the same group 
revealed that R1648H increased the probability of channel openings after inactivation over 
a voltage range. Additionally, a smaller percentage of channels exhibited prolonged 
opening times (Vanoye et al., 2006). Ensemble-average currents showed that both factors 
contributed to persistent currents (Vanoye et al., 2006).  
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In the same year, the group published a computational analysis of NaV1.1-R1648H based 
on a modified Markov model for NaV1.1. They proposed that fast inactivation involves an 
intermediate inactivated, non-conducting, phase where the channel is inactivated but the 
IFM gate is not „locked‟ (Kahlig et al., 2006). The authors surmised that the mutation 
destabilizes the locked state and shifts the equilibrium to the intermediate „unlocked‟ phase, 
increasing the likelihood of channels briefly returning to the open-state (Kahlig et al., 
2006).  In comparable experiments involving the skeletal VGSC, NaV1.4, a change in an 
analogous arginine, to a histidine, did not produce persistent currents (Alekov et al., 2000) 
but a equivalent change in rat NaV1.2 expressed in oocytes significantly slowed the rate of 
current decay, stabilizing the open state of the channel (Kühn & Greeff, 1999) implying 
that the position of the arginine mutation can influence different VGSCs in different ways.  
If NaV1.1-R1648H does de-stabilize inactivation, at a single-cell level it is likely it causes 
neuronal hyperexcitability. For example, a mutant NaV1.2 channel shown to increase 
persistent currents in heterologous systems was used to generate a transgenic mouse model 
of epilepsy (Kearny et al., 2001). These mice exhibited spontaneous seizures which were 
partly attributed to increased persistent currents in the CA1 region of the hippocampus. 
Kearny and colleagues hypothesized that the 2% augmentation in current increased the 
resting membrane potential, and could lead to pathological excitability. However, because 
NaV1.1 is relevant in interneurons an increase in INaP at a system level might lead to net 
loss of activity through enhanced inhibition.   
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Indeed, an opposing observation from macroscopic currents of human NaV1.1-R1648H 
expressed in tsa201 cells indicated they had a significant reduction in channel recovery 
from inactivation, which would lead to neuronal hypoexcitabilty, not hyperexcitablity 
(Lossin et al., 2002). These experiments were the first indication that changes in the voltage 
sensor may introduce a loss of channel function. Two recent R1648H rodent models 
support this hypothesis, and suggest that activity of inhibitory neurons is particularly 
impaired. This impairment is consistent with the loss of SCN1A function, and reduced 
inhibitory interneuron excitability, that is associated with the more severe manifestation of 
SMEI/Dravet.  
1.2.18 The transgenic mouse carrying R1648H 
The first mouse model of GEFS+ generated used a bacterial artificial chromosome (BAC) 
to make transgenic mice (Tang et al., 2009). The SCN1A-R1648H sequence was introduced 
into the pronucleus of a fertilized mouse egg with an additional mutation: E945Q, which 
conferred TTX and STX resistance. Addition of these toxins to extracellular recording 
solutions allowed the authors to isolate NaV1.1-R1648H from endogenous sodium currents 
in neuronal cultures.  The neuronal-type influenced channel behaviour. For instance, there 
was a significant reduction in inhibitory bipolar neuronal current density compared to 
excitatory pyramidal neurons. In the former, gating was unaffected, but the voltage 
dependence of inactivation was shifted to more negative potentials in excitatory cells. In 
contrast to the electrophysiological studies in tsa201 cells, in both types of neuron, there 
were no observed increases in persistent current (Lossin et al., 2002). Moreover, NaV1.1-
R1648H slowed the recovery from inactivation and increased use-dependence inactivation. 
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This was more pronounced in GABAergic inhibitory cells and again differed from previous 
findings in heterologous systems (Spampanato et al., 2001). The transgenic mice were not 
epileptic but were more susceptible to kainic acid induced seizures compared to transgenic 
wild-type animals (Tang et al., 2009). Overall this study of transgenic mice supports the 
hypothesis that GEFS+ causes a loss in neuronal inhibition. However, the phenotype of the 
mice did not completely replicate GEFS+ and precipitation of seizures by „fever‟ 
temperatures was not addressed. Recordings were carried out at room temperature and the 
expression of the transgenic gene was low, leading to low amplitude currents and poor 
quality recordings. Disruption of gene product expression and the broader mouse genome is 
a possibility with pronuclear injection of foreign DNA (Hickman-Davis & Davis, 2006). 
However, a more exact, knock-in mouse model demonstrated several parallels to the BAC 
transgenic model (Martin et al., 2010). 
1.2.19 The R1648H knockin mouse 
In another study the R1648H mutation was introduced into the endogenous SCN1A mouse 
gene, allowing analysis of mice with one or two copies of the mutation. Results from 
heterozygous mice may better reflect the consequence of R1648H on neuronal behavioural 
as patients are also heterozygous for the mutation (Escagy et al., 2000). Again, mutant 
sodium currents recorded from GABAergic inhibitory cells derived from homozygote and 
heterozygote animals had decreased current densities, delayed recovery from inactivation 
and elevated use-dependence inactivation compared to wild-type neurons (Martin et al., 
2010). These effects were not observed in excitatory neurons. In fact, channels expressed 
from glutamatergic cells from two-week SCN1A
RH/RH 
mice recovered faster from 
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inactivation than wild-type channels: an unaccounted gain of function that did not affect 
use-dependence inactivation.  Persistent currents originating from mutant channels were not 
detected from whole-cell voltage clamp recordings in either cell background (Martin et al., 
2010). Current clamp recordings suggested that R1648H caused a reduction in inhibition 
synaptic input in both cell types. 
In NaV1.1-R1648H homozygous mice the number of action potentials elicited by 
depolarizing injections over a current range were significantly decreased in both bipolar 
and pyramidal cells. A reduction in neuronal excitability was more evident at higher 
magnitudes of current for inhibitory cells but at lower levels for glutamatergic cells. The 
physiological relevance of this remains unclear. All SCN1A
RH/+
 neurons demonstrated 
similar neuronal excitabilities compared to wild-type cells. A reduction in GABAergic 
inhibition and failure to propagate action potentials in these cells resulted in an epileptic 
phenotype for SCN1A
R1648H
 mice. Homozygotes, for instance, exhibited spontaneous 
generalized often severe seizures and died, on average, within three weeks after birth. 
Heterozygotes had a comparable survival rate to wild-type littermates and demonstrated a 
milder phenotype. For example, only a small percentage of rodents exhibited infrequent 
spontaneous seizures and showed a decreased threshold to fluorthyl- but not kainic acid-
induced seizures. For the kainic acid model, opposite observations made for the BAC 
transgenic model, perhaps reflecting possible differences in spatial and temporal expression 
of mutant sodium channel subunits between the two strains of mice. The knock-in study 
highlighted that both heterozygous and homozygous mutants showed a reduced threshold 
and latency to seizure onset in response to hyperthermia, implying the higher body 
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temperatures can undermine the function of these mutant channels. The relatively mild 
phenotype of the heterozygous mice is consistent with the incomplete penetrance and 
variable severity observed with this mutation in humans (see Figure 1.7).  
Although the results from the two mouse models are not identical, they do suggest that 
NaV1.1-R1648H channels compromise neuronal inhibition, which is likely to impair the 
control of postsynaptic glutamatergic neurons and in turn increase the probability of 
pathological network firing.  Electrophysiological studies into other SCN1A GEFS+ and 
SMEI causing mutations expressed in HEK cells both corroborate and contradict this 
hypothesis suggesting the full mechanism of the disease may be more complex. A recently 
reported rat strain with a targeted mutation in SCN1A reinforces the suggestion that 
disruption of inhibition plays an important role in the mechanism of GEFS+ (Mashimo et 
al., 2010). 
1.2.20 Merging conflicting data on functional effects of GEFS+ mutations with a 
mechanism of seizures   
As with the in vivo data, electrophysiological studies into heterologously expressed GEFS+ 
causing mutant NaV1.1 channels also exhibit mixed biophysical properties, a few of which 
are summarized in Table 1.5. There are, however, large variations in the methodologies 
used to investigate these mutants. Earlier studies used NaV1.2, NaV1.4 or rat orthologs of 
NaV1.1 because human NaV1.1 is difficult to clone and manipulate. There are disparities in 
cell models, intracellular recording solutions, and the identity of splice variants are either 
90 
 
unrecorded, or different in themselves. β subunit co-expression is also inconsistent, and β3, 
β4 modulation has not been examined.  
These inconsistencies in functional data raise the following questions: 
1. What is the true pathological mechanism of SMEI and GEFS+ mutations?  
2. Why do mutations that similarly alter channel function present in patients with 
dramatically different phenotypes?  
3. How do AEDs that target sodium channel inactivation prevent seizures?  
The answers in the field are ardently debated. A gain of function (for instance, an increase 
in persistent current) would elevate intrinsic neuronal excitability. This conforms to the 
hypothesis that seizures result from brain hyperexcitability, and AEDs act to block this 
activity by reducing sodium channel function.  
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Table 1.5 Functional effects of SCN1A mutations that cause GEFS+ 
Mutation Channel Region in NaV1.1 Cell type 
β subunit 
co-
expression Splice variant? Functional effect 
Gain or loss 
of function 
Intracellular 
solution    
D188V rNaV1.2 
D1/S2-S3 intracellular 
loop HEK β1 Adult 
Decrease use-dependence; faster 
recovery from inactivation 
Gain of 
function 
Cesium-
Aspartate 
Cossette et al. 
(2003) 
R859C rNaV1.1 D2/S4 
Xenopus 
oocytes  β1 Adult 
Positive shift of activation; slowed 
recovery from slowed inactivation; 
reduced current 
Loss of 
function - Barela et al. (2006) 
T875M rNaV1.1 D2/S4 
Xenopus 
oocytes  β1 Adult Enhanced slow inactivation 
Loss of 
function - 
Spamanato et 
al.(2001) 
 hNaV1.4  tsa201 none Adult Increased fast and slow inactivation 
Loss of 
function 
Cesium 
Fluoride Alekov et al. (2001) 
  hNaV1.1   tsa201 β1, β2 Adult Increased persistent current 
Gain of 
function 
Cesium 
Fluoride Lossin et al. (2002) 
W1204R hNaV1.1 L2 tsa201 β1, β2 Adult Increased persistent current 
Gain of 
function 
Cesium 
Fluoride Lossin et al. (2002) 
  rNaV1.1   
Xenopus 
oocytes  β1 Adult 
Negative shift of activation and 
inactivation; negative shift of window 
current   - 
Spamanato et al. 
(2001) 
V1353L hNaV1.1 D3/S5 tsa201 β1, β2 
Adult, Full-
length No sodium current 
Loss of 
function 
Cesium 
Fluoride Lossin et al. (2003) 
I1656M hNaV1.1 D4/S4 tsa201 β1, β2 
Adult, Full-
length Positive shift of activation 
Loss of 
function 
Cesium 
Fluoride Lossin et al. (2003) 
R1657C hNaV1.1 D4/S4 tsa201 β1, β2 
Adult, Full-
length 
Positive shift of activation; reduced 
expression 
Loss of 
function 
Cesium 
Fluoride Lossin et al. (2003) 
A1685V hNaV1.1 D4/S5 tsa201 β1, β2 
Adult, Full-
length No sodium current 
Loss of 
function 
Cesium 
Fluoride Lossin et al. (2003) 
M1841T hNaV1.1 C-terminus tsa201 β1, β2 
Adult, NaV1.1[-
33] Folding/trafﬁcking defect 
Loss of 
function 
N-methyl-D-
glucamine Rusconi et al.(2007) 
D1866Y rNaV1.1 C-terminus 
Xenopus 
oocytes    ? Increased persistent current 
Gain of 
function   
Spampanato et 
al.(2004) 
R1916G hNaV1.1 C-terminus tsa201 β1, β2 
Adult, NaV1.1[-
33] Folding/trafﬁcking defect  
Loss of 
function 
N-methyl-D-
glucamine 
Rusconi et al. 
(2009) 
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However, both SMEI genetics and data from GEFS+ rodent models suggest that it is more 
likely that neuronal inhibition is impaired in both of these diseases; this is the favoured 
hypothesis in the current literature (Ragsdale 2008; Catterall et al., 2010) In support of this 
idea, GEFS+ or SMEI causing sequence aberrations in several GABAA subunit genes have 
been shown to reduce neuronal inhibition through defects in receptor trafficking, subunit 
oligomerization and folding (Kang & MacDonald, 2009). This implies that disruption in the 
control of network excitability through loss of inhibition is a common pathological cause 
for childhood epilepsies.  
From clues given in disease models concerning different VGSCs, some argue that even an 
increase in persistent current would lead to a loss of inhibition. For example, specific 
mutations in the skeletal VGSC cause an increase in INaP but a paradoxical decrease in 
cellular excitability that leads to muscle inexcitability and episodes of paralysis. Cannon 
(2006) surmises that the increased INaP would depolarize the resting membrane potential 
and inactivate transient sodium currents responsible for the upstroke of the muscle action 
potential.  
1.2.21 Interactions with other channels 
As previously discussed, the genetic background significantly altered the severity of 
epileptic phenotype observed in SCN1A
+/-
 mice indicating that genetic modifiers may 
provide some explanation of patient phenotypic heterogeneities. For example, SCN8A
med-jo 
„motor endplate disease‟ mice have a point mutation within the NaV1.6 D3:S4-S5 
intracellular linker and display an ataxic, „jolting‟ phenotype (Kohrman et al., 1996). 
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Compared to wild-type animals heterozygous SCN8A
med-jo 
mice were more resistant to 
pharmacologically induced seizures (Martin et al., 2007). Current clamp recordings 
demonstrated that spontaneous bursting activity in dissociated SCN8A
med-jo 
cerebellar
 
purkinje cells was significantly attenuated and NaV1.6 was essential for the correct 
functioning of excitatory neurons (Raman et al., 1997). Therefore, impairment in NaV1.6 
function (Smith & Goldin, 1999) may reduce neuronal excitability and elevate seizure 
resistance in mutant SCN8A mice.  Martin and colleagues (2007) crossed SCN8A
med-jo/+ 
and 
SCN1A
+/-
 animals to produce heterozygous SCN8A
med-jo/+
/SCN1A
+/- 
mice. After exposure to 
ﬂurothyl, double heterozygote mice demonstrated comparable seizures thresholds to wild-
type animals. Moreover, the SCN8A
med-jo
allele prevented the premature deaths of SCN1A
+/-
 
mice and prolonged the survival of SCN1A
-/-
 mice.  The authors surmised that the reduction 
in excitability of pyramidal neurons opposed the attenuation of sodium current in inhibitory 
interneurons, rescuing the SCN1A knock-out phenotype. This implies that interactions 
between populations of VGSCs expressed in different cell types alter seizure severity and 
may partly explain the heterogeneity of SMEI and GEFS+ phenotypes. 
May this kind of interaction be occurring in humans with SMEI/GEFS+? It is possible that 
some patients suffer harbour mutations in more than one ion channel gene, which may have 
an additive effect on their phenotype. For example, Ohmori et al. (2008) sequenced the 
coding regions of SCN1B, GABRG2 and CACNB4 genes in 38 SMEI patients. 
Abnormalities in both GABRG2 (gamma-aminobutyric acid receptor gene) and CACNB4 
(voltage dependent calcium β4 subunit gene) cause a broad spectrum of childhood 
epilepsies (Wallace et al., 2001; Herrmann et al., 2005).  One AED-resistant SMEI patient 
94 
 
inherited a point mutation in the c-terminus of calcium channel β4 subunit from his father. 
The c-terminal of the β subunit is involved in trafficking the α channel-forming subunit to 
the plasma membrane. Electrophysiological analysis in Baby Hamster Kidney fibroblast 
(BHK) cells demonstrated that an alteration in the β-α interaction introduced by β4-R468Q 
significantly increased the current density of P/Q type calcium channels. Unfortunately this 
patient suffered with severe generalized convulsions and died at a young age. His father, 
however, only suffered with a febrile seizure in his childhood. Further screening of this 
patient identified a de novo premature stop codon, R568X, within the region coding for the 
first intracellular loop of NaV1.1. Therefore, the haploinsufficiency of SCN1A, specifically 
a loss of neuronal inhibition, in combination with increased levels of presynaptic calcium 
and therefore excitatory neurotransmitter release, appears to have dramatically exaggerated 
the milder epileptic CACNB4 mutation phenotype (Ohmori et al., 2008).  
Other genetic modifiers are emerging in similar models of childhood epilepsies. Mice 
carrying a three point mutation in NaV1.2 D3:S4-S5 intracellular linker, denoted SCN2A
Q54
, 
demonstrated an increase in persistent current in their CA1 hippocampal neurons (Kearney, 
2001); but the epileptic phenotype of these mice is strongly influenced by genetic 
background. For instance, the frequency of spontaneous seizures and animal lifespan were 
dramatically altered in two mouse strains carrying SCN2A
Q54
 (Bergren et al., 2005). The 
specific genes responsible for the severer phenotype were mapped to chromosomes 11 and 
19 (Bergren et al., 2005). A later study, however, showed that mutations in the voltage-
gated potassium channel KCNQ2 exacerbated the milder SCN2A
Q54
 phenotype observed for 
one particular mouse strain (Kearney 2006). KCNQ2 codes for a subunit that forms a 
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potassium channel that conducts the M-type current, this activates and inactivates slowly 
limiting neuronal excitability (Selyanko et al., 2001). Two mutant KCNQ2 mouse lines 
were crossed with SCN2A
Q54/+
mice. The Szt1 line has a 300 bp deletion in chromosome 3 
that results in the deletion of the KCNQ2 c-terminus and nicotinic acetylcholine receptor 
(CHRNA4) haploinsufficiency. Heterozygous Szt1 mice have a lower resistance to 
proconvulsant drugs compared to wild-type mice (Otto et al., 2004).  Another KCNQ2 mice 
line, KCNQ2
V182M
, was generated so that there was a point mutation in the third segment of 
the KCNQ2 subunit; these mice did not exhibit spontaneous seizures. However, double 
heterozygotes, namely, SCN2A
Q54/+
/KCNQ2
szt1/+
and SCN2A
Q54/+
/KCNQ2
V182M/+
 mice, 
demonstrated spontaneous generalized tonic–clonic seizures after P12 and on average died 
within a week of onset (Kerney et al., 2006). The authors hypothesized that an increase in 
persistent sodium current on depolarization and the loss of M-current during repolarisation 
would spread hyperexcitability and lead to severe spontaneous seizures. No SMEI patients 
with inherited or de novo mutations of SCN1A carried mutant KCNQ2 alleles (Kerney et 
al., 2006); however, the sample size was too small to disregard KCNQ2 as a gene modifier 
in these patients.  
Previous functional characterization of GEFS+ causing mutations failed to determine why 
patients exhibit age-dependent changes in seizure frequency and severity. Changes in 
inhibition due to a developmental switch in GABA function may be one possible 
explanation (Ben-Ari 2002). In the developing nervous system the intracellular 
concentration of chloride is high because of the relative expression of two co-transporters 
with opposing functions: KCC2 causes chloride efflux and NKCC1 chloride influx (Ben-
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Ari 2002). The latter is predominant in immature neurons. Outward GABAA chloride 
currents depolarize the membrane and in the developing brain may encourage seizure 
generation (Ben-Ari 2006). However, during development the expression levels of KCC2 
and NKCC1 switch and in mature neurons GABAergic transmission becomes inhibitory as 
GABAA receptors pass an inward chloride current (Ben-Ari 2002). 
Another possible explanation is that the immature nervous system comprises a different 
milieu of ion channels compared to the fully developed nervous system. During this 
gestation period the kinetics of ion channels expressed by immature neurons are different to 
those expressed by fully formed cells, and this establishes specific firing patterns essential 
for proper development (Moody & Bosma, 2005). Differences may be due to dissimilar 
channel expression (SCN3A dominates early on), or may result from alternative splicing 
(see below). Indeed, SCN1A is alternatively spliced producing developmentally regulated 
splice variant channels (Copley 2004). 
1.3.1 Overview of alternative splicing 
Alternative splicing is the mechanism by which a single transcript from a gene is processed 
into several possible mature mRNAs. In splicing introns (non-coding DNA regions, ranging 
between 200 to several 1000 nucleotides) are removed, and exons (coding DNA regions, 
ranging between 50–300 nucleotides) are connected together (Figure 1.8). Mature spliced 
mRNA is exported from the nucleus to the cytoplasm where it is translated by ribosomes, 
producing polypeptide chains that ultimately fold into functional proteins.  It is estimated 
that 40-60 % of human genes are alternatively spliced, finely tuning physiological function 
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(Modrek & Lee, 2002). In a genome-wide analysis study of human tissue, the greatest 
numbers of tissue-specific splice variants were found in the brain (Xu et al., 2002). 
Unsurprisingly the first example of tissue specific alternative splicing was identified in the 
brain, whereby a specific variant of the calcitonin gene related peptide gene was only 
upregulated in the hippocampus (Amara et al., 1982).  
Reports within the last 30 years suggest that alternative splicing in the nervous system has 
three primary functions (Blencowe & Graveley, 2007). Firstly, alternative splicing expands 
whole-brain neuronal structure. For example, splice variants of pre-synaptic receptors 
called neurexins only bind to particular isoforms of post-synaptic ligands called 
neuroligins, establishing and regulating specific synapses within the brain (Chih et al., 
2006). Secondly the diversity that arises from splicing can widen neuronal responses to 
network activity. Genes encoding ion channels, including VGSCs, undergo extensive 
alternative splicing (Blencowe 2006), and in some cases this links network activity to 
channel behaviour. For instance, neuronal activity dictates the ER export of splice isoforms 
of the NMDA receptor. Increased activity favours the inclusion of one exon and activity 
blockade biases the expression of another. This splicing mechanism helps regulate NMDA 
receptor cell-surface expression (Mu et al., 2003). Lastly, alternative splicing is thought to 
diversify protein function within neuronal subtypes.  For example, two isoforms of the 
voltage gated calcium channel CaV2.2, which differ in their c-terminal domains are 
differentiately expressed in particular cell types. One variant is specifically expressed in 
nociceptive sensory neurons and demonstrates altered biophysical properties compared to 
the other variant that is upregulated in most neuronal tissues (Bell et al., 2005).   
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Short consensus sequences along the length of introns are essential for alternative splicing. 
The 5‟ and 3‟ end of most mammalian introns contain the specific sequences GU and AG 
respectively, and preceding AG is an intronic polypyrimidine tract. In vertebrates, 
approximately 10-40 nucleotides upstream of the polypyrimidine rich-region is the 
branchpoint sequence: 5‟-CURAY-3‟ (Figure 1.8 B; Turner et al., 2001). In simplified 
terms splicing occurs in two-steps (Figure 1.8 A). The bond after the 5‟-end G residue, that 
is the 5‟-splice-site, is attacked by a 2‟-hydroxyl group of the A nucleotide within the 
branchpoint sequence (Turner et al., 2001). This creates a loop of mRNA called the lariat 
and liberates the first exon (Figure 1.8). During the second stage, pre-mRNA is cleaved at 
the 3‟splice-site, that is, after the G at the 3‟ end of the intron. The two exons ligate and the 
lariat is released and rapidly degraded (Turner et al., 2001).  
Five small nuclear ribonucleoproteins (snRNPs) U1, U2, U4, U5, U6, working with a 
collection of regulatory proteins and ATP, catalyze alternative splicing (Turner et al., 
2001). The 5‟ end of U1 base-pairs with the 5‟ splice site. A sequence within U2 base-pairs 
with the branchpoint sequence (Lodish et al., 2000). U4 and U6 base-pair to form a 
molecule that binds to U5. The U4/U5/U6 complex binds to the pre-mRNA and undergoes 
a series of re-arrangements, so that the pre-mRNA is held in the correct orientation for 
splicing (Lodish et al., 2000). This complex of snRNPs and pre-mRNA is called the 
spliceosome (Figure 1.8 B) and catalyzes two transesterification reactions that free the 
lariat (Lodish et al., 2000; Turner et al., 2001).   Splicing can occur in either a constitutive 
fashion whereby exons are combined or excluded in series (Figure 1.8 C) or are mutually 
exclusive in which one exon is included, and another excluded, in the final mRNA 
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transcript (Figure 1.8 C).  Other methods of alternative splicing are also extensively used; 
for example, intron retention and usage of alternative 5‟ donor and/or 3‟ acceptor splice 
sites (Lee & Irizarry, 2003). 
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Figure 1.8 Splicing of eukaryotic pre-mRNA A. The two-step reaction. B. Involvement 
of snRNPs in spliceosome formation. C. Two forms of regulated alternative splicing: 
consecutive exon inclusion or skipping splicing (top) or mutually exclusive splicing 
(bottom). Abbreviations as in text. Redrawn from Turner et al. 2001 and Lipscombe 2005.  
 
A B 
C 
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1.3.2 Alternative splicing in SCN genes 
SCN1A is alternatively spliced at exon 5. SCN1A contains two copies of exon 5. These 
isoforms are denoted 5N and 5A or Neonatal and Adult according to their relative 
expression during development but both are expressed in the human adult brain (Tate et al., 
2005). Both copies of exon 5 encode nearly identical sequences in domain I. However, 
three amino acid changes in the extracellular loop between S3 and S4 differ between the 
two exons (adult to neonatal): Y203F, D207N, and V211F (Copley 2004; Figure 1.9). 
Alternative splicing of exon 5 SCN1A is partly modulated by the splice-modifier protein 
Nova2. Increased expression of Nova2 biases splicing towards the neonatal exon (Heinzen 
et al., 2007). Microarray studies on brain tissues from Nova2 null mice revealed that this 
protein coordinated exons in genes expressed mainly in inhibitory neuronal synapses, 
supporting the role of NaV1.1 in inhibition (Ule et al., 2005). Exon 5N and 5A encode 
channels that differ in a domain of the ion channel thought to be important for voltage-
sensing. Consequently, even subtle effects of alternative splicing might have important 
consequences for neuronal behaviour. An additional five VGSCs undergo similar 
alternative splicing, including SCN2A, SCN3A (Sarao et al., 1991; Gustafson et al., 1993; 
Lu & Brown 1998), SCN8A (Plummer et al., 1997) and SCN9A (Belcher et al., 1995), 
replacing a neutral residue, typically asparagine, with a negatively charged aspartate when 
switching from exon N to A in this region. Within SCN5A, analogous alternate splicing 
replaces a positively charged lysine with aspartate (Schaller et al., 1992; reviewed in 
Copley 2004; see Figure 1.9).  
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Figure 1.9 (previous page) Molecular differences between „neonatal‟ and „adult‟ 
VGSC splice variants A. The genomic structure of human VGSC genes surrounding 
neonatal (N, green) and adult exons (A, blue) Exon 5N encodes the neonatal isoforms of 
human SCN1A (NaV1.1), SCN8A (NaV1.6) and SCN9A (NaV1.7) and Exon 6N the neonatal 
isoforms of human SCN2A (NaV1.2), SCN3A (NaV1.3) and SCN5A (NaV1.5). B. The 
peptide sequences of VGSCs genes encoded by the alternative „neonatal‟ exon are shown 
on the top line and the sequences encoded by the „adult‟ exon are shown on the bottom line. 
Table taken from Raymond et al.,2004. C. Schematic indicating the region of VGSCs 
encoded by exon 5N/6N or 5A/6A in the first domain of the channel. This region, 
corresponding to the end of the third transmembrane segment (S3), a short extracellular 
linker (thick black line) and the entire voltage-sensing fourth transmembrane segment (S4; 
indicated in purple).   
 
Within the analogous rodent intronic region to human SCN1A exon 5N (Gazina et al., 
2010) there is a premature stop-codon; therefore, only the adult isoform is expressed in rats 
and mice. Consequently, determining the relative expression of NaV1.1-5N and NaV1.1-5A 
in vivo is problematic, and expression of exon 5N may not be physiologically relevant in 
SCN1A in rodents. However, northern blot and quantitative PCR studies performed in 
rodents suggest that SCN1A is strongly upregulated during the first week of birth, being 
detectable at E10 but escalating to peak at P15 (Beckh et al.,1989; Gazina et al., 2010). 
SCN1A is most abundant in midbrain areas, thalamus and cerebellum, and displays a 
weaker mRNA signal in the cortex and hippocampus (Beckh et al., 1989; Gazina et al., 
2010). The remaining VGSC genes shown in Figure 1.9 B are alternatively spliced in rats 
and mice, as well as in all other mammalian sequences known.  Although denoted 
„neonatal‟ and „adult‟, studies in rodents suggest that this nomenclature may be misleading. 
For example, there are conflicting reports of the relative expression levels of NaV1.3-6N 
and NaV1.3-6A during development. Gustafson et al. (1993) showed that rat NaV1.3-6N 
was predominant isoform at E18, by P4 levels of NaV1.3-6N and NaV1.3-6A were equal 
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and by P10 the adult isoform replaced NaV1.3-6N expression. However, a more recent 
quantitative PCR report performed in mice implied that NaV1.3-6A was predominant 
between P0 and P15 (Gazina et al., 2010). Similarly, in three reports the adult isoform of 
SCN8A was the primary channel in newborn and two-week old rodent brains (Raymond et 
al., 2004; Mechaly et al., 2005; Gazina et al., 2010). However, a recent quantitative PCR 
study suggest that SCN2A expression follows the „neonatal‟ and adult‟ paradigm. In the 
newborn mouse cortex and hippocampus, NaV1.2-6N expression levels were at least 1.5 
times that of NaV1.2-6A (Gazina et al., 2010); this supported earlier data described by 
Gustafson et al. (1993). A previous investigation using the same technique showed that 
NaV1.7-5N was the main channel expressed not only in fetal but also the adult brain 
(Raymond et al., 2004). The same study demonstrated that NaV1.7 is dramatically 
upregulated in fetal compared to adult brain; data corroborated by a later PCR study where 
overall NaV1.7 expression was detected in rat cortex at stage P1 but not P13 (Mechaly et 
al., 2005). NaV1.5-6N was observed in the neonatal (P1) mouse brain (Chioni et al., 2005), 
but the relative expression levels between NaV1.5-6N and NaV1.5-6A was undetermined.  
1.3.3 Alternative splicing in VGSC genes during epilepsy 
Interestingly, in experimental epilepsy and/or following seizures, the neonatal channel 
isoform is upregulated in multiple sodium channels, including SCN1A. In one study, 
NaV1.1-5N was upregulated in resected temporal lobe tissue from patients (Tate et al., 
2005), but this finding was not replicated in a follow-up study (Heinzen et al., 2007), 
whereby neonatal transcripts had a trend towards downregulation in comparable tissues. 
Unlike SCN1A, other channel mRNAs can be investigated in rodent models of epilepsy 
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where the N>A splicing is conserved. NaV1.3-6N and NaV1.2-6N were both transiently 
upregulated for approximately 12 hours in the rat hippocampus, following kainate-induced 
seizures (Gastaldi et al., 1997). After electrically-induced status epilepticus (SE), another 
epilepsy rodent model, the neonatal transcripts of NaV1.2 and NaV1.3 were persistently 
upregulated in the hippocampus for 3 months, while the adult isoforms were transiently 
upregulated for only 4 hours (Aronica et al., 2001). In both studies the dentate gyrus was 
particularly affected compared to other regions of the hippocampus. In similar epilepsy 
models, three other GEFS+ genes were persistently up- (GABRA2) and down-regulated 
(GABRD and HCN2) in the dentate gyrus (Sperk et al., 1998; Nishimura et al., 2005; 
Powell et al., 2008). This implies that gene transcription in this area is more susceptible to 
long-term changes in response to neuronal hyperexcitability, but the implications for 
GEFS+ epileptogenesis are unknown. 
1.3.4 Functional studies of SCNnA splice variants 
Although the N>A alternative splicing changes the linker adjacent to the voltage sensor its 
functional impact remains controversial. Functional effects have been shown for splicing in 
several related sodium channels, including NaV1.2, NaV1.7 and NaV1.5 and these are 
summarized in Table 1.6 (references therein). However, these heterologous expression 
studies are compromised by limitations similar to those described for NaV1.1-R1648H 
channels. Extrapolation to NaV1.1 is also limited because there are several amino acid 
substitutions between NaV1.1 and other VGSCs splice variants. In addition, in spite of the 
role of VGSCs in the pharmacology of AEDs (discussed below) no report addresses the 
pharmacological consequences of alternative splicing in a VGSC. Nonetheless from these 
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studies, inactivation, particularly the rate of current decay and recovery from inactivation 
are two properties affected by alternatively splicing in these genes (Table 1.6). 
Interestingly, these parameters of CNS VGSCs are also modulated by AEDs. Moreover, no 
mutations have been found to affect NaV1.1-5A and NaV1.1-5N splicing per se but a cluster 
of missense and frameshift mutations at amino acids 211-213, around the third amino acid 
switch (residue 211) are found in GEFS+ patients, suggesting that D1:S3-S4 loop is 
functionally important in GEFS+. 
Table 1.6 Functional differences between „neonatal‟ and „adult‟ VGSC channel 
isoforms 
 
Channel Cell type 
β subunit 
expression? 
Functional differences between 
variants 
Intracellular 
solution  
  
rNaV1.2 
Xenopus 
oocytes 
none No differences - 
Auld et 
al.,1990 
hNaV1.2 HEK 293 none 
Neonatal variant: ↓ rate of 
current decay, Adult variant: 
depolarizing shift inactivation,  
recovery from inactivation 
Cesium 
Fluoride 
Xu et al.,2007 
hNaV1.2 tsa201 β2,β2 No differences 
Cesium 
Fluoride 
Liao et 
al.,2010 
hNaV1.5 EBNA-293 
All isoforms 
endogenously 
expressed 
Adult variant: depolarizing shift 
activation;   rate current decay; 
↓ recovery from inactivation 
Cesium 
Chloride 
Onkal et 
al.,2008 
hNaV1.7 tsa201 β1 
Adult variant: slower 
development of inactivation  
Cesium 
Fluoride 
Chatelier et 
al.,2008 
hNaV1.7 HEK 293 β1,β2 Adult variant:   ramp current  
Cesium 
Chloride 
Jarecki et 
al.,2009 
 
1.3.5 Biophysical consequences of disease causing mutations in SCNnA splice variants 
Different mutations in both NaV1.7 and NaV1.2 are differentially affected by changes in the 
D1:S3-S4 linker (Xu et al., 2007; Liao et al., 2010; Jarecki et al., 2009; Choi et al., 2010). 
Studies into the effects of heterologously expressed NaV1.2-6N and NaV1.2-6A containing 
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BFIC mutations demonstrated subtle biophysical differences (Xu et al., 2007; Liao et al., 
2010). For example, a mutation in D4:S4 accelerated the rate of channel inactivation but 
only in the neonatal background (Xu et al., 2007). A later study showed that a mutation in 
the pore region of D1 did not change its gating in either splice variant background. In 
contrast, a mutation in the same region demonstrated an increase in persistent current in 
NaV1.2-6N channels (Liao et al., 2010). Similarly, a mutation in NaV1.7 D1:S1 did not 
have an effect on either channel isoform (Jarecki et al., 2009) but a mutation in the 
inactivation gate, slowed channel current decay and increased ramp currents in the adult but 
not neonatal background. Results from these studies imply that changes in neuronal 
excitability can be altered by alternative splicing but are a dominant effect of individual 
mutations. 
1.3.6 Alternative splicing in other VGSC regions 
First intracellular loop 
VGSCs are extensively alternatively spliced to produce a myriad of channel isoforms but 
little is known about their biophysical properties (Diss et al., 2004). For clarity select 
variants, particularly NaV1.1 isoforms, found in mammalian neuronal tissues will be 
discussed. SCN1A is alternatively spliced in exon 11, which codes for a region within the 
first intracellular loop. Two additional shortened isoforms are generated: NaV1.1[-33] and 
NaV1.1[-88]which lack 11 and 28 amino acids respectively, compared to the full length 
protein (Lossin et al., 2002). The clone used in this study was NaV1.1[-33] and is the 
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predominant isoform in rat brain (Schaller et al.,1992). The functional consequence of exon 
11 splicing in NaV1.1 is unknown (Lossin et al., 2008).  
NaV1.3, NaV1.6 and NaV1.7 channels are spliced in the same region producing at least two 
more isoforms for each channel (Schaller et al., 1992; Klugbauer et al., 1995; Dietrich et 
al., 1998; Plummer et al., 1998). NaV1.3 and NaV1.6 splice variants are found in the rodent 
brain (Schaller et al., 1992; Plummer et al., 1998; Diss et al., 2004). One NaV1.3 isoform is 
truncated within the loop producing a channel with one domain but its biophysical 
properties are yet to be elucidated (Diss et al., 2004). NaV1.7 isoforms play a role in the 
PNS and non-neuronal tissues (Klugbauer et al., 1995; Sangameswaran et al., 1997; 
Toledo-Aral et al., 1997). Splicing in this region is hypothesized to regulate channel 
phosphorylation because within the first intracellular loops of VGSCs there is a high 
concentration of serine residues; however, longer NaV1.1 isoforms do not contain putative 
phosphorylation sites (Berendt et al., 2010).  
Second intracellular loop 
In rat brain alternative splicing of exon 16 within SCN2A and SCN3A and exon 17 within 
SCN9A introduces a premature stop codon within the second intracellular loop producing 
two domain channels (Kerr et al., 2008). Human analogues of these channels have not been 
identified but the authors argue the alternative splicing sequences for these channels are 
highly conserved in humans (Kerr at al., 2008). Similarly, isoforms of NaV1.5 produced by 
alternative splicing have second intracellular loops with variable lengths and are found in 
rodent brain (Korsgaard et al., 2004). Shortening of this region by 53 amino acids altered 
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the gating and TTX sensitivity of NaV1.5 in an embryonic precursor cell line (Korsgaard et 
al., 2004). This effect maybe dependant on cell background as no changes in NaV1.5 
properties were observed from this isoform expressed in HEK 293 cells (Zimmer et al., 
2002c).  SCN5A and SCNA10 are also alternatively spliced in this region to produce an 
isoform with a deletion of a glutamine. However, the electrophysiological properties of 
these NaV1.5 and NaV1.8 isoforms are indistinguishable from their full-length counterparts 
(Schoeter et al., 2010; Schirmeyer et al., 2010).  
Third domain 
Exon 20 of NaV1.1 is alternatively spliced producing one isoform truncated in the third 
domain and another with a structurally distinct pore loop in the same region (Oh & 
Waxman, 1998). These isoforms were detected in rat spinal cord astrocytes and were 
inducible upon cAMP administration. It is undetermined how these variants change the 
functional properties of NaV1.1 channels (Oh & Waxman, 1998). Exon 18 of human 
SCN8A, NaV1.6, is also alternatively spliced in the same domain, generating two 
developmentally regulated splice variants 18A and 18N.  NaV1.6-18N is truncated at D3:S3 
and upregulated in the fetal brain (Plummer et al., 1997). NaV1.6-18A is a full length 
isoform that is expressed only in adult brain (Plummer et al., 1997). There are no reports on 
the functional significance of these isoforms but NaV1.6-18N is predicted to form non-
functional channels (Diss et al., 2004). The voltage sensor of the third domain, in one 
NaV1.9 variant weakly expressed in the brain, is truncated by splicing (Jeong et al., 2000).  
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1.3.7 Functional significance of VGSC splice variants 
The few functional reports on VGSC splice variants suggest that channel isoforms possess 
subtly different biophysical properties. No studies have investigated how the VGSC splice 
variant profile of individual neurons affects their cell-specific output. However, a recent 
SC-RT-PCR study into the crab VGSC: CbNaV, which undergoes alternative splicing to 
produce nine splice variants showed that 10 different cell types from the Stomatogastric 
Ganglion had specific CbNaV splice variant profiles (Dai et al., 2010). Splice variant 
expression was heterogeneous not only between cholinergic and glutamatergic cells but 
also within the same cell type (Dai et al., 2010). This suggests that sodium channels within 
each neuron, particularly within this small circuitry neuronal system, play a very specific 
role. Moreover, Mechaly and colleagues (2005) combined SC-RT-PCR and 
electrophysiology techniques to characterize the gating properties of VGSCs expressed in 
rat hippocampal pyramidal and utricular hair cells. Individual cells expressed up to three 
combinations of VGSCs but splice variants were unspecified. Single hippocampal and 
utricular cells with the same VGSC expression profile showed different action potential 
profiles and INa gating. Although the authors speculated that this likely to result from 
alternative splicing of VGSC genes (Mechaly et al., 2005) they did not fully investigate this 
possibility.  
1.3.8 Alternative splicing GEFS+ syndromes 
Aberrant splicing in SCN1A causes severe epilepsy phenotypes; 65 mutations in splice 
acceptor or donor sites within the majority of SCN1A introns cause SMEI but only one 
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mutation in a donor site causes GEFS+ (Table 1.4).  In the report discussed previously, 
which provides evidence that mutations in SCN9A may act as a genetic modifier in SMEI 
harbouring SCN1A mutations, several splice site mutations in SCN1A were investigated 
(Singh et al.,2009). In a cohort of 109 patients with SMEI, 7 individuals had mutations in 
both genes, of which 3 had changes that affected splice donor and acceptor sites in SCN1A. 
Aberrant splicing also occurs in other GEFS+ genes. For example, a patient with febrile 
seizures who later developed childhood absence epilepsy harboured a splice-donor 
mutation rendering the γ2 subunit non-functional (Kananura et al., 2002).  
1.3.9 AEDs and splicing  
Many AEDs inhibit VGSC including established drugs like phenytoin and carbamazepine 
and newer anticonvulsants, for example, lamotrigine. Phenytoin, like many 
neuromodulatory drugs (Keiser et al., 2009) has off-target effects and has been reported to 
bind to calcium and potassium channels (Remy & Beck, 2006).  Although structurally 
distinct (Figure 1.10 A) VGSC blockers have two common features: a positively charged 
nitrogen group and an aromatic group at opposite ends (Mantegazza et al., 2010). AEDs 
bind to an inner vestibule of the pore formed by S6 residues within all domains but D2 
(Mantegazza et al., 2010; see Figure 1.10 B for details). Other AEDs, for example, 
specifically block calcium channels and facilitate potassium channels and other agents 
enhance GABAergic neurotransmission (Rogawski & Löscher, 2004).  
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Figure 1.10 The structure and binding sites of AEDs A. “Stick and space-filling views 
showing the ureide ring (CO(NH2)2) common to the sodium-channel-blocking antiepileptic 
drugs phenytoin, lamotrigine and carbamazepine”.  Explanation and figure taken from 
Rogawski &  Löscher 2004. B. “Molecular modelling of the drug binding site suggests that 
the positively charged amine interacts strongly with a phenylalanine in domain IV and, to a 
lesser extent, with a leucine in domain III, whereas the aromatic group interacts with a 
tyrosine in domain IV and an asparagine in domain I”. Explanation and figure taken from 
Mantegazza et al. 2010.  
1.3.10 Can alternative splicing affect AED efficacy? 
At present, AED treatment of epilepsy is unpredictable; approximately 30% of patients are 
resistant to the first two to three drugs they are administered (Remy & Beck, 2006). The 
cause of pharmacoresistence is obscure. SMEI patients have been reported to be not only 
resistant to particular AEDs but their seizures can be aggravated by the VGSC blockers 
carbamazepine and lamotrigine (Wakai et al., 1996; Guerrini et al., 1998; Abe et al., 2008), 
although phenytoin is less aggravating (Genton 2000). Drug sensitivity may alter due to 
subtle differences in multi-drug transporters, voltage-gated channels, neurotransmitter 
systems and genetics between individuals (Remy & Beck, 2006; Schaub et al., 2007). 
Indeed in a rat experimental epilepsy model, one strain was subdivided into two groups that 
A B 
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either responded or did not respond to phenytoin (Löscher & Rundfeldt, 1993), a difference 
not found in another phenytoin-responsive breed (Löscher et al., 1998). 
A seminal study exploring whether a European heterogeneous population of 425 epilepsy 
patients were genetically predisposed to respond to specific anti-epileptics, demonstrated 
that a SNP, rs3812718, in SCN1A was associated with a significant shift in the maximal 
dosage of two AEDS: phenytoin and carbamazepine (Tate et al., 2005; Figure 1.11). The 
polymorphism rs3812718 is located in the consensus sequence of the 5‟ splice donor site 
downstream of the neonatal exon 5N (exon 5N+5G>A). The alleles of the SNP, the 
„ancestral‟ allele G and the „mutant‟ allele A, are approximately equally prevalent in 
humans chromosomes (Heterozygous = 0.50 ± 0.05 (average ±SEM); NCBI refSNP Cluster 
Report; Weale et al., 2003). The G allele is conserved across vertebrates (Zhang 1998) and 
is present in homologous CNS VGSC genes that are alternatively spliced within D1:S3-S4. 
Since the +5G site is located within the spliceosome recognition sequence, it is possible 
that a switch to the A allele at this site interrupts recognition of the neonatal exon by the U1 
snRNA (Zhang & Weiner, 1986). Indeed, in temporal lobe neocortex taken during autopsy 
of healthy individuals, the exon 5N+5GA variant (AA) was associated with a 
significantly lower proportion of neonatal transcripts. The ratio of exon 5N transcripts 
increased sequentially in brain tissue taken from people with AG and GG genotypes 
(Heinzen et al., 2007). The disruption of the splice recognition site by the A allele was 
confirmed by a minigene assay in HEK cells (Heinzen et al., 2007).  Tissue from epilepsy 
patients demonstrate comparable genotype-phenotype correlations (Heinzen et al., 2007), 
but as discussed, it is ambiguous whether seizures cause an up or down-regulation of the 
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neonatal variant in SCN1A (Tate et al., 2005; Heinzen et al., 2007). Mammals have 
divergent mechanisms of splice site recognition and alternate exons are known to use 
multiple mechanisms to regulate their inclusion, so an absolute effect of splicing in vivo is 
not predictable from the nucleotide sequence alone. For instance, increased levels of 
NOVA2 mRNA expression correlated with an upregulation of exon 5N transcripts in 
homozygous AA healthy and epileptic individuals (Heinzen et al., 2007).   
 
Figure 1.11 The complete sequence of SCN1A exon 5 aligned with exon 5A. The codons 
encoding the three amino acid changes between exon 5N and 5A are boxed. The conserved 
amino acid switch is boxed in purple. The location of rs3812718 is indicated by the arrow. 
Redrawn from Tate et al. (2005) 
 
Tate et al. (2005) demonstrated that maximum AED dosage consecutively decreased in 
epilepsy patients with AA, AG and GG genotypes. As maximum dosage is not an accurate 
determinant of drug efficacy the original study was repeated on a Chinese cohort of 71 
patients, and Tate et al. (2006) confirmed that rs3812718 was associated with phenytoin 
serum concentration at maintenance dose (Tate et al., 2006). Because this significance was 
marginal, the authors tentatively postulated that individuals that express a greater 
percentage of 5N, that is carry the G allele of the SNP on one or both their alleles, may 
require a lower drug maximum dosage. One aim of this study is to link the effect of the 
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rs3812718 on splicing of exon 5N, together with a demonstration that splicing has a 
biophysical and pharmacological consequence for NaV1.1. This could provide a 
mechanistic explanation for the association between this polymorphism and AED dosage. 
Since the polymorphism is extremely common, a mechanism connecting it to the treatment 
of epilepsy would imply that genetic variability of SCN1A has a far broader impact for 
epilepsy in the population than currently appreciated from rare, individual mutations. In 
fact, the AA genotype conferred a three-fold increased risk of developing childhood febrile 
seizures in an Austrian cohort (Schlachter et al., 2009). However, the same group did not 
find an association in a cohort of 558 Australian epilepsy patients (Petrovski et al., 2009). 
A similar association between rs3812718 and lamotrigine serum levels in 50 Russian 
patients has been recently reported (Krikova et al., 2009), providing evidence that this SNP 
affects the dosage of a range of AEDs.  Moreover, another study of 222 Japanese epilepsy 
patients demonstrated that individuals with the AA genotype were on average, nearly three 
times more resistant to carbamazepine (Abe et al., 2008). However, the effects of 
rs3812718 should be treated with some scepticism. Two studies have failed to replicate the 
Tate et al. findings (2005, 2006). The maintenance dosage of carbamazepine in 369 
Austrian patients did not correlate with genotype (Zimprich et al., 2008) and no 
relationship was found in 377 Chinese patients between sodium channel blocking AEDs 
and rs3812718 (Kwan et al., 2008). One may argue, therefore, that this association is 
unproven but the positive findings may still provide a plausible hypothesis connecting 
patient genotype with drug response. Since discrepancies between these studies may result 
from varying cohort size, heterogeneity of epilepsy syndromes in population samples and 
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differences in ethnic backgrounds. These studies focus on sodium channel blocking drugs 
and within the cohorts the cause of epilepsy is unknown. Different cohorts may have 
different ratios of genetically-related and non-genetically related epilepsy syndromes, 
which may or may not involve SCN1A or other VGSCs genes. Therefore, the effect of 
rs3812718 on AED dosage may be obscured or overridden in some populations.  As 
previously discussed studies involving experimental epilepsy models imply that there is a 
significant change in neuronal phenotype in response to seizures, which may change 
responses to AEDs (Gastaldi et al., 1997; Aronica et al., 2001). Indeed, SC-RT-PCR and 
electrophysiological analysis of dentate granule cells from a rat pilocarpine model of 
epilepsy demonstrated that the subunit composition of GABAA receptors was altered which 
in turn reduced zolpidem (an anticonvulsant) sensitivity (Brooks-Kayal et al., 1998). One 
aim of this study is to determine whether phenytoin differentially affects the biophysical 
properties of NaV1.1-5N and NaV1.1-5A channels, to provide a potential mechanistic 
explanation for AED discrimination. 
1.3.11 Mechanism of AED block on VGSCs 
Phenytoin is effective at protecting against GTCS and partial epilepsy. Its mechanism is 
typical of sodium channel blockers and dependent on channel conformation (Figure 1.12). 
AEDs like phenytoin selectively block high-frequency repetitive firing and only weakly 
suppress normal nerve activity (Rogawski & Löscher, 2004; Mantegazza et al., 2010). The 
modulated receptor hypothesis assumes that phenytoin-like drugs strongly bind to 
inactivated or open VGSCs channels, at more depolarized potentials, and have weaker 
affinity for resting channels at more negative potentials (McLean & MacDonald, 1983; 
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Ragsdale et al., 1991).  AED action is „use-dependent‟, that is, inhibition is significantly 
increased during rapid trains of depolarizing pulses, similar to sustained firing during ictal 
episodes (Matsuki et al., 1983; Kuo & Bean, 1994). During each pulse a greater proportion 
of channels open and inactivate: conformations that enhance drug binding. Both phenytoin 
and lamotrigine bind to and dissociate from VGSCs slowly (Rogawski & Löscher, 2004). 
Therefore firstly, the normal time-course of VGSC gating is unaltered and „normal‟ firing is 
mostly unaffected. Secondly drug dissociation is slower than VGSC recovery from 
inactivation enabling block to accumulate during rapid, prolonged firing (Ragsdale & Avoli 
1998). Moreover, VGSC blockers stabilize the inactivated state, decreasing channel 
availability, shifting the voltage dependence of VGSC inactivation in a hyperpolarized 
direction (Ragsdale et al., 1991).  In a heterologous system persistent sodium currents were 
more sensitive to several AEDs, including phenytoin, and were blocked at lower dosages 
compared to transient currents (Kohling 2002).  In vivo neuronal INaP have also been 
reported to be inhibited by phenytoin and lamotrigine (Chao & Alzheimer 1995; Gebhardt 
et al., 2001).  
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Figure 1.12 Effects of AEDs on VGSCs A. (Top panel) the first pulse is unaffected by 
AED administration. However, recovery from inactivation is inhibited and this is the 
mechanism underling „use-dependent‟ inhibition. (Bottom panel) when peak sodium 
currents are <10% blocked persistent sodium currents are ~60% inhibited. This has only 
recently been recognized as an important feature of AED inhibition. The net effect is a 
reduction of sodium currents by the drugs, particularly during strong activation of neurons. 
B. The modulated receptor model. “In this model, the drug binds with higher aﬃnity to 
inactivated channel states than to resting channel states”. Explanation taken and figure 
redrawn from Mantegazza et al. 2010. 
 
It is unknown what the impact of NaV1.1-R1648H and other mutations is on channels in a 
neonatal „background‟, or if rs3812718 contributes to the variability of GEFS+ Type 2 
phenotypes. Mutant VGSCs like NaV1.1-R1648H may increase persistent currents (Lossin 
et al., 2002). Because AEDs disproportionably inhibit INaP another aim of this study is to 
determine if phenytoin differentially affects NaV1.1-R1648H in exon 5N and 5A 
backgrounds. This may provide another possible mechanism for the association of genetics 
with drug dosage.  Further, if NaV1.1-5N is upregulated early in development, this may 
partly explain why the syndromes associated with SCN1A mainly manifest during 
A B 
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childhood. However, as suggested by the variable results of biophysical investigations into 
the consequences of the NaV1.1-R1648H mutation, it is likely that any assessment of the 
functional impact of inclusion of exon 5N or 5A will be highly sensitive to recording 
conditions. Given the temperature sensitivity of the seizure disorders associated with 
SCN1A and elevated temperatures are known to reduce VGSC blocker affinity (Strichartz 
& Zimmermann 1983), temperature may also play an important role in modulating channel 
and variant function in the presence or absence of AEDs. 
120 
 
Genomic level 
Alternative splicing 
mRNA level
Protein level
Clinical level
With G-allele either 
neonatal exon 5N or 
adult exon 5A 
mRNA but no 
neonatal splice 
product with A-
allele
VGSC neonatal and 
adult variants 
differ by 3 amino 
acids in voltage 
sensor region
Possibly different 
AED dosage 
requirements for A-
and G-carriers
rs3812718
Intronic G>A polymorphism in 
conserved consensus sequence 
of 5’ splice donor site
A-allele interrupts consensus 
sequence. As a consequence no 
neonatal splice products
Expression of neonatal and adult 
splice variants are dynamically 
and differentially regulated (i.e. 
indirect evidence for functional 
relevance)
Electrophysiological or 
pharmacological effects on 
Nav1.1 properties are unknown 
Suggestion of pharmacogenetic 
relevance
 
Figure 1.13 The rs3812718 SNP in the SCN1A gene can affect the alternative splicing of exon 5. NaV1.1-5N and NaV1.1-5A 
are likely to have different biophysical properties. This may explain why patients have altered AED requirements depending on 
their genotype.  (Redrawn from Loscher et al., 2009).  
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1.4.1 Overview of modulation of NaV1.1 
A large part of this work was focused on determining the conditions where the different 
splice variants of SCN1A could be studied in isolation. A major hurdle to this sort of 
comparison is that even in heterologous cells that express few other channels, many 
endogenous and exogenous factors modify sodium channel behaviour. For the purposes of 
this project, to attempt to clamp the channels in comparable states three broad sources of 
variability were controlled and one pharmacological test was used: firstly, G-proteins, 
which are known to modulate these channels, and which are present and can be 
constitutively active in all cells. Secondly, temperature is, as described previously, an 
important precipitant of seizures in patients with mutations in SCN1A. However many 
recordings of these channels are carried out at room temperature, therefore the effects of 
temperature were investigated. Finally, for convenience and stability many heterologous 
recordings use fluoride based intracellular solutions. This work early on identified fluoride 
as an unpredictable modifier of sodium channel gating, and therefore recordings were 
carried out to compare the effects of this anion on channel behaviour. Pharmacologically, 
sodium channels are sensitive to many AEDs, and the genotype of the SNP in SCN1A 
associated with splicing changes AED dosage. For these reasons, the impact of a 
representative AED was tested against splice variants of SCN1A. 
1.4.2 G-protein regulation of NaV1.1 derived INaP  
One aim of this project is centred on untangling the interactions between NaV1.1 splice 
variants and Gβγ subunits. Many ion channels are regulated by neurotransmitters and 
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hormones via G-protein coupled receptors (GPCRs).  Upon ligand binding, GPCRs 
undergo a conformational change and activate heteromeric G-proteins. These are composed 
of three subunits: α, β and γ. This structural change promotes the exchange of GDP for 
GTP at the Gα subunit, followed by the disassociation of Gα-GTP and Gβγ (Figure 1.14). 
The functions of G-proteins are principally dictated by their α subunits (Figure 1.14). These 
are encoded by 16 genes and are split into four groups Gαs, Gαi/o, Gαq/11 and Gα12 
(Gomperts et al., 2002). Stimulated Gαs and Gαi subunits activate and inhibit respectively, 
adenylate cyclase. Gαq/11 stimulates Phospholipase C-beta (PLCβ) another enzyme 
involved in cellular signalling pathways, and Gα12 regulates the activity of tyrosine kinases 
and GTPases. Activated Gα subunits can modulate ion channels via direct physical 
interactions or indirectly through protein kinases and second messengers (Dascal 2001).  
Alternatively, the liberated Gβγ subunits can directly modulate target proteins. Indeed, Gβγ 
subunits modulate NaV1.1-derived persistent currents (Ma et al., 1997; Mantegazza et al., 
2005). Gβγ modulation has been widely investigated for two ion channel families: G-
protein activated inwardly rectifying K+ channels (GIRKs) that are activated by Gβγ, and 
voltage-dependent Ca
2+
 channels, which are inhibited by Gβγ (Dascal 2001). There are 5 
subtypes of Gβ subunits and at least 12 subtypes of Gγ proteins, which are tethered to the 
membrane by post-translational fatty acid modification of Gγ. The number of potential Gβγ 
complexes is potentially vast. However, some combinations do not occur, for instance, 
Gβ2γ1, and some are tissue specific like Gβ1γ1, which is only found in the retina 
(Gomperts et al., 2002). Nonetheless, six different combinations of Gβγ subunits have been 
shown to differentiately regulate the open probability of a heart potassium channel 
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(Wickman et al., 1994). It is possible that particular Gβγ subunits may distinguish between 
different VGSCs and even their splice variants. 
 
Figure 1.14: The disassembly of an activated G-protein into signalling components. 
(left) In the unstimulated state, the receptor and the G protein are both inactive. In some 
cases they are associated in a preformed complex. (middle) Binding of an extracellular 
ligand to the receptor changes the conformation of the receptor, which in turn alters the 
conformation of the G-protein that is bound to the receptor. The alteration of the α subunit 
of the G-protein allows it to exchange its GDP for GTP. (right)This causes the G-protein to 
break up into two active components - an α subunit and a βγ complex, the latter regulates 
the activity of voltage-gated ion channels. Redrawn and explanation from Alberts et al. 
(2002). 
 
Few studies have investigated the regulation by Gβγ of VGSC α subunits. Ma et al. (1997) 
were the first to show that in tsa201 cells overexpression of several combinations of Gβγ 
including Gβ2γ3, with rNaV1.2-6A, produced INaP that was not attenuated by the presence 
of β1. This increase in persistent current was not mediated by Gα subunits because co-
expression of rNaV1.2-6A with pertussis toxin sensitive Gα subunits, known to modulate 
rNaV1.2-6A transient currents (Ma et al., 1994) did not up-regulate INaP. GTPγS is a non-
hydrolysable analogue of GTP that binds to all G-protein α subunits, locks them in the 
„active‟ form and in turn releases βγ subunits (Figure 1.14). In control recordings, up-
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regulation of rNaV1.2-6A derived INaP was not observed from tsa201 cells dialyzed with 
GTPγS (Ma et al., 1997).  In vivo kinases, namely PKC and PKA, inhibit Na+ persistent 
currents (Cantrell & Catterall, 2001) but in the Ma et al. study intracellular dialysis of a 
PKC inhibitor had no effect on rNaV1.2-6A derived INaP (Ma et al., 1997). 
The authors demonstrated that in the presence of Gβ2γ3 the voltage dependence of 
activation for both rNaV1.2-6A persistent and transient currents were comparable. 
However, the voltage dependence of inactivation of the slow/incomplete current was 
shifted positively compared to transient current inactivation. Interestingly, only an excess 
of Gβγ subunits up-regulated persistent currents since co-expression of Gαi with Gβ2γ3 in 
the presence or absence of GTPγS masked the effect of the Gβγ proteins (Ma et al., 1997).  
The sequence motif, QxxER is found within many proteins that interact with Gβγ subunits, 
including G protein-dependant receptor kinases (GRKs). This consensus sequence is also 
found within the c-terminal tail of rNaV1.2-6A. Ma and colleagues designed a Gβγ binding 
25 amino acid peptide based on this region within rNaV1.2-6A that incorporated QxxER.  
Micromolar concentrations of the peptide introduced via the recording pipette solution 
significantly decreased rNaV1.2-6A Gβ2γ3 modulated persistent currents and the authors 
hypothesized that it was through interactions with c-terminal tail binding motif. Marin et al. 
(2001) showed that Gβ co-immunoprecipitates with VGSC α subunits expressed by mice 
cortical neurons providing evidence that there is a direct interaction between VGSC α 
subunits and G-proteins.  
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A major advantage of the Ma et al. study was that the main intracellular anion was 
aspartate, not fluoride which disrupts the function of G-proteins (see discussion of anions 
below). A more thorough investigation, that also used an aspartate-based intracellular, was 
carried out by Mantegazza and colleagues (2005). In their experiments overexpression of 
Gβ2γ3 in the tsa201 cells substantially increased both rNaV1.2-6A and hNaV1.1-5A derived 
persistent currents. This indicates that Gβγ modulation is not species specific or unique to 
NaV1.2 channels. Additionally Gβ2 alone was sufficient to increase rNaV1.2-6A persistent 
currents (Mantegazza et al., 2005). In the absence of exogenous Gβγ subunits, two clonal 
cell lines stably expressing hNaV1.1-5A demonstrated varying levels of persistent current, 
suggesting that even subtle changes in cellular background can dramatically alter INaP. 
Mutagenesis and channel chimera studies illustrated that the QxxER sequence alone was 
insufficient to regulate persistent currents, in contrast to the earlier report. However, more 
distal residues within the last 28 amino acids of the rNaV1.2 c-terminal tail were essential 
for Gβγ modulation of persistent currents. Sequence alignments show that NaV1.1, NaV1.3 
and NaV1.7 share a high sequence identity with the last 28 amino acids of rat and human 
NaV1.2 (Figure 1.15). Unlike other PNS, cardiac and skeletal sodium channels (Figure 
1.15). Indeed, the c-terminal of NaV1.3 has been shown to interact with Gβ1γ2 subunits 
(Lenkowski et al., 2004). Therefore it is possible that NaV1.1 channels are modulated in a 
similar manner. Moreover, Mantegazza and colleagues (2005) surmised that the QxxER 
motif could tether Gβγ to the pore region, thereby concentrating subunits in the correct 
channel region and increasing the likelihood of channel regulation in low Gβγ conditions.  
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rNav1.2         PPSYDSVTKPEKEK---FEKDKSEKEDKGKD---IRESKK-------
hNav1.2         PPSYDSVTKPEKEK---FEKDKSEKEDKGKD---IRESKK------- 100
hNav1.3         PPSYDSVTKPDKEK---FEKDKPEKESKGKE---VRENQK------- 79
hNav1.7         PPSYDSVTKPDKEK---YEQDRTEKEDKGKD---SKESKK------- 79
hNav1.1         PPSYDRVTKPIVEK---HEQEGKDEKAKGK----------------- 55
hNav1.6         LPSYDSVTKPEKEKQQRAEEGRRERAKRQKE---VRESKC------- 44
hNav1.5         PPSYDSVTRATSDNLQVRGSDYSHSEDLAD----FPPSPDRDRESIV 26
hNav1.8         PPSYESVTRGLSDRVNMRTSSSIQNEDEATSMELIAPGP-------- 23
hNav1.4         GPTMGLMPISPSDT--AWPPAPPPGQTVRPG---VKESLV------- 14
hNav1.9         -P-LQTLCNGDLSS---FGVAKGKVHCD------------------- 8
*    :     .                                  
rNav1.2         PPSYDSVTKPEKEK---FEKDKSEKEDKGKD---IRESKK-------
hNav1.2         PPSYDSVTKPEKEK---FEKDKSEKEDKGKD---IRESKK------- 100
hNav1.3         PPSYDSVTKPDKEK---FEKDKPEKESKGKE---VRENQK------- 79
hNav1.7         PPSYDSVTKPDKEK---YEQDRTEKEDKGKD---SKESKK------- 79
hNav1.1         PPSYDRVTKPIVEK---HEQEGKDEKAKGK----------------- 55
hNav1.6         LPSYDSVTKPEKEKQQRAEEGRRERAKRQKE---VRESKC------- 44
hNav1.5         PPSYDSVTRATSDNLQVRGSDYSHSEDLAD----FPPSPDRDRESIV 26
hNav1.8         PPSYESVTRGLSDRVNMRTSSSIQNEDEATSMELIAPGP-------- 23
hNav1.4         GPTMGLMPISPSDT--AWPPAPPPGQTVRPG---VKESLV------- 14
hNav1.9         -P-LQTLCNGDLSS---FGVAKGKVHCD------------------- 8
*    :     .                                  
 
Figure 1.15 The c-terminal tails of human VGSCs aligned to the last 28 amino acids of 
rNaV1.2 (indicated by arrow). These residues were essential for Gβγ modulation of 
persistent currents in the Mantagazza et al. 2005 study. Human brain VGSCs show a higher 
sequence identity than cardiac, skeletal and PNS VGSCs. Figures indicate the percentage 
amino acid similarity compared to rNaV1.2. All sequences are derived from the full 
transcripts published by the Ensembl database 
                  
Experimental standards used to determine whether an ion channel is modulated by G-
protein subunits have been established from studies involving potassium and calcium 
channels.  These criteria are taken from Dascal 2001: 
1. “Co-expression or direct application of the G-protein subunit mimics the effect 
of the transmitter; sequestration or knockdown of the G-protein subunit 
removes the effect of the transmitter”.  
2. “The protein mimics the effect of the neurotransmitter in a membrane delimited 
fashion”. 
3. “The G-protein subunit physically interacts with the channel”. 
4. “Prevention of G-protein binding to its established binding site (by competition 
and/or by mutation of the binding site) abolishes the regulation”. 
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In determining whether NaV1.1 is modulated by Gβγ part of the first and third criteria had 
been fulfilled by studies previously mentioned. In this study a second approach was 
employed to complete the first category, whereby scavenger proteins were used to 
selectively reduce endogenous Gβγ subunits. The c-terminal tails of GRKs have been 
extensively used as Gβγ sequesterants (Faivre et al.,2000; Lei et al.,2000; Lohberger et 
al.,2000; Kammermeier et al.,2000; Fernández-Fernández  et al.,2001; Melliti et al.,2001; 
Guo & Schofield 2002; Meza et al.,2007; Thapliyal et al.,2008; Figure 1.16 B). GRKs are 
involved in GPCR endocytosis by β-arrestins and GRK translocation to the membrane 
during this process is aided by Gβγ subunits. There are seven members of the GRK family, 
GRK 1-7, of which GRK2-3 and GRK5-6 are widely expressed including the brain (Penela 
et al., 2003). However, only GRK2 and GRK3 have Gβγ binding domains at their c-
terminal ends that are 39% identical (Pitcher 1998). This sequence variability results in the 
two proteins binding to specific and overlapping Gβ subunits. For example, only GRK3ct 
binds to Gβ3, but both GRK3ct and GRK2ct were co-purified with Gβ1 and Gβ2 (Daaka et 
al., 1997). It is thought that the Gγ subunits confer different Gβ-GRK binding affinities 
(Pitcher 1998).  
In this report GRK2ct and GRK3ct were co-expressed with NaV1.1 splice variants to 
selectively sequester Gβγ subunits and GRK5ct was used as a control peptide. A fatty acid 
signal (myristic acid) was attached to the peptides to promote membrane delimited protein 
interactions (Toby et al., 1997). Administration of a neurotransmitter to initiate dissociation 
of Gαβγ is not essential because GPCRs are constitutively active in continuous cell lines 
(see Figure 1.16 A, Hart et al., 1998; Gomperts et al., 2002) including HEK 293 cells used 
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in this study (data not shown). In response to a hyperpolarizing ramp protocol, for example, 
endogenous HEK 293 cell Gβγ subunits amplified GIRK currents that were attenuated by 
GRK2ct (Lei et al., 2001).  Since the specific GPCR(s) that Gβ2γ3, and NaV1.1, 
directly/indirectly interact with are speculative no ligand was applied to the cells.  
Another Gβγ sequesterant tool is Gα transducin (Gαt; Figure 1.16 B). This Gα subunit 
transduces light signals via the GPCR rhodopsin exclusively in retinal cells (OMIM 
139330). Gαt non-selectively sequesters Gβγ subunits because it possesses a high affinity 
for rhodopsin; therefore, if Gαt is exogenously over-expressed in HEK cells it is likely that 
Gαtβγ is formed. This „mops up‟ endogenous Gβγ as the Gαtβγ complex would only 
disassociate on rhodopsin stimulation (Federman et al., 1992; Barren et al., 2006). Similar 
to GRKct peptides Gαt has been used extensively in potassium and calcium channel 
research (Let et al.,2001; Cantí & Dolphin 2003; Filippov et al.,2004; Meza et al.,2007; 
Rangel et al.,2010). In a recent study, GTPγS up-regulated NaV1.9 derived persistent 
currents in small diameter sensory neurons (Ostman et al., 2008). Although in the Ma et al. 
(1997) study no increase of rNaV1.2 currents were observed by GTPγS stimulation and the 
Mantegazza et al. (2005) paper demonstrates that this maybe due to cell background. 
Therefore, this analogue of GTP was also used to assess G-protein subunit regulation of 
NaV1.1 splice variant persistent and transient currents.  
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Figure 1.16 Gβγ sequesterant peptides. A. Endogenous GPCR receptors can exist in two 
conformation states inactive (left large arrow, r) and active (right large arrow, R). In an 
active conformation GPCRs can initiate downstream events. The equilibrium between these 
two states exists regardless of the presence or absence of a ligand. Therefore, Gβγ 
sequesterant peptides are still effective in the absence of an agonist. However, for 
completeness, agonists bind to the active conformation (LIG.R) and will increase the rate 
constant (K.L) so that the percentage of active receptors is greater.  Inverse agonists bind to 
the inactive receptor conformation (lig.r) shifting the equilibrium, rendering a greater 
number of receptors inactive (Redrawn from Gomperts et al.,2002). B. The c-terminal tails 
of GRK2 and GRK3 act as selective sequesterants (top) and Gαt as a non-selective 
sequesterant of Gβγ subunits (bottom).  
 
1.4.3 The effect of temperature 
It is likely that the influence of both genetic and environmental factors generates FS in the 
developing brain of infants. FS can be triggered by fevers in response to infection, 
inflammation or stress (Vezzani & Granata 2005). Indeed, an inflammatory response, 
involving the secretion of cytokines is triggered in the brain area of seizure onset and 
A 
B 
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propagation in FS rodent models (Vezzani & Granata 2005).  One inflammatory mediator is 
Interleukin-1β (IL-1β), a pyrogenic cytokine that may directly evoke FS in the developing 
rodent brain (Dube et al., 2005; Vezzani & Granata 2005). IL-1β receptor null mice 
demonstrated significantly increased hyperthermic promoted seizure thresholds. Large 
doses of IL-1β elicited seizures without additional stimuli in healthy young mice but not 
their mutant IL-1β receptor counterparts (Dube et al., 2005). Moreover, increased levels of 
IL-1β have been found within CSF samples taken from children suffering with FS 
(Tütüncüoğlu et al., 2001; Haspolat et al., 2003). The pathological mechanism of IL-1β is 
undetermined but may deleteriously affect NMDA receptor function (Dube et al., 2005; 
Dube et al., 2009). In animal models hyperthermia induced hyperventilation and alkalosis 
induced FS (Schuchmann et al., 2006; Dube et al., 2007). An elevation in rat brain pH can 
be epileptogenic (Aram & Lodge 1987) but the role of alkalosis in human FS is 
controversial and its etiological contribution unknown (Dube et al., 2009).  TRP (transient 
receptor potential) channels are non-selective cation pores that open in response to various 
stimuli. TRPV1 and TRPV4 are heat activated and may be involved in the epileptogenesis 
of FS. TRPV4 channels have been shown to regulate the resting membrane potential in the 
hippocampus (Shibasaki et al., 2007). However, at fever temperatures these channels are 
up-regulated and may disrupt neuronal homeostasis. Furthermore, TRPV1 knockout mice 
were less susceptible to hyperthermic induced seizure thresholds compared to wild-type 
littermates (Kim et al., 2008). These studies imply that increased brain temperature may be 
sufficient to provoke FS.  
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A rare syndrome, hot-water epilepsy, has been documented in individuals who suffer either 
complex partial seizures or GTCS on exposure to hot water between 40 – 50oC  but 
underlying genetic causality is undetermined (Satishchandra 2003). Similar findings have 
been observed in SMEI patients (Fukada et al., 2009). Seizures are also induced in healthy 
rodent pups exposed to hyperthermic stimuli (Holtzman et al.,1981; Morimoto et al.,1991; 
Toth et al.,1998; Dube et al.,2000) but in one report different mouse strains demonstrated 
distinctive temperature induced seizure thresholds (Dube et al.,2005). This suggests that 
genetic factors are not necessary to cause FS but can greatly influence their severity. The 
Oakley et al. (2009) study discussed previously, which involved the SMEI mouse model 
showed that network vulnerabilities in the developing brain caused by reduced NaV1.1 
expression were only exposed at higher temperatures. At a molecular level, studies suggest 
that increased temperatures may perturb the trafficking of GEFS+ mutant channels.  For 
example, immunofluorescence investigations showed that HEK cells transfected with 
GABAA receptors containing one of the three mutant γ2 subunits previously described, at 
„fever‟ temperatures demonstrated γ2 and α subunit trafficking and membrane expression 
deficits. Under the same conditions patch-clamp recordings of mutant channels showed 
significantly attenuated chloride currents compared to wild-type channels (Kang et al., 
2006). However, trafficking defective GEFS+ NaV1.1 mutant channels are rescued when 
incubated at cooler temperatures (27
o
C; Rusconi et al., 2007; Rusconi et al., 2009).  
The biophysical properties of wild-type and mutant NaV1.1 channels are likely to be 
affected by temperature. In the advent of voltage clamp experiments clamping sodium 
currents was problematic because VGSCs would open before the charging of the membrane 
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capacitance was complete (Murray et al., 1990 and references therein). This has 
circumvented by technical advances in equipment but maintaining a stable seal at higher 
temperatures is still challenging, especially in heterologous systems. This study does not 
directly address the effects of „fever‟ temperatures on NaV1.1 splice variants but the 
experiments were performed at physiological temperatures. This was essential because 
recordings at low temperatures may give inaccurate data or mask subtle variations in VGSC 
behaviour (Andersen & Moser 2005).  
1.4.4 Intracellular anions  
Most work on heterologously expressed NaV1.1 employs intracellular solutions based on 
CsF to improve cell stability. Early experiments involving the squid giant axon, 
preparations perfused with fluoride ions demonstrated more stable resting membrane 
potentials, minimal action potential run-down, reduced leakage conductance and survived 
hours longer compared to axons perfused with chloride ions (Tasaki et al., 1965; Adelman 
et al., 1966; Chandler & Meves, 1970). The reason for this phenomenon is still eludes 
electrophysiologists (Lenz et al., 1997; Coste et al., 2004) but suggests that fluoride and 
chloride differentially affect the biophysical properties of sodium (and potassium) channels. 
Indeed, the gating and kinetics of NaV1.9 in several studies was dependent on the 
intracellular halide ion (Rugiero et al., 2003; Coste et al., 2004; Maingret et al., 2008).  
Despite its advantages fluoride exerts deleterious affects on the function of intracellular 
proteins. For instance, if fluoride is combined with aluminium leached from borosilicate 
electrode glass, it can disrupt G-proteins, which as previously discussed, are central to the 
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regulating NaV1.1 derived INaP. Aluminium fluoride ions (fluoroaluminate, AlF
-
4) associate 
with GDP forming a complex similar to GTP in its transition state during the GTPase 
reaction (Bigay et al., 1987). At lower, unspecified concentrations this activates G-proteins 
and in turn, affects the biophysical properties of G-protein modulated ion channels (Adams 
& Oxford, 1983; McCloskey & Cahalan, 1990; Ito et al., 1994; Terzic et al., 1994; Inoue & 
Imanaga 1995; Walsh et al., 1996; Kamouchi et al., 1997; Denson et al., 2005). However, 
at higher concentrations of AlF
-
4 the affects of G-protein activity are suppressed (Harwood 
et al., 1973a; Harwood et al., 1973b). During experiments using CsF an unknown quantity 
of fluoroaluminate is formed and its consequences therefore are unpredictable, and may 
introduce variability between recordings.  
Fluoride ions also inhibit phosphatases (Pinske et al., 1999). These are enzymes that 
regulate protein activity by removing phosphate groups from serine, threonine, or tyrosine 
residues (Lodish et al., 2000). Phosphatases modulate the activity of many voltage and 
ligand gated ion channels expressed in various cell types (Herzig & Neumann 2000). These 
include L-type calcium channels, GIRKs, NMDA receptors, GABAA receptors and other 
chloride channels to name a few (Herzig & Neumann 2000). Specific subtypes of 
phosphatases were shown to dephosphorylate rat neuronal VGSCs serine residues targeted 
by PKA (Chen et al., 1995). It is likely, therefore, that high concentrations of fluoride ions 
introduce further inconsistencies by interfering with VGSCs kinase modulation.  Because 
INaP is potentially contributing to drug effects, the properties of NaV1.1 splice variants 
using CsF and CsCl-based intracellular solutions were compared to determine whether the 
identity of the anion altered the kinetics of macroscopic currents from these channels. 
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1.4.5 Cell models for characterization of VGSCs  
It is clear from in vitro experiments that cellular background plays a vital role in α subunit 
regulation. It is possible that different splice variants are expressed in different types of 
neurons or astrocytes (Bordey & Spencer, 2004), or in the same neuron but in specific 
microdomains and could cause opposing effects. Non-neuronal cells do not replicate 
neuronal diversity, genetic background or subcellular specialization (Avanzini et al., 2007). 
Studies, using primary cell cultures allow these properties to be retained. There are 
different disadvantages to neuronal cultures, for instance, neurons express a plethora of 
other channels and the channel of interest cannot always be pharmacologically isolated 
(Avanzini et al.,2007). Moreover, neuronal input and outputs are lost on cell dissociation; 
this process may change neuronal phenotype. Another aim of this study is to determine the 
phenotype of cultured cells using the SC-RT-PCR method. This enables the examination of 
gene expression from a single cell. This paper describes preliminary SC-RT-PCR 
investigations that determine the phenotype of two-week cultured rat hippocampal cells. 
Although NaV1.1-5N is not produced in rodents, rat neurons were used to optimize this 
technically challenging method for use in other cell models.  
1.4.6 Human neuronal cell models 
Because of this loss of exon 5N in rodents, an additional aim is to find and optimize 
neurons or neuronal cells that do have alternative splicing at this site. This is difficult 
because primary cultures of human neurons cannot be used. A human cell line, 197VM, 
was investigated. These neural stem cells derived from the 10 week mesencephalon have 
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been engineered into a multipotent stable line that can be differentiated into neuronal-like 
cells within three weeks (Donato et al., 2007). Using SC RT-PCR and the whole-cell patch 
technique, their gene expression and „neuronal‟ functions were characterized to determine 
whether these cells were appropriate model candidates for use in NaV1.1 splice variant 
physiology.   
1.4.7 Animal neuronal cell models 
A non-rodent mammal would have to be easily obtainable, economical and with a short life 
span. Both Cavia porcellus (guinea pig) and Gallus gallus (chicken), two potential animal 
neuronal models investigated, fulfill these criteria.  Between the 1970-80s the Fayoumi 
epileptic strain (F.Epi) of chickens, a commonly used model for photosensitivity epilepsy, 
were extensively analyzed (Johnson & Tuchek 1987). The disease causing gene is still 
unknown but is inherited in an autosomal dominant manner (Sarkisian 2001). Although not 
a GEFS+ model per se both 2-5 day old F.Epi homozygous and heterozygous chicks 
displayed febrile GTCS induced by hyperthermia (Johnson et al., 1983). This effect was not 
observed in adult mutant fowl (Johnson et al., 1983). Additionally, their febrile seizures 
were resistant to particular AEDs including phenytoin but responded to phenobarbital 
(Johnson et al., 1983). Therefore, if exon 5 splicing is retained in this animal it would prove 
to be neuronal model for studies into SCN1A mutations.  
1.5 Experimental aims 
 To determine whether exon 5 SCN1A alternative splicing changes the behaviour of 
NaV1.1 channels. 
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 To evaluate the effect of intracellular anions and temperature on NaV1.1 channel 
behaviour. 
 To examine the effect of alternative splicing on the behaviour of NaV1.1 channels 
containing the GEFS+ causing mutation R1648H. 
 To assess the reponse of NaV1.1 wild-type and mutant channel isoforms to 
phenytoin. In an attempt to reveal a mechanistic mechanism for the association of 
rs3812718 polymorphism and AED dosage in patients with or without a GEFS+ 
mutation. 
 To characterize neuronal cell models to assess their suitability for investigating the 
behaviour of NaV1.1 channels in a neuronal background. 
 To examine the effect of G-protein regulation, in particular Gβγ modulation, of 
NaV1.1 splice variants. 
 To test whether distinct β subunit pairs differentially regulate the gating of NaV1.1 
isoforms. 
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Chapter 2: General materials and methods 
2.1 Molecular biology methods 
2.1.1  Bacterial media and reagents 
2.1.1a LB Broth 
20g LB Broth (Luria Bertani medium, Sigma) was dissolved in 1 litre of ddH2O. 
Autoclaved and stored at RT. 
2.1.1b LB agar 
17.5g LB agar (Sigma) was dissolved in 500 ml of ddH2O. Autoclaved and stored at RT. 
2.1.1c Antibiotics, LB plates and broth 
Antibiotic stocks were stored at -20
o
C in 1 ml aliquots. Stock preparations and 
concentrations are shown in table 2.1. To prepare LB plates, agar was melted and cooled 
before the correct concentration of antibiotic(s) was added (table 2.1). Agar was poured 
into 10 cm plates (VWR international), allowed to set and stored at 4
o
C. For culture of 
transformed E.coli, concentrations of antibiotics added to LB broth are also shown in table 
2.1.  
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Table 2.1 Antibiotic stock concentrations and dilutions for preparation of selective 
agar plates and bacterial culture media 
 
Antibiotic Stock concentration 
LB agar 
selection plate  
concentration 
LB broth culture   
concentration 
Ampicillin (Sigma) 100 mg/ml (ddH2O) 100 μg/ml 100 μg/ml 
Chloramphenicol 
(Sigma) 
30 mg/ml (ddH2O) 30 µg/ml 30 µg/ml 
Kanamycin (Gibco) 50 mg/ml (ddH2O) 50 μg/ml 50 μg/ml 
Tetracycline (Sigma) 
25mg/ml (100% 
ethanol) 
5 μg/ml 5 μg/ml 
Ampicillin & 
Tetracycline 
(as above) 
100 μg/ml &        
5 μg/ml 
100 μg/ml &           
5 μg/ml 
2.1.2 Bacterial culture 
2.1.2a Preparation of competent bacteria 
To prevent contamination equipment and surfaces were cleaned with 70% ethanol; glass- 
and plasticware were autoclaved and work was carried out in a fume cupboard (Fumair, 
Hertford, UK). 7 μl of either TOP10® or TOP10/P3® (Invitrogen) E.coli stock was grown 
overnight at 37
o
C on an agar plate. 2 ml of LB was inoculated with a single colony and 
incubated overnight with shaking at 37
o
C. The overnight culture was added to 500 ml of 
LB and incubated with shaking until OD596nm was 0.25 – 0.7. Cells were placed on ice for 
10 mins, centrifuged at 6000 rpm at 4
o
C for 10 mins (J2-21 High-Capacity Centrifuge, 
Beckman). Sterile filtered TB buffer prepared in 1 litre of ddH2O (10 mM PIPES, 55 mM 
MnCl2, 15 mM CaCl2, 250 mM KCl, pH 6.7) was pre-chilled to 0
o
C. The pellet was 
resuspended in 160 ml in TB and incubated on ice for 10 mins. E.coli were harvested as 
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previously, and resuspended in 40 ml of TB. The suspension was gently swirled as 2.8 ml 
DMSO was added dropwise to the bacteria.  Cells were kept on ice for 10 mins, then 
aliquoted into 1.5 ml tubes (Eppendorf). Aliquots were snap-freezed in liquid nitrogen and 
stored at -80
o
C.  
2.1.2b Transformation of E.coli by heat shock 
50 μl of TOP10® E.coli was thawed on ice. 2 μl of 50 ng of supercoiled DNA or 5 μl 
ligation reaction was added to the cells and incubated on ice for 30 mins. Bacteria were 
heat shocked for 30 seconds at 42
o
C and returned to ice for 3 mins. Cells were diluted in 
150 µl of S.O.C medium (20g/l (2% w/v) bacto-tryptone, 5g/l (0.5% w/v) bacto-yeast 
extract, 5g/l NaCl, 10 mM MgCl2, 10 mM MgSO4, 2 mM glucose; Sigma), at 24
o
C before 
being shaken (225 rpm, IKA Incubating Shaker) for an hour at 37
o
C.  The transformation 
volume was spread on an agar plate containing the appropriate antibiotic selection and 
incubated at 37
o
C overnight.  
2.1.2c Transformation of E.coli with NaV1.1 constructs 
2 µl SCN1A constructs and its variants were transformed into TOP10/P3
®
 E.coli by heat-
shock as previously described. These bacteria contain a low copy-number plasmid, P3, 
which includes tetracycline- and ampicillin-resistant genes. These are inactive during 
normal E.coli life-cycle, since they carry amber mutations rendering them inactive. pcDM8 
encodes the suppressorF gene that nullify these mutations, inducing bacterial resistance 
(Invitrogen 2008; Figure 2.1).    
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Figure 2.1 TOP10/P3 E.coli transformations with SCN1A-pcDM8 The antibiotic 
resistant genes in the P3 plasmid, within the E.coli, have an amber mutation (stop codon). 
SCN1A-pcDM8 contains repressor genes for the amber mutation. Therefore after 
transformation of this plasmid the resistant genes are switched on (i.e. the amber mutation 
is repressed). However, the amber mutation can revert i.e. mutate and the repressor genes 
can become in ineffective. This leads to excessive growth of non-transformed E.coli and 
poor DNA yields. This is prevented by growing bacteria in both antibiotics. 
 
SCN1A has a high spontaneous mutation rate when propagated in bacteria (Mantegazza et 
al., 2005). To minimise this phenomenon, during incubation cells were heated to 28
o
C. In 
conjunction with using a low-copy plasmid, this reduced propagation and therefore, 
metabolic burden on the E.coli. To reduce reversion rates cell were grown on plates 
containing both ampicillin and tetracycline (Table 2.1; Figure 2.1). 
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2.1.2d Overnight cultures 
To prepare cultures to purify approximately 100 ng/μl DNA or >500 ng DNA, 5 ml and 
200 ml respectively, of LB broth containing the appropriate antibiotic(s) (Table 2.1) was 
inoculated with a single colony of transformed bacteria. Cultures were incubated with 
shaking until OD600nm of 0.35 at 37
o
C (TOP10
®
 E.coli) or 28
o
C (TOP10/P3
®
 E.coli). 
Obtaining an OD600nm of 0.35 was vital when culturing TOP10/P3
®
 E.coli transformed with 
NaV1.1 clones.  Close monitoring of cell growth prevented bacteriophage infections, 
reduced mutation rates and DNA nicking.  
2.1.2e Glycerol stocks 
80% (v/v) glycerol was prepared and autoclaved. Equal volumes of the desired culture and 
glycerol were vortexed and aliquoted. Stocks were snap-freezed in liquid nitrogen and 
stored at -80
o
C.  
2.1.2f QIAfilter Maxi Plasmid Purification Kit 
200 ml overnight bacterial cultures were centrifuged at 6 000 rpm, for 15 mins at 4
o
C. 
Supernatants were removed and cell pellets resuspended in 10 ml of chilled P1 buffer (50 
mM Tris/HCl pH 8.0, 10 mM EDTA, 100 μg/ml RNase A). Samples were vortexed for 30 
secs to disperse bacterial clumps that can prevent effective lysis. Cells were lysed in 10 ml 
P2 buffer (200 mM NaOH, 1 % (w/v) SDS), inverted 10 times and incubated at RT for 5 
mins. During incubation Qiagen tips were equilibrated with 10 mls of equilibration buffer 
(750 mM NaCl, 50 mM MOPS, pH7.0, 15% (v/v) ethanol 0.15% (w/v) Triton-X). These 
contain a membrane covered in resin that binds to plasmid DNA. Samples were treated 
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with 10 mls of chilled neutralization P3 buffer (3.0 potassium acetate pH 5.0) before being 
poured into the barrel of a Qiagen cartridge. These cartridges contain a filter membrane that 
separates plasmid DNA from bacterial proteins and DNA. Samples were incubated at RT 
for 10 mins before their lysates were filtered through into a Qiagen tip and allowed to flow 
through the resin by gravity.  Tips were washed with 60 ml of QC wash buffer (1.0M NaCl, 
50mM MOPS pH 7.0, 15% (v/v) ethanol) to remove smaller proteins and bacterial RNA. 
DNA was eluted in 15 ml of QF buffer (1.25 mM NaCl, 50 mM Tris/HCl pH8.5, 15% (v/v) 
ethanol) and desalted by the addition of 10.5 ml isopropanol. Samples were centrifuged at 2 
500 rpm (Falcon 6/300R) for 90 mins at 4
o
C. Pellets were washed with 5 ml 70% ethanol 
and centrifuged at 2 500 rpm for 30 mins at 4
o
C. Finally, supernatants were removed and 
pellets air dried for 10 mins to allow for complete ethanol evaporation. DNA samples were 
resuspended in 150 μl ddH2O, and stored at -20
o
C. 
2.1.2g GenElute Plasmid Miniprep Kit for purification of 100 ng/μl DNA 
Although from a different company, this kit works on the same principles as the Qiagen 
purification maxiprep kit. 5 ml overnight bacterial cultures were pelleted at 4 000 rpm, for 
10 mins at RT (MSE Micro Centaur Plus). The supernatant was removed before the pellet 
was processed as described above. 50 μl eluted DNA in ddH2O was stored at -20
o
C. 
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 2.1.3 DNA manipulation  
2.1.3a DNA quantification 
The concentration of DNA samples were calculated using a spectrophotometer (Nanodrop 
ND-1000, Thermoscientific).  Although a ratio of absorbance at 260 nm and 280 nm 1.8 
indicates pure DNA this can alter depending on pH and the DNA nucleic acid content; 
therefore, samples <1.6 were discarded. 
2.1.3b Digestion of plasmid DNA with restriction endonucleases 
Restriction endonucleases stored in glycerol were obtained from New England Biosciences 
(NEB).  Digests were based on the manufacturer‟s guideline: at least 10 U of enzyme was 
used to digest 1 μg DNA. A high concentration of glycerol increases the rate of enzyme star 
activity (Wei et al., 2008). Therefore, the final reaction was >10 times the volume of 
enzyme to reduce aberrant digestion. The reactions were supplemented with x1 enzyme 
buffer to stabilize the endonucleases, and 100 µg/ml BSA to prevent enzymes interacting 
with plastic and/or the air-liquid interface (Williams et al., 1996). Typical digestion 
reactions are detailed in table 2.2 and were incubated for 1-12 hours at 37
o
C. Enzymes were 
subsequently inactivated by heating at 65
o
C for 20 mins. Digests were analyzed by agarose 
gel electrophoresis. 
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Table 2.2 Endonuclease enzyme recipes for digestion of DNA for various applications 
 
Type of digest 
Conc of 
DNA (ng) 
Volume of 
enzyme (μl) 
Units of 
enzyme 
(U) 
Volume of 
enzyme buffer 
(μl) 
Volume 
of x10 
BSA (μl) 
Final reaction 
volume in 
ddH2O (μl) 
Diagnostic 
digest 
30 0.5 10 1.5 1.5 15 
Large scale 
plasmid digest 
150 
5 
 
100 20 20 200 
PCR amplicon 
digest 
50 5 100 20 20 200 
 
2.1.3c Agarose gel electrophoresis 
DNA samples were separated by gel electrophoresis using 1–3% (w/v) agarose gels. 
Smaller fragments (100-500 bp) were resolved in 3% gels and larger DNAs (<500bp) in 
1.0% gels. Agarose (Sigma) was dissolved in x1 TBE (100 mM Tris, 83 mM Boric acid, 
1mM EDTA) and boiled. 1 μg/ml of ethidium bromide (Molecular Probes, Invitrogen) was 
added and the mixture was poured into an electrophoresis tray and allowed to set. On 
exposure to UV light, ethidium bromide bound to DNA fluoresces more intensely and 
permits nucleic acids detection. Prior to loading, one fifth total volume of 6x Orange G dye 
(10 mM Tris-HCl (pH 7.6), 0.15% orange G, 0.03% xylene cyanol FF, 60% glycerol, 
60 mM EDTA; Fermentas Life sciences) was added to each sample to monitor DNA 
migration. Reference molecular weight markers: 1kb and 100 bp DNA ladders (NEB) were 
run either side of the samples. Gels were electrophoresed at 100 V for an hour and 
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visualized using a UV-light transilluminator. Records were photographed digitally using 
the Gene Genius BioImaging System (Syngene).  
2.1.3d DNA fragment purification from agarose gels 
DNAs were run on TBE buffered agarose gels and viewed using a long wavelength (365) 
UV lamp to reduce mutations. Bands were cut from the gel using a sterile scalpel. DNA 
was extracted and purified using the QIAGEN DNA gel extraction kit following the 
manufacturer‟s instructions. 
2.1.4  Cloning 
2.1.4a Mutagenesis reactions 
Mutations were introduced into plasmid DNA using the QuikChange™ mutagenesis 
(Stratagene, CA) protocol. Mutagenesis primers were designed using the Primer X 
(website: http://www.bioinformatics.org/primerx/). All enzymes were chosen for their high 
fidelity in the amplification of DNA fragments of up to 12 kb. All PCRs were performed 
using a 2720 thermal cycler (Applied Biosystems) and constructs were sequenced at the 
Wolfson Institute for Biomedical Research, Scientific Support Services, UCL, to confirm 
successful mutagenesis and sequence integrity. 
The three amino acid changes encoded by exon 5N and D207N were introduced into the 
human SCN1A cDNA in the pcDM8 vector, using the following primers, reactions and 
cycling parameters: 
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5N primers from 5' to 3' sequence 
Forward: 
CATTACATTTGCGTTCGTCACAGAGTTTGTGAACCTGGGCAATTTCTCGGCATT
GAG 
Reverse: 
CGAGAAATTGCCCAGGTTCACAAACTCTGTGACGAACGCAAATGTAATGACAG
TG 
D207N primers from 5' to 3' sequence 
Forward: CAGAGTTTGTGAACCTGGGCAATGTCTC  
Reverse: ACATTGCCCAGGTTCACAAACTCTGTGAC 
 Polymerase chain reaction: 100 µl volume of 50 ng of DNA, 75 pmol each primer, 
200 µM mixed dNTPs, 10µl native Pfu 10x buffer (Stratagene) and 2.5 U of native 
Pfu polymerase (Stratagene). 
 Thermal cycling method: 95°C for 45 s, followed by 18 cycles of 95°C for 45 s, 
55°C for 45 s, 72°C for 15 mins and 72°C for 30 mins. 
The 5N primers and the above PCR conditions were also used to mutagenize SCN1A-
R1648H-pcDM8 to SCN1A-R1648H-5N. 
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2.1.4b Mutagenesis of β subunits tricistronic construct  
SCN1B - ECMV IRES - SCN2B - polio IRES – EGFP was a kind gift from Professor John 
Wood, UCL. Unfortunately, this construct had a premature start codon before the SCN2B 
sequence. Therefore to introduce a stop codon three nucleotides upstream of the SCN2B 
ATG codon the following mutagenesis reaction was performed:   
Primers from 5' to 3' sequence 
Forward: GAAAAACACGATGATAATTAGGCCACAACCATGCACAG 
Reverse: CTGTGCATGGTTGTGGCCTAATTATCATCGTGTTTTTC 
PCR conditions: 
 Polymerase chain reaction: 100 µl volume of 50 ng of SCN1B - ECMV IRES - 
SCN2B - polio IRES – EGFP, 25 pmol each primer, 200 µM mixed deoxynucleotide 
triphosphatases (dNTPs), 10 µl native Pfu 10x buffer (Stratagene) and 2.5 U of 
native Pfu polymerase (Stratagene). 
 Thermal cycling method: 95°C for 45 s, followed by 18 cycles of 95°C for 45 s, 
60°C for 45 s, 68°C for 16 mins and 68°C for 20 mins 
This plasmid was then used as a template for SCNXB - ECMV IRES - SCN2B - polio  
IRES – EGFP (Figure 2.2).  
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SCNXB-ECMV IRES-SCN2B polio IRES-EGFP
EGFP reporter
SV40 promoter
Kanamycin
resistent gene
Terminator
sequence
pBR322 origin
CMV promoterSCNXB
EMC IRES
SCN2B
Polio IRES
~7600bp
XhoI
BamHI
 
Figure 2.2 Schematic of the tricistronic vector SCNXB - ECMV IRES - SCN2B - polio 
IRES – EGFP Vector. SCN1BB and SCN3B were subcloned after the CMV promoter into 
the XhoI and BamHI cloning site (blue letters). RNA polymerase binds to the CMV 
promoter to initiate transcription. EMV IRES is internal ribosome entry site originated from 
encephalomyocarditis virus and allows for translation initiation within the mRNA 
sequence.  The EGFP reporter gene is under the control of a second, weaker IRES site 
derived from the polio virus. All three genes are therefore translated from a single strand of 
mRNA. The kanamycin resistant gene allows for selection and is under control of SV40 
promotor, cloned from the Simian virus 40. Terminator denotes the polyadenylation signal 
site which allows the end of transcription. pBR322 origin of replication ensures the vector 
is replicated in HEK 293 cells. It is derived from the pBR322 vector designed by Bolivar & 
Rodriguez, 1977.   
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2.1.4c Amplification of β subunits 
Non-mutagenic primers were designed using Primer3 available at 
http://workbench.sdsc.edu/. Annealing temperatures were 5
o
C – 10oC lower than the primer 
melting temperatures (Tm) calculated by the software. All primers were bought from 
Sigma-Aldrich. Extension times and temperatures were ascertained from the polymerase 
protocols provided by the manufacturer.  
SCN3B was amplified from human whole brain obtained from the Human Developmental 
Biology Resource at the Institute of Child Health (ICH). Reverse transcription is described 
in section 2.4. The coding sequence of SCN3B was amplified using the following Primers 
(designed against sequence NM_018400+3) and PCR conditions: 
Primers from 5' to 3' sequence 
Forward: CACCATGCCTGCCTTCAATAGATTGTT 
Reverse: TCACACTGCTCCTGTTCTATTCC 
PCR conditions: 
 Polymerase chain reaction: 100 µl volume of 50 ng of DNA, 25 pmol each primer, 
200 µM mixed dNTPs, 10 µl native Pfu 10x buffer (Stratagene) and 2.5 U of native 
Pfu polymerase (Stratagene). 
 Thermal cycling method: 95°C for 45 s, followed by 35 cycles of 95°C for 45 s, 
55°C for 45 s, 72°C for 1 min and 72°C for 5 mins. 
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Following protocols the PCR fragment was cleaned using the QIAquick PCR Purification 
Kit and subcloned into pcDNA3.1/V5-His-TOPO using the pcDNA3.1 directional TOPO
®
 
Expression Kit (Invitrogen), following instructions. SCN1B splice variant B cloned into the 
pCMV6-XL5 mammalian expression vector was bought from Origene Technologies, USA. 
Both vectors were used as templates to amplify β subunit DNAs with 5‟ XhoI and 3‟ 
BamHI restrictions sites ready to be subcloned into SCNXB - ECMV IRES - SCN2B - polio 
IRES – EGFP. The following primers and PCR condition were used (lower case letter 
indicate enzyme recognition sequences): 
SCN3B Primers from 5' to 3' sequence 
Forward: CCGctcgagCACCATGCCTGCCTTCAATAGATTGTT 
Reverse: CGCggatccTCACACTGCTCCTGTTCTATTCC 
SCN1BB Primers from 5' to 3' sequence 
Forward: ACGctcgagCACCATGGGGAGGCTGCTGGCC 
Reverse: CGCggatccTCAAACCACACCCCGAGA 
PCR conditions: 
 Polymerase chain reaction: 22.5 µl volume of Accuprime pfx supermix (Invitrogen) 
with 50 ng of DNA, 25 pmol each primer. 
 Thermal cycling method: 95°C for 5 mins, followed by 30 cycles of 95°C for 15 s, 
55°C for 30 s, 68°C for 1.5 min and 68°C for 10 mins. 
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SCN1B was excised from SCNXB - ECMV IRES - SCN2B - polio IRES – EGFP using 
appropriate restriction endonucleases (New England Biolabs, following the digestion 
protocol in Table 2.2). 100 μl linearized vector was ethanol precipitated in 900 μl 99% 
ethanol (VWR) and 40 μl 0.3M sodium acetate. The mixture was spun for 10 mins at 12 
000 rpm and washed in 500 μl 70% ethanol. After aspiration of the wash, the vector was 
air-dried for 10 mins before resuspension in 25 μl ddH20. The vector and PCR fragments 
were gel and column purified respectively. SCN3B and SCN1BB were inserted into vector 
using a 10 µl ligation reaction containing 1 µl 50ng vector, 1 µl 50ng insert, 1 µl ligase x10 
buffer (Promega) and 1U T4 ligase (Promega).  
 
2.1.4d Attachment of myristic acid attachment signals to the family of GRKs c-
terminals:  
The c-terminal (amino acids 495-689) of human GRK2, was amplified from whole human 
brain acquired from Institute of Child Health, UCL using the following primers (designed 
against sequence NM_001619+3) and PCR procedure: 
GRK2ct primers from 5' to 3' sequence 
Forward: CACCATGGGAATCAAGTTACTGGACAGTGATCAGG 
Reverse: CAGAGGCCGTTGGCACTG 
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PCR conditions: 
 Polymerase chain reaction: 100 µl volume of 50 ng of DNA, 25 pmol each primer, 
200 µM mixed dNTPs, 10 µl native Pfu 10x buffer (Stratagene) and 2.5 U of native 
Pfu polymerase (Stratagene), 8 μl dimethyl sulfoxide. 
 Thermal cycling method: 95°C for 45 s, followed by 35 cycles of 95°C for 45 s, 
57°C for 45 s, 72°C for 2 mins and 72°C for 5 mins. 
The DNA fragment was cleaned and subcloned into pcDNA3.1/V5-His-TOPO. The latter 
was a template for a second PCR reaction, where the c-terminus was amplified using the 
conditions above, with sense and antisense oligonucleotides containing EcoRI and NotI 
restriction sites, respectively:  
Forward: GTGgaattcGGAATCAAGTTACTGGACAGTGATCAGG 
Reverse: GTGgcggccgcCAGAGGCCGTTGGCACTG 
The mammalian expression vector pGTM (Toby et al., 1998) and was linearized with the 
appropriate restriction endonucleases (New England Biolabs), ethanol precipitated and gel 
purified. The cleaned c-terminus of GRK2 was inserted in-frame with a myristic acid 
attachment signal (MAS) within pGTM using the ligation reaction just described.  
GRK3 and GRK5 subcloned into bacterial expression vectors were acquired from 
Geneservice Ltd, Cambridge, UK.  These constructs were used as templates to amplify the 
c-terminals of GRK3 and GRK5 (corresponding amino acids 495-687 and 464-638; Figure 
2.3) using sense and antisense oligonucleotides containing EcoRI and NotI restriction sites 
respectively: 
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GRK3ct primers from 5' to 3' sequence 
Forward: GTGgaattcGGGATTAAGCTACTTGATTGCGAC 
Reverse: GTGgcggccgcCTAGAGGCCGTTGCTGTTTC 
GRK5ct primers from 5' to 3' sequence 
Forward: GTGgaattcGGGATTAAGCTACTTGATTGCGAC 
Reverse: GTGgcggccgcCTAGAGGCCGTTGCTGTTTC 
PCR conditions for amplification of both products: 
 Polymerase chain reaction: 100 µl volume of 50 ng of DNA, 25 pmol each primer, 
200 µM mixed dNTPs, 10 µl native Pfu 10x buffer (Stratagene) and 2.5 U of native 
Pfu polymerase (Stratagene) 
 Thermal cycling method: 95°C for 45 s, followed by 25 cycles of 95°C for 45 s, 
57°C for 45 s, 72°C for 4 mins and 72°C for 20 mins. 
GRK3ct and GRK5ct were subcloned into pGTM as described for GRK2ct.  
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GRK3          VNAADAFDIGSFDEEDTKGIKLLDCDQELYKNFPL-VISERWQQEVTETVYEAVNADTDK 
GRK2          VNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPL-TISERWQQEVAETVFDTINAETDR 
GRK5          VYCKDVLDIEQFS--TVKGVNLDHTDDDFYSKFSTGSVSIPWQNEMIETECFKELNVFGP 
              * . *.:** .*.   .**::* . *:::* :*.   :*  **:*: **         .  
 
GRK3          IEARKRAKNKQLGHEEDYALGKDCIMHGYMLKLGNPFLTQWQRRYFYLFPNRLEWRGEGE 
GRK2          LEARKKAKNKQLGHEEDYALGKDCIMHGYMSKMGNPFLTQWQRRYFYLFPNRLEWRGEGE 
GRK5          NGTLPPDLNRNHPPEPP------------------------------------------- 
                :     *::   *                                              
 
GRK3          SRQNLLTMEQILSVEETQIKDKKCILFRIKGGKQFVLQCESDPEFVQWKKELNETFKEAQ 
GRK2          APQSLLTMEEIQSVEETQIKERKCLLLKIRGGKQFILQCDSDPELVQWKKELRDAYREAQ 
GRK5          ---------------------KKGLLQRLFKRQHQNNSKSSPSSKTSFNHHINSNHVSSN 
                                   :* :* ::   ::   . .* .. ..:::.:.. . .:: 
 
GRK3          RLLRRAPKFLNKPRSGTVELPKPSLCHR-NSNGL 
GRK2          QLVQRVPKMKNKPRSPVVELSKVPLVQRGSANGL 
GRK5          STGSS----------------------------- 
 
Figure 2.3 GRK3 and GRK5 were aligned with GRK2ct to determine their analogous 
c-terminal regions. Sequences were aligned using the multiple sequence alignment 
program, ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/index.html) 
 
2.1.4e Subcloning G-protein βγ subunit sequestering constructs into IRES-DsRed2 
Gαt cDNA cloned into pcDNA3.1 was purchased from Missouri S&T. For identification of 
successful transfections all G-protein βγ subunit sequestering constructs were subcloned 
into the pIRES2-DsRed2 vector (Takara/Clontech, France, Figure 2.4). DNAs were 
amplified with forward primers containing a NheI site and reverse primers containing 
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BamHI (GRKXct-MAS) and EcoRI (Gαt) restriction sites (Figure 2.4). The 
oligonucleotides and PCR procedures are as described: 
GRKxct-MAS primers from 5' to 3' sequence 
Forward: GTGgctagcCGACTCACTATAGGGAGACCC 
Reverse: GTGggatccGCCTAGCATTTAGGTGAACTA 
Gαt primers from 5' to 3' sequence 
Forward: gctagcGTTTAAACTTAAGCTT 
Reverse: GTGgaattcGTTTAAACGGGCCCTCTAGAT 
PCR conditions 
 Polymerase chain reaction: 22.5 µl volume of Accuprime pfx supermix (Invitrogen) 
with 50 ng of DNA, 25 pmol each primer. 
 Thermal cycling method: 95°C for 5 mins, followed by 30 cycles of 95°C for 15 s, 
52°C for 30 s, 68°C for 1.5 min and 68°C for 10 mins. 
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pIRES-DsRed2-MAS-GRK2ct
5902bp
Kanamycin
SV40 promoter
DsRed2
EMC
IRES
MAS-GRK2ct
CMV promoter
pBR322 origin
Terminator
sequence 
NheI
BamHI
 
pIRES-DsRed2-MAS-GRK5ct
5627bp
Kanamycin
SV40 promoter
DsRed2
IRES
EMC
MAS-GRK2ct
CMV promoter
pBR322 origin
Terminator
sequence 
NheI
BamHI
 
A 
B 
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pIRES-DsRed2-MAS-Gαt
6367bp
Kanamycin
SV40 promoter
DsRed2
IRES
EMC
Gα Transducin
CMV promoter
pBR322 origin
Terminator 
sequence
NheI
EcoRI
 
Figure 2.4 Schematics of the bicistronic vectors pIRES-DsRed2-MAS-GRK2ct (A), 
pIRES-DsRed2-MAS-GRK5ct (B) and pIRES-DsRed2-MAS-Gαt (C). Regions are 
described in Figure 2.2. DNAs were subcloned into sites denoted in blue letters. DsRed2 is 
the reporter gene. 
 
Ligations were carried out as described previously. GRK3ct-MAS-pIRES2-DsRed2 was 
made by Klaus Wanisch within Dr Schorge‟s lab. Sources of all other plasmids used in this 
study are detailed overpage. 
 
 
 
 
 
 
C 
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Table 2.3 Sources of plasmids used in this study 
 
Protein Vector Source 
NaV1.1-5A pcDM8 
Prof. Massimo Mantegazza, 
Milan University, Milan 
NaV1.2-6N pcDNA3 
Prof. Holger Lerche, Ulm 
University, Germany 
NaV1.2-6A pcDNA3 Prof. Holger Lerche 
NaV1.1-5A R1648H pcDM8 Prof. Holger Lerche 
GIRK 1,4 GIRK1-IRES-GIRK4/pcDNA3 
Prof. Andrew Tinker, UCL, 
London 
Voltage-gated sodium channel 
subunits β1, β2 
SCNxB - ECMV IRES - SCNxB 
- polio IRES - EGFP 
Prof. John Wood, UCL, London 
Voltage-gated sodium channel 
subunit β1 splice variant 1B 
pCMV6-XL5 Origene Technologies, USA 
DsRed2 pIRES2 ClonTech, France 
GRK3 pCMV-sport6 Geneservice Ltd, Cambridge, UK 
GRK5 pOTB7 Geneservice Ltd, Cambridge, UK 
Gαt pcDNA3.1 Missouri S&T, USA 
2.2 Cell culture 
2.2.1 HEK 293 cell culture and transfection  
HEK 293 cells were maintained in Dulbecco‟s Modified Eagles medium (D-MEM Sigma), 
supplemented with 10% (v/v) foetal calf serum (Gibco), 1 % glutamine (2 mmol/l, 
Invitrogen) and 1 % penicillin–streptomycin solution (Pen/Strep 10 000 IU/ml to 10 000 
IG/ml, Gibco) at 37
o
C in a humidified atmosphere of air: CO2 (95:5%).  Cultures were 
passaged twice weekly by trypsination (Gibco ⁄ Invitrogen). 24 hours prior to transfection, 
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cells were grown to 20 - 30% confluency in 35 mm dishes (Nunc, Denmark) that contained 
sterilized 13 mm poly-D-lysine-coated coverslips (Menzel-Glaser).  Transfections were 
performed using Lipofectamine 2000 (Invitrogen) according the manufacturer‟s 
recommendations. 3 ug of total plasmid DNA was used. GFP was used as an indicator of 
successful transfectants. 
2.2.2a 197VM culture 
Non-differentiated 197VM cells were maintained in B27 growth medium supplemented 
with B27 neural cell supplement mix (Gibco), L-Glutamine (2 mM, Gibco), heparin (10 
Units/ml, Sigma), Gentamicin (50 μg/ml, Gibco), bFGF (10 ng/ml, Invitrogen) and EGF 
(20 ng/ml, Sigma). Cells were grown on laminin (Invitrogen) coated T25 cm
2
 flasks (Nunc 
Easyflask) in a humidified atmosphere of air: CO2 (95:5%). If cells became over 80% 
confluent cell viability and differentiation potential was dramatically reduced (Donato et 
al., 2007). Therefore, cells were strictly passaged every three days. Two hours prior to 
passaging, uncoated flasks were incubated with 20 µg/µl laminin diluted in 2.5 ml ice cold 
DMEM:F12 (Invitrogen), at 37
o
C. Monolayers were washed with 10 ml HBSS minus 
Ca
2+
/Mg
2+
 (Invitrogen) and treated with 2.5 ml x10 trypsin (Sigma) until cell detachment. 5 
ml of soyabean-trypsin inhibitor (Sigma) was added and cells were centrifuged at 500 g × 
for 5 min. Coated flasks were washed with 5 ml warmed DMEM:F12 and cells were 
replated at 3.5 x10
3 
cells/cm
2
 in fresh growth medium.  
2.2.2b 197VM differentiation  
In growth medium, cells were seeded at 10,000 cells/well in an uncoated 96-well plate 
(Corning Incorporated) and left to form aggregates for 7 days. After gentle titration, 
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dissociated masses from each well were plated on a corresponding 13 mm laminin coated 
Thermanox (Nalge Nunc International) coverslip. These were contained in 4 well plates 
(Corning Incorporated) and maintained for 3 – 4 days. Differentiation was started by 
starving the cells of growth factors for a specific time: 10 days for SC-RT-PCR analysis 
and 4 – 6 weeks prior to patch clamping. Media was routinely changed weekly.    
2.2.3 Rat hippocampal neurons 
Primary hippocampal cultures from newborn Sprague-Dawley rats were cultured under 
standard conditions and obtained from Dr Kirill Volynski, UCL.  
2.2.4 Chicken neuronal cultures 
Fertilized chicken eggs were obtained from Winter Egg Farm, Hertfordshire, UK.  A E14 
White Leghorn chicken embryo was decapitated. Its telencephalon, identified as two 
prominent lobes behind the optic cups, was dissected. Immature cerebral tissue was 
immediately digested in 500 μl trypsin and triturated using a 1 ml sterile pasteur pipette for 
2 mins. To aid dissociation cells were trypsinized for a further 14 mins. Cells were pelleted 
(300 rpm, 5 mins) and resuspended into DMEM supplemented with 10% FBS. Neurons 
were spun as before and washed in 2 mls ice-cold Hanks balanced salt solution 
(Gibco⁄Invitrogen). The suspension was centrifuged and resuspended in DMEM 
supplemented with 2% of the serum-free supplement B27 (Gibco⁄Invitrogen). 20 μl of the 
suspension was plated onto Poly-D-Lysine coated coverslips in 4-well plates and left at 
37
o
C in a humidified atmosphere of air: CO2 (95:5%) for 7 days. The culture medium was 
changed every 3 days. 
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2.3  Electrophysiology 
2.3.1 Voltage clamp recordings in the whole-cell configuration 
Voltage clamp recordings were made in the whole-cell configuration to functionally 
characterize macroscopic currents from transiently transfected NaV1.1 and GIRK 1,4 
channels. The same configuration was used to investigate whole-cell currents from 197VM 
differentiated neurons and chicken neurons.  
Details of components within the electrophysiological rig used in this study are shown in 
Figures 2.5 & 2.6, some are briefly discussed here. The Axoclamp 700B is an operational 
amplifier that not only maintained the voltage clamp, but also measured the macroscopic 
current.  It received two inputs: the recorded potential and the holding potential (voltage 
clamp). An electronic feedback system compensated for differences between these two 
signals by injecting a current that was representational but opposite in polarity of the 
membrane current. The latter was sent as an analogue signal to an analogue-digital 
converter (BNC-2090A, National Instruments), which relayed digitized signals to the 
computer to for manipulation/storage. Conversely, command digital signals from the 
computer, via the analogue-digital converter, were delivered to the amplifier to control the 
membrane potential clamp.  
Within the micropipette was a reversible Ag/AgCl2 electrode, which allowed electrons to 
flow from a copper wire connected to the Axoclamp 700B amplifier to the bath solution or 
vice versa. This reaction is finite and AgCl coating would wear off by either chemical or 
mechanical means. This occasionally would result in polarisation of the electrode and lead 
to drifting tip potentials in recordings.  Therefore at the start of weekly experiments the 
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silver wire was chlorinated with household bleach overnight. Additionally, the chamber 
was regularly cleaned to prevent crystallized salt forming around the bath introducing 
ground loops. All perfusion tubing was regularly washed with 70% ethanol to avoid 
bacterial and fungal growth.  
Typically 24-72 hours post-transfection, cell-attached coverslips were placed in a 
microscope-mounted recording chamber (Olympus; Figure 2.5) that was continually 
perfused (~1 ml/min, Figure 2.5) with extracellular solutions either at ~21
o
C or at 35 – 
39
o
C using a heated perfusion tube (Figure 2.6). Cultured neurons were only perfused in 
room temperature solution. It was essential that perfusion was stable before recording 
started to reduce noise. Recordings were made using filamented borosilicate glass pipettes 
(GC120F-10, Harvard Appparatus) pulled to resistances of 1-3 M (P-87 microelectrode 
puller; Sutter instrument company).  Under coarse control the electrode was lowered into 
the bath. A 10 mV seal test was used to calculate the resistance of the pipette, by clicking 
the resistance checkbox on the Axoclamp 700B commander (this can also be calculated 
using Ohm‟s Law: by dividing the test potential amplitude by the current response 
amplitude). Positive pressure was then applied to prevent debris blocking the end of the 
micropipette.   
Cells were chosen based on size, that is, cells with a capacitance more than 40 pF were 
discarded to avoid space-clamp errors and shape, preferentially convex. The micropipette 
was manoeuvred under fine control to hover over the cell before the positive pressure was 
released. To ensure the command and membrane potentials were equal, the pipette offset 
was immediately zeroed manually or using the amplifier commander. The pipette was 
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lowered so that it touched the membrane indicated by a slight reduction in the current 
response from the seal test. Gentle suction was then applied until a two gigaohm seal was 
formed between the micropipette and the cell lipid bilayer. The membrane was clamped to 
a holding potential of -80 mV to encourage seal formation. Once achieved, fast and slow 
capacitance transients were cancelled using the amplifier software. At higher temperatures 
it was essential that a good quality seal was formed, before a brief, forceful suck was 
applied rupturing the membrane, to form a whole cell configuration.    
The seal test was removed and whole-cell toggle on the software was clicked. This allowed 
for large transients formed by cell capacitance in series with pipette and access resistance to 
be cancelled (Molleman 2007). The cell capacitance and series resistance were also 
calculated using the amplifier software. At higher temperatures the series compensation on 
the Axoclamp 700B was unreliable and through an unknown mechanism would often 
introduce large transients. Therefore, in the majority of recordings the series resistance was 
<2 MΩ and compensation was avoided. Voltage protocols were started immediately as cell 
viability significantly reduced after 10 mins at physiological temperatures.  Current traces 
were Bessel filtered at 10 kHz and were acquired at a rate of 50 kHz.   
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Faraday cage Blocked
environmental electrical
noise (inherited from DMK).
Anti-vibration table Prevented
the introduction of mechanical
noise. It was cushioned by
pressurized nitrogen gas
(donated by DMK).
Gravity perfusion system Extracellular solutions were poured into two 50 ml syringes
and flow was controlled by multi-way taps. Superfusates streamed into the bath via
plastic tubing under gravity. This allowed for phenytoin administration during
experiments. Rate of flow was 1 ml/min.Operational amplifier
(Multiclamp 700B, Molecular
devices).
Oscilloscope This was
used to monitor current
responses during voltage-
clamp experiments
(Tektronic TDS 100 2B,
National Instruments)
PC Allowed for data
acquisition and analysis
(Dell). The amplifier was
controlled by Multiclamp
700B commander software
(Molecular Devices). Voltage
clamp protocols were
performed using custom
programs in Labview 8.0
(National Instruments).
Micromanipulator (arrow points
to control cube) Two
manipulators (Patchstar) both
with coarse and fine controls
were used to position the
headstage and micropipette
across the X,Y and Z axis.
Inverted microscope
(Olympus IX71) Cells were
viewed under x10 and x40
magnifications. Fluorescence
was excited by 120-watt lamp
(X-cite series 120, Exfo) and
wavelengths were filtered by
low signal to noise ratio cubes.
This allowed visualization of
red (DsRed2) and green (GFP)
fluorescence. Cubes were
fitted into the filter turret.
Cells could also be viewed in
bright field.
Recording chamber
Suction pipette
Perfusion waste was
aspirated (by a Watson
Marlow 5058 pump) and
collected into a 5 litre
round bottom flask.
Analogue - digital converter
(BNC-2090A, National
Instruments).
 
Figure 2.5 Components of the electrophysiological rig 
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Micromanipulator
Micropipette holder Secured
the position of the
microelectrode during
experiments (G23
Instruments, UCL)
Temperature probe
Measured the bath
temperature and was
monitored electronically by
ALA Scientific Instruments
software installed on the
PC.
Silver / silver chloride
ground pellet Grounded
the bath solution to
ensure low-noise during
recordings (Warner
Instruments).
Bath Chamber in which cells
were perfused with
extracellular solution
Waste aspirator
Tube leading to 
suction pipette Heated Perfusion Tube The
perfusion tubing was inserted into
a heated aluminum coil. To obtain
temperatures of 37oC the coil was
heated to 51oC and externally
controlled by software installed on
the PC (HPT-2a, ALA Scientific
Instruments software ).
 
Figure 2.6 Components of the electrophysiological rig surrounding the bath 
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2.3.2 Electrophysiology solutions 
 HEK 293 cells were perfused with (mM): NaCl 145, KCl 4, CaCl2 1.8, MgCl2 1, 
HEPES 10, (pH 7.35 with NaOH)  and patch electrodes were filled with either (in 
mM):  CsCl 150, EGTA 10, HEPES 10, (pH 7.35 with CsOH) or CsF 130, CsCl 
10, EGTA 10, HEPES 10 (pH 7.35 with CsOH). For potassium channel recordings 
the following intracellular solution was used (in mM): KCl 150, EGTA 10, HEPES 
10 (pH 7.35 with KOH). 
 The extracellular solution used for 197VM and rat hippocampal neurons was (in 
mM): NaCl 125, KCl  2.5, CaCl2 2, MgCl2 2, Glucose 30, HEPES 25, NBQX 10 
µM (pH 7.4 with NaOH), and intracellular solution (in mM) KMS 135, HEPES 10, 
Na-Phosphocreatine 10, MgCl2 4, Na-ATP 4, Na-GTP 0.4 (pH 7.2 with KOH). 
 Chicken neurons were perfused with (mM): 140 NaCl, 1.5 KCl, 2.5 CaCl2, 1 
MgCl2, 11 glucose, 10 HEPES (pH 7.4 with NaOH) and patch electrodes were filled 
with (in mM) 100K-gluconate, 40 KCl, 10 HEPES, 0.1 CaCl2, 2 MgCl2, 1.1 EGTA, 
2 Na-ATP (pH 7.2 with KOH). 
2.3.3  Voltage clamp analysis software 
Labview 8.0 (National Instruments) was used to design and control voltage protocols and 
analyze recorded current traces. Raw data was exported to Microsoft Excel and subsequent 
curve fitting and statistical analysis was performed by GraphPad Prism 5 (GraphPad 
Software, Inc, USA).  Membrane potentials were not corrected offline for the liquid 
junction potentials but were calculated as -4.4 mV in the Cesium chloride based 
intracellular solution, -9.3 mV in the Cesium fluoride based internal solution, -16.9 mV in 
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197VM stem cell recording solutions and -13.1 mV in chicken neuronal recording solutions 
using Clampex software (Molecular Devices).  
2.3.4 Current-voltage protocols and analysis 
From a holding potential of -80 mV, 100 ms voltage steps in 10 mV increments were 
administered every 10 seconds from -100 mV to +60 mV. From this protocol, normalized 
conductance curves, peak transient current densities, persistent current-voltage 
relationships, rate of current decay and 10 – 90 % current rise times were calculated as 
described below.  
2.3.4a Normalized conductance curves 
For individual cells the peak current amplitude at voltages 10 – 30 mV was plotted against 
the voltage step and fitted with a linear regression (y = mx + c). The reversal potential was 
x when y = 0.  Conductance was calculated using the following equation: G = I/(V-Vrev), 
where G is conductance (Siemens), I is the peak current (pA), V is the membrane potential 
(mV) and Vrev is the calculated reversal potential (mV). Conductance was normalised so 
that values were a fraction of the maximum conductance. Normalized conductance against 
voltage potential (-60 mV to +20 mV) was fitted with a Boltzmann equation: G/Gmax = 
(A+(B-A))/(1+exp((V50-V)/k)),where G/Gmax is the normalised conductance value, A is 
bottom of the curve (lowest value), B is the or top of the curve (highest value), V50 is the 
potential for half maximum normalized conductance, V is the test potential and k is the 
slope factor.  Boltzmann curves were fitted from average conductance values for each 
experiment. Mean V50 and slope factors were derived from Boltzmann fits of normalized 
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conductance-voltage data (-60 mV to -20 mV) from individual cells.   
2.3.4b Peak current density 
Currents from individual cells were normalized to their cell capacitance (pA/pF). The 
maximum current densities for each experiment were averaged.  
2.3.4c Persistent current-voltage relationships 
The mean current during the 20 – 30 ms after the initiation of the voltage step was 
normalized to cell capacitance. Mean current densities were plotted against the membrane 
potential (-100 mV - +60 mV). 
2.3.4d 10 – 90 % current rise times 
10 – 90 % rise-time to peak was calculated from normalized current from individual cells 
after a step from -80 mV to test potentials ranging between -20 mV and +20 mV. 
2.3.4e Rate of current decay (τh) 
The normalized current from individual cells was fit to a one-phase exponential decay from 
a holding potential of -80 to steps between -20 mV and +20 mV from 90% of peak current 
amplitude. The following equation was used: Y=(Y0 - Plateau)*exp(-K*X) + Plateau.  
Where Y is the normalized current,Y0 is the normalized current value when X (time) is 
zero (pA), Plateau is the normalized current at infinite times (pA), K is the rate constant 
(1/ms; taken from GraphPad prism 5)  
2.3.5 Voltage dependence of fast inactivation and percentage persistent current 
The voltage dependence of fast inactivation and percentage persistent current were assessed 
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using the following protocol: from a holding potential of -80 mV, cell membranes were 
voltage clamped with a run of -100 mV-+60 mV 100 ms prepulses, in 10 mV increments 
followed by a 30 ms test pulse to –10mV every 10 seconds.  
2.3.5a Fast inactivation 
Peak currents elicited by the test pulse were normalised as before described for 
conductance. Boltzmann curves were fitted from average normalized current values against 
voltage (-100 mV – 10 mV) for each experiment using the following function: I=(A+(B-
A))/(1+exp((V50-V)/k)) where I is the fraction of normalized current available, A is the 
bottom - , B top - of the curve, V50 is the voltage giving the half-maximal current, V is the 
test potential and k is the slope factor. Mean V50 and slope factors were derived from 
Boltzmann fits of normalized current-voltage data (-100 mV – 10 mV) from individual 
cells.   
2.3.5b Percentage persistent current 
%INaP was calculated as the mean current from the last 10 ms of the -10 mV test pulse 
from -80mV and expressed as a fraction of the maximum transient current. Due to the 
variability of this parameter the INaP from each voltage clamp protocol cycle, run during a 
single recording, was calculated from each cell and averaged. For each experiment mean 
values from single cells were used to calculate the total mean %INaP. 
2.3.6 Recovery from fast inactivation 
Recovery from inactivation in the presence or absence of 50 μM Phenytoin (PHT) was 
assessed using two-pulse protocol consisting of initial step to -10 mV for 100 ms, 
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sequential recovery intervals of 2 ms, 10 ms and 20ms at -80mV, and a test step to -10 mV 
for 30 ms. The current amplitude of the test pulse was expressed as a fraction of the current 
from the initial step to give a measure of fractional recovery, expressed as a percentage.  
2.3.7 Phenytoin preparation 
Stock solutions of PHT 100 mM were prepared in DMSO was stored at -20
o
C. Prior to 
electrophysiological recording, 50 µM PHT was prepared in extracellular solution and 
administered via the gravity perfusion system.  
2.3.8 GIRK 1,4 voltage protocols and analysis 
A 0.9 second ramp hyperpolarisation was applied from a holding potential of -50 mV down 
to -140 mV.   Mean values of the potassium conductance recorded from individual cells 
was calculated from a linear regression fit to the slope of the current-voltage data from -100 
to -120mV.  
2.3.9 Differentiated 197VMs voltage protocols and analysis  
Cells were held at -80 mV and stepped 100 ms to voltages between -100 and +40 mV in 10 
mV intervals every 10 seconds.  Individual currents recorded from the differentiated 
197VMs cells were normalized to their cell capacitance. Average values were plotted 
against the membrane potential.   
2.3.10 Chicken neuron voltage protocols  
To assess macroscopic neuronal currents, cells were held at -80 mV and stepped to voltages 
between -100 and +30 mV in 10 mV intervals every 10 seconds. After attaining the whole-
cell configuration the resting membrane potential (RMP) was measured in the current-
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clamp I = 0 mode. 
2.3.11 Leak subtraction 
Leak current was subtracted online using a -P/4 protocol. This involved subtracting 
summated, passive current responses to small positive voltage steps, from macroscopic 
waveforms produced after each test pulse. 
2.3.12 Statistics 
Results are expressed as means (±SEM) and graphing of the data and statistical analyses 
were performed using GraphPad Prism 5.  Individual statistical analyses are described in 
the text and a statistical significance was considered P<0.05. 
2.4 SC-RT-PCR 
The principle of nested SC-RT-PCR is shown overleaf in Figure 2.7. 
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Figure 2.7 Principle of nested SC-RT-PCR 
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2.4.1 Prevention of RNase contamination 
High levels of RNase‟s are found in bodily fluids therefore, equipment was handled with 
gloves. Working spaces and equipment were cleaned with 70% ethanol and Microsol™ 
(Anachem) to remove potential RNase sources. This was followed by treatment with an 
RNase decontamination solution RNAse-Zap (Ambion). Aerosol resistant tips (Axygen) 
were used to prevent RNase/DNA contamination via the pipettors. Tips, Ultrapure™ water 
(Invitrogen) and 0.2 ml thin walled tubes (Thermoscientific) were RNase-free. Glassware 
and plasticware used to prepare solutions were autoclaved. Where possible, equipment was 
stored in an air tight box to prevent environmental RNase contamination.  
Electrophysiological solutions were not prepared under strict RNAase-free conditions. 
However, all chemicals were opened using RNase-Zap decontaminated gloves and handled 
with RNAse-free tools. Before each experiment, both intracellular and extracellular 
solutions were 0.2 µm syringed-filtered (Supelco). The electrode-wire was rechlorinated at 
the start of each session or when RNase contamination was suspected.  
2.4.2 Cell harvesting & DNA decontamination 
Under visual observation, cell content including the nucleus, was aspirated using gentle 
negative pressure, into a <2MΩ pipette containing 6 µl intracellular solution. Care was 
taken to avoid DNA/RNA contamination from the bath solution and neighbouring cells. 
Using an adapted 1ml syringe content was injected into a chilled 0.2 ml thin-walled tube 
(Thermoscientific) containing 40U RNasin, a ribonuclease inhibitor (Promega). The 
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solution was decontaminated from genomic and stray DNA using the TURBO DNA-free™ 
kit (Ambion) following the manufacturer‟s instructions 
2.4.3 RNA reverse transcription 
1.5mM of mixed deoxynucleotide triphosphatases (dNTPs, Invitrogen) and 50 pmol of each 
oligonucleotide (Sigma), to amplify selected RNAs (Tables 3-6), were added to the single-
cell content.  The mixture was incubated at 70
o
C for 7 mins before being cooled at RT for a 
further 7 mins.  Contents were collected by a brief centrifugation before 4ul of 
Superscript™ 5x first-strand buffer (Invitrogen), 1µl of dithiothreitol (DTT, 0.1M, 
Invitrogen), 1µl of 200U Superscript™ III reverse transcriptase (Invitrogen) were added. 
To propagate cDNA synthesis samples were warmed to 55
o
C for an hour, followed by a 15 
min 70
o
C incubation to inactivate the enzyme. Samples were stored at -20
o
C until further 
processing.  
2.4.4 Amplification of cDNAs 
Each gene was amplified in a single 0.2 ml tube containing 2 µl template cDNA, 200 pmol 
outer oligonucleotides (Table 3-6), 200 µM mixed dNTPs (Invitrogen), 1mM MgCl2, 5µl 
10x Thermo-start
®
 buffer (Promega) and  3U Thermo-start
®
 DNA polymerase (Promega) in 
a final volume of 25 µl. A first polymerase chain reaction (PCR) consisted of 15 min hot 
start at 95
o
C followed by 25 cycles:  95
 o
C  for 45 secs, 57
 o
C  for 45 secs and 72
 o
C for 60 
secs; followed by a final elongation step at 72
 o
C  for 10 mins. A second, comparable PCR 
reaction was conducted with „nested‟ oligonucleotides using 2µl of the previous reaction as 
a template (Tables 2.4-2.7). The amplification protocol was repeated but reactions went 
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through 35 PCR cycles. The final products were visualized by ethidium bromide staining 
after electrophoresis in 3% agarose gels. Cells were considered positive for a given gene if 
the correct base-pair amplicon size was detected (Tables 2.4-2.7). 
Successful cellular aspiration and reverse transcription were only considered in reactions 
where either glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or βIII tubulin 
(TUBB3) mRNAs were detected. For each PCR amplification, controls for contaminating 
artifacts were performed by using sterile water, intracellular solution and extracellular 
solution removed from the bath instead of cDNA. Since the nucleus was harvested, the 
detection of genomic DNA was avoided by treating the aspirated contents with DNase and 
designing primers that targeted only exons. 
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Table 2.4: List of all nested oligonucleotides used in rat hippocampal SC-RT-PCR studies 
 
mRNA 
Seq reference 
number 
Oligo Primers from 5' to 3' seq Amplicon size (bp) 
GADPH NM_017008 Sense AGACAGCCGCATCTTCTTGT 142 
  Antisense TGATGGCAACAATGTCCACT  
SLC17A7 NM_053859 Sense TGAGGATCCTTCAGGGATTG 169 
  Antisense TACTGTACCAGGACCCCAGC  
GAD67 M76177 Sense GTTTGATCCGATCCAGGAGA 126 
  Antisense TCTATGCCGCTGAGTTTGTG  
TH NM_012740 Sense CAGGGCTGCTGTCTTCCTAC 247 
  Antisense GGGCTGTCCAGTACGTCAAT  
ChAT XM_224626 Sense TCATTAATTTCCGCCGTCTC 173 
  Antisense CCGGTTGGTGGAGTCTTTTA  
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Table 2.5:  List of all outer oligonucleotides used in rat hippocampal SC-RT-PCR studies 
 
mRNA 
Seq reference 
number 
Oligo Primers from 5' to 3' seq Amplicon size (bp) 
GADPH NM_017008 Sense TCTCTGCTCCTCCCTGTTCT 308 
  Antisense GATCTCGCTCCTGGAAGATG  
SLC17A7 NM_053859 Sense GTCTTTGGCTTTGCCATTGT 315 
  Antisense CAGGTACCAAAAGATCCCGA  
GAD67 M76177 Sense ACAAAAGGGATTTGTTCCCC 316 
  Antisense CTGGAAGAGGTAGCCTGCAC  
TH NM_012740 Sense CAGGGCTGCTGTCTTCCTAC 296 
  Antisense CTCCAAGGAGCGCTGGAT  
ChAT XM_224626 Sense TGGCCCAGAAGAGCAGTATC 275 
  Antisense CTCGATCATGTCCAGGGAG  
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Table 2.6: List of all nested oligonucleotides used in 197VM SC-RT-PCR studies 
 
mRNA 
Seq reference 
number 
Oligo Primers from 5' to 3' seq Amplicon size (bp) 
GADPH NM_002046 Sense GAGTCAACGGATTTGGTCGT 185 
  Antisense GACAAGCTTCCCGTTCTCAG  
SLC17A7 NC_000019.8 Sense CCATGGTCAATAACAGCACG 225 
  Antisense CTGAGGGGATCAGCATGTTT  
GAD67 NM_000817 Sense CCAACAGCCTGGAAGAGAAG 324 
  Antisense GGTGGTCAGAGAGCTCCAAG  
TH NC_000011.8 Sense AGTGCACCCAGTATATCCGC 203 
  Antisense GAACTCCACCGTGAACCAGT  
ChAT NC_000010.9 Sense TTTTGTGAGAGCCGTGACTG 283 
  Antisense CACAGGACCATAGCAGCAGA  
TUBB3 NC_000016.8 Sense CAGATGTTCGATGCCAAGAA 162 
  Antisense GGGATCCACTCCACGAAGTA  
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Table 2.7: List of all outer oligonucleotides used in 197VM SC-RT-PCR studies 
 
mRNA 
Seq reference 
number 
Oligo Primers from 5' to 3' seq Amplicon size (bp) 
GADPH NM_002046 Sense ACAGTCAGCCGCATCTTCTT 312 
  Antisense TTGATTTTGGAGGGATCTCG  
SLC17A7 NC_000019.8 Sense ATGAGTGGTCTGGGCTTCTG 324 
  Antisense CACGAAGATGACACAGCCAT  
GAD67 NM_000817 Sense CAGAAAACTGGGGCTCAAGA 404 
  Antisense TGTCTCTGCAGTCAACCAGG  
TH NC_000011.8 Sense GGGAAGACAATATCCCCCAG 484 
  Antisense GTCTGGTCTTGGTAGGGCTG  
ChAT NC_000010.9 Sense ACAACATCAGATCGGCCACT 275 
  Antisense GTAGCAGGCACCATACCCAT  
TUBB3 NC_000016.8 Sense GCGCCTGCACTTCTTCAT 250 
  Antisense GGCCACCTTCACGTTGTT  
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2.4.5 G-protein α subunit expression profiles in HEK 293s 
Confluent HEK 293 cells grown in T25 flasks from three different passages were harvested 
by scraping in 1 ml cold PBS (Gibco). Total RNA was extracted using Trizol agent 
(Invitrogen) following the manufacturer‟s instructions and stored at -80oC until further 
processing. Reverse transcription and a single round of cDNA amplification was carried out 
as described in section 2.4.3. Due to cDNA volume limitations, a maximum of seven 
oligonucleotides priming for specific genes, per reverse transcriptase reaction were used 
(Tables 2.8-2.10). 
2.4.6 Sequencing of SCN1A R1648H patient DNA 
Patient genomic DNA (150-650 ng/ul) was received from Dr Stephanie Baulac, Université 
Pierre et Marie Curie, France. Patient DNA was processed, sequenced and analyzed by 
Klaus Wanisch, a postdoc with Dr Stephanie Schorge‟s lab. 
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Table 2.8: List of all nested oligonucleotides used to amplify G-protein α subunits 
 
mRNA Expression
1
 
Seq reference 
number 
Oligo Primers from 5' to 3' seq Amplicon size (bp) 
GNAS Ubiquitous NM_016592 Sense GCCCAGTACTTCCTGGACAA 459 
   Antisense CTCGGGAGTAGCATCCTCAG  
GNAI1 Widely distributed NM_002069 Sense TTTTAGGGTGATGGCTTTGG 299 
   Antisense GTTGATCCAAAGGCAGGTGT  
GNAI2 Ubiquitous NM_002070 Sense CAGCCATCATCTTCTGCGTA 136 
   Antisense ATGGACGTGTCTGTGAACCA  
GNAI3 Widely distributed NM_006496 Sense ATCATAAGAGCCATGGGACG 174 
   Antisense GCTGAAGCAAGCTTGTACCC  
GNAO Neuronal BC030027 Sense TTTCCTGAATACACAGGCCC 258 
   Antisense CAACAGCAAAGAGTCCGTGA  
GNAZ Neuronal NM_002073 Sense ATGACTACGGCAAATCAGGC 357 
   Antisense GGGCTGCTTCTTTTTCCTCT  
GNAQ Ubiquitous NM_002072 Sense GGATCAACGACGAGATCGAG 242 
   Antisense TGGGATCTTGAGTGTGTCCA  
GNA11 Ubiquitous NM_002067 Sense GTCAGTGCCATCAAGACCCT 286 
   Antisense TCACGTTCTCAAAGCAGTGG  
1 
Wettschureck & Offermanns, 2005 
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Table 2.9: List of all nested oligonucleotides used to amplify G-protein β subunits 
 
mRNA Expression
1
 
Seq reference 
number 
Oligo Primers from 5' to 3' seq Amplicon size (bp) 
GNB1 Widely distributed NM_002074 Sense CTTGTGATGCTTCAGCCAAA 166 
   Antisense TCAGCACGAAGGTCAAACAG  
GNB2 Widely distributed NM_005273 Sense CTGGGTAATGACCTGTGCCT 193 
   Antisense CCCAGAGCTGGTGATGATTT  
GNB3 Widely distributed NM_013530 Sense ACAACCTCAAATCCCGTGAG 236 
   Antisense CCCCGAAATGAAGAGATTGA  
GNB4 Widely distributed NM_021629 Sense GCCAGGTCACACAGGGTACT 129 
   Antisense CCAGTGAATGTGGTGGTCTG  
GNB5 Neuronal NM_016194.3 Sense GGGAACAAAGTCCTGTGCAT 193 
   Antisense TATCCAAACCACCACAAGCA  
1 
Wettschureck & Offermanns, 2005 
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Table 2.10: List of all nested oligonucleotides used to amplify G-protein γ subunits 
mRNA Expression1 
Seq reference 
number 
Oligo Primers from 5' to 3' seq Amplicon size (bp) 
GNG3 Brain, blood NM_012202 Sense CACTTCGGAGAACCCCTTC 267 
   Antisense CATATCTCTGGGGTGCTTGG  
GNG4 Brain NM_004485 Sense AGCCTGTATGGACAGGGTCA 248 
   Antisense ATGCATGGTCTCTACAGGGG  
GNG5 Widely distributed NM_024377 Sense ACCATGTCTGGCTCCTCCAG 297 
   Antisense GCTTTTGTACAGGCTTCAAATGT  
GNG7 Widely distributed NM_024138 Sense CATCTCAAGTCCCCAAAACC 489 
   Antisense GGGTTCAACCATCACAATCC  
GNG8 Olfactory epithelium NM_010320 Sense AGACGGTGGAACAGCTGAAG 172 
   Antisense AGCAGAACACAAAAGAGGCG  
GNG10 Widely distributed NM_001017998 Sense CAGCTGCAGAGCTTCAACAGT 300 
   Antisense TTCACCCAGTTTTCTCACTCAA  
GNG11 Widely distributed NM_004126 Sense TAACCCTCATCTAGCACCCG 363 
   Antisense TGCAACTTCACTTCTTTGCG  
GNG12 Widely distributed NM_018841 Sense CTCTCCTTGTCCCAGCTTTG 358 
   Antisense TGTGAGGGCTATATTTGGGC  
GNG13 Brain, taste buds NM_016541 Sense CCCGACCTGATGAAGAACAA 224 
   Antisense TCACAGGATGGAGTGAATGG  
1 
Wettschureck & Offermanns, 2005 
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2.4.7  Microarray analysis of HEK 293 cells 
Messenger RNAs from three passages of HEK 293 cells, one passage harvested in 2007 
and another two in 2009 were extracted as above. Samples were decontaminated from 
genomic and environmental DNA using the TURBO DNA-free™ kit (Ambion) following 
the manufacturer‟s instructions. The quality of mRNA was verified by spectrophotometry 
and samples with a 260/280 ratio below 1.8 were rejected. 50 μg mRNA was processed and 
hybridized to Affymetrix Human Gene 1.0 ST Arrays. All microarray and computational 
analysis using Affymetrix Expression Console was performed by Dr Simone Sharma and 
Mrs Priya Banerjee, at the Wolfson Institute for Biomedical Research, Scientific Support 
Services, UCL. 
2.4.8 Analysis of SCN1A splicing in Guinea Pig 
Cavia porcellus leg muscle was obtained from Pnemolabs (UK). DNA from 100 mg tissue 
was extracted using the Wizard genomic purification kit
®
 (Promega) according to the 
manufacturer‟s recommendations. The published guinea pig SCN1A sequence (Ensemble 
transcript ID ENSCPOT00000002700) is incomplete and therefore, it was impossible to 
determine whether the region that codes for DI:S3 was alternatively spliced.  The neonatal 
human SCN1A sequence lies within introns 4-5 (Vega transcript ID 
OTTHUMT00000102661). Nucleotides 570-578 within human exon 4 align to nucleotides 
186-194 within guinea pig exon 2. It was reasoned that the unpublished guinea pig exon 3 
aligned to human exon 5 sequence. The following primers were used to amplify guinea pig 
exon‟s 2 to 5: sense TTACTTTCCTTCGAGATCCAT, antisense: 
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TGACTTCCAGTCAAACTCGTACA. In a final volume of 100 µl the 3kb DNA fragment 
was amplified with 50 ng of DNA, 25 pmol each primer, 200 µM mixed dNTPs, 10µl 
native Pfu 10x buffer (Stratagene) and 2.5 U of native Pfu polymerase (Stratagene). The 
PCR reaction was performed as follows:  95°C for 45 s, followed by 35 cycles of 95°C for 
45 s, 50°C for 45 s, 72°C for 4 min with a final extension of 72°C for 10 mins. Intron 2 was 
then sequenced using the following forward primer: TGTTTATCA 
TTTAAAATCACCAGGAA.  
2.4.9 Analysis of VGSC expression the chicken embryo 
The immature cerebral lobes from two E14 chicken embryos were dissected as previously 
described in section 2.2.5. Tissue was grounded with a chilled dounce homogenizer. Total 
mRNA was extracted immediately using Trizol agent (Invitrogen) following the 
manufacturer‟s protocol.  Primers were designed using predicted and verified sequences 
from the Ensembl database and are shown in table 2.11. Extreme care was taken in 
ensuring primers did not anneal to overlapping regions due to VGSCs sharing a high 
sequence similarity. Reverse transcription reactions and nested PCR protocols were 
performed as described in sections 2.4.3 and 2.4.4 (primers are listed in Table 2.11). 
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Table 2.11: List of all oligonucleotides used to amplify chicken VGSC genes 
mRNA 
Ensembl Seq reference 
number  
Oligo  Outer primers from 5' to 3' seq Inner primers from 5' to 3' seq Inner amplicon size (bp) 
SCN1A XM_422021.2 Sense TGTACCACCAGGACCAGACA TGTACCACCAGGACCAGACA 227 
  Antisense TGACAGTGAAATCGAGCCAG CCATATCTTCCAAGGGCTCA  
SCN2A O42420_CHICK Sense ATTTCGCAAATCCGAATCAG TTCTCTTCCCCACACCAGTC 107 
  Antisense GGCAGAAGCTGTCCAGTAGG ACATCCTTTGCACGACCTCT  
SCN3A 
scn3a_predicted_ 
when_aligned_with_human 
Sense 
GATTGCTGGAGTCCATGGTT TGGAGTCCATGGTTAAAAGTAAAA 
113 
  Antisense GGTTTCCCACAGAAAGGACA TCCATGGCCATAAACAAGGT  
SCN4A IPI00820559.1 Sense CCATATTCGGGATGTCCAAC ATCCTAAACAGTGGTCCCCC 141 
  Antisense GTCCAGGCAGTGGATTTTGT ATTGACCACGATGAGGAAGG  
SCN5A O42418_CHICK Sense TTGTCTATGGAGTCGAGGGG ACTGCAGCAGAGCTCACAAA 141 
  Antisense GCAAACTCAGGGATCTGCTC CACTGTGCTGCCTTCAGAAA  
SCN8A IPI00602451.2 Sense CTACGTTGGAGGAGGCAGAG ACGGTCTCTGAGGATGCTGT 138 
  Antisense CCTTCCGACAGCTCTTTGTC CGACAGCTCTTTGTCCTTCC  
SCN9A O42419_CHICK Sense GGGTGGTTGTGAATGCTCTT CTTGGGAACACTGCATCAGA 141 
  Antisense TACATGGGCTGCTTCCCTAC CCTAGAGTCAACGGCAGCAT  
SCN10A 
scn10a_predicted_ 
when_aligned_with_human 
Sense 
CCTTCAGACTGCTGAGGGTC GTCCTGGCAATCATCGTTTT 
109 
  Antisense CCCTTATGAATCCGAGCAAA GCCAGCGTATTTCACCATTT  
SCN11A 
scn11a_predicted_ 
when_aligned_with_human 
Sense 
GCGCAGAAAGTTGTGTCAAA AAGTTTCCAGGCAGCACTTG 
223 
  Antisense CTGAGAGACTTCAGGGCACC CCCATTTCAGAAGCATCTCC  
TUBB3 TBB3_CHICK Sense GCTGAACGTGCAGAACAAAA TCTGCCACGTTCATTGGTAA 134 
  Antisense GAACAAAGGAGACGAGCCTG TGTGAATTCCATCTCGTCCA  
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2.5 Immunofluorescnce 
2.5.1 Preparation of 4% Paraformaldehyde 
20g paraformaldehyde (PFA, Sigma-Aldrich) was dissolved in 500 ml of 1x PBS (Sigma-
Aldrich), pH 7.4. The solution was heated to 55ºC for two hours to encourage the PFA to 
dissolve. Using 1M NaOH the pH was adjusted to 7.4. The solution was 0.2 µm syringed-
filtered and stored at -20ºC in 40 ml aliquots. 
2.5.2  Preparation of Immunocytochemistry buffers 
250 mg of Albumine Bovine (Sigma-Aldrich) was dissolved 5 ml of 1x PBS to make 5% 
BSA. This was further diluted in 50 ml PBS to make the block buffer: 0.5% BSA. 1 ml of 
0.1% Triton (Sigma-Aldrich) was dissolved in 10 ml of block buffer to prepare the 
permeabilization buffer. All solutions were stored at 4
o
C for up to a week.  
2.5.2  Immunocytochemistry 
Prior to transfection HEK 293 cells were grown on sterilized 13 mm Poly-D-lysine coated 
glass coverslips. Cells were (co-) transfected for 12hrs with the appropriate DNA using 
Lipofectamine 2000. Cells were fixed directly in DMEM using 4% PFA for 3 mins and 
washed in 1x PBS three times. Cells were permeabilized for 5 mins using the 0.1% Triton 
in block buffer and were washed in 1x PBS three times and blocked in 0.5 % BSA for 1 
hour. All antibodies were diluted in block buffer. To detect NaV1.1, cells were incubated 
with diluted 1:200 rabbit anti-NaV1.1 (Millipore) for 24 hours at 4
o
C. Cells were washed 
three times in 1x PBS for 10 minutes. Coverslips were then incubated with fluorophore 
conjugated secondary antibodies: donkey anti-rabbit Alexa Fluor® 568 (Invitrogen), 
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diluted 1:1000, for 1 hour at RT. Cells were washed in distilled water and paper-blotted to 
prevent salt crystallization. Coverslips were mounted using Moviol (Calbiochem) 
containing 25mg/ml DABCO anti-fade reagent. Cells were viewed using a Zeiss 
AxioImager A1 fluorescent microscope. The microscope and immunofluorescence images 
were manipulated by Mr George Chennell at the Wolfson Institute for Biomedical 
Research, Scientific Support Services, UCL. The same protocol was repeated by Elin 
Reeves in immunocytochemistry experiments using CHO cells. Specific antibodies are 
noted in the text. 
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Chapter 3: The functional characterization of NaV1.1 splice 
variants 
3.1 Hypothesis and aims 
Hypothesis: Since splicing changes part of the ion channel thought to be important for 
sensing changes in membrane voltage, it was surmised that NaV1.1-5A and NaV1.1-5N 
would possess different biophysical properties. It was predicted that these would be altered 
by different intracellular anions, known to distinctively act on downstream signalling 
pathways and by temperature. The AA genotype of the rs3812718 polymorphism is 
associated with higher phenytoin dosage suggesting that its efficacy is decreased when 
acting on a higher proportion of the 5A variant. It was therefore hypothesized that 
phenytoin would demonstrate an enhanced effect when acting on NaV1.1-5N compared to 
NaV1.1-5A channels. 
Many of the α subunits of sodium channels are alternatively spliced in their first domain 
and one amino acid in the extracellular linker is consistently different between the two 
exons. Whereby neonatal exon encodes a neutral amino acid, asparagine, the adult exon 
encodes a negatively-charged amino acid, aspartate. It was hypothesized that any channel 
behavioural differences between the two isoforms would be due to this conserved amino 
acid change. 
Experimental aims: There were several aims to this chapter. The main aim was to 
investigate the impact of exon 5N on the NaV1.1 channels and secondary to this, to assess 
the impact on channel gating by the conserved amino acid change. Therefore, in transfected 
 190 
HEK cells, using whole-cell patch clamp, the macroscopic properties of INaT and INaP of 
the two splice variants and NaV1.1-D207N were assessed. Another aim was to establish 
optimal physiological recording conditions; therefore the impact of internal solutions, cell 
background and temperature on NaV1.1 behaviour were examined. The last aim was to 
reveal a mechanistic mechanism for the association of rs3812718 polymorphism and AED 
dosage; consequently, NaV1.1 splice variant sensitivity to phenytoin was investigated.  
The results are divided into the following sections: 
1. Genetic and electrophysiological evaluation of HEK 293 cells. 
2. Comparison of NaV1.1 splice variant channel behaviour at RT using CsCl and CsF-
based internal solutions. 
3. Assessment of NaV1.1 splice variant and NaV1.1-D207N gating at 37
o
C using CsCl-
based intracellular solutions. 
4. Comparison of RT and 37oC NaV1.1 macroscopic recordings using CsCl-based 
intracellular solutions. 
5. Assessment of the recovery from inactivation of NaV1.1 isoforms and NaV1.1-
D207N in the presence and absence of phenytoin. 
3.1.1: Controls: Untransfected HEK 293 cells do not express voltage-activated currents  
Endogenous channels would potentially distort data from the expressed channels. The clone 
of HEK 293 cells used in these experiments (derived from ATCC) was assessed for 
currents during protocols used for comparing sodium channels. The HEK 293 cell line is an 
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established expression system used for electrophysiological studies into voltage-gated ion 
channels. Immunocytochemistry and microarray analysis suggest that these cells belong to 
a neuronal (Shaw et al., 1992) rather than a metanephric lineage (Graham & Smiley, 1977).  
Indeed, endogenous voltage-activated currents are present in particular HEK 293 cell lines, 
including currents from voltage-gated sodium, calcium, chloride and potassium channels 
(Ukomadu et al., 1992; Cummins et al., 1993; Berjukow et al., 1996; Zhu et al., 1998; 
Avila et al., 2004). Although in the Zhu et al. 1998 study the potassium currents were 
blocked by cesium within the internal solutions.   
To detect possible intrinsic voltage-activated currents recordings were performed at room 
temperature from untransfected HEK 293 cells using the whole-cell configuration. Both 
150 mM CsCl and 130mM CsF based internal solutions were used. Cells were held at -80 
mV and stepped to voltages between -100 mV and +60 mV in 10 mV steps. The current 
density for each cell was calculated by normalizing the current amplitude in the last 
millisecond of the 100 ms voltage step to cell capacitance. Small inward and outward 
currents peaking at +60 mV were observed using CsCl (mean ±SEM = -17.1 ± 3.5 pA/pF; 
n=5), and CsF (mean ±SEM = 23.3 ± 14.2 pA/pF; n=7; Figure 3.1 A) solutions 
respectively. At -10 mV - an experimentally relevant voltage with regards to calculating 
percentage persistent current (see chapter 6) - negligible peak current densities were 
observed: using CsCl, mean (±SEM) non-specific currents were -5.2 ± 2.1 pA/pF (n = 5, 
Figure 3.1) and using CsF 4.9 ± 4.3 pA/pF (n=7; Figure 3.1 A). 
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Figure 3.1 Electrophysiological properties of untransfected HEK 293 cells used in this 
study. At room temperature negligible currents were observed from whole-cell patch clamp 
recordings of untransfected HEK 293 cells using either a 150 mM CsCl (n=5) or 130mM 
CsF (n=7) based intracellular solutions. Cells were held at -80 mV and stepped to voltages 
between -100mV and 60 mV in 10 mV intervals (inset). Currents were normalized to cell 
capacitance. 
 
3.1.2: Controls: The gene expression profile of three HEK 293 passages used in this 
study were comparable   
Several groups have noted the properties of cell lines can change over time (reviewed in 
Hughes et al., 2007), and these changes can introduce non-intrinsic changes to 
heterologously expressed ion channels (for example by altering kinase/phosphatase 
activity). The experiments described here were carried out over many months and to assure 
the cells used were comparable, gene expression was examined in three different batches of 
HEK cells from timepoints spanning more than one year. 
It is unsurprising that the behaviour of NaV1.1 channels, which are heavily modulated by 
intracellular signalling pathways are dramatically altered by cellular background (Avanzini 
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et al., 2007). This is particularly significant when considering INaP current. A previous 
study demonstrated that levels of NaV1.1-5A derived INaP was considerably altered within 
two clonal lines originating from the same HEK 293 cell line (Mantagazza et al., 2005).  
Therefore to accurately characterize and compare both splice variants it was essential to 
establish that cell background conditions were stable. 
The mRNA harvested from three batches of HEK 293 cells was subjected to microarray 
analysis as described in the methods (Chapter 2). Briefly, one batch of mRNA originated 
from a passage of cells from in 2007 and two batches were from different passages in 2009 
(the majority of electrophysiological recordings were carried out in 2009). A Pearson‟s 
ranked correlation determines the extent of fluorescent signal linearity between mRNA 
samples: a rank of „1‟ indicates a perfect correlation, while „0‟ indicates no correlation 
between groups. There was a strong correlation between the normalized fluorescence 
between the three passages (Figure 3.2). The two RNA batches from cells harvested in 
2009 demonstrated a higher linearity at ~0.99,   compared to the passage from 2007 at 
~0.95 (Figure 3.2).  Unfortunately there were too few samples to provide an accurate 
indication of the relative abundance of VGSC transcripts.  Nevertheless electrophysiology 
and microarray data confirmed that this HEK 293 cell line was a suitable cell model for 
electrophysiological investigations, and that gene expression in these cells was relatively 
stable over different batches. 
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Figure 3.2 Gene expression profiles of three HEK 293 passages used in this study were 
indistinguishable.  Messenger RNA was harvested the same HEK 293 cell line but from 
three different passages in years 2007 and 2009. Each passage was analyzed by 
microarrays. The above Pearson‟s correlation plot, where 1 indicates a perfect correlation 
and 0 no correlation, shows that the normalized fluorescence between the three passages 
was highly linear. Note the scale begins at a very high correlation of 0.95 (blue). 
 
3.1.3: Controls: Endogenous currents and filtering at physiological temperatures 
Because voltage-gated ion channels can be activated at higher temperatures (Dhaka et al., 
2006), control recordings were repeated on untransfected HEK 293 cells, in bath solutions 
at 34 ± 3
o
C using CsCl-based intracellular solutions. In addition, because sodium channels 
activate and inactivate significantly faster at physiological temperatures, the distortion 
introduced by filtering that is acceptable in RT recordings, may distort currents at higher 
temperatures. Thus the peak currents were compared for currents filtered at decreasing 
bandwidths to determine what cut-off provided the best compromise between noise and 
peak dampening. As at room temperature, minimal currents were recorded, with a mean 
(±SEM) peak inward current of -4.0 ± 1.6 pA/pF (n=26) at 50 mV. At -10 mV the mean 
(±SEM) current was –1.8 ± 0.5 pA/pF (n=26, Figure 3.3 A).  
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Figure 3.3 10 kHz filter is optimal for recording NaV1.1 currents at biological 
temperatures. A. At temperatures averaging 34
o
C negligible currents were observed from 
whole-cell patch clamp recordings of untransfected HEK 293 cells using CsCl (n=26) 
based intracellular solutions. Cells were held at -80 mV and stepped to voltages between -
100mV and 60 mV in 10 mV intervals (inset). Currents were normalized to cell 
capacitance. B. Mean (±) 10-90% rise times to peak were calculated from NaV1.1-5A 
currents (n=3) elicited by a test pulse to -10 mV from -80 mV. Currents were filtered at 
frequencies ranging from 20-0.1 kHz. Little variation in rise times weas observed between 
6 and 20 kHz (P=0.9; one-way ANOVA). Since the peak current (C) decreased at 6 kHz, 
and 20 kHz may have introduced too much noise, 10 kHz was selected.  
 
The MultiClamp 700B possesses a 4-pole Bessel filter and at room temperature whole-cell 
currents were filtered at 10 kHz and sampled at 50 kHz. However, at increased 
temperatures a 10 kHz cut-off frequency may have not been adequate. To prevent the 
distortion of data currents need to be filtered approximately ten times faster than the 
expected 10-90% rise time of a step input. “The filtered 10-90% risetime (Tr, in ms) of a 
step input depends on fc (in kHz) approximately as: Tr ≈ 0.35/fc” (Axoclamp 700B 
manual).   To determine which fc was optimal at physiological temperatures cells 
transfected with NaV1.1-5A were held at -80 mV and stepped to a -10 mV – a potential 
estimated to elicited ~90 % peak sodium current - for 100 ms for six cycles. Each cycle was 
filtered at a different frequency ranging from 0.1 to 20 kHz (Figure 3.3 B). Experiments 
were performed at 37 ± 4 
o
C.   The mean 10-90% rise time to peak at 20 kHz, 10 kHz and 6 
A B C 
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kHz was 0.4 ms (n=3; Figure 3.3 B). According to the above equation 10 kHz was optimal, 
as 20 kHz may have introduced too much noise and at 6 kHz the peak current was clipped 
(Figure 3.3 C).  
3.2 Comparing NaV1.1 splice variants in conditions typical in literature and those more 
relevant to physiology 
It was important to establish recording conditions that would allow accurate measurement 
of the effects of AEDs, namely phenytoin, on the biophysical properties of the two splice 
variants. This is because altered phenytoin dosage is associated with rs3812718 and this 
drug is thought to work via two mechanisms: either delaying recovery from inactivation 
and /or blocking persistent sodium current (Matsuki et al., 1984; Kuo & Bean 1994; Chao 
& Alzheimer, 1995; Gebhardt et al., 2001). Both of these processes are likely to be 
sensitive to different recording conditions.  
In the literature investigations into heterologously expressed NaV1.1 predominantly use 
CsF-based intracellular solutions (Lossin et al., 2002; Spamanato et al., 2001) as the 
electrophysiologist can achieve rapid gigaohm seals and whole-cell recordings are more 
stable. Aluminium fluoride ions, however, are known to disrupt the functions of G-proteins 
and phosphatases, both of which are known to regulate VGSC derived INaP (Cantrell & 
Catterall, 2001; Mantegazza et al., 2005). Since persistent current is a potential target of 
phenytoin, and an important modulator of neuronal excitability, the presence of fluoride 
could potentially obscure the physiological impact of this drug. The first portion of this 
section (Fluoride/chloride: 3.2.1) compares the transient and persistent currents of NaV1.1 
splice variants using CsF- and CsCl-based intracellular solutions. The results presented 
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here demonstrate that a change in internal anion significantly affects NaV1.1 splice variant 
behaviour for several biophysical parameters. The purpose of these experiments was to 
establish whether CsF, a less physiological solution, did significantly alter channel gating 
not to reveal a physiological mechanism for these changes. 
A second potential difference between the work reported here and most published data on 
cloned sodium channels is the temperature of recordings. Most reports on heterologously 
expressed sodium channels use RT recordings; however sodium channels may behave 
differently at RT and 37
o
C. Additionally, the epilepsies associated with sodium channels, 
are profoundly sensitive to changes in temperature. In fact, fever-induced seizures are a 
hallmark of genetic epilepsy caused by mutations in SCN1A. The second part of this section 
(Temperature: 3.2.2) systematically compares the effects of increasing temperatures on 
NaV1.1 splice variants.  
3.2.1 Fluoride/Chloride 1: NaV1.1 transient current density is unaffected by intracellular 
anion   
HEK 293 cells were transiently transfected with either NaV1.1-5N or NaV1.1-5A. 
Macroscopic currents were recorded in the whole-cell configuration. Example traces of 
sodium currents from NaV1.1-5A and NaV1.1-5N, evoked from voltage steps shown in the 
inset, recorded using CsF- (top panel) and CsCl- (bottom panel) based intracellular 
solutions are shown in Figure 3.4 A.  To obtain the current-voltage relationships for each 
NaV1.1 splice variant, cells were held at -80 mV and stepped to voltages between -100 and 
+60 mV in 10 mV intervals for 100ms.The transient current density, at each test potential, 
for each cell, was calculated by normalizing current amplitude to cell capacitance (pA/pF). 
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A two-way ANOVA reveals that the mean (±SEM) peak current density for NaV1.1 was 
unaffected by splicing or intracellular anion (P=0.2; Figure 3.4 B).  
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Figure 3.4 Peak current densities of NaV1.1 splice variants were not affected by 
intracellular anions  A. Raw traces of NaV1.1-5A (left) and 5N (right) sodium currents 
using CsF (top) and CsCl (bottom) intracellular solutions. Sweeps were recorded from the 
current protocol depicted in the inset. B. Mean (±SEM) peak current densities were 
calculated from I-V relationships of individual cells normalized to cell capacitance. A two-
way ANOVA did not reveal any differences between the splice variants. 
3.2.1 Fluoride/Chloride 2: NaV1.1 derived persistent current is more stable using CsCl 
based solutions 
The current density of the persistent, or non-inactivating, current was calculated from the 
activation current protocol. The mean current during the 20-30 ms after the initiation of the 
voltage step was normalized to cell capacitance (Figure 3.5 A). As shown in Figure 3.5 B 
the NaV1.1 persistent current was voltage dependent, peaking at -10 mV using CsF-based 
solutions and 0 mV using CsCl-based solutions (mean ± SEM peak current density: CsF 
5A: -9.4 ± 3.0 pA/pF, n=9; 5N: -3.5 ± 1.3 pA/pF, n=14; CsCl 5A: -15.2 ± 6.5 pA/pF, n=14; 
5N: -13.6 ± 2.3 pA/pF, n=11).  At no voltage step was the persistent current density 
A B 
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significantly different between the two splice variants using CsCl-based solutions (P=0.2, 
two-way ANOVA). Using CsF internal solutions, however, the average current density 
between the two isoforms was significantly different (P=0.005, two-way ANOVA). At -10 
mV and 0mV with NaV1.1-5A demonstrated a greater ~ 5pA/pF current density compared 
to NaV1.1-5N (P<0.05, Bonferroni‟s post test).   
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Figure 3.5 At RT NaV1.1 persistent current is voltage dependent and was greater 
using CsCl-based solutions A. The current density of the persistent current was calculated 
from the activation current protocol (right). The mean current during the 20-30 ms after the 
initiation of the voltage step was normalized to cell capacitance. Times shown in the figure 
are estimates. B. I-V relationship of persistent currents derived from NaV1.1 splice variants 
all conditions. Using CsF- and CsCl-based solutions the persistent current was voltage 
dependant and in latter more stable. NaV1.1-5N persistent current was significantly reduced 
in fluoride compared to NaV1.1-5A channels (two-way ANOVA, **P=0.005).  
A 
B 
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It was assumed that persistent current was a proportion of heterologous expressed NaV1.1 
that remained active. %INaP was calculated from the inactivation protocol, as the mean 
current from the last 10 ms of the -10 mV test pulse from -80mV and expressed as a 
fraction of the maximum transient current (Figure 3.6 A). In agreement with the current 
density data there were no differences in the %INaP between the splice variants using CsCl 
(5A versus 5N, P=0.9, 2-tailed t-test) but there was a significant increase in persistent 
current derived from NaV1.1-5A (7.8 ± 1.7%, n=12) compared to NaV1.1-5N channels (3.6 
± 1.1%, n=13) using CsF (P=0.04, two-tailed t-test; Figure 3.6 B). 
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Figure 3.6 The NaV1.1-5A persistent currents were significantly increased using CsF 
solutions only A. %INaP was calculated from the inactivation protocol (right), as the mean 
current from the last 10 ms of the -10 mV test pulse from -80mV (indicated by arrow) and 
expressed as a fraction of the maximum transient current (red circle). The mean %INaP was 
then calculated for individual cells representing the average INaP over the complete 
timecourse of recordings.  B. Mean (±SEM) NaV1.1-5A derived %INaP was significantly 
increased using CsF but nor CsCl internal solutions compared to NaV1.1-5N channels. 
*P=0.04, two-tailed t-test. 
 
 
In presence of chloride the persistent component of the current was more stable and this 
effect was more pronounced for NaV1.1-5N channels. A change in anion did significantly 
A B 
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alter NaV1.1-5A persistent current density overall (CsF versus CsCl P=0.003, two-way 
ANOVA) but not at a specific voltage (Bonferroni‟s post-test). However, NaV1.1-5N was 
more sensitive to the change in intracellular anion. A significantly greater persistent current 
at voltages between -10 mV and + 60 mV was observed using CsCl compared to CsF based 
intracellular solutions (P<0.001, for each noted test potential, two-way ANOVA, 
Bonferroni‟s post test). 
The persistent current was extremely variable both between cells and over time within the 
same recording. The scatter plot in Figure 3.7 shows that %INaP at -10 mV at 4, 8 and 12 
minutes after whole-cell configuration, for both splice variants in the two internal solutions. 
Times are approximate because experiments were stopped for brief intervals to correct for 
small changes in capacitance and series resistance. This plot presents an example of the 
temporal aspect of NaV1.1 persistent current (although for clarity, in the remainder of the 
study the average persistent currents accounting for all time intervals will be used).  In 
support of the current density data presented in Figures 3.5 and 3.6, the persistent current 
was more prominent in the presence of chloride, with NaV1.1-5N having a significantly 
greater average %INaP compared to CsF recordings (Mean ± SEM %INaP CsF 3.6 ± 1.1%, 
n=13; CsCl 12.2 ± 1.7, n=8; P<0.01, two-way ANOVA, Bonferroni‟s post-tests). There was 
also a similar but non-significant trend for NaV1.1-5A (Mean ± SEM %INaP CsF 7.6 ± 
1.7%, n=12; CsCl 12.8 ± 2.5, n=10, Figure 3.6). As demonstrated by Figure 3.7 it is only 
after 8 minutes into whole-cell the NaV1.1-5N persistent current significantly reduces  
using CsF internal solutions (at 8 and 12 minutes, CsF, 0.5 ± 1.5 %, n=10;  0.9 ± 0.8, n=10 
versus CsCl, 15.0 ± 2.3%, n=6; 10.9 ± 2.2 %, n=4; P<0.001; two-tailed t-test; Figure 3.7). 
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This effect was less marked for 5A-containing channels (Figure 3.7).    
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Figure 3.7 Persistent currents from the two splice variants are variable in HEK cells 
but remain stable during the timecourses of recordings using CsCl but not CsF. %INaP 
was calculated as shown in Figure 3.6 A. The graph shows the persistent current from 
individual cells at 3 times points during a single recording. Unlike 5A-containing channels, 
using CsF after 8 minutes after obtaining whole cell configuration, the amount of NaV1.1-
5N persistent current significantly decreases (***P<0.0001, two-tailed t-test).  
Additionally, post 8 minutes both splice variants consistently produce larger persistent 
currents in the absence of fluoride. 
3.2.1 Fluoride/Chloride 3: NaV1.1 splice variant rate of current decay is slowed in the 
presence of chloride 
The normalized current from individual cells was fit to a mono-exponential decay after a 
step from -80 mV to test potentials ranging between -20 mV and +20 mV from 90% of 
peak current amplitude. The mean (±SEM) rate of decay (τh) was calculated from 
individual fits at each test voltage. This increased stability of non-inactivating current in 
chloride is consistent with the slower rate of inactivation for both variants in this 
intracellular solution. In fluoride the NaV1.1-5N currents decayed significantly faster 
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between -10 mV and 20 mV compared to in chloride, (P<0.001, at each potential, two-way 
ANOVA, Bonferroni‟s post-tests). Although the NaV1.1-5A rate of inactivation overall was 
faster in fluoride (P=0.002, two-way ANOVA), there was no significant change in rate at 
any individual voltage (Bonferroni‟s post-test; Figure 3.8).  
In the same intracellular anion, the rate of inactivation between splice variants was 
different. For example, using CsCl solutions the overall rate of inactivation for NaV1.1-5N 
was significantly slower than NaV1.1-5A (P=0.003, two-way ANOVA). Using CsF 
solutions, however, the opposite was the case:  NaV1.1-5A rate of current decay was 
significantly slower (P=0.01, two-way ANOVA). As seen in Figure 3.8 this reversal in the 
relative rate of inactivation was due to the much larger shift experienced by NaV1.1-5N 
channels when the anion was changed (open symbols). Compared to channels with the 
„adult‟ exon, channels with exon 5N, appeared much more sensitive to intracellular 
fluoride, slowing ~4 fold at several potentials, while NaV1.1-5A channels only slowed ~2-
fold at similar potentials (e.g. 0 to 20 mV). These data are consistent with data in Figure 3.8 
showing only NaV1.1-5N channels had increased persistent currents using CsCl. Current 
decay for these channels appears to be both slower and less complete in chloride than in 
fluoride, while decay of currents from NaV1.1-5A was less sensitive to changes in anion.  
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Figure 3.8 Semilogarithmic plot of the fast time constants derived from mono-
exponential ﬁts to the decay of the current over a range of test potentials.  The rate of 
current decay was significantly slowed in the presence of CsCl compared to CsF for 
NaV1.1-5N only (***P<0.0001, two-way ANOVA, Bonferroni‟s post test). Moreover, the 
NaV1.1 do show a differential rate of current decay in both solutions (**P<0.01; two-way 
ANOVA, Bonferroni‟s post test) but using CsCl NaV1.1-5A currents decay faster and 
conversely using CsF more slowly, compared to NaV1.1-5N channels.  
3.2.1 Fluoride/Chloride 4:  Both NaV1.1 splice variants have more hyperpolarized voltage 
dependence of activation in fluoride 
Not only did the change in anion alter the rate of inactivation and stability of persistent 
currents as might be predicted from disruption of G-proteins (Figure 3.9 B), but the 
presence of fluoride also changed the voltage-dependence of activation (Figure 3.9 A). 
However, unlike inactivation the effect of fluoride on activation was similar for both splice 
variants. The V50 activation for both splice variants was significantly shifted by ~ 6 mV in 
depolarizing direction in the presence of chloride (mean ±SEM V50act CsF: 5A -21.2 ± 1.7 
mV, n=9 versus CsCl 5A -15.4 ± 1.3 mV, n=18, P<0.01; CsF: 5N -22.8 ± 1.2 mV, n=14 
versus CsCl 5N -17.8 ± 1.3 mV, n=13, P<0.01, two-way ANOVA, Bonferroni‟s post-test). 
The voltage sensitivity of activation was unaffected by intracellular anion (mean ±SEM k: 
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CsF versus CsCl: P=0.7, two-way ANOVA; Figure 3.9 B). Additionally the time course of 
activation was significantly accelerated for both splice variants in presence of fluoride 
(mean ±SEM ms: 5A CsF versus CsCl: P=0.02; 5N CsF versus CsCl: P<0.0001, two-way 
ANOVA; Figure 3.9 B). 
These results also indicate that within the same internal solution the activation midpoints of 
NaV1.1 splice variants were comparable (mean ±SEM V50act: CsF 5A versus 5N: P=0.4; 
CsCl 5A versus 5N: P=0.3, two-tailed t-test). However, using CsCl-based solutions NaV1.1-
5N time-course of activation was significantly slowed compared to NaV1.1-5A, which was 
not the case in fluoride (between -20 mV and + 20 mV mean ±SEM ms: CsF 5A versus 5N 
P=0.7; CsCl 5A versus 5N P=0.03, two-way ANOVA: Figure 3.9, C), suggesting fluoride 
conceals possible differences in the activation kinetics between the two splice variants. The 
10 – 90 % rise-time to peak was calculated from normalized current from individual cells 
after a step from -80 mV to test potentials ranging between -20 mV and +20 mV.  
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Figure 3.9 (previous page) A change in the intracellular anion changes the gating and 
kinetics of NaV1.1 splice variant activation Normalized conductance of NaV1.1 splice 
variants using CsCl and CsF based solutions (A) and mean (±SEM) V50 of activation 
derived from Boltzmann fits of individual cells (B) show that the voltage dependence of 
NaV1.1 splice variant activation is shifted in a more depolarized direction in the presence of 
chloride (**P=0.01, two-way ANOVA, Bonferroni‟s post-tests. Voltage protocol as in 
inset. Mean (± SEM) steepness of curves (k) were unaffected. C. In the presence of 
fluoride, the kinetics of NaV1.1 splice variant activation were accelerated (***P<0.001; 
two-way ANOVA) and concealed a slowing of NaV1.1-5N channels exposed using CsCl 
intracellular solutions (*P<0.05; two-way ANOVA). Conductance was calculated from the 
current-voltage curve as described in the methods. The mean (±SEM) V50 values and slopes 
factors (k) were calculated from Boltzmann fits of individual cells. The V50 for activation is 
the voltage at which 50% channels are activated. The slope of describes the steepness of the 
curve and is an indicator of the voltage dependency of activation.   
 
3.2.1 Chloride/Fluoride 5: Voltage dependence of inactivation is less sensitive to changes 
in intracellular solutions 
Figure 3.10 A shows the relationship between prepulse potential and current available at -
10 mV for both splice variants using CsCl- and CsF-based internal solutions. The mean 
(±SEM) V50 values and slope factors (k) of inactivation were calculated from Boltzmann 
fits of individual cells (Figure 3.10 B). V50 of inactivation represents the voltage that 
produces half maximal channel inactivation. Only fast inactivation was assessed using a 
protocol that looked at the current available at -10 mV, 30 ms test pulse following a range 
of voltage prepulses lasting 100 ms.   
The V50 of inactivation for both splice variants was unaffected by a change in intracellular 
anion (two-way ANOVA, Bonferroni‟s post-test). However at individual points there were 
some small but significant differences in channel availability. At more hyperpolarized 
potentials (-60 mV and -50 mV) fewer NaV1.1-5A channels were available using fluoride 
(CsCl versus CsF: P<0.01 for noted potentials, Bonferroni‟s post test). Additionally in the 
presence of this anion NaV1.1-5A the mean (±SEM) slope factor was increased by 1.9 ± 1.0 
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mV/e-fold change suggesting decrease in voltage sensitivity (mean ±SEM k 5A: CsF 8.1 ± 
0.9 ms, CsCl 6.2 ± 0.5 ms; CsCl versus CsF: P<0.05; Bonferroni‟s post test). The presence 
of fluoride altered voltage dependence of NaV1.1-5N inactivation at more depolarized 
potentials, between -50 mV and -30 mV; again significantly fewer channels were available 
(CsCl versus CsF: P<0.05 for noted voltages, Bonferroni‟s post-test). Importantly, when 
compared using the same intracellular anion, the voltage dependence of inactivation 
between the splice variants was not significantly altered at any voltage (CsF: 5A versus 5N: 
P=0.13; CsCl: 5A versus 5N: P=0.4; two-way ANOVA).  
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Figure 3.10 The voltage dependence of NaV1.1 splice variant inactivation shifts to 
more depolarized potentials at specific voltages using CsCl intracellular anions. A. The 
voltage dependence of inactivation of maximal peak transient currents shows that at more 
hyperpolarized potentials significantly fewer NaV1.1-5A channels were available in 
fluoride compared to chloride. **P<0.01; two-way ANOVA Bonferroni‟s post test. This 
was similar for NaV1.1-5N but at more depolarized potentials. ***P<0.0001, *P<0.05, two-
way ANOVA Bonferroni‟s post test. Voltage protocol as in inset. B. In all conditions the 
mean (±SEM) NaV1.1 midpoints of inactivation were comparable. The mean (±SEM) slope 
factor for NaV1.1-5A was significantly increased using CsF but not CsCl based intracellular 
solutions; indicative of a decrease in voltage sensitivity of inactivation. *P<0.05, two-way 
ANOVA, Bonferroni‟s post-test.  
A B 
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3.2.1 Chloride/Fluoride 6: Summary  
Not only did the change in anion alter the stability of persistent currents and rate of 
inactivation but the presence of fluoride also changed the voltage-dependence of activation, 
and to a lesser extent voltage-dependence of inactivation. Voltage dependence of activation 
is not thought to be a key target of AEDs; however, the rate of inactivation and stability of 
INaP are both likely to contribute to the two mechanisms of AED block. Consequently, 
changes introduced by the presence of fluoride, including those which are more pronounced 
in NaV1.1-5N, could obscure the impact of AEDs on the splice variants. The remainder of 
this study was completed using CsCl-based solutions.  
3.2.2 Temperature 1: The effects of elevated temperatures on the biophysical properties 
of NaV1.1 splice variants 
Mutations in SCN1A are associated with temperature dependence of epilepsy symptoms 
and the polymorphism rs3812718 may be associated with vulnerability to febrile seizures. 
Therefore it was investigated whether the NaV1.1 splice variants were also different when 
currents were recorded at physiological temperatures.  
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Figure 3.11 (previous page) at physiological temperatures both variants and the 
D207N mutant generate comparable macroscopic currents A. The sequence of the 
DI:S3-S4 linker encoded by exon 5N, 5A and by the D207N mutant that differs from exon 
5A only by the single conserved amino acid, D207N. Topology of NaV1.1 showing the 
location of D-N substitution (bottom panel). B. Representative traces from a cell expressing 
NaV1.1-5A, NaV1.1-5N and NaV1.1-D207N. C. At physiological temperatures all three 
variants have small but stable persistent currents (P=0.1, one-way ANOVA) D. Changes in 
the D1 S3:S4 linker do not alter the rate of inactivation (decay) over a range of test 
potentials (5A vs 5N, P=0.2; 5A vs D207N, P=0.3; 5N vs D207N, P=0.8; two-way 
ANOVA) E. Current densities for all three channels are similar (P=0.3; one-way ANOVA). 
F. There are no differences in voltage dependence of activation (5A vs 5N, P=0.2; 5A vs 
D207N, P=0.1; 5N vs D207N, P=0.6). G. NaV1.1-5N kinetics of activation were 
significantly faster than NaV1.1-5A, and NaV1.1-D207N channels over the voltage range, 
5A vs 5N, *P=0.02, 5N vs D207N, *P=0.04 two-way ANOVA. This parameter was 
indistinguishable between NaV1.1-5A and NaV1.1-D207N channels (P=0.9, two-way 
ANOVA). H. Steady state inactivation between the three channels was similar (5A vs 5N, 
P=0.6; 5A vs D207N, P=0.8; 5N vs D207N, P=0.9). 
 
3.2.2 Temperature 2: At physiological temperatures splicing has little effect on 
macroscopic currents from NaV1.1 channels  
The raw traces of NaV1.1 splice variant sodium currents are shown in Figure 3.11 A and 
were evoked from current protocol shown in the inset. At physiological temperatures, 
averaging 37 ± 2 
o
C, NaV1.1-5A and NaV1.1-5N had comparable mean (±SEM) percentage 
persistent currents (5A: 8.5 ± 1.6%, n=16; 5N: 5.2 ±1.0 %, n=11; P=0.2, Mann-Whitney; 
Figure 3.11 B); although, %INaP was variable among individual cells transfected with 
either variant. The values calculated for NaV1.1-5A derived mean %INaP displayed a larger 
27% range (n=15) compared to 13% calculated for NaV1.1-5N mean %INaP (n=11; Figure 
3.11 A). Consistent with %INaP results, the overall rate of inactivation was comparable 
between the two isoforms over a range of test potentials (P=0.2, two-way ANOVA; Figure 
3.11 C). Moreover, the two channel isoforms had similar mean (±SEM) peak current 
densities (5A -97.1 ± 20.1 pA/pF; 5N : -100.9 ± 20.8 pA/pF; P=0.9; Mann-Whitney); 
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midpoints and slope factors of activation (V50act (5A versus 5N P=0.8) 5A: -18.5 ± 0.9 mV, 
n=15; 5N: -18.8 ± 0.8 mV, n=18; k (5A versus 5N P=0.7); 5A: 6.7± 0.4 mV/e-fold change; 
5N: 6.5 ±0.3 mV/e-fold change; Mann-Whitney) and V50 and slope factors of inactivation 
(V50inact(5A versus 5N P=0.8) 5A: -54.2 ± 1.2 mV, n=14; 5N: -53.1 ± 1.3 mV, n=11; k (5A 
versus 5N P=0.9); 5A: 6.4 ± 0.3 mV/e-fold change; 5N: 5.9 ± 0.7 mV/e-fold change; Mann-
Whitney; Figures 3.11 E-H). However, although the change was small, NaV1.1-5N 
channels did activate significantly faster than NaV1.1-5A channels (P=0.02; two-way 
ANOVA; Figure 3.11 G).  
3.2.2 Temperature 3: Which amino acid? 
NaV1.1-5A and NaV1.1-5N differ at three amino acids (Figure 3.11 A). As a further control, 
NaV1.1-5A channels were engineered to contain only the D>N switch that is conserved in 
several channels belonging to the VGSC family (Figure 3.11 A, position shown in red in 
the channel topology diagram). Two phenylalanines are introduced at positions 203 and 
211 in human NaV1.1-5N in addition to the D>N substitution. (Figure 3.11 A). Further 
experiments asked whether these supplementary amino acid changes obscured possible 
differences created by the D>N change (Figure 3.11 A). However, apart from the kinetics 
of activation the biophysical properties of NaV1.1-D207N were indistinguishable from 
either NaV1.1-5A or NaV1.1-5N (Figure 3.11, red triangles). NaV1.1-5N did enter activation 
significantly faster than NaV1.1-D207N channels, over the voltage range (5N, n=16; =11; 
P=0.04, two-way ANOVA).  
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3.2.2 Temperature
+
 4: Experiments conducted at ‘fever’ temperatures were too unstable 
to produce sufficient data 
It is possible that an increase of temperature by a few degrees from 37
o
C to 40
o
C to 
replicate „fever‟ conditions associated with seizures in GEFS+ and SMEI, could introduce 
new differences between the macroscopic properties of both splice variants. Unfortunately 
recordings at +40
o
C for NaV1.1-5A were not stable enough to produce data sufficient to 
make statistical comparisons. However, the data collected between 38-39
o
C for NaV1.1-5A 
and between 38-41
o
C for NaV1.1-5N did not suggest there was a robust difference between 
the voltage dependence of activation (5A versus 5N: P=1.0, two-way ANOVA; 5A n=6; 5N 
n=8; Figure 3.12 A), or inactivation (5A versus 5N: P=0.7, two-way ANOVA; 5A n=4; 5N 
n=5; Figure 3.12 B). Therefore any differences between the variants, at slightly higher 
temperatures, were likely to be very subtle.  
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Figure 3.12 Preliminary experiments showed at „fever‟ temperatures only subtle 
differences between NaV1.1 splice variants gating were introduced. The voltage 
dependence of activation of peak conductance (A) and voltage dependence of inactivation 
maximal currents (B) for both splice variants calculated from recordings performed at 
A B 
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(previous page) temperatures above 38
o
C. No significant differences NaV1.1 splice variants 
were revealed for these gating parameters (Activation: 5A vs 5N, P=0.7; Inactivation: 5A 
vs 5N, P=0.3, two-way ANOVA).  
3.2.2 Temperature 5: On comparison of room and physiological temperature recordings 
the rate of current decay was most affected by changes in temperature 
Several parameters altered by fluoride, particularly those associated with fast inactivation, 
were also altered by temperature in similar ways, and as with fluoride, NaV1.1-5N channels 
appeared more sensitive to changing temperature than NaV1.1-5A channels. Elevation to 
37
o
C reduced the %INaP for both splice variants compared to RT recordings. The mean 
(±SEM) %INaP derived from NaV1.1-5N at 37
o
C was significantly decreased from 12.8 ± 
2.5% (n=10) at RT to 5.2 ± 1.1% (n=11) at 37
o
C (P<0.05; two-way ANOVA, Bonferrroni‟s 
post-test, Figure 3.13 A).  NaV1.1-5A followed a similar, although statistically non-
significant trend, demonstrating a reduction of mean (±SEM) %INaP from 12.2 ± 1.7 % 
(n=8) at RT to 8.6 ± 1.6 % (n=16) at 37
o
C.  As expected the overall rate of inactivation was 
significantly accelerated overall by a minimum of 1.5 ms for both channel isoforms (5A 
21
o
C versus 5A 36 ± 1
o
C: P<0.001; 5N 21
o
C versus 5N 36 ± 1
o
C: P<0.001; two-way 
ANOVA, Figure 3.13 B) suggesting that at higher temperatures the fast inactivation is 
enhanced and long or late openings are suppressed. 
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Figure 3.13 (previous page) Slow inactivation is more stable at lower temperatures. 
NaV1.1-5N persistent current was particular vulnerable to change in temperature *P<0.05, 
two-way ANOVA, Bonferroni‟s post test (A) although the rate of current decay 
significantly accelerated at higher temperatures for both splice variants (B). ***P<0.0001, 
two-way ANOVA. 
 
In contrast to the rate and stability of inactivation, the voltage-dependence of activation and 
inactivation were largely unaffected by an increase in temperature (Boltzmann fits 
activation 5A 21
o
C versus 5A 37±2
 o
C P=0.1; 5N 21
o
C versus 5N 37±1
o
C, P=0.6; two-way 
ANOVA, Bonferrroni post-tests; Figures 3.14 A & B) Although at -60 mV, at 37
o
C upon 
inactivation significantly more NaV1.1-5N channels were available compared to those at 
21
o
C (P<0.01; two-way ANOVA, Bonferrroni post-tests; Figures 3.14 C & D). This subtle 
change was not seen for 5A-containing channels (P=0.08; two-way ANOVA, Figures 3.14 
C&D). 
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Figure 3.14 An increase in temperature has subtle effects on the gating of NaV1.1 
splice variants. The maximum conductance at several voltages, midpoints of activation 
and slope factors for both  NaV1.1 splice variants was unchanged by ~16
o
C increase in 
temperature (A&B) This was similar for the voltage dependence of inactivation although at 
-60 mV a greater proportion of NaV1.1-5N channels had inactivated at RT. **P=0.01, two-
way ANOVA, Bonferroni‟s post-test (C&D). 
 
Although the voltage dependence of activation was unaffected at biological temperatures, 
the time-course of activation was significantly accelerated for both NaV1.1-5A and NaV1.1-
5N (P<0.001; 37
o
C versus 21
o
C for both splice variants, two-way ANOVA; Figure 3.15). 
This implies that overall temperature affects the kinetics of gating rather than its voltage 
dependency. This is in contrast to the effects of fluoride, which although showing a similar 
A B 
C D 
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trend for effects on rate of inactivation were different on activation: Fluoride altered the 
voltage-dependence of activation for both splice variants, but temperature had no effect on 
voltage-dependence. 
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Figure 3.15 The timecourse of activation is significantly slowed at RT for both channel 
isoforms. ***P<0.0001, two-way ANOVA. A slowing in of NaV1.1-5N rise to peak at RT 
compared to NaV1.-5A channels is suppressed at higher temperatures. ***P<0.0001, two-
way ANOVA.  
 
3.2.2 Temperature 6a: NaV1.1-5N recovers more rapidly from inactivation compared to 
NaV1.1-5A at biological temperatures  
Recovery from inactivation is thought to underlie the use-dependence of anti-epileptic 
drugs, including phenytoin. Splice variants were investigated for whether they differed in 
this parameter at physiological temperatures. Recovery from inactivation was assessed 
using a two-pulse protocol consisting of an initial step to -10 mV for 100 ms, a recovery 
interval of 2 ms, 10 ms and 20 ms at -80mV, and a test step to -10 mV for 30 ms. The 
current amplitude evoked by the test pulse was expressed as a fraction of the current from 
the prepulse to give a measure of fractional recovery. The raw trace in Figure 3.16 A show 
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the individual sweeps elicited from the recovery protocol from a cell transfected with 
NaV1.1-5N. Unfortunately, at physiological temperatures, cells were too unstable to 
complete a detailed time course of recovery from inactivation.  
The NaV1.1-5N channels were significantly faster than NaV1.1-5A over the time range 
tested (5A n=8, 5N n=10; P<0.0001; two-way ANOVA; Figure 3.16 A) and particularly at 
longer time intervals. At 10 ms and 20 ms proportionally more NaV1.1-5N channels had 
recovered compared to 5A-containing channels (5A versus 5N at 10 ms, P<0.01; 5A versus 
5N at 20 ms, P<0.05; Bonferroni‟s post test). Additionally, this difference appears to 
depend entirely on the D>N substitution, as NaV1.1-D207N channels were 
indistinguishable from NaV1.1-5N channels (D207N n=13; P=0.06, two-way ANOVA; 
Figure 3.16 C). In contrast over the complete time course NaV1.1-D207N channels were 
significantly faster than NaV1.1-5A channels (P=0.0018, two-way ANOVA; Figure 3.16 
C).  
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Figure 3.16 Channels containing exon 5N recover more rapidly from inactivation and 
the conserved amino acid change D207N is sufficient to account for the change. A. 
Raw traces from cells transfected with NaV1.1-5N. Currents were evoked using the protocol 
at top. B.  NaV1.1-5N channels are more available for activation than NaV1.1-5A channels 
for time points between 2 and 20 ms after prolonged depolarisations. ***P<0.0001 C. 
NaV1.1-D207N is not different from NaV1.1-5N. P=0.06, two-way ANOVA. But this 
mutant does recover faster from inactivation than NaV1.1-5A channels **P=0.002, two-way 
ANOVA. 
3.2.2 Temperature 6b: Phenytoin masks differences in recovery from inactivation 
between NaV1.1 splice variants 
Figures 3.17 A & B show preliminary NaV1.1-5A phenytoin dose-response curves at 11 ms 
and 19 ms recovery intervals, performed by Stephanie Schorge. These experiments were 
lengthy and were recorded at RT to improve stability and allow multiple drug doses to be 
tested on individual cells.  The calculated IC50 at 11 ms and 19 ms were 53 μM and 64 μM 
A 
C 
B 
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(n=3-6) respectively. In the following experiments, therefore, 50 μM phenytoin was used, 
as this concentration is similar to clinically relevant serum levels (Scheyer et al., 1994).  
0
40
80
1 10 100C W
[PHT] M
P
e
rc
e
n
ta
g
e
re
c
o
v
e
ry
 1
1
 m
s
0
40
80
1 10 100C W
[PHT] M
P
e
rc
e
n
ta
g
e
re
c
o
v
e
ry
 1
9
 m
s
 
Figure 3.17 Concentration response curve for NaV1.1-5A at RT. Recovery from 
inactivation for NaV1.1-5A channels after 11 ms (A) or 19 ms (B) in control (C, squares), 
phenytoin (circles), and wash (W, triangles). n=3-6 for all points. IC50 at 11 ms was 53 μM. 
IC50 at 19 ms was 64 μM. 
 
A two-way ANOVA revealed in the presence of phenytoin the difference in the rate of 
recovery from inactivation over the time-interval range between the splice variants was 
concealed (5A n=8, 5N n=6; P=0.3; Figure 3.18 A).  This suggests that individuals with a 
A 
B 
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higher percentage of the neonatal variant may have proportionately larger effects on the 
recovery from inactivation in the presence of clinically relevant doses of phenytoin. 
Moreover, because over the experimental time range NaV1.1-5N and NaV1.1-D207N were 
comparable in their response to this drug (D207N n=6; P=0.6; two-way ANOVA; Figure 
3.18 B), and in control conditions, the change in drug efficacy may also be relevant to other 
VGSCs containing the conserved D>N substitution. 
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Figure 3.18 Addition of phenytoin (PHT) obscures the difference in recovery from 
inactivation.  A. There is was no difference in the recovery from inactivation between the 
splice variant channels in the presence of 50 μM PHT. P=0.3, two-way ANOVA. B. 
NaV1.1-D207N is reduced to a similar rate of recovery of NaV1.1-5N channels. P=0.6, two-
way ANOVA. 
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 222 
3.3 Discussion 
The main aim of this chapter was to determine whether biophysical differences between 
NaV1.1-5A and NaV1.1-5N could explain the link between the rs3812718 polymorphism in 
SCN1A and altered drug responsiveness in patients. NaV1.1 splice variants differ in a region 
close in proximity to the voltage sensor in the first domain, providing a molecular rationale 
behind this hypothesis. Several reports indicate that patients homozygous for the mutant A 
allele are expected to have a greater proportion of NaV1.1-5A (Tate et al., 2005; Heizen et 
al., 2007) require higher phenytoin and lamotrigine dosages at maintenance and serum 
levels respectively (Tate et al., 2006; Krikova et al., 2009). In another study involving a 
large Japanese cohort, homozygous AA patients were more likely to be resistant to 
carbamazepine (Abe et al., 2008). However not all studies have shown a relationship 
between the SNP and AED therapy (Kwan et al., 2008; Zimprich et al., 2008). To 
determine the possible functional impact these two splice variants in the presence or 
absence of phenytoin, macroscopic currents from whole-cell voltage clamp of HEK 293 
cells transfected with NaV1.1 splice variants were analyzed.  
Ideally these experiments would have been performed in neurons. Neuronal models were 
investigated and are detailed in Chapter 6; but because of the technical difficulties with 
cloning unstable SCN1A cDNAs into mammalian expression vectors, this experimental 
avenue could not be pursued. Because the cell background was non-neuronal several 
measures were taken to make other recording conditions as comparable to the environment 
NaV1.1 channels experience in vivo as possible. These focused on altering intracellular 
solutions to remove fluoride and, because GEFS+ causing mutations in SCN1A are 
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associated with fever, temperature. The latter was particularly important as the rs3812718 
AA genotype has also shown to contribute to the development of childhood febrile seizures 
(Schlachter et al., 2009).  
The main findings of this chapter will be discussed in order of importance: 
1. NaV1.1-5N channels recover faster from inactivation compared to NaV1.1-5A 
channels, which is dependant on a conserved amino acid change. 
2. Phenytoin disproportionally inhibits NaV1.1-5N channel recovery from inactivation. 
3. Internal anions and temperature have significant effects on NaV1.1 channel 
behaviour and therefore establishing accurate physiological recording conditions is 
essential. 
4. Differences between NaV1.1 splice variant behaviour were not due to changes in 
HEK 293 cell background or endogenous currents. 
3.3.1 Recovery from inactivation 
NaV1.1-5N channels recovered significantly faster than NaV1.1-5A over the time range 
tested and relied on the D207N change, as NaV1.1-D207N channels were indistinguishable 
from NaV1.1-5N channels. This suggests that the changes seen in recovery from 
inactivation of NaV1.1-5N at physiological temperatures may also be present in other 
sodium channels with the D>N substitution at this site. Summarized in Table 1.6 (page 
106) are the effects VGSCs exon 5 (or 6) splice variants at RT, heterologously expressed in 
various cell backgrounds, in the presence or absence of different combinations of β 
subunits and internal solutions. In support of this report this table demonstrates that in a 
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variety of conditions kinetics of inactivation, stability of slow inactivation and recovery 
from fast inactivation are primarily affected by splicing. Unfortunately, only Xu et al. 2007 
(NaV1.2) and Onkal et al. 2008 (NaV1.5) used comparable intracellular solutions to this 
study. Unlike NaV1.1 channels, the recovery of NaV1.2-6A was significantly faster 
compared to NaV1.2-6N channels; a smaller difference was shown for NaV1.5 splice 
variants.  It is difficult to determine whether the variation in recovery from channel 
inactivation is VGSC sub-type specific or simply that channels behave differently at lower 
temperatures, because NaV1.1 splice variants share a high sequence identity to NaV1.2 
isoform. There is only the conserved asparagine to aspartate switch between NaV1.2 
isoforms but a (positive) lysine to aspartate between NaV1.5 splice variants, plus an 
additional six amino acid changes (Figure 1.9). Onkal et al. 2008 mutangenized the 
NaV1.5-6N lysine to aspartate and showed that the mutant channel recovered from 
inactivation faster than both NaV1.5 channel isoforms. Together with the results in this 
study, this shows that a change in the amino acid in a position analogous to NaV1.1-D207 
has significant consequences for recovery from inactivation for another sodium channels. 
Onkal et al. 2008 surmised that this residue changes the local electric field detected by 
D1:S4 changing its outward movement depending on the charge of the critical residue. 
However NaV1.1 and NaV1.2 neonatal channels have a neutral charge at 207 but opposing 
inactivation recovery times compared to adult exon containing channels. NaV1.1-5N 
contains additional changes in the S3-S4 linker, two large non-polar phenylalanines, which 
are less hydrophobic, compared to NaV1.2-6N valines in comparable positions (Engelmen 
et al., 1986), which may change the channel conformation in the lipid bilayer. Additionally 
differences in NaV1.1 and NaV1.2 may result from changes in experimental temperatures or 
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cell background. 
The cellular localization of NaV1.1 suggests that these channels contribute to action 
potential generation and propagation in GABAergic interneurons. From these data it is 
possible that patients homozygous for the mutant A allele experience a disproportionately 
slower recovery from NaV1.1 inactivation which may disproportionately alter inhibition.  In 
the immature nervous system, decreased inhibitory firing rates may be pro-excitatory at 
elevated body temperatures. Interestingly, different neuronal types show varying responses 
to changes in temperature (Guatteo et al., 2005).  In rat dopaminergic neurons elevated 
temperatures caused cellular depolarization and increased firing rates (Guatteo et al., 2005) 
but in rat cortical visual cells under similar conditions contrasting effects were observed 
(Volgushev et al., 2000). Therefore, it is possible that, in humans, inhibitory interneurons 
are particularly vulnerable to fever temperatures and the onset of febrile seizures may be 
coupled with the switch in SCN1A splicing in addition to other neuronal sodium channels. 
If the change in recovery from inactivation is only influenced by splicing in SCN1A, then 
inhibitory interneurons would be more sensitive to temperature-dependent changes in 
recovery from inactivation. However, it is possible that cells relying on SCN2A/SCN8A also 
have altered recovery from inactivation which is toggled as splicing shifts during 
development. In rodents, because SCN1A is not alternatively spliced, the comparison to 
humans is complicated, and only cells relying on SCN2A/SCN8A are likely to be affected 
by changes in splicing, including any changes in recovery from inactivation. It should be 
noted that although in rodents NaV1.1 is upregulated in inhibitory interneurons it is not 
known whether this is mirrored in humans (Kalme et al., 2007). 
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Briefly, what is the physiological role of NaV1.1-5N during development? The immature 
nervous system comprises a different milieu of ion channels compared to the fully 
developed nervous system. Neurons within the immature nervous system are spontaneously 
active. This activity initiates an increase in intracellular calcium transients, which in turn 
switches on gene expression, leading to the transcription of growth factors, ion channels 
and other cellular machinery that eventually forms the mature nervous system (Moody & 
Bosma, 2005).  During this gestation period the kinetics of ion channels expressed by 
immature neurons are different to those expressed by fully formed cells. This establishes 
specific firing patterns essential for proper development (Moody & Bosma, 2005) and may 
partly result from alternative splicing. It is difficult to select example studies of 
spontaneous immature neuronal activity that may be informed by splicing in SCN1A 
because many investigations use rodents models (Nam & Hockberger, 1997). However, 
clues to the role of NaV1.1-5N may be given by NaV1.3 channels, which are predominantly 
expressed in neonatal tissues (Felts et al., 1997, but it should be noted that the function of 
SCN3A exon 6 splice variants is undetermined). Nonetheless, within rat DRG, like NaV1.1-
5N channels, NaV1.3 channels were found to recover from inactivation rapidly (Cummins 
et al., 2001) and their transient up-regulation corresponds to a period of spontaneous 
activity in immature rat DRGs, which may play a role in their normal development (Felts et 
al., 1997; Cummins et al., 2001; Moody & Brosma, 2005). Moreover, NaV1.3 is expressed 
in Cajal-Retzius
 
cells of the mouse preplate which are precursors of cortical neurons 
(Albrieux et al., 2004). After birth NaV1.3 expressing cells are capable of fast firing rates 
(Radnikow et al., 2002). Controversially, this neuronal activity may contribute to their 
excitotoxic cell death, thought to be an important end process in corticogenesis (Radnikow 
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et al., 2002; Albrieux et al., 2004).  Interestingly, in both hippocampal cells from SCN1A 
knock-out mice (Yu et al., 2006) and axotomized rat DRG cells (Cummins et al., 2001) 
NaV1.3 is upregulated. Perhaps this is either a neuronal compensatory mechanism or a 
marker of a pathological state?  
3.3.2 The effects of Phenytoin 
The main aim of this chapter was to determine why patients homozygous for the G allele of 
rs3812718, with an increased expression of exon 5N in NaV1.1 respond better to AEDs and 
in particular phenytoin (Tate et al., 2005; Tate et al., 2006). From these results phenytoin 
obscured the difference in recovery from inactivation between the NaV1.1 splice variants. 
Therefore patients homozygous for the wild-type allele of rs3812718, that is, with a greater 
proportion of NaV1.1-5N channels, would undergo a more pronounced inhibition of NaV1.1 
activity compared to their AA homozygous counterparts (Figure 3.18 A). This 
demonstrates that alternative splicing of exon 5 in SCN1A alters recovery from inactivation: 
a biophysical parameter specifically targeted by AEDs. In terms of NaV1.1 localization and 
SCN1A pathology these data are paradoxical because a complete loss of NaV1.1 function 
leads to SMEI. Secondly, NaV1.1 predominates in GABAergic interneurons and increased 
NaV1.1 inhibition would lead to instability in the control of network excitability as 
GABAergic activity was surpressed, encouraging ictal activity. Possibly, the altered 
response is modified by other changes in NaV1.1. SCN1A is not only alternatively spliced in 
exon 5 and incorporation/exclusion of other SCN1A regions may change the behaviour and 
drug response of NaV1.1-5A or NaV1.1-5N; although further work is needed determine their 
precise effects.   
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However, another perspective is that a reduction in inhibition of NaV1.1 via the 
predominant expression of NaV1.1-5A may be therapeutically beneficial. It is highly likely 
that in vivo phenytoin does not act solely on NaV1.1 channels as it does not discriminate 
between VGSCs and can also bind to voltage-gated calcium and potassium channels. 
Therefore, patients with the AA genotype, which promotes the skipping of exon 5N, may 
tolerate increased levels of phenytoin because they have less inhibition of NaV1.1 channels 
in GABAergic neurons, relative to inhibition in other cell types. This may result in less off-
target AED reduction of inhibition, or shift the balance of AED block towards excitatory 
neurons.  
The heterogeneity in GEFS+ patient AEDs drug response who harbour the same SCN1A 
mutation and the discrepancies in studies associating rs3812718 with drug dosage suggest 
that the molecular mechanisms of AEDs are not straightforward. Similar splicing occurs in 
other VGSCs, expressed in different neuronal types and could result in comparable 
interactions with phenytoin.  For example, NaV1.2 and NaV1.6 are up-regulated in 
excitatory neurons (Chen et al., 2002) and conserve the D>N switch; therefore, a change in 
splicing could alter drug efficacy in these neurons. Moreover in experimental epilepsy 
neonatal VGSCs are upregulated including NaV1.2-6N (Aronica et al., 2001). NaV1.2-6A 
channels recover from inactivation faster than NaV1.2-6N channels (Xu et al. 2007) but as 
discussed above their behaviour at elevated temperatures and interactions with AEDs is 
unknown.  Further experiments assessing whether NaV1.1-5N channels recover faster from 
inactivation and have a greater AED inhibition compared to NaV1.2 and NaV1.6 splice 
variants may help to explain why people with the AA genotype might tolerate higher 
dosages, that is, have proportionately less inhibition of interneurons for the same dose of 
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AED. 
The association between rs3812718 and AED dosage is inconsistent (Zimprich et al., 2008; 
Kwan et al., 2008). Therefore, AED maintenance dosages in patients are likely to result 
from cumulative differences in genetic background or the association is spurious. Other 
SNPs within intronic and exonic regions of SCN1A and SCN2A, and another GEFS+ gene 
GABRA2 also conferred multidrug resistance in ethnically diverse epilepsy patients (Chou 
et al., 2003; Wang et al., 2008; Kwan et al., 2008; Lakhan et al., 2009).  There are also 
genetic variations in the genes encode proteins that absorb, distribute, metabolize and 
eliminate AEDs, which contribute to the maintained dose of GEFS+ patients (Loscher et 
al., 2009). For example, several SNPs within the drug-transport pump gene ABCB1, which 
is expressed in the BBB and large intestine, significantly altered patient phenytoin plasma 
levels and efficiency of drug transport into the brain (Kerb et al., 2001; Simon et al., 2007).  
Additionally, in epilepsy models, post SE three GEFS+ genes coding for GABAA receptor 
subunits and the HCN2 channel are dynamically regulated. This may affect in parallel 
neuronal, particularly GABAergic, phenotypes (Sperk et al., 1998; Nishimura et al., 2005; 
Powell et al., 2008). The large problem with drug association studies is that there is limited 
information on the specific cause of epilepsy. If genetic, and a patient has severe mutation 
in GABRA2 for example, the relative expression of NaV1.1-5N or NaV1.1-5A may be 
inconsequential. Moreover, phenotypic variation maybe further introduced by mutations in 
genetic modifier genes like SCN9A. Interestingly, NaV1.7-5N is the main isoform expressed 
within the brain, which may also contribute to the sensitivity to phenytoin. Therefore, AED 
is likely to be a compromise between effectiveness and tolerability.  
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Although these results do not explain why in one report individuals with the AA genotype 
were significantly more resistant to carbamazepine (Abe et al., 2008), observations do 
imply that  the conserved D>N amino acid was a target of phenytoin, and perhaps therefore 
other AEDs. As shown in Figure 1.10 A, the structures of phenytoin and carbamazepine are 
dissimilar and it is possible that the configuration of NaV1.1-5N is more effectively blocked 
by the carbamazepine.  AEDs could be designed to specifically to block NaV1.1 splice 
variants or, more likely, other VGSCs splice variants expressed in varying neuronal types. 
This may be feasible because both NaV1.1 and NaV1.5 for instance, have several amino acid 
differences in the D1:S3-S4 linker.  Similar future experiments could determine the effects 
of sodium channel blockers like carbamazepine on VGSC splice variants. Splice variants of 
a cockroach VGSC that undergoes analogous splicing are pharmacologically distinct, with 
significantly different responses to the insecticide deltamethrin (Tan et al., 2002), and 
demonstrates the possibility of distinguishing between closely related sodium channel 
variants. 
3.3.3 NaV1.1 macroscopic gating properties are changed by intracellular ions 
One aim was to establish intracellular solution recording conditions that would allow 
reproducible measurements of the intrinsic macroscopic gating properties NaV1.1 splice 
variants; particularly concerning the effects of phenytoin.  At RT, the presence of fluoride 
changed the gating of both NaV1.1 isoforms, shifting the voltage-dependence of activation 
(and to a lesser extent inactivation) in a leftward direction. Hyperpolarizing shifts in gating 
voltage dependency has also been observed in cell types in which NaV1.9 channels are 
thought to predominate (Coste et al., 2004): guinea pig (V50 activation only) and rat 
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myenteric sensory neurons (SNaC currents) and rat small DRG neurons (NaN currents; 
Rugiero et al., 2003; Coste et al., 2004). This change in gating was not observed in medium 
sized rat DRG neurons that express SNS/NaV1.8 currents, suggesting that the effects of 
fluoride maybe dependant on cell background/VGSC sub-type.  Indeed, the presence of 
fluoride also rendered NaV1.1-5A channels to be less sensitive to voltage changes, 
suggesting that different internal ions can change distinctive channel properties. 
The Costa et al. (2004) study is the most comprehensive report that has compared the 
properties of macroscopic sodium currents using either CsF or CsCl-based intracellular 
solutions. In the literature it is advised that cells expressing VGSCs should be dialyzed with 
CsF for at least 30 mins before voltage-clamp protocols are begun. In the whole-cell 
configuration, after 30 minutes of intracellular CsF equilibration Vanoye et al. (2006) 
demonstrated that the voltage dependence of activation was shifted in a ~7 mV 
hyperpolarizing direction from heterologously expressed NaV1.1-5A channels. In this study 
currents were analyzed from recordings taken between 5 – 10 mins, not 30 mins, after 
breakthrough. Firstly, because fluoride shifted the voltage dependence in a hyperpolarizing 
direction compared to chloride, a longer dialysis time may have exacerbated this affect and 
not provided greater information about NaV1.1 gating. Shorter experiment times prevented 
washout of intracellular regulatory proteins. Fluoroaluminate disrupts downstream 
signalling pathways and therefore persistent fluoride dialyzation may have increased the 
likelihood of uncontrolled variability in ion channel modulation by disrupted G-protein 
signalling. Lastly, preparations at elevated temperatures were stable for ~15 mins; 
therefore, longer experiment times would have made comparisons between recordings 
performed at RT and 37
o
C unreliable. It should be noted that Coste and colleagues (2004) 
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also allowed a shorter 5 – 8 mins intracellular solution equilibration time after 
breakthrough. 
In the presence of chloride, the non-inactivating component of NaV1.1 splice variant 
currents was more stable. Control recordings from untransfected HEK cells suggested that 
the persistent current component was derived from NaV1.1, not endogenous channels. This 
was supported by NaV1.1 channel overexpression in HEK cells and the voltage dependency 
of the persistent currents (Figure 3.5). The length of the voltage clamp protocol was not 
sufficient to determine whether there was a shift in the V50 of activation or inactivation for 
INaP. To assess NaV1.1 slow inactivation/persistent currents the prepulse to -10 mV in the 
availability protocol would be extended from 100 ms to 1 sec, to allow for complete 
channel recovery from fast-inactivated states.   
The kinetics of NaV1.1 splice variant gating and in particular NaV1.1-5N were significantly 
slower in the presence of chloride. This suggests that the three amino acid switch, in 
particular changing the surface-charge of the protein by the neutralization the extracellular 
D1:S3-S4 aspartate, may have affected the speed of NaV1.1 activation and current decay 
(Hille 2001). Negatively charged sialic acids are attached to the Ig domain of β1 subunits 
and when associated with α-subunits contribute to a negative surface potential (Johnson et 
al., 2004). CHO cells co-transfected with either NaV1.7 or NaV1.2 and un-sialylated β1 
subunits demonstrated slower current decays compared to those transfected with wild-type 
β1 subunits (Johnson et al., 2004), implying that a loss in surface-charge may slow channel 
gating.  However, this hypothesis is highly speculative as between NaV1.1-5A and NaV1.1-
5N there is only one charge change, and the solutions used in the latter study contained 
 233 
CsF. However, from studies involving heterologously expressed channel chimeras of 
skeletal and cardiac VGSCs, D1 does appears to play a predominant role in the in the 
development of slow inactivation (Chahine et al., 1996; O‟Reilly et al., 1999). Again, in 
these papers preparations were at RT, chimera channels were of mixed rat and human 
origin and the authors used CsF-based intracellulars. As discussed in the introduction it is 
extremely difficult to make strict comparisons with data in the literature because there are 
too many variables between papers and because slow inactivation/persistent currents are 
poorly understood and defined.  
It is not clear why a change in current decay of NaV1.1-5N was only revealed in chloride.  
Several intracellularly applied chemical agents and enzymes including tannic acid, 
formaldehyde, glyoxal, trypsin, slow VGSC inactivation (Hille 2001); but their chemical 
groups and actions are varied and provide little explanation into the selective mechanism of 
internal ions. It may not be the intracellular anion per se but G-protein regulation. 
Intracellular solutions used in by Coste et al. were supplemented with 0.4 mM GTP and 
slow inactivation and persistent currents derived from NaN and SNaC currents, both 
sensitive to changes in intracellular solution in this study, were similar in the presence of 
both halides. However when the CsCl and CsF intracellular solutions were not 
supplemented by GTP, the V50 of NaV1.8, that is, sodium currents shown by Coste et al. not 
to be affected by intracellular ions, inactivation was shifted to the right (Saab et al., 2003). 
This implies that G protein activity may cancel the affects of metal ions acting on „less 
sensitive‟ channels and differentially modulate VGSC voltage dependency and the kinetics 
of inactivation.   
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During the first 12 mins after going whole-cell (Figure 3.7) NaV1.1-5A derived %INaP was 
stable in both intracellular solutions. However, only in chloride was the proportion of 
NaV1.1-5N derived persistent currents stable during the whole recording. During the first 
few minutes after breakthrough, in fluoride, neonatal channel derived %INaP was a similar 
proportion of peak INaT compared to NaV1.1-5N %INaP recorded in chloride. Yet after 4 
mins NaV1.1-5N slow inactivation stabilized to a smaller %INaP state. Again, this 
highlights the temporal aspect of fluoride in changing VGSC properties (Vanoye et al., 
2005; Coste et al., 2004). From these results NaV1.1-5N %INaP maybe particularly 
sensitive to changes in modulatory proteins activated by AlF4
- 
over time
 
and/or are more
 
sensitive to accumulating concentrations of
 
fluoroaluminate.  
To avoid changes due to the presence of fluoride, experiments were completed in „more 
physiological‟ chloride. This was especially important because the rate of inactivation and 
stability of INaP were both likely to be sensitive to AED block as well as because NaV1.1-
5N channels were more sensitive to fluoride than NaV1.1-5A. Moreover, through single-
channel analysis of SNaC currents, Coste et al. demonstrated that the properties of 
Ensemble currents best resembled macroscopic currents recorded using CsCl and not CsF. 
However, physiologically only 8 mM of Cl
-
 is found within cells (McCormick 1990), 
which is nearly 19-fold less than the contents of the intracellular pipette used in this study. 
It is possible, therefore that abnormal concentrations of Cl
-
 ions may also have had adverse 
affects on channel gating. High concentrations of intracellular chloride significantly 
attenuated G-protein regulated currents recorded from rat hippocampal neurons, compared 
to currents recorded in higher concentrations of methane-sulfonate (Lenz et al., 1997). The 
authors surmised that chloride ions may also disrupt G-protein function or the directly 
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membrane channels expressed by CA1 neurons (Lenz et al., 1997).   
Coste and colleagues (2004) tried to address why fluoride affected the gating of specific 
VGSC currents by measuring the effects different internal solutions on NaN and SNS 
gating currents.  From their results the authors surmised that through an unknown dynamic 
mechanism fluoride traps the voltage sensor in a pre-open closed state, preventing it 
returning to deeper closed states that perhaps can occur in chloride. Consequently a smaller 
change in the voltage across the membrane is required to open the channel. The authors 
hypothesized that fluoride could exert this effect via three mechanisms:  
1. Fluoride may screen the surface-charges more effectively compared to chloride, 
changing voltage sensor properties. Although they argued this theory was 
improbable because no effects were observed for SNS currents and both halide ions 
have the same valency number.   
2. Fluoride ions may bind to positive surface charges on the channel decreasing 
surface charge concentrations and potentials. Again Coste et al. 2004 dismissed this 
hypothesis as fluoride ions have a very low affinity to positively-charged groups. 
3. Lastly, fluoride may exert its effects indirectly through downstream signalling 
pathways. The authors favoured this explanation as this may also account for why 
distinct VGSC currents were differentially affected. 
The third hypothesis could be tested by supplementing the intracellular solutions with 
deferoxamine, an aluminium chelator; this would prevent the formation of AlF4
-
 ions. This 
is not common practice and in this study deferoxamine was not used as experiments 
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involving NaV1.1-R1648H could not have been compared to those in the literature. 
Moreover, the effects of protein kinases could also could be assessed by supplementing 
different internal solutions with agents that manipulate their function; for instance, the non-
selective Isoquinoline sulfonamide protein kinase inhibitor, H7 (Saab et al., 2003).  
3.3.4 The effects of temperature on NaV1.1 behaviour 
In the presence of chloride, at elevated temperatures both the voltage dependency and 
kinetics of gating of NaV1.1 splice variant and NaV1.1-D207N channels were 
indistinguishable. This implies that in vivo there are no differences in these parameters for 
NaV1.1 splice variant channels. Experiments conducted above 38
o
C suggested that at fever 
temperatures the voltage dependency of activation and inactivation of NaV1.1 isoforms are 
also similar.  However, because too little data was collected for extensive biophysical 
analysis, differences in other parameters cannot be excluded. A few cells did survive high 
temperatures, but were often larger than normal HEK cells (~60 pF) and derived from a 
„healthier‟ low passage number. Although these studies would be feasible in future 
experiments the integrity of the cell membrane was probably better preserved in larger cells 
and this would pose problems for clamping the membrane. Therefore, it is unlikely that 
these studies could be routine and would have to be performed in a low passage „window‟. 
Elevating the temperature of recordings to 37
o
C significantly reduced %INaP from NaV1.1-
5N. Additionally, the rate of current decay and entry into activation was significantly 
accelerated for both NaV1.1 splice variants at biological temperatures. This implies that 
higher temperatures increased the kinetic rates of gating and therefore slower states of 
inactivation observed at RT are more likely to reflect a reduction in kinetic energy rather 
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than a true physiological property. The voltage dependency of activation and inactivation 
were largely unaffected by a change in temperature. However, at lower temperatures 
significantly fewer NaV1.1-5N channels were available at –60 mV. Perhaps at this voltage 
neonatal channels are closer to an inactivated state compared to adult channels, a difference 
which is concealed at higher temperatures.  
This is the first study to examine the effects of temperature on VGSC splice variant 
channels. A similar study was performed using NaV1.2-5A channels expressed in HEK 293 
cells (Thomas et al., 2009). The voltage dependency of activation and inactivation was 
sequentially shifted to more depolarized potentials with increasing temperatures: 
22
o
C37oC41oC. However, a CsF-based intracellular was used and only an n of 4 was 
obtained for 41
o
C recordings, therefore the results may be unreliable. Similar to the results 
in this study the speed of sodium current inactivation was accelerated at higher 
temperatures (Thomas et al., 2009). Similarly, the kinetics of fast inactivation for NaV1.4 
channels were significantly slower at RT compared to recording performed at 30-32
o
C 
(Sugiura et al., 2003; Carle et al., 2009). The voltage dependence of NaV1.4 gating at 
different temperatures differed between the two studies but experiments were performed in 
varying internal solutions. 
The biophysical effects of elevated temperatures on the VGSCs in vivo have been 
investigated intermittently over the past 30 years. However, recordings originate from 
different preparations and species and contain mixed populations of channels. At one 
extreme, VGSC gating at room and physiological temperatures is indistinguishable in 
human myoballs, rat peripheral myelinated nerve balls and skeletal muscle (Schwarz 1986; 
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Pröbstle et al., 1988; Ruff 1999). In guinea pig cardiac myocytes, however, the voltage 
dependence of activation and inactivation was shifted depolarized potentials (Murray et al., 
1990). Other effects observed included increased sodium current density and channel Na+ 
conductance at higher temperatures (Murray et al., 1990).  Lastly, similar to reports 
involving heterologously expressed VGSCs the rate of current decay sodium currents in 
vivo are significantly faster at biological temperatures, suggesting that the kinetics of 
inactivation are particularly affected by temperature (Schwarz 1986; Pröbstle et al.,1988; 
Murray et al.,1990; Ruff 1999).  
Changes in gating parameters are not readily separable using macroscopic data. Therefore 
from this study it cannot be determined absolutely whether changes in temperature and 
intracellular solutions resulted from alterations in activation or inactivation.  From a 
biophysical perspective it would be interesting to gain a better understanding of NaV1.1 
splice variants function under different conditions. The ideal strategy would be to record 
from the splice variants in single-channel out excised patch configuration. At a single 
channel level it is possible to accurately determine whether more rapid current decays are 
coupled with faster inactivation and slow activation or slow inactivation and fast 
inactivation combined with a lowered probability of activation (Hille 2001 – p590). In 
addition, these recordings could determine if changes in persistent currents were due to late 
re-openings or to longer individual or bursting open states.  
3.3.5 HEK 293 cell line is suitable cell model for investigating the biophysical properties 
of NaV1.1 splice variants 
Further controls demonstrated that untransfected HEK 293 cells at RT in the presence of 
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both fluoride and chloride and at 37
o
C in chloride did not express contaminating currents. 
Microarray analysis demonstrated that the cellular background only slightly altered year to 
year.  This may be due to changes in cell-culturing conditions, for example, serum changes 
within growth media. Although the samples were quality checked before hybridization the 
older mRNA sample was frozen at 80
o
C and prolonged storage may have degraded the 
mRNA with periodic drops in temperature increasing the possibility of RNase activity. 
Nonetheless, from these results it is likely that the biophysical differences observed 
between NaV1.1 splice variants in this study were physiological and not artefacts resulting 
from endogenous currents or cell background. Although the latter cannot be completely 
excluded and the numbers of HEK 293 microarray mRNA samples were too small to 
determine the expression levels of individual genes. This would have been helpful in 
determining the relative expressions of modulatory proteins including protein kinases. 
Despite this disadvantage the overall genetic background was consistent. This was 
particularly important with regards to NaV1.1 persistent currents and β subunit regulation as 
both factors have been reported to be dramatically altered either by differential gene 
expression or cell type (Mantegazza et al., 2005; reviewed in Avanzini et al., 2007). 
The experimental design of the microarray analysis could have been improved.  The 
samples were not taken at consistent time-points throughout the three years of the study and 
the passage numbers were random. As mentioned previously the properties of cell lines can 
change with passage number (Hughes et al., 2007). Using a one-way ANOVA algorithm, 
the microarray analysis software, Affymetrix Expression Console requires at least six 
samples to identify differentially expressed genes (UCL Scientific Support Services). The 
fluorescent value for each gene was normalized to a median value of all the 1000s of 
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probes on the array to ensure that individual signals were above the background levels of 
fluorescence. A change in fluorescent intensity was a deviation from the overall signal of 
the array. Another way to assess the change in abundance of a gene would be to compare 
relative signal between the gene of interest and a reference (housekeeping) gene. 
Housekeeping genes are thought to be highly expressed in all somatic cells, under all 
conditions but cell confluency can affect their gene transcription levels (Greer et al., 2010). 
In numerous cell lines, however, β-actin is stably expressed at varying cell confluences 
(Greer et al., 2010). Therefore, to achieve more reliable results the cells would be harvested 
at 50% confluency in 35 mm dishes, similar to transfected HEK cells plating conditions. 
The relative intensities would be compared to β-actin signal to try to eliminate 
inconsistencies in gene expression caused by passage number and cell density.  
The control recordings demonstrated that the sampling rate and filtering conditions used in 
this study were adequate for recording sodium currents at physiological temperatures. In 
the past, electrophysiologists have been reluctant to record INa at 37
o
C. The kinetics of 
sodium channels are too fast for older amplifiers to achieve successful voltage clamp. 
VGSC would open during the charging of membrane capacitance, before the membrane 
had been properly voltage clamped (Murray et al., 1990). Improvements in the speed of 
modern amplifier circuits, ensuring that the series resistance was maintained below 2 MΩ 
and the small capacitance of HEK cells (average around 15 pF with a range up to 30 pF, 
personal estimation) circumvented this problem. Indeed, labs now routinely record sodium 
currents expressed in smaller cells at physiological temperatures (Cooper et al., 2005). In 
this report series resistance compensation was very carefully used. Using a CsCl-based 
intracellular solution can be technically demanding as it often introduced a drop in holding 
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current of up to 200 pA, but only after going whole-cell. This is partly why many 
experimenters prefer to use CsF-based intracellulars. In these „leaky‟ CsCl conditions, if the 
recording was stable series resistance compensation or supercharging was not used because 
the increased holding current would introduce fluctuating capacitance transients. However, 
compensation was often unnecessary if low series resistance was maintained by patching 
with wide-tipped, 1-2 MΩ, pipettes. According to the Axoclamp 700B manual, if the series 
resistance was 1 MΩ and cell capacitance 20 pF, in response to a voltage command the 
amplifier would clamp the membrane potential with a time constant of 20 μS, which is 
much faster than the opening of sodium channels even at physiological temperatures (10-
90% rise time >100 μS). Moreover, the low series resistance combined with relatively 
small currents (typically less than 2 nA) ensured that even during peak inward currents the 
error introduced was less than 4mV during a voltage step. In addition, the voltage clamp 
was assessed off-line to permit confirmation of the raw-data that the voltage clamp was 
accurate.    
3.3.6 Summary 
In summary, recovery from inactivation, the parameter that robustly differs between NaV1.1 
channel isoforms is significantly attenuated by phenytoin, with NaV1.1-5N channels 
demonstrating a greater sensitivity compared 5A-containing channels. These data provide 
two possible explanations for the association of the mutant allele with higher phenytoin 
dosage levels (Tate et al., 2005; Tate et al., 2006). The same concentration of the drug 
would demonstrate a smaller affect on channel availability in AA homozygous individuals, 
perhaps leading to a dose increase. However, in vivo the loss of NaV1.1 results in severe 
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epilepsy, and changes that reduce inhibition of NaV1.1 that is, splicing of SCN1A could be 
protective. Therefore, patients with a decreased transcription of exon 5N may tolerate 
higher doses of phenytoin because they experience less inhibition of NaV1.1 channels. 
Future studies are necessary to determine whether conserved splicing in additional VGSCs 
also change drug efficacy. This may be relevant to drug actions throughout the central and 
peripheral nervous systems and in the heart and may impact future treatment for VGSC 
related pathologies.  
In addition the biophysical properties of NaV1.1 channels containing the neonatal exon are 
particularly affected by internal anions and temperature changes. These variables would be 
important to control in future work. 
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Chapter 4: The functional effect of splicing on the GEFS+-
associated SCN1A mutation R1648H 
4.1 Hypothesis and aims 
Hypothesis:  Since NaV1.1-5N is upregulated in early development and patients with 
GEFS+ frequently exhibit age-dependent changes in seizure frequency and severity; it was 
hypothesized that the GEFS+-associated SCN1A mutation R1648H would differentially 
affect NaV1.1-5N and NaV1.1-5A. Because many individuals with mutations in SCN1A 
manifest seizures with only an increase in body temperature, it was surmised that 
recordings at higher temperatures would deleteriously alter the biophysical properties of 
both mutant channels.  
Members of the family harbouring NaV1.1-R1648H demonstrate a wide-ranging response 
to AEDs. Another proposal for this work was that R1648H patients with comparable 
rs3812718 genotypes - and therefore a similar ratio of NaV1.1 splice variant channels - 
would have similar drug histories. Because it was hypothesized that NaV1.1-R1648H 
channels in alternative splice variant backgrounds would respond differently to AEDs, 
particularly phenytoin. 
Background and experimental aims: Missense mutations in SCN1A are associated with 
several monogenetic epilepsy syndromes, which often manifest during early childhood that 
may continue into adulthood with variable phenotypes. The aim of this section was to 
determine whether changes in alternative splicing could play a role in modifying disease 
severity, by altering the functional impact of mutations in SCN1A that cause epilepsy. In 
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vitro electrophysiological experiments using NaV1.1-5A indicate that these mutations cause 
relatively subtle effects on channel behaviour, particularly on persistent currents. One 
mutation, R1648H, is associated with GEFS+ and in heterologous systems has been shown 
to produce an increased persistent current.  This mutation affects a conserved positively 
charged arginine in the voltage sensor of the fourth domain. As previously discussed the 
GG genotype of rs3812718in SCN1A is associated with lower phenytoin dosage. This
 
may 
result from this drug delaying proportionally more NaV1.1-5N channel recovery from 
inactivation. The widely reported increase in NaV1.1-R1648H derived persistent current 
may be an additional target for phenytoin, and it may be modulated by the altered 
inactivation of channels containing exon 5N.  
4.2 Genetic background: R1648H is likely to co-exist with exon 5N in NaV1.1 
The original multigenerational family in which R1648H was identified provides an 
opportunity for determining whether the mutation in SCN1A segregates with the SNP 
rs3812718 which alters splicing in this gene. Although the mutation is too far from the SNP 
to determine directly whether the polymorphism and the mutation are allelic, segregation 
analysis can be used to show co-inheritance. The identity of the second allele of the SNP 
should be correlated with a varying amount of NaV1.1-5N during development. If the 
presence of NaV1.1-5N alters severity of epilepsy or seizures, then individuals with 
different alleles of the SNP may display different manifestations. While the distance 
between the SNP and the mutation are too far for direct sequencing, they are too closely 
linked for recombination to be likely even in a relatively large family. Therefore, only the 
allele of the SNP on the chromosome without the mutation is likely to vary. As detailed 
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phenotypic data for this family is available (Baulac et al., 1999; Escagy et al., 2000), it 
should be possible to determine whether clinical manifestation is correlated with the 
genotype of the SNP.  
Analysis performed by Klaus Wanisch (a postdoc in the lab) showed that of the original 
NaV1.1-R1648H pedigree (Escayg et al., 2000; Figure 4.1) all 12 affected individuals for 
whom DNA was available, carried at least one G allele of the SNP rs3812718. Of these, 
over 50% were homozygous for the SNP (the genotype of one patient was unidentified). 
There was no obvious difference in phenotypes when comparing between GG and GA 
individuals, although the sample size was small. Two healthy individuals were AA; which 
would provide them with a bias towards the adult exon. Because the G allele is present in 
all affected individuals, patients carrying the R1648H mutation are likely to have a larger 
proportion of NaV1.1-5N channels, and it is probable that the mutation is carried with the G 
allele, although this would need to be confirmed. Investigating the properties of NaV1.1-
R1648H in exon 5N background is therefore important because previous reports have used 
only investigated the behaviour of adult mutant isoform.  
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Figure 4.1 R1648H pedigree detailing patient rs3812718 genotype. The original pedigree is based on information from 
Baulac et al. 1999 and Escagy et al. 2000. 
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4.3 Effects using CsF-based intracellular solutions 1: NaV1.1-5A derived persistent 
currents were unaffected by R1648H using CsF-based solutions  
To establish a comparison with the data describing functional effects of NaV1.1-
R1648H-5A heterologously expressed in HEK cells, the two splice variants were 
initially compared using CsF-based intracellular solutions at RT. NaV1.1-5N channels 
were engineered to carry the R1648H mutation (Figure 4.2 A, top panel). Raw traces are 
shown in Figure 4.2 A (bottom panel, current protocol shown in the inset). Peak 
transient current density of NaV1.1 was not significantly affected by splicing or the 
R1648H mutation (P=0.7, two-way ANOVA). Unlike previous reports, using the CsF-
based internal solution used in this study, NaV1.1-R1648H-5A demonstrated 
indistinguishable mean (±SEM) %INaP to wild-type channels (5A: 7.8 ± 1.6 %, n=12 
versus R1648H-5A: 7.4 ±1.3 %, n=13; P>0.05, two-way ANOVA, Bonferroni‟s post-
test; Figure 4.2 B).  This was not the case for NaV1.1-5N, as mutant channels displayed 
a greater mean (±SEM) %INaP (8.1 ±1.6 %, n=9) compared to wild-type channels (3.6 ± 
1.0 %, n=13). However, this was not significant when accounting for the combined 
influences of splicing and the mutation using a two-way ANOVA with Bonferroni‟s 
post-tests (P>0.05, Figure 4.2 B). Nonetheless, NaV1.1-R1648H-5N channels 
demonstrated a significantly slowed rate of inactivation between -20 mV and + 20 mV, 
compared to wild-type NaV1.1-5N channels (P<0.0001, two-way ANOVA; Figure 4.2 
C).  
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Figure 4.2 The non-inactivating component of NaV1.1-R1648H 5N transient 
currents is more stable compared to wild-type channels A. Location of the R1648H 
mutation in the voltage sensor in the fourth domain is shown by the yellow circle. The 
region changed by alternative splicing of SCN1A exon 5, is shaded a darker grey.  B. 
Representative traces from cells transfected with NaV1.1-R1648H-5A or 5N. Currents 
elicited by protocol as in inset C. NaV1.1-R1648H-5A does not increase mean ±SEM 
%INaP, although this may have been a qualitative effect for 5N containing channels; 
reflected in the slowing of NaV1.1-R1648H 5N mean ±SEM current decay, over a range 
of voltages compared to wild-type channels (D). ***P<0.0001, two-way ANOVA.   
 
4.3 Effects using CsF-based intracellular solutions 2: R1648H does not alter splice 
variant voltage dependence of activation or inactivation  
Other reports did not detect changes in voltage dependence of activation or inactivation 
of NaV1.1-R1648H-5A channels expressed in HEK 293 cells (Lossin et al., 2002; 
Kahlig et al., 2006; Vanoye et al., 2006).  In these conditions the voltage dependence of 
A B 
C D 
 249 
inactivation was also unaffected for both splice variants carrying the mutation (5A 
versus R1648H-5A, P=0.9; 5N versus R1648H-5N, P=0.9, two-way ANOVA; Figure 
4.3 C&D).   
There was a trend for NaV1.1-R1648H voltage dependence of activation to be shifted ~ 
3 mV to more depolarized potentials in both splice variant backgrounds (clearly 
depicted in Figure 4.3 A), but a two-way ANOVA with post hoc tests revealed no 
significant differences in the mean (±SEM) midpoints (V50act 5A versus R1648H-5A, 
P>0.05; 5N versus R1648H-5N, P>0.05; Figure 4.3 B). In contrast, the same statistical 
tests indicated that the voltage dependency of the mutation in the neonatal splice variant 
background was significantly reduced with an increase of 1.1± 0.1 mV/e-fold change 
(mean ±SEM k: 5N, n=14, versus R1648H 5N, n=8, P<0.05).  Lastly, the time-course of 
activation was unchanged in mutant channels compared to wild-type channels (data not 
shown, 5A versus R1648H 5A, P=0.06; 5N versus R1648H 5N, P=0.1; two-way 
ANOVA). 
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Figure 4.3 NaV1.1 splice variants voltage dependence activation and inactivation is 
largely unaffected by R1648H A greater percentage of NaV1.1-R1648H mutant 
isoforms activated at more depolarized potentials (A), but the mean±SEM midpoints 
were not significantly changed (B) but the voltage sensitivity of NaV1.1-R1648H-5N 
activation was significantly decreased (B). *P<0.05, two-way ANOVA, Bonferroni post 
test. C, D. In all conditions, the voltage dependence of inactivation was unaffected over 
the voltage range and no change was observed in the mean±SEM V50 inactivation or 
slope factors of Boltzmann fits. Currents elicited by protocol as in insets. 
 
At RT in the presence of fluoride, the inclusion of exon 5 altered the stability of NaV1.1-
R1648H persistent currents. In contrast to the literature, the non-inactivating component 
of NaV1.1-5A was unaffected by R1648H (Lossin et al., 2002; Vanoye et al., 2006). 
A B 
C D 
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Because patients with GEFS+ frequently exhibit fever associated seizures, it was asked 
next whether the R1648H mutation was differentially affected by splicing at 
physiological temperatures using fluoride free solutions. Experiments were attempted at 
40
o
C in the presence of CsCl to replicate pathological conditions but cells transfected 
with the mutated channels were too fragile for recordings (data not shown).  
4.4 Physiological conditions 1: The R1468H mutation significantly increases 
persistent currents in both splice variant backgrounds  
In Chapter 3 it was shown that the gating of NaV1.1 channels is altered in several ways. 
In particular, increasing the temperature of recordings suppressed persistent currents by 
increasing fast inactivation, and equalized the voltage-dependence of macroscopic 
gating between the two splice variants. The goal of this section was to determine how 
the mutation interacted with the different splice variants in more physiological 
conditions.  
As clearly depicted in the raw traces shown in Figure 4.4 A, at elevated temperatures 
and using CsCl-based solutions the NaV1.1-R1648H persistent currents in both splice 
variant backgrounds were pronounced.  The current-voltage relationship in Figure 4.4 A 
shows that persistent currents from NaV1.1-R1648H-5N were significantly larger 
compared to wild-type 5N channels (5N, n=18 versus R1648H-5N, n=13 P=0.02; two-
way ANOVA). A significant increase of persistent current between NaV1.1-R1648H-5A 
and wild-type 5A channels was also observed over the voltage range (5A, n=10 versus 
R1648H-5A, n=8 P=0.008; two-way ANOVA). Persistent currents derived from mutant 
channels were also voltage dependant, peaking at -10 mV and 0mV respectively. 
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NaV1.1-5N mean (±SEM) peak current density was -11.1 ± 3.4 pA/pF (n=8), ~ 7 pA/pF 
greater than NaV1.1-5A at -3.9 ± 1.3 pA/pF (n=12; difference in pA/pF was not 
significant, P=0.3; two-tailed t-test). However over the voltage range NaV1.1-R1648H-
5N persistent currents were significantly increased compared to 5A-containing mutant 
channels (P=0.0006, two way ANOVA).  
There are two possible ways of comparing INaP measured from mutant and normal 
channels. Differences may be measured as changes in the percent of current that is 
persistent as a proportion of the total „peak‟ transient current, or changes may be more 
directly measured as simple amplitude of INaP density. In previous reports, single-
channel analysis has shown that persistent currents derived from heterologously 
expressed NaV1.1-R1648H channels resulted from the late re-openings of the pore. 
These data suggest that the same channels underlie both the early fast transient 
openings, and the late „persistent‟ openings. Therefore, %INaP may be a more direct 
representation of this channel property than total amount of INaP, because %INaP 
reflects the proportion of channels that re-open as a part of the total channels available. 
In contrast, a direct comparison of INaP current density from different channels would 
be confounded by any changes in channel expression levels, as well as changes in 
likelihood of channels re-opening later in voltage-steps.  
NaV1.1-R1648H-5N mean (±SEM) %INaP was dramatically increased compared to 
wild-type channels (5N R1648H 15.2 ± 3.2%, n=13 versus 5N 5.2 ± 1.1%, n=11; 
P<0.01, two-way ANOVA, Bonferroni‟s post-test; Figure 4.4 C). Comparable 
observations were made for NaV1.1-5A mutant compared to wild-type channels 
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channels (R1648H-5A 17.6 ± 1.7%, n=17 versus 5A 8.5 ± 1.6%, n=16; P<0.01, two-
way ANOVA, Bonferroni‟s post-test; Figure 4.4 C). 
The proportion of persistent current for both channels was comparable (P=0.2, two-
tailed t-test; Figure 4.4 C). Overall the transient current was unaffected by splicing and 
the R1648H mutation (P=0.6, two-way ANOVA; Figure 4.4 D), although there was a 
trend towards smaller peak transient currents from NaV1.1-1648H-5A channels 
compared to NaV1.1-1648H-5N channels (25.6 ± 18.3 pA/pF, P=0.2, two tailed t-test; 
clearly shown in Figure 4.4 D).  The increase of INaP from the mutant channels is 
consistent with the significant deceleration of inactivation seem over a range of voltages 
(5A versus R1648H 5A, P=0.01, 5N versus R1648H 5N, P=0.02; two-way ANOVA; 
Figure 4.4 D). Splicing did not affect this parameter as both mutant channels had 
comparable rates of current decay (P=0.5, two-way ANOVA, Figure 4.4 E).  
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Figure 4.4 NaV.1-R1648H increases persistent current in both splice variant 
backgrounds at biological temperatures A. Raw traces of NaV1.1-R1648H 5A-
containing channels (top) and 5N-containing channels (bottom). B. Mean (±SEM) 
persistent current density of wild-type and mutant channels.  Persistent currents derived 
from NaV1.1-R1648H were significantly increased compared to wild-type channels, and 
were voltage dependant. 5A vs R1648H-5A **P=0.008; 5N vs R1648H 5N *P=0.02, 
two-way ANOVA. C. Splicing did not affect the mean (±SEM) increase in %INaP for 
NaV1.1-R1648H channels, but %INaP was significantly increased for both mutants 
compared to wild-type channels. **P<0.01, two-way ANOVA, Bonferroni‟s post-test D. 
The R1648H mutation and splicing did not significant change mean (±SEM) peak 
current density of NaV1.1. Although there was a significant increase in the persistent 
current density for NaV1.1-R1648H 5N channels (***P=0.0006, two-way ANOVA, B), 
the %INaP was similar for both mutant isoforms, because of a reduction in NaV1.1-
R1648H-5A transient peak current density. E. Consistent with a decreased stability of 
inactivation NaV1.1-R1648H channels demonstrated a slower rate of current decay over 
a range of voltages compared to wild-type channels. 5A vs R1648H 5A, *P=0.01, 5N vs 
R1648H-5N, *P=0.02, two-way ANOVA. 
A B 
C D E 
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4.4 Physiological conditions 2: The R1648H mutation causes a rightward shift in the 
voltage dependence of activation of both splice variants 
In both splice variant backgrounds, the midpoints of mutant channels were significantly 
shifted by 6.5 ± 1.5 mV and 3.0 ± 1.3 mV in a rightward direction for 5A and 5N 
containing channels respectively (5A -18.5 ± 0.9 mV, n=15 versus R1648H-5A -12.0  ± 
1.2 mV, n=9; P<0.001; 5N -18.8 ± 0.8 mV, n=18 versus R1648H 5N -15.8 ± 1.0 mV, 
n=13; P<0.05, two-way ANOVA, Bonferrroni‟s post tests; Figures 4.5 A&B). Moreover 
NaV1.1-R1648H-5A channels activated at significantly more depolarized potentials than 
NaV1.1-R1648H-5N channels (P=0.02, two-tailed t-test) suggesting that unlike NaV1.1-
R1648H persistent currents, transient currents produced by this mutation were 
differentially modulated by splicing. The kinetics of activation for both NaV1.1-R1648H 
splice variants were unchanged compared to wild-type channels over the voltage range 
(5A versus R1648H 5A, P=0.7; 5N versus R1648H 5N, P=0.7; two-way ANOVA; 
Figure 4.5 C). 
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Figure 4.5 R1648H causes a loss of function in NaV1.1 splice variant voltage 
dependence of activation  A. The voltage dependence of activation for NaV1.1-R1648H 
in both splice variant backgrounds was shifted in a rightward direction. Currents were 
elicited by protocol in inset B. 5A containing channels were more sensitive to a change 
in the voltage sensor and mean (±SEM) midpoints of activation were shifted to more 
depolarized potentials compared to wild-type channels and NaV1.1-R1648H-5N. The 
average (±SEM) slope factors were comparable in all conditions. ***P<0.0001, 
*P<0.05, two-way ANOVA. Bonferroni‟s post-test. C. The mean (±SEM) 10-90 % rise 
time to peaks over a voltage range was similar for both NaV1.1 splice variant wild-type 
and mutant channels.  
 
 
 
 
 
 
A 
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4.4 Physiological conditions 3: The mutation R1648H decreased the voltage sensitivity 
of inactivation for both channel variants 
The mean (±SEM) V50 of NaV1.1 inactivation was unaffected by R1648H and splicing 
(P=0.5; two-way ANOVA; Figures 4.6 A&B). However the voltage dependency was 
reduced for both channels with an increase in the mean steepness of Boltzmann fits 
compared to wild-type channels (P=0.0005, two way ANOVA; Figure 4.6 A). More 
specifically, when considering individual channels increase of 1.7 ± 0.7 mV/e-fold 
change was observed in NaV1.1-R1648H-5A channels compared to controls (P<0.05, 
two-tailed t-test; Figure 4.6 B). A similar decrease in the voltage dependency of 
inactivation was demonstrated by a -2.2 ± 0.8 mV/e-fold change increase slope factor 
NaV1.1-R1648H-5N channels compared to NaV1.1-5N channels (P<0.05, two-tailed t-
test; Figure 4.6 B). 
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Figure 4.6 The voltage sensitivity of inactivation was decreased for NaV1.1-R1648H 
splice variant channels. A. The voltage dependence of inactivation for NaV1.1-R1648H 
channels was comparable to wild-type channels. B. The mean (±SEM) k values were 
significantly increased for both NaV1.1-R1648H isoforms compared to wild-type 
channels. *P<0.05, two-way ANOVA, Bonferroni‟s post-test.  
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4.4 Physiological conditions 4: Phenytoin does not significantly reduce persistent 
currents derived from channels containing the R1468H mutation 
In both splice variant backgrounds the mutation R1468H introduced a substantial 
increase in persistent current, which is a potential target for AED block.  To assess the 
contribution of this parameter to phenytoin responsiveness the proportional difference in 
INaP between a 200ms -10 mV inactivating prepulse followed 18 ms recovery interval at 
-80 mV was followed by a -10 mV test potential. This protocol was preceded by a 20 ms 
interval sweep, to allow for the use-dependent block of AEDs. As expected phenytoin 
did reduce persistent currents for both wild-type and mutant channels (mean ±SEM % 
decrease INaP: 5A 32.8 ± 8.2 %, n=8; 5N 21.0 ± 5.3%, n=6; R1648H-5A 35.9 ± 10.4%, 
n=7; R1648H 5N 44.7 ± 10.6%, n=7; Figure 4.7 B). However, a two-way ANOVA did 
not reveal a significant difference in the proportion of drug inhibition of NaV1.1 
compared to NaV1.1-R1648H derived persistent currents (P=0.2), suggesting that 
phenytoin block INaP derived from mutant channels may not alter drug responsiveness 
in patients with this mutation.  
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Figure 4.7 Phenytoin did not disproportionally inhibit NaV1.1-R1648H persistent 
currents A. Schematic showing the parameters use to calculate proportional inhibition 
by phenytoin of persistent currents. Mean currents were taken from 20 ms – 30 ms after 
a -10 mV prepulse and 20 ms – 30 ms after a subsequent -10 mV test potential, 
following a 18 ms interval at -80 mV. The reduction in the persistent current from the 
second pulse for each cell was expressed as a percentage.  B. In the presence of 
phenytoin persistent currents derived from all channels were proportionally reduced but 
no differences in percentage inhibition were observed between mutant and wild-type 
channels. NS: P=0.2, two-way ANOVA. 
4.4 Physiological conditions 5: R1648H slows the recovery from inactivation for both 
splice variants  
The remaining parameter targeted by both phenytoin and by alternative splicing is 
recovery from inactivation. The R1648H mutation is not located in the inactivation 
module, but as shown in previous studies R1648H slows the rate of recovery from 
inactivation (Martin et al., 2010). Similarly, the changes in the voltage sensor caused by 
R1648H mutation in NaV1.1-5N channels slowed recovery from inactivation (5N n=10, 
R1648H 5N n=8; P<0.0001; two-way ANOVA; Figure 4.8 A). This slowing was 
particularly pronounced at longer time intervals (10 ms and 20 ms, P<0.0001, 
Bonferroni‟s post-tests). R1648H had slightly smaller effects on recovery from 
B A 
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inactivation in NaV1.1-5A compared to NaV1.1-5N but these were not significantly 
different at any specific recovery time (5A n=8, R1648H-5A n=11; P=0.03; two-way 
ANOVA; Figure 4.8 B).  However, the consequences of the larger inhibition of recovery 
in the NaV1.1-5N background meant that the recovery from inactivation from both 
splice variants containing the mutation were comparable (P=0.7, two-way ANOVA; 
Figure 4.8 C).  
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Figure 4.8 Channels containing R1648H recovered from inactivation more slowly 
compared to wild-type channels. The recovery from inactivation was significantly 
slowed at time points between 2 and 20 ms after prolonged depolarisations for 5N (A) 
and 5A (B) R1648H channels compared to wild-type channels ***P<0.0001, *P=0.03, 
two-way ANOVA. C. R1648H eradicated the difference between recovery from 
inactivation between wild-type channels. The recovery was reduced to similar 
percentages for NaV1.1-R1648H channels in both splice variant backgrounds. P=0.7, 
two-way ANOVA. Currents were elicited as in inset. 
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4.4 Physiological conditions 6: Phenytoin demonstrates a proportionally greater 
inhibition when acting on R1648H channels in NaV1.1-5N background  
As expected, phenytoin significantly inhibited recovery from inactivation of both mutant 
channels in both splice variant backgrounds. This was true across the time-interval range 
(R1648H 5A, n=11, versus R1648H-5A + PHT, n=7; P=0.005; R1648H 5N, n=8, versus 
R1648H 5N + PHT, n=7; P<0.0001; two-way ANOVA; Figure 4.9 A&B). Interestingly, 
the AED had a significantly greater efficacy when acting on NaV1.1-R1648H-5N 
channels compared to NaV1.1-R1648H-5A (P=0.04; two-way ANOVA; Figure 4.9 C), 
indicating that splicing does alter the drug responsiveness of NaV1.1-R1648H.  
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Figure 4.9. (previous page) Splicing significantly effects the drug responsiveness of 
R1648H channels A, B. 50 μM phenytoin significantly inhibited recovery from 
inactivation of both mutant channels at three times interval indicated. ***P<0.0001, 
**P=0.005, two-way ANOVA C. Recovery from inactivation of 5N-mutant channels 
was disproportionally decreased by phenytoin compared to NaV1.1-R1648H-5A 
channels. *P=0.04, two-way ANOVA. 
 
In the presence of phenytoin mutant NaV1.1-5N channels were significantly delayed 
compared to wild-type channels (P<0.0001; two-way ANOVA; Figure 4.10 A). In 
contrast, under the same conditions 5A-containing channels were indistinguishable 
(P=0.1; two-way ANOVA; Figure 4.10 B). Implying that polymorphism rs3812718 and 
genetic heterozygosity, may have significant implications in drug treatment for inherited 
NaV1.1 epilepsies.  
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Figure 4.10 The effect of phenytoin on the recovery of inactivation for wild-type 
and mutant channels A. In the presence of phenytoin NaV1.1-5N channels recovered 
more rapidly compared to NaV1.1-R1648H 5N channels, over time intervals ranging 
from 2 -20 ms.***P<0.0001, two-way ANOVA.  B. The drug responsiveness of mutant 
and wild-type 5A containing channels was comparable. P=0.1, two-way ANOVA.  
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4.5 Discussion 
The main positive findings of this chapter were: 
1. Patients harbouring the R1648H mutation had a least one copy of the G allele of 
rs3812718. This allele favours the inclusion of 5N. Therefore investigating the 
effects of this mutation in a neonatal „background‟ was essential to understand 
its true biophysical consequences on NaV1.1 behaviour.  
2. The behaviour of NaV1.1-R1648H channels presented in this work using CsF 
based internal solutions at RT did not compare with reports in the literature, 
highlighting the influence of cell background on channel properties.  
3. At physiological temperatures R1648H causes both a loss and gain of NaV1.1 
function.  
4. Alternatively splicing differentially affects NaV1.1 mutant channel gating. 
5. R1648H similarly slows channel recovery from inactivation of both NaV1.1 
isoforms and phenytoin disproportionally inhibits this parameter of NaV1.1-
R1648H-5N channels.  
6. No direct link between patient AED phenotype/drug treatment, rs3812718 
genotype and NaV1.1-R1648H behaviour was revealed. 
4.5.1 The G allele of rs3812718 is associated with R1648H 
This chapter attempted to determine whether alternative splicing of NaV1.1 would affect 
the behaviour and drug response of a GEFS+ mutation, R1648H. Genotyping the 
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members of this family that harbours R1684H showed that all affected individuals had 
at least one copy G allele of rs3812718. Therefore, as adults these individuals would 
express NaV1.1-5N. However, because these patients are heterozygous for the mutation, 
further sequencing would ascertain whether the mutation and SNP are consistently 
located on the same chromosome. It is unlikely that in this pedigree, there is a direct 
association with drug dosage and rs3812718, because irrespective of their genotype each 
individual experienced varying responses to AEDs.   
4.5.2 The behaviour of NaV1.1-R1648H-5A channels in this report using CsF-based 
intracellular solutions at RT contrasted with earlier reports  
Previous reports have investigated heterologously expressed NaV1.1-R1648H-5A in 
HEK derivative cells, using CsF-based internal solutions. Results derived from this 
study in similar conditions, were different than those reported by other groups. One 
distinguishing feature of this mutation is that it increases the level of NaV1.1-5A derived 
%INaP and does not alter the voltage dependence of NaV1.1-5A gating (Lossin et al., 
2002; Kahlig et al., 2006; Vanoye et al., 2006).  However, from these data no increase 
of %INaP was observed for NaV1.1-R1648H-5A channels but a switch to exon 5N 
decreased the rate of current decay. Although not significant the mutation caused a mild 
loss of function in the voltage dependency of activation and the voltage sensitivity of 
NaV1.1-5N channel activation was decreased. Together with the current decay 
observations these data imply that in fluoride, NaV1.1-5N channel activation and 
inactivation are more sensitive to the loss of an arginine within the voltage sensor.  
Discrepancies in NaV1.1-R1648H-5A channel behaviour in this report and the literature 
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may result from several variables. For instance, the NaV1.1 clone used in the Lossin et 
al. and Vanoye et al. investigations was the full length SCN1A gene, thus the shorter 
exon 11 NaV1.1[-33] variant used in this study may account for changes in NaV1.1 
activation. Indeed, DRG cells expressing a NaV1.7 adult onset inherited erythermalgia 
mutation in an exon 5A with a longer exon 11 background had a reduced action 
generation threshold and firing compared to cells expressing shortened mutant channels 
containing 5N (Choi et al., 2010). Alternatively β subunit modulation may have masked 
these subtle affects in previous reports or differences in cell background may have 
influenced channel gating. Because results from electrophysiology experiments using 
CsF are unlikely to represent the true physiology of these channels (Coste et al., 2004), 
conclusions on the effect of R1648H on NaV1.1 behaviour will be based on CsCl 
recordings at physiological temperatures. 
4.5.3 NaV1.1-R1648H increases %INaP  
Elevated temperatures revealed that R1648H causes an increase in %INaP and a slowing 
of the rate of inactivation and this gain of function is unaffected by SCN1A alternative 
splicing. Therefore, a shift in the 5N/5A ratio would not change this parameter. Single 
channel analysis and computer modelling provided strong evidence that R1648H 
increases the probability late channel openings after inactivation, possibly by 
destabilizing the IFM inactivation gate (Kahlig et al., 2006; Vanoye et al., 2006). 
Mutations of NaV1.5 inner D4:S4 arginines also increased persistent currents, suggesting 
that these residues play an important role in VGSC inactivation (Zimmer & Surber, 
2005). Xu & Clancy (2008) demonstrated that NaV1.1-R1648H derived persistent 
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currents encouraged neuronal bursting, in a single-compartment model of a CA3 
hippocampal pyramidal neuron. However, If NaV1.1 channels are upregulated in 
inhibitory interneurons in humans, how would a gain of channel function cause 
epileptogenesis? Some clues are given in disease models concerning different VGSCs. 
Specific mutations in the skeletal VGSC cause an increase in INaP but a paradoxical 
decrease in cellular excitability that led to muscle inexcitability and episodes of 
paralysis. Cannon (2006) surmises that the increased INaP would depolarize the resting 
membrane potential and inactivate transient sodium currents responsible for the upstroke 
of the muscle action potential. However, muscle and neuronal channels serve different 
physiological roles and it is likely that the Ensemble of channels plays a greater role. 
This is demonstrated by a loss of function mutation in NaV1.7 that is associated with a 
pain disorder. The mutation, L858H results in hypo- and hyperexcitability of different 
PNS neurons which is explained by the presence of NaV1.8 in one cell type but not the 
other. For example, in sympathetic neurons, cells that lack NaV1.8, the mutation 
decreases cell excitability.  In sensory neurons, however, NaV1.8 is upregulated and in 
wild-type neurons NaV1.7 is activated before NaV1.8 which is resistant to inactivation at 
more positive potentials. The absence of this renders the sensory neurons hyperexcitable 
(Rush et al., 2006).  Because there was a pronounced increase in NaV1.1-R1648H 
derived %INaP in this study, and in the previous reports (in the presence of β subunits), 
it is very surprising that persistent currents were not detected in neurons in both mouse 
models of this mutation (Tang et al., 2009; Martin et al., 2010).  
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4.5.4 NaV1.1-R1648H also causes a loss of gating function 
R1648H also introduced a loss of NaV1.1 gating function, a rightward shift in the 
voltage dependence of activation and a decrease in the voltage sensitivity of 
inactivation. R1648H is a mutation in the fifth (out of six, closest to the extracellular 
side) arginine in NaV1.1 fourth voltage sensor. Previous reports have neutralized or 
charge substituted the middle/outer arginines within D4:S4 of different VGSCs. 
Observations from whole-cell patch clamp experiments using heterologously expressed 
mutant channels are inconsistent. Some studies correlated with this study, that is, the 
voltage dependence of VGSC activation was shifted to more depolarized potentials, the 
voltage sensitivity of inactivation was decreased and/or that rate of current decay was 
slowed (Chen et al., 1996; Wang et al., 1996; Kuhn & Greeff, 1999; Frustaci et al., 
2005). Conversely other reports demonstrated that activation was unaffected and/or 
current decay was accelerated (Kontis et al., 1997; Sheets et al., 1999). Despite these 
discrepancies, the changes in NaV1.1-R1648H gating shown in this study are consistent 
with a disruption of activation-inactivation coupling (Chen et al., 1996) and a 
destabilization of fast inactivation (Kuhn & Greeff, 1999). Analogous residues within 
the D4:S4 of another to VGSC genes SCN4A and SCN5A are also mutation hotspots that 
cause hypokalemic periodic paralysis (Matthews et al., 2009) and Brugada syndrome 
(Frustaci et al., 2005) respectively.   
The shift in the voltage dependency of NaV1.1-R1648H activation is not observed in 
R1648H transgenic mice (Tang et al., 2009; Martin et al., 2010). The sodium current 
voltage dependency of activation and inactivation was unaffected in inhibitory 
 268 
interneurons from both models (Tang et al., 2009; Martin et al., 2010). In excitatory 
neurons originating from the BAC transgenic model the midpoint of NaV1.1-R1648H 
inactivation was shifted to the left and the voltage sensitivity was reduced; however, the 
latter was not highlighted by the authors (Tang et al., 2009). Both mouse model studies 
demonstrated that peak sodium currents in GABAergic neurons were significantly 
reduced. This affect was not shown in these data from heterologous expression. This 
may result from a trafficking defect that could be masked by channel overexpression in 
non-neuronal cells, or interactions with specific neuronal proteins may hinder sodium 
permeation. Because there were differences in gating between excitatory and inhibitory 
neurons it is likely that the inconsistencies between these results and mouse models are 
due to cell background.  
Based on the results in vivo how could a loss and gain of NaV1.1 channel function cause 
GEFS+? Further insights may be given in a rat model of GEFS+ harbouring a mutation 
that caused opposing changes in NaV1.1 channel function. Mashimo and colleagues 
(2010) introduced the missense mutation N1417H, into rat native SCN1A using a potent 
mutagen called N-ethyl-N-nitrosourea (EMU). Although not an epilepsy causing 
mutation per se, the pore of the third domain where this mutation occurrs is a mutation 
hotspot for SMEI and GEFS+ mutations in humans (Ohmori et al., 2002; Sugawara et 
al., 2002; Fujiwara et al., 2003; Berkovic et al., 2006; Mancardi et al., 2006; Harkin et 
al., 2007; Marini et al., 2007; Zucca et al., 2008). Similar to R1648H models the main 
deleterious effects of N1417H were observed in GABAergic hippocampal neurons from 
homozygous pups. Recordings from SCN1A
N1417H/N1417H 
excitatory neurons showed no 
changes in the biophysical properties of mutant compared to wild-type channels. 
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Interestingly, NaV1.1-N1417H channels in both HEK cells and hippocampal inhibitory 
interneurons showed a significant increase in persistent current and a shift to the left in 
voltage dependency of channel inactivation. This was a similar contrasting gain and loss 
of a function observed for NaV1.1-R1648H in this study. It could be argued that 
functional discrepancies of NaV1.1-R1648H in mouse neurons and HEK cells may not 
rely on cellular background but species. However, mouse full length SCN1A has 2% 
more sequence identity to human SCN1A than to the rat gene (unpublished alignment), 
so this seems an unlikely explanation. Alternatively, the variability of functional effects 
on interneurons, may partly contribute to variability of severity and manifestation of 
seizures. Indeed, homozygous NaV1.1-N1417H rats did not exhibit spontaneous 
seizures, although they were extremely susceptible to hyperthermic stimuli compared to 
heterozygous and wild-type littermates. Approximately 20% SCN1A
N1417H/+
 rats 
exhibited clonic seizures after submergence into a 45
o
C bath, an 80 % reduction 
compared to SCN1A
N1417H/N1417H
 animals.  
A later study by the Mashimo group (Ohno et al., 2010) measured in vivo responses of 
SCN1A
N1417H/N1417H
 CA1 hippocampal pyramidal cells to test or pair-pulse stimulation of 
the Schaffer collateral pathway. Implementing the latter, CA1 cells can receive GABAA 
receptor (inhibitory) and NMDA receptor (excitatory) mediated inputs (Ohno et al., 
2010). Single test pulses stimulating the stratum radiatum elicited normal CA1 
responses in both wild-type and mutant rats. However, paired-pulsed stimulation of 
SCN1A
N1417H/N1417H
 CA1 neurons showed a significantly greater number of spikes 
compared to healthy cells. This result could be reproduced in the wild-type rats in the 
presence of biciulline, a GABAA antagonist suggesting that abnormal NaV1.1 function, 
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not necessarily a gain or loss of function per se, disrupts GABAergic synaptic 
transmission in the rat hippocampus.  
It is possible that the increase in NaV1.1-R1648H %INaP may negate the loss voltage 
dependency of NaV1.1 activation. However, as described in the introduction elevated 
temperatures attenuates GABAergic transmission, possibly through aberrant trafficking 
of GABA receptor subunits (Kang et al., 2006). SCN1A
N1417H/N1417H
 rats have a lower 
hyperthermia induced seizure threshold. Perhaps subtle alterations in NaV1.1 and 
GABAA mediated inhibition are only revealed at elevated temperatures, promoting 
epileptogenesis. Similar brain slice recordings from R1648H rodents could determine 
whether this mutation has comparable deleterious affects. Because the voltage 
dependence of activation of NaV1.1-R1648H-5A was significantly more depolarized 
than NaV1.1-R1648H neonatal channels, individuals with GA rs3812718 genotype may 
be more vulnerable to FS. However, the seizure history of this family challenges this 
hypothesis. From a biophysical perspective these data suggest that the changes in the 
extracellular linker of domain D1 may play a secondary role in activation-inactivation 
coupling to the D4 voltage sensor. In future studies it would be interesting to investigate 
other NaV1.1 GEFS+ mutations that do not lie within the voltage sensor. 
4.5.5 NaV1.1-R1648H slows channel recovery from inactivation 
One common effect of this mutation in different cell models, including the HEK cells in 
this study, is that R1648H slows the recovery of NaV1.1 inactivation (Lossin et al., 
2002; Tang et al., 2009; Martin et al., 2010). This is the first report to show that both 
NaV1.1-R1648H isoforms exhibited similar recovery from inactivation timecourses. 
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Consequently, irrespective of the rs3812718 allele, NaV1.1-R1648H would hinder action 
potential propagation especially in parvalbumin-positive interneurons where NaV1.1 is 
expressed at the AISs, axons and somata (Ogiwara et al., 2007). It is expected that this 
loss of function would contribute to the impairment of GABAergic synaptic 
transmission similar to that observed for SCN1A
N1417H
 rats (Ohno et al., 2010).  The 
family harbouring NaV1.1-R1648H are heterozygous for the mutation and consequently 
their neurons would express both wild-type and NaV1.1-5A mutation channels. Because 
wild-type NaV1.1-5N channels recover faster from inactivation than NaV1.1-5A 
channels, and mutant NaV1.1-5N channel have a more hyperpolarized activation 
midpoint, homozygous GG individuals may be better protected from a loss of inhibition 
caused by R1648H compared to relatives with one copy each of the A. Again, the 
seizure history of the pedigree does not support this theory, suggesting that either these 
data do not represent the physiological affect of the mutation in vivo, or there are other 
modifying genetic or environmental factors that determine the phenotypic outcome of 
this missense mutation. Indeed two individuals: II-7 and IV-7 who do not harbour 
R1648H but exhibited febrile and afebrile seizures.       
The therapeutic effectiveness of phenytoin treating seizures in this family is unknown. 
The NaV1.1-R1648H persistent currents were not inhibited by phenytoin; thus, if in vivo 
R1648H does increase %INaP phenytoin is unlikely to reduce sodium currents by acting 
on this parameter. Ironically this may be therapeutically beneficial as increased 
persistent currents may maintain neuronal inhibition and phenytoin may 
disproportionally inhibit VGSCs expressed in pyramidal neurons reducing 
hyperexcitability. In fact, NaV1.1-R1648H channels weakly expressed in glutamatergic 
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cells from two-week homozygous SCN1A
RH 
mice recovered faster from inactivation 
than wild-type channels (Martin et al., 2010). Phenytoin showed a proportionally greater 
inhibition of channel recovery from inactivation acting on NaV1.1-R1648H-5N 
compared to both NaV1.1-5N and mutant adult channels. Therefore, patients who are 
homozygous for the G allele experience greater inhibition. From these results it could be 
argued that heterozygous GA individuals may benefit better from AED treatment, but 
again the molecular, genetic and clinical data do not correlate (Baulac et al., 1999; 
Escagy et al., 2000; Tate et al., 2006). Although the two GA patients may still have a 
large proportion of NaV1.1-5N channels because this isoform is upregulated after ictal 
activity (Tate et al., 2005). However, it does support the idea that the neonatal variant 
maybe a better substrate for phenytoin. In future, it would be useful to re-examine the 
clinical data and determine if a common AED is beneficial in treating this family. Its 
pharmacological affects could be assessed using electrophysiology.  
These data also highlights the need for better detail in gene association studies. In future, 
to exploit the potential association between drug dosage and genetics fundamental 
questions need to be answered: What epilepsy syndrome does each patient suffer within 
the cohort? Do they harbour a genetic mutation; if so in which gene? The effects of 
SNPs for instance, can be assessed in three patient categories:  
1. Individuals with structural/metabolic/unknown epilepsies. 
2. Patients with mutations in the same SNP containing-gene.  
3. Individuals harbouring mutations in the same gene.  
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Additionally, precise drug history is essential. Not all AEDs act on the same protein or 
have the same mechanism. As this study demonstrates it is unlikely that there is a single 
conserved pathological mechanism between patients, even within the same family. This 
is reflected in the variability of their phenotypes, even if their symptoms are classified as 
a part of the same syndrome. If the ideal is to be achieved, „custom designed‟ AED 
treatment based on genotype, a greater scope of clinical data is needed. Basic science 
studies and in particular, electrophysiological investigations need to be consistent too. A 
large problem is that there are too many experimental inconsistencies between studies, 
and working in HEK cells can only provide information about the relative affects of 
alternative splicing or a mutation. The true physiological consequences of these 
mutations can only be determined in vivo where their consequences must be 
disentangled from closely-related, pharmacologically similar channels.  
4.5.6 Can alternative splicing of exon 5 in SCN1A account for time dependent 
manifestation of GEFS+? 
In the R1648H family three of 12 sufferers did not exhibit childhood FS (Baulac et al., 
1999); therefore, can alternative splicing fully account for the time-dependant 
manifestation of GEFS+? A similar question was asked by Liao and colleagues (2010) 
because alternative splicing did not dramatically alter the behaviour of NaV1.2 BFIC 
mutations. They discovered in two regions of the rat hippocampus that a developmental 
switch caused NaV1.2, which was dominant at P8, was largely replaced by P30 with 
NaV1.6 which was significantly upregulated, while NaV1.2 expression remained 
constant. The authors hypothesized that subtle changes in NaV1.2 caused by mutations 
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may account for seizure generation at an early age, which remiss later because of 
increased NaV1.6 expression. In future experiments it would be useful to determine if 
comparable developmental changes occur in GEFS+ mutant rodents in not only VGSCs 
but other GEFS+ genes, including GABAA subunits.  
The study involving the SCN1A
N1417H
 rat compared the relative expression of SCN1A 
transcripts in wild-type and homozygous pups over 10 weeks. Susceptibility to 
hyperthermia induced seizures was correlated with lower levels of SCN1A for both wild-
type and SCN1A
N1417H/N1417H
 rodents. SCN1A expression peaked at 5 weeks for both 
genotypes, a time-point in which wild-type rats became resistant to hyperthermic 
stimuli. The mutant strain, however, continued to develop clonic seizures up to 10 
weeks. This implies that the developing nervous system is vulnerable to hyperthermic 
stimuli, which may partly be caused by a reduction in NaV1.1. However, because 
regulation of exon 5 SCN1A splicing in humans is not replicated in rodents it cannot be 
assumed that human NaV1.1 channels are also developmentally downregulated.  
For questions about the role of splicing the time-dependent manisfestation of GEFS+ 
symptoms, chicken neurons, discussed in Chapter 5, would be an ideal model to use 
because exon 5N is conserved. Electrophysiological experiments are described later the 
same chapter but the effect of knocking down each splice variant in a GEFS+ chicken 
model could be analyzed using siRNA delivered to the cell via genetically engineered 
viruses.  
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Chapter 5: The characterization of neuronal cell models  
5.1 Background and aim: Why new neuronal models are needed 
The NaV1.1 channels encoded by SCN1A are almost exclusively restricted to excitable 
cells, particularly neurons. These channels are also known to be sensitive to intracellular 
signalling (Cantrell & Catterall 2001; Mantegazza et al., 2005), and it is likely that 
pathways which target NaV1.1 channels in neurons vary among different cell types. 
Since these channels seem to be specialised in interneurons (Yu et al., 2006) they may 
have specific mechanisms in place to modulate them. In order to determine how or 
whether splicing alters the modulation of NaV1.1 channels in neurons, it is necessary to 
express these channels in neuronal cells. The aim of this section was to explore different 
possible neuronal systems for characterising the modulation of NaV1.1 channel splice 
variants. 
5.2 Rodents: SC-RT-PCR analysis of rat hippocampal cells 
One of the commonest neuronal models used in laboratory settings is the primary 
culture of neurons from neonatal rat pups. This model has the advantage that it is widely 
used and well studied, however, even when harvested from relatively homogenous 
hippocampal regions, the cultures contain a mixture of cell types. The first goal of this 
section was to establish, as much as possible, the identity and diversity of cellular 
phenotypes in primary neuronal cultures, and to develop SC-RT-PCR protocols that 
robustly identified different cell types when aspirated from individual cultures. 
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Methods that classify cellular phenotypes, for example, anatomy/morphology analysis, 
immunohistochemisty and in-situ hybridisation, are limited in determining molecular 
diversity of individual cells. For instance, adjacent cells with similar morphology may 
be functionally dissimilar. Imaging techniques typically allow only up to four markers to 
be analysed largely because of difficulties distinguishing between several coloured 
indicators. In this respect, SC-RT-PCR is a superior technique. It is possible to identify 
over 20 genes expressed in a single neuron (Richardson et al., 2000).  However, since 
only ~1pg of RNA can be harvested from a single cell the method is technically 
demanding. In preparation for future analyses this method was optimized using cultured 
P0 rat hippocampal cells (14 DIV). Cells analysed were taken from three separate 
cultures and broad neuronal phenotypes were classified using the following gene 
markers: cholinergic: choline acetyltransferase (ChAT); dopaminergic: tyrosine 
hydroxylase (TH); excitatory: sodium-dependent inorganic phosphate cotransporter, 
member 7 (SLC17A7); inhibitory: glutamate decarboxylase (GAD67) and control: 
Glyceraldehyde 3-phosphate dehydrogenase (GADPH).  
Nearly 40% of neurons expressing the chosen markers were of a mixed inhibitory and 
excitatory phenotype. A quarter of the cells sampled were solely inhibitory and 
approximately 15% possessed an excitatory phenotype. One cell expressed both ChAT 
and GAD67.  Approximately 20% cells could not be categorized into the chosen 
phenotypes (Figure 5.1). In vivo, it unlikely that the majority of hippocampal cells 
would possess a mixed phenotype. These data highlight the importance of neuronal 
inputs and outputs in maintaining phenotype, and suggest that neurons in culture may 
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fail to develop specialised phenotypes. 
Non-neuronal
GAD67
SLC17A7
GAD67 + SLC17A7
GAD67 + ChAT
 
Figure 5.1: SC-RT-PCR was used to identify neuronal phenotype of two-week 
cultured rat hippocampal neurons. A. A typical photograph of the RT-PCR products 
from rat hippocampal cells showing GAD67 (inhibitory) and SLC17A7 (excitatory) 
mRNA expression. GAPDH is shown as a control marker. B. RNA was isolated and 
reverse transcription was performed with specific nested primers. Gene markers were 
amplified using the two-rounded nested primer method. Phenotypes (see legend) in 
order of lowest to highest percentage: GAD67 & ChAT, 4%; SLC17A7, 14%; GAD67, 
25% and GAD67 & SLC17A7, 39%. 18% cells did not display a neuronal phenotype. 
(n=28). 
5.3.1 Human neuronal cell lines: SC-RT-PCR analysis of 197VMs 
Ideally, to fully understand the functional impact of NaV1.1 splice variants recordings 
would be performed in human-derived neurons. This is of particular importance in 
studies concerning NaV1.1 due to enormous variations in its regulation in different cell 
lines (Isom 2001) and its upregulation in inhibitory interneurons (Yu et al., 2006). 
Primary cell cultures from rodents are simpler to obtain and more robustly (albeit not 
completely) neuronal in phenotype. However, exon 5 is not alternatively spliced in 
SCN1A in rodents (Tate et al., 2005; Gazina et al., 2010). A suitable alternative may be 
the 197VM cell line. This is an immortalized human fetal neural stem cell line derived 
A B 
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from the ventral mesencephalon that can potentially differentiate into cells with active 
sodium currents (Donato et al., 2007). Briefly, the differentiation involved plating the 
multipotent cells onto uncoated plastic and allowing neurospheres to develop for a 
week. Cells were than transferred onto laminin and maintained for 4 days in the 
presence of growth factors. Finally, 197VMs were starved of growth factors for a 
following week, according to published reports (Donato et al., 2007). To determine the 
success of the differentiation protocol, the phenotypes of undifferentiated cells were 
assessed using SC-RT-PCR. Two cells spontaneously differentiated into individual 
cholinergic and dopaminergic phenotypes. No cells expressed more than one marker and 
nearly 90% cells did not possess a categorized neuronal phenotype. 
  
The Donato et al. study demonstrated that differentiated 197VMs stained positively for 
βIII tubulin, a neuronal microtubule protein, encoded by TUBB3. Therefore this gene 
was used a control marker to confirm successful cell aspiration in SC-RT-PCR 
experiments on differentiated cells. Additionally, immunohistochemisty staining 
suggested that when differentiated, 197VMs possessed a dopaminergic phenotype. This 
was confirmed in SC-PCR-RT experiments where 25% cells stained positively for TH 
(n=12; Figure 5.2 B). Some SC-PCR-RT rat hippocampal and 197VMs data had false 
GADPH positives, all these cells were discarded from further analysis. 
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Figure 5.2: The percentage of differentiated 197VM cells that express TH mRNA 
A. A typical photograph of the RT-PCR products from a differentiated 197VM showing 
TH and TUBB3 (control) mRNA expression. Ladder effect of TUBB3 amplicon 
indicated that this gene is abundantly transcribed. B. RNA was isolated and reverse 
transcription was performed with specific nested primers. Gene markers were amplified 
using the two-rounded nested primer method. 25% of cells possessed a dopaminergic 
phenotype (n=12).  
 
5.3.2 Human neuronal cell lines: Electrophysiological characterization of 
differentiated 197VM cells 
To investigate whether the SC-RT-PCR data was consistent with the 
electrophysiological behaviour of differentiated 197VM cells, their voltage-dependent 
currents were assessed. Donato et al. (2007) were able to elicit neuronal firing behaviour 
by stepping the current command from -60 to +20 mV in 20 mV steps from a resting 
potential of -75 mV using stem cells differentiated for two-weeks by starving them of 
growth factors. Additionally, recorded macroscopic TTX-sensitive sodium currents were 
recorded in Donato et al., with an average amplitude of 200 pA. However, in the present 
A B 
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study, no sodium currents were recorded by initial whole-cell patch clamp on cells 
differentiated using the published protocol. Only an unspecified outward current was 
observed.  
In the published report a small proportion of one-month differentiated 197VM cells still 
possessed firing properties. Consequently, electrophysiology investigations were 
extended to 197VMs differentiated for 4 – 6 weeks.  Cells maintained in culture for 
longer than 4 weeks were held at -80 mV and stepped to voltages between -100 and +30 
mV in 10 mV intervals. Again, an unclassified, although an outward current was 
recorded (Figure 5.3) with a maximal conductance of 537.3 ± 62.1 pS (n=8). 
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Figure 5.3: Average conductance-voltage relationship for 4 - 6 week differentiated 
197VMs. A robust outward current was observed but no sodium currents (n=8)  
5.4.1 Potential animal neuronal models: Online sequences of SCN1A exon 5N 
The differentiation of human stem cell lines is unreliable, both in experiments tested 
here and within informal reports from other groups. RT-PCR data suggest these cells 
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produce ambiguous neuronal phenotypes. Electrophysiological data suggest they are not 
ideal for routine electrophysiology that requires close comparison of multiple recordings 
over long periods of time from different batches of cells. 
 
The alternative approach to differentiating human stem cells into neurons is to use 
primary neuronal cultures from animal sources which do alternatively splice SCN1A. 
Consequently, alternative splicing in SCN1A throughout phyla was investigated using 
the sequences databases from NCBI and Ensembl. Unfortunately, of the laboratory 
animals approved for use in the UK, only Monodelphis domestica (Opossum) faithfully 
conserves splicing with human exon 5 in the published database (Figure 5.4).  
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Chromosome 2; 2q24.3 SCN3A GALNT3 SCN1A SCN9A SCN7ASCN2A
Hs F V  T  E  F  V  N L  G  N  F S  A  L  R  T  F  R  V  L  R  A  L  K  T  I  S  V  I  P
Hs GTTTGTAACAGAATTTGTAAACCTAGGCAATTTTTCAGCTCTTCGCACTTTCAGAGTCTTGAGAGCTTTGAAAACTATTTCGGTAATTCCAGgtaaa
Pt GTTTGTAACAGAATTTGTAAACCTAGGCAATTTTTCAGCTCTTCGCACTTTCAGAGTCTTGAGAGCTTTGAAAACTATTTCTGTAATTCCAGgtaag
Cf GTATGTAACAGAATTTGTAAGCCTAGGCAATTTTTCAGCTCTTCGAACTTTCAGAGTCTTGAGAGCTTTGAAAACTATTTCTGTAATTCCAGgtaag
Bt GTATGTAACAGAATTTGTAAGCCTAGGCAATTTTTCAGCTGTTCACACTTTCAGAGTCTTGAGAGCTTTGAAAACTATTTCTGTAATTCCAGgtaag
Md GTATGTAACAGAATTTGTAAACCTAGGCAATTTTTCAGCTCTTCGAACTTTCAGAGTCTTGAGAGCTTTGAAAACTATTTCTGTAATTCCAGgtaag
Gg GTATGTAACAGAATTTGTAAACCTAGGCAATGTTTCAGCTCTTCGAACTTTCAGAGTATTGAGAGCTTTGAAAACTATTTCTGTAATCCCAGgtaag
Y V  T  E  F  V  N L  G  N  F S  A  L R T  F  R  V  L  R  A  L  K  T  I  S  V  I  P
Mm * V  T  K  F  V  Y  L  G  N  F  * L  F  T  H  L  E  D  * V     * R  P  F  P  H  F  *
Mm GTAAGTAACAAAGTTTGTATACCTAGGTAATTTTT-AGCTATTCACACATTTAGAGGATTGAG---TCTAAAGACCATTCCCACATTTCTAAttaga
Rn GTAAGTACCAGAATTTGTAAACCTGGGTAATTTTT-AGCTCTTGGCTCATATAGAGCATTGAG---TCTAAAGACGGTTTCCACAATTCTAGctata
rs3812718
A
B
 
Figure 5.4 Exon 5N in SCN1A is widely conserved among amniota vertebrates, but is lost in rodents. A. Overview of sodium 
channel gene cluster on chromosome 2 in humans. The cluster is conserved among amniota vertebrates, and the position of surrounding sodium 
genes as well as GALNT3 was used to distinguish exon 5N in SCN1A from that of the nearby and closely-related sodium channel genes. B.  
Alignment of exon 5N and flanking 3‟splice sequence from genomic sequences of a selection of amniota vertebrates. Individual nucleotides that 
vary are bold and underlined. The human translation is shown at top with residues that alter between exon 5N and 5A in humans italicised. The 
consensus translation of exon 5N in SCN1A is shown at the bottom of the alignment of conserved exons, with varying residues underlined (note 
that while the cow (Bt) has 3 varying residues, in all other cases 2 or fewer differ from the consensus translation). For comparison, the mouse 
(Mm) translation is shown above the rodent alignment. While the rat (Rn) and mouse nucleic sequences and translations differ substantially, as is 
usual for non-coding regions, the presence of 4 stop codons and the frameshift in exon 5N are conserved. For completeness, the position of 
rs3812718 is indicated as the A genotype in the human sequence to emphasize the conservation of this nucleotide among amniota vertebrates, 
excepting rodents.  Hs = Homo sapiens, human NC_000002.10; Pt = Pan troglodytes, chimp NC_006470.2; Cf = Canis familiaris, dog 
NC_006618.2; Bt = Bos taurus, cow NW_980441; Md = Monodelphis domestica, opossum ENSMODG00000006537; Gg = Gallus gallus, 
chicken NC_006094; Mm = Mus musculus, mouse NC_000068.5; Rn = Rattus norvegicus, rat NC_005102.2. All sequences from NCBI genome 
data, except Md which is from Ensembl. Sequences were located using exon 5A, confirming the position of SCN1A in the gene cluster and 
searching the flanking intron for sequences homologous to exon 5N in humans.  
A 
B 
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5.4.2 Potential animal neuronal models: No exon 5 alternative splicing in Guinea Pig 
SCN1A 
The Cavia porcellus (guinea pig) genome sequence was not published online in a complete 
form, however, guinea pigs are easy animals to acquire and handle. They are also approved 
for laboratory work in the UK. Exon 5 of human SCN1A is 92 nucleotides long. The guinea 
pig putative SCN1A sequence was available to mid intron 2. However, Ensembl predicted 
that exon 3 was 92 nucleotides long and consequently, could be the equivalent of human 
exon 5. Fortunately, the intron 4 sequence was available. Therefore, primers were designed 
to align to the end of intron 2 and the beginning of intron 4.  A band approximately 4kb 
was amplified by PCR and sequenced. This sequence was aligned to human SCN1A in the 
region and it appears the guinea pig exon 3 corresponds to the human SCN1A exon 5A 
(Figure 5.5). The assumed guinea pig exon 5N sequence that lies with intron 2 has an in 
frame stop codon, indicating that guinea pig SCN1A, like rodent SCN1A, is not alternatively 
spliced in this region (Figure 5.5).   
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SCN1A 5N     GTTTGTAACAGAATTTGTAAACCTAGGCAATTTTTC      
.|...|||||||||.|||||. |||||||.|||||. 
GP intron 2   ATACATAACAGAATGTGTAAG-CTAGGCACTTTTTAAGTTCTTTGCAATCTCATATTTTCCAG 
 
AATTTTGACAACTACTTACATAACCCAGAGTAAGAAGTAGTTAGTATAAAGCACAGATTCCTA 
 
SCN1A 5A                                                   GTACGTCAC                                                                              
.|||||.|| 
GP exon 3? CAACTCTTTCTTTGTGTCTTCTTGTTGTGTCTGTGTGTGAACTCCCTATTACAGATACGTGAC 
                                           
AGAGTTTGTGGACCTGGGCAATGTCTC      
||||||||||||||||||||||||||| 
AGAGTTTGTGGACCTGGGCAATGTCTCAGCGTTGAGAACATTCAGAGTTCTCCGAGCACTGAAA 
Figure 5.5: Sequence alignments of the intron-exon border 2-3 of guinea pig SCN1A 
with human adult and neonatal SCN1A sequences. Nucleotide changes between the 
human splice variants are in bold. Sequence in blue is unpublished. The putative NaV1.1-
5N guinea pig sequence within intron 2 is interrupted by an in frame stop codon (red 
letters). The putative NaV1.1-5A guinea pig in exon 3 is conserved with human NaV1.1-5A.  
 
5.4.3 Potential animal neuronal models: Chick embryonic neurons genotype and 
phenotype 
Chicken SCN1A is alternatively spliced (Figure 5.4, in red), and conserves the D>N switch. 
Chick embryos are also used for primary cultures, albeit the anatomy is less well conserved, 
and cell types may be distinct from those found in humans and other mammals. Whole-cell 
patch clamp experiments were performed to establish if telencephalon neurons prepared at 
E14 and cultured for seven days exhibited neuronal sodium currents.  After attaining the 
whole-cell configuration the resting membrane potential (RMP) was measured in the 
current-clamp I = 0 mode. Typical for immature neurons, the RMP of chick E14 neurons 
was depolarized (Belleau & Warren, 2000) at -8.4 ± 7.8 mV (n=3). To assess macroscopic 
neuronal currents, cells were held at -80 mV and stepped to voltages between -60 and +30 
mV in 10 mV intervals. As demonstrated by the raw trace in Figure 5.6 these immature 
neurons expressed robust sodium and potassium currents. A number of cells were patched 
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but currents were too large to clamp efficiently (data not shown).  
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Figure 5.6 Immature chick cultured chick neurons are likely to express sodium and 
potassium currents. A 7-day cultured E14 chick neuron macroscopic current elicited at -
10 mV from a holding potential of – 80 mV,  
 
A challenge to recording from heterologously expressed splice variants in neurons is 
isolating currents from the channels of interest in the presence of a complex background. 
One approach used by several groups is to isolate exogenous human NaV1.1 currents in 
chick neurons by generating TTX-resistant mutant variants of the human channels.  
Through experimenting in the presence of TTX, the currents from each splice variant could 
be isolated from other TTX-sensitive channels in the chick cells. This depends on the 
currents in the chick neurons being sensitive to TTX. RT-PCR was used to determine 
which members of the VGSC were transcribed in the immature chick brain. At E14 only 
TTX-sensitive sodium channels were expressed (Figure 5.7) and confirmed that this 
neuronal model would be excellent for investigating in NaV1.1 splice variants.  
 286 
100 bp
200 bp
300 bp
400 bp
500 bp
700 bp
 
 
Figure 5.7: VGSC gene expression profile of the chick telencephalon at E14. RNA was 
isolated and reverse transcription was performed with specific primers designed using 
predicted chicken VGSC gene sequences published by Ensembl. PCR only detected the 
expression of TTX-sensitive sodium channels (from left to right) the control gene TUBB3 
(134 bp); SCN1A (227 bp); SCN2A (107 bp); SCN3A (113 bp); SCN8A (138 bp) and 
SCN9A (141 bp). 
 
To avoid the toxicity of transfection reagents NaV1.1 splice variants can be transduced into 
chicken neurons using lentiviral vectors. The human sodium channel cDNAs are known to 
be difficult to maintain in high copy vectors. Although several attempts were made to insert 
SCN1A coding sequences into a lentiviral expression vector, it was not possible to produce 
full-length clones in this background (data not shown). Consequently, although this model 
has several advantages it was abandoned in the interest of time.  
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5.5 Discussion 
5.5.1 SC-RT-PCR analysis of rat hippocampal cells 
The majority of two-week cultured hippocampal cells, that expressed neuronal markers, up-
regulated both inhibitory, GAD67 and excitatory SLC17A7 mRNAs. Classically, the 
hippocampus is thought to comprise of strictly defined neuronal types, with glutamatergic 
and GABAergic phenotypes segregated.  However, data in the present study are in 
agreement with the few studies that have investigated the phenotype of hippocampal 
neurons in culture using SC-RT-PCR and shown less clearly defined expression profiles. 
For example, Gómez-Lira and colleagues (2005) showed that all cultured hippocampal 
granule cells from juvenile rats (P15) possessed a mixed excitatory/inhibitory phenotype. In 
similar hippocampal preparations to those in this study, neurons that evoked EPSPs also 
expressed an isoform of GAD67, GAD65 (Cao et al., 1996). Lastly, 20% hippocampal 
neurons from two week old rats co-expressed GAD67 and SLC17A7. In vivo, certainly for 
granule cells, it is now recognized that glutamatergic cells are capable of synthesizing 
GABA (For reviews see Gutiérrez 2005 and Scharfman 2002).    
Conversely, since neurons were grown in culture for two weeks it is possible that changes 
in the external environment may have changed the transcriptional regulation of a mainly 
inhibitory neuronal population, as 25% of cells were positive for GAD67. Further, since 
post-translational processes were not investigated it is impossible to decipher whether the 
mRNA transcribed for both excitatory and inhibitory markers was translated. There may be 
an RNA binding protein that suppresses translation of one marker and not the other, so 
although these cells may transcribe both mRNAs the proteins may be regulated at the level 
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of translation. Even if an mRNA is transcribed and translated, the proteins may be 
subjected to post-translational processing such as: phosphorylation, localization or 
degradation (Sucher et al., 2000). To address this ambiguity in future, SC-RT-PCR should 
be coupled with electrophysiological recordings and, if possible, additional 
immunohistochemical or morphological data. This would allow a thorough examination of 
gene expression at transcriptional and functional levels combined with protein localization. 
It is likely that inhibitory interneurons were aspirated as quarter of cells were solely 
inhibitory. Fewer SLC17A7 cells were harvested which is surprising as the main 
hippocampal projectory pyramidal neurons are excitatory.  In the studies mentioned 
previously, no sole inhibitory or excitatory phenotypes were observed. Since the sample 
sizes were relatively small, typically 10 – 30 cells, it is unlikely a true phenotypic 
representation was covered in these studies. Additionally, the number of markers used was 
limited. There are at least three isoforms of SLC17A7 and GAD, each may be functionally 
similar but able to confer specific properties to different neuronal regions. Therefore, a 
neuron may have used glutamate as its principle neurotransmitter but its transporter may 
have been a different isoform to SLC17A7, that is, vGLUT2. In experiments by Danik et 
al. (2005) 60% of hippocampal neurons were positive for two isoforms of SLC17A7, 
vGLUT1 and 2 but no cell expressed exclusively one transporter, suggesting that the 
expression of one affects the regulation of the other. This interaction would not have been 
detected in this present study. One cell possessed a dual inhibitory and cholinergic 
phenotype. This has not been observed from hippocampal neuronal cultures in the 
literature. However, SC-RT-PCR involving brain slices suggests that fast spiking neurons 
within the medial septum-diagonal band complex release both GABA and acetylcholine 
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(Sotty et al., 2003).  
The main caveat to the SC-RT-PCR technique is contamination. It is estimated that each 
vertebrate neuron contains 1 pg of mRNA; consequently any DNA or RNA, derived from 
dead cells for instance, would severely affect the results. Originally random primers were 
used to generate cDNA and the PCR reaction contained specific primers for the 
amplification of any gene. However, there was a high level of GAPDH contamination 
within controls taken from the bath and intracellular solutions.  Therefore the „nested‟ 
primer technique was adopted as it was hypothesized the GAPDH may have share a high 
sequence similarity with several genes. Although low, contamination was still present. 
Another step was added, the mRNA was pre-treated with DNase, to degrade any DNA that 
may have contaminated the equipment or solutions. However, impurity levels were not 
greatly improved and data was frequently lost. In the present study, only experiments where 
GAPDH was absent in control reactions were used. The consistent absence of TH from 
hippocampal neurons, along with its presence in 197VMs, and in controls using whole 
brain mRNA, suggests that the detection of marker mRNAs was specific.  
A drawback to using gene specific primers instead of random primers is that additional 
information about gene co-localizations, pathway crosstalk and other interactions cannot be 
investigated in these samples (Dixon 2000).  This may be overcome by using „three-prime-
end amplification PCR‟. This involves amplifying the 3‟ ends of all mRNAs in a single 
cell. This has allowed for 40 transcripts to be detected for one cell (Dixon et al., 1998). A 
disadvantage is that this technique is not quantitative. There are quantitative techniques that 
use radioactively-labelled primers. Since the sample size is minute these methods are at 
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best likely to be semi-quantitative and could give informative on the relative differences of 
two markers rather than the quantity of mRNA transcribed (Sucher et al., 2000).   
5.5.2 Transcriptional and functional characterization of 197VMs  
197VMs were originally developed to generate dopaminergic cells to be used in neuron 
replacement therapies to treat neurodegenerative disorders, for instance, Parkinson‟s 
disease. 197VMs are derived from progenitor cells dissected from the ventral 
mesencephalon, of a 10 week old foetus. Within this area three clusters of progenitor cells, 
A8-A10 give rise to a region of the red nucleus, the substantia nigra pars compacta and the 
ventral tegmental area, respectively. In the adult brain these regions are rich in 
dopaminergic neurons (Abeliovich & Hammond, 2007). It is not too surprising; therefore, 
that TH was expressed by a single undifferentiated 197VM cell. The ventral 
mesencephalon also gives rise to the tegmentum, where cholinergic neurons involved in 
wakefulness and arousal send their projections to the thalamus. The end phenotype of cells 
is dependent on local environment as well as their innate properties (Gage 2000). Since one 
cell also spontaneously differentiated to express ChAT, these cells could be directed to a 
cholinergic fate, possibly if grown in the presence of specific growth factors.  
As previously discussed the for SC-RT-PCR analysis GAPDH was present in many control 
reactions. In the Donato et al. (2007) paper immunocytochemistry images showed that the 
differentiated 197VMs expressed a neuronal microtubule protein βIII tubulin. This change 
in marker was very successful and contamination vanished. Since electrophysiological 
studies were done in parallel, and demonstrated that differentiated cells did not produce 
active currents, it was decided that these cells would be not be use a model for the NaV1.1 
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studies. This analysis, however, did confirm the findings from Donato et al. these 
multipotent cells when differentiated did express βIII tubulin and a proportion also 
expressed TH.  
In this study, the 197VMs differentiated for 2-6 weeks did not develop into functional 
neurons. In the Donato et al. study, similar cells differentiated for 10 days generated action 
potentials and had TTX-sensitive sodium currents and potassium currents. Although the 
culture conditions were followed exactly, there may have been other variables; for example, 
different 197VM batches, unstable growth factors, laminin from different strains of mice, 
variations in exposure times to growth factors, or different cryogenic techniques may all 
have altered the expression profile of these cells. 
197VMs were immortalized using a human oncogene, V-MYC. Gage (2005) hypothesizes 
that cell lines immortalized with this gene undergo subsequent mutations that may render 
them tumorigenic or disrupt their normal cell homeostasis. Mutations within the chicken 
homolog C-MYC changes its transforming capacity to a lesser or greater extent (Frykberg 
et al., 1987). In the Donato et al. study a cortical stem cell was differentiated in the same 
manner but also did not produce voltage-gated channels.  This cell line was created using 
the „less potent‟ C-MYC and may have been the crucial determinate in cell fate rather than 
the differentiation protocol.  Within the literature, laboratories using the similar cell lines 
receive varying results (Cho et al., 2002; Donato et al., 2007). Suggesting that stem cell 
research still relies on unknown factors that greatly influence cell fate.  
5.5.3 Exon 5N is lost in Guinea Pig SCN1A but not chicken SCN1A 
While splicing is conserved in six VGSCs (Raymond et al., 2004), exon 5N has been lost in 
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Rodentia including rat, mouse and guinea pig SCN1A (Raymond et al., 2004). However, 
the D>N switch in exon 5 is conserved in chicken SCN1A. As previously discussed, one 
aim of the study was to determine whether the upregulation of NaV1.1-5N leads to changes 
in neuronal excitability that are correlated with epileptic behaviour and/or drug dosage. 
Determining what effect a shift in splicing of SCN1A has on the behaviour of neurons 
would have been the most direct way to address this goal. To achieve this aim, transducing 
chick neurons with NaV1.1-5N and NaV1.1-5A clones would have been a promising 
electrophysiological preparation. Indeed, biophysical investigations into the neuronal 
networks and ion channels of the avian auditory system frequently employ cultured 
embryonic chick neurons (Kuenzel et al., 2007; Wirth et al., 2008; Kuenzel et al., 2009).  
The pCDH1-copGFP lentivector (System Biosciences, CA) has been used successfully to 
transduce KV1.1 channels into cultured hippocampal neurons in the lab (Heeroma et al., 
2009). However, cloning human SCN1A into the same vector proved unfeasible for 
technical reasons. Frequently during subcloning, fragments of SCN1A sequence were 
deleted, duplicated and often rearranged, and the effort was stopped because material and 
DNA sequencing costs were escalating and HEK experiments were a necessary 
compromise.  
These results show that E14 immature chick telencephalon neurons only expressed TTX 
sensitive VGSCs. If inserting human SCN1A into the lentivector were successful, currents 
mediated by the splice variants would be isolated by generating TTX-resistant variants by 
introducing a single amino acid change, E945Q, into the construct (Kontis & Goldin, 
1993).  In the presence of TTX, the currents from each NaV1.1 isoform could be isolated 
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from all other TTX sensitive VGSCs in the neuronal cells. Using a Cs-Aspartate-based 
intracellular and TEA-Cl-containing extracellular solutions NaV1.1 splice variant currents 
in chicken neurons could be isolated from endogenous sodium and potassium currents. The 
intracellular solution would contain ATP and GTP, to preserve downstream signalling 
pathways.   
Electrophysiological characterization of transduced neurons could be coupled with SC-RT-
PCR analysis to determine if NaV1.1 splice variants behave differently in different cell 
backgrounds. The chick genome is yet to be fully sequenced. One caveat of this analysis is 
that many of the oligonucleotides used to amplify chick VGSC genes (and therefore those 
that would be used to amplify genetic cell marker genes) were designed using predicted 
DNA sequences. Therefore, the VGSC gene expression profile of E14 chick neurons may 
be inaccurate. Ensembl are continuing to update the chicken DNA sequence database so 
future gene expression profiling may be more reliable (Last updated May 2010; 
http://www.Ensembl.org/Gallus_gallus/Info/StatsTable). Moreover, one report documented 
that between E7 to E20 two voltage-gated potassium channel isoforms were up-regulated in 
hindbrain auditory chick neurons. Expression of one isoform gradually increased and 
transcription of another was switched on at E14 (Kuenzel et al., 2009). Computer 
modelling showed that this switch would in vivo dramatically alter the firing properties of 
these immature neurons (Kuenzel et al., 2009). From the electrophysiological results in this 
study and the literature it is possible to record from dissociated chick neurons between E6.5 
– E14 (Kuenzel et al., 2007). Therefore this model would be ideal to examine the effects of 
neuronal development on the behaviour of wild-type and mutant NaV1.1 splice variants. 
Chick NaV1.1-5N or NaV1.1-5A could be selectively knocked-down and/or GEFS+ 
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mutations could be introduced.  
Not only could voltage clamp protocols, similar to those described in this study be 
performed but also current clamp protocols could assess differences in firing properties of 
neurons expressing wild-type or mutant NaV1.1-5N or NaV1.1-5A channels in dissociated 
cultures. These experiments could be used in conjunction with immunocytochemistry 
(Chapter 7) and would give an indication if firstly, if the subcellular localization of each 
splice variant varies and if so, their relative contributions to spike development, especially 
with regards to inhibitory interneurons. Neurons could be cultured in the presence of 
GABA receptor antagonists, NMDA receptor activators or low magnesium conditions, 
which can induce SE-like neuronal firing discharges (Sombati & Delorenzo, 1995; Pitkänen 
et al., 2005, p330). Pharmacology experiments could determine whether healthy or 
„epileptic‟ neurons of different sub-types fire differently in response to AEDs depending on 
their SCN1A exon 5 identity. 
Additionally the neuronal RMP, input resistance and capacitance could be calculated and 
single action potential parameters could be assessed with a brief, 1 ms, current clamp 
protocol. Here, action potential threshold, amplitude, spike width, AHP and rise time could 
be calculated and would determine how significantly each NaV1.1 splice variant contributes 
to neuronal spike-phenotypes (Bean 2007). In a neuronal context these types of 
experiments may help to answer what is the real functional impact of splicing on NaV1.1 
properties, the role of NaV1.1 isoforms in epileptic neurons, or if individual NaV1.1 splice 
variants should be specifically targeted by future AEDs. 
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Chapter 6: Lack of G-protein effects on INaP at physiological 
temperatures 
6.1 Hypothesis and aim: 
Hypothesis: NaV1.1 splice variants are differentially modulated by G-protein receptor 
signalling pathways and more specifically by G-protein βγ subunits. 
Background and experimental aims: When heterologously expressed in HEK cells, 
NaV1.1 channels exhibit extremely variable levels of persistent or non-inactivating current. 
An examination into the factors that supported this current indicated that activation of G-
protein βγ subunits was sufficient to increase the current from these channels (Mantegazza 
et al., 2005). In preliminary experiments (carried out with Stephanie Schorge) it was 
demonstrated that NaV1.15A derived INaP in HEK cells was inhibited by Pertussis toxin, a 
Gαi/o inhibitor, suggesting the presence of endogenous G-proteins in these cells were 
capable of modulating INaP. The aim of this section was to determine whether G-proteins, 
particularly βγ subunits exert splice variant specific effects on the INaP of NaV1.1-5N. 
In an effort to determine what contributes to INaP and to control the expression of this 
current in recordings in HEKs a series of experiments were carried out to identify and 
control G-protein βγ subunits that are active in HEK 293 cells. Molecular and 
pharmacological tools were constructed, verified and used, including: the GRKs, which 
bind to and inactivate different subsets of G-protein βγ subunits;  and the α subunit of 
transducin the retinal G-protein, which has a high affinity for all βγ subunits, and can be 
used to disrupt all βγ-dependent G-protein signalling; finally GTPγS which is a non-
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hydrolysable analogue of GTP that binds G-protein α subunits and locks them in the 
„active‟ form, and releases the βγ subunits. GTPγS is a non-specific activator of G-proteins 
while the other reagents are more specific inactivators of subsets of βγ subunits only. These 
data show that at physiological temperatures none of the molecular or pharmacological 
manipulations of G-protein signalling alter INaP, although several other parameters of 
NaV1.1 macroscopic currents are altered. G-protein dependent modulation of INaP was only 
present in RT recordings.  
6.2 Establishing tools 1: Which G-proteins are expressed in HEK 293 cells? 
One aim of this study was to determine which G-proteins interact with NaV1.1 variants. 
Heterotrimeric G-proteins are extremely diverse. There are 16 genes that code for α 
subunits, some are alternatively spliced, producing a total of 20 gene products. There are 5 
β subtypes and at least 12 γ isoforms. The potential Gαβγ and more importantly βγ 
combinations are numerous. In vivo, however, not all possible arrangements exist. For 
instance, there is β1γ2 but not β2γ1 and β1γ1 is solely expressed by photoreceptors 
(Gomperts et al., 2003). Indeed, the latter did not induce INaP derived from NaV1.2 (Ma et 
al., 1997) but Gβ2γ3, Gβ1γ3 and Gβ5γ3 all produced NaV1.2 cells with slowly inactivating 
currents.  
Using PCR, 22 G-protein subunit expression profiles of three consecutive passages of HEK 
293 cells (cultured in 2007) were assessed, to determine which specific subunits were 
potentially modulating NaV1.1. Bands corresponding to amplified subunit mRNAs were 
rated for relative brightness: a saturated band, 1, denoted abundant expression, a visible 
band, 0.5, moderate expression and no band detection was given 0.  
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In each passage all but two Gα subunits were moderately to abundantly expressed. GNAO 
was absent in all but one passage and GNAZ was not detected. Both genes are thought to 
exclusively neuronal (Wettschureck & Offermanns, 2006). All Gβ subunits were highly 
expressed in the three samples. The expression profiles of Gγ were more variable. In 
general, the majority of Gγ subunits were moderately to abundantly expressed. However, 
two subunits, GNG8 and GNG13 were not detected. This is expected since the former is 
detected only in the olfactory epithelium and the latter in taste buds (Wettschureck & 
Offermanns, 2006).  In summary, this cell line expresses a wide range of G-protein subunits 
(Figure 6.1); the expression is also relatively consistent over multiple passages (Figure 6.2).   
 
 
Figure 6.1: A typical image showing the PCR products from one HEK 293 passage.  
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Figure 6.2: The G-protein expression profile of three passages of HEK 293 cells. 
Expression levels of genes denoted were rated using band signal: 1 = abundant; 0.5 = 
moderate and no expression = 0. Each chart shows data from a single experiment.  
 
6.2 Establishing tools 2: Verification of the effectiveness of molecular sequestration tools 
Given the wide range of G-protein subunits present in HEK cells, multiple strategies for 
sequestering subsets of endogenous subunits were necessary. Molecular sequestration tools 
(see Figures 6.3 & 6.4), were cloned and heterologously expressed. To test the 
effectiveness of each clone at suppressing G-protein modulation, the effects of each 
sequestrant was measured on channels with well-known G-protein modulation, the GIRKs. 
GIRK 1,4 is an heterotetrameric inwardly rectifying potassium channel that is activated by 
Gβ proteins (Figure 6.3 A). It is well established that heterologous expressed GIRK 1,4 
currents are inhibited by proteins that sequester intrinsic Gβ subunits (Figure 6.3 A; Lei et 
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al., 2000). These proteins were subcloned into the pIRES-DsRed2 vector and fluoresced 
after transfection into HEK 293 cells. However, the control „empty‟ vector did not 
fluoresce (data not shown).  Therefore, it was necessary to verify that the sequesterants 
were translated when subcloned into pIRES-DsRed2,  
Whole cell currents were elicited from HEK 293 cells transiently co-transfected with GIRK 
1,4 with the sequesterant or reporter constructs indicated (Figure 6.3, B), by using a voltage 
ramp command (change in -90mV; 0.1V/s) applied at 0.1Hz, from holding potential of -
50mV (replicated from Lei et al., 2000). Conductance was calculated from a linear 
regression fit to the slope of the current-voltage data from -100 to -120mV. The ramp 
protocol evoked inwardly rectifying potassium currents with a mean conductance (±SEM) 
of 35 ± 9.0 pS (n=5; Figure 6.3 B) in cells transfected with GIRK 1,4 channels that were 
not present in untransfected cells 3.4 ± 1.0 nS (n=5; P<0.01; one-way ANOVA; 
Bonferroni‟s post-test; Figure 6.3, B). GIRK currents were significantly attenuated by both 
sequesterants, Gαt (mean pS ±SEM: 11.1 ± 4.1 nS, n=6, P<0.05; one-way ANOVA; 
Bonferroni‟s post-test; Figure 6.3 B) and GRK2ct (mean nS ±SEM: 10.8 ± 2.8 pS, n=7, 
P<0.05; one-way ANOVA; Bonferroni‟s post-test; Figure 6.3 B). The c-terminal of GRK5, 
which does not bind to Gβ, did not significantly inhibit GIRK 1,4 currents (mean nS 
±SEM: 20.1 ± 2.6 nS, n=3, P>0.05; one-way ANOVA; Bonferroni‟s post-test; Figure 6.3 
B). Collectively these data suggest that the constructs were functional and specific. Based 
on these results it was assumed that pIRES-DsRED2-GRK3ct was also functional.  
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Figure 6.3 Verification of Gβ sequesterants function when subcloned in pIRES-
DsRED2 A. Gβγ subunits activate GIRK 1,4, a inwardly rectifying potassium channel; via 
activation, for example, of cardiac muscarinic receptors (M2). Previous reports suggest that 
channel activity is inhibited when Gβγ is sequestered by c-terminals of GRKs or Gαt (Lei 
et al., 2000). This paradigm was used to test the function of inserts subcloned in to pIRES-
DsRED2. B.  The potassium conductance of GIRK 1,4 currents recorded from HEK 293 
cells transiently transfected with the channel and denoted constructs.  Cells were held at a 
holding potential of -50 mV and currents were elicited using a ramp protocol described in 
the text. Conductance was calculated from the slope of current-voltage curve between -100 
and 120 mV; mean ±SEM.  Currents evoked in cells transfected with GIRK 1,4 alone (and 
GFP) were not active in untransfected cells, and were inhibited by Gαt and the c-terminal 
of GRK2. Currents were unaffected by the c-terminal of GRK5 - a protein fragment that 
does not bind to Gβ.  Signiﬁcant differences from GIRK 1,4 are indicated by *and** 
(P<0.05 and P<0.01 respectively, by one-way ANOVA, with Bonferroni‟s post-test). 
6.3 The persistent current of NaV1.1-5A is distinctly modulated by different subsets of 
Gβ  proteins  
To assess the impact of subsets of G-protein β subunits on INaP from NaV1.1 variants, 
individual sequestrants were co-expressed with each variant and the amount of INaP was 
assessed by measuring the amount of persistent current as a proportion of the peak, 
transient current. All experiments were carried out in average temperatures ranging from 
35-37
o
C and used CsCl intracellular solutions. To assess the consequences of sequestering 
A B 
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different G-protein subunits, HEK 293 cells were co-transfected with individual channel 
isoforms and Gβ binding proteins at a 3:1 ratio, to minimise the toxicity of the IRES 
vector (higher ratios caused cell death, data not shown).  
Figure 6.4 shows families of sodium currents from both splice variants (5A, left; 5N, right) 
whole-cell recordings in the presence of denoted constructs (left figure panel). As 
demonstrated in chapter 3 persistent current is substantially reduced at higher temperatures. 
At physiological temperatures, in the absence of sequestrants, both splice variant channels 
demonstrated erratic persistent currents, which had similar means (Figure 6.5). The 
distribution of INaP as a percent of INaT from NaV1.1-5A had a slightly larger range (3% -
30%; n=15) compared to that from NaV1.1-5N (0%-11%; n=11; Figure 6.5). This 
variability may be an indicator of differential Gβ modulation in different cells.  
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Figure 6.4 Raw traces of sodium currents derived from either NaV1.1-5A (left panel) 
NaV1.1-5N (right panel) channels when co-expressed with indicated Gβ sequesterant 
proteins. Currents were evoked with the current protocol depicted in the inset. C-terminal 
tails of GRK2 and GRK3 (green) bind to different and overlapping Gβ pairs, (shown in 
blues and yellow). GRK5ct (light blue) does not bind to Gβ proteins unlike Gαt (dark 
blue) that binds to all Gβ subunits. GTPS activates all Gα and in turn Gβ subunits 
(Bottom). All recordings were performed at physiological temperatures using CsCl-based 
solutions. 
 
On consideration of whether both splicing and G-protein regulation affected NaV1.1 
persistent current, only GRK2ct significantly reduced the %INaP in cells co-transfected 
with NaV1.1-5A. (5A: 8.6 ± 1.6 %, n= 15 versus 5A + GRK2: 3.6 ± 1.3 %, n= 9; P<0.05; 
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two-way ANOVA, Bonferroni‟s post-test; Figure 6.5). In contrast, sequestration of subsets 
of Gβ by GRK2ct did not affect %INaP derived NaV1.1-5N (5N: 5.2 ± 1.1 %, n=11 versus 
5N + GRK2: 5.4 ± 1.1 %, n=9; P>0.05; Bonferroni‟s post-tests; Figure 6.5).  The binding 
of a different subset of Gβ subunits by GRK3ct had no affect on the mean %INaP recorded 
for each splice variant, nor the presence of GRK5ct (two-way ANOVA, Bonferroni‟s post-
test; Figure 6.5). These data indicate that the subset of Gβ subunits sequestered by 
GRK2ct may specifically activate the persistent current from the NaV1.1-5A variant. While 
those Gβ subunits that are sequestered by GRK3ct do not interact with either splice 
variant. In a final test, complete Gβ sequestration was carried out by co-expression of Gαt. 
Interestingly, there was no attenuation of %INaP from either splice variant (P>0.05, two-
way ANOVA, Bonferroni‟s post-test; Figure 6.5).  
All the previous experiments relied on suppressing endogenously active G-proteins in HEK 
cells. A complementary strategy is to activate G-proteins pharmacologically. Unlike the 
sequestrants described above, GTPγS is broadly active, and not thought to distinguish 
between subsets of Gα subunits. 
A significant reduction in NaV1.1-5A derived persistent current was observed after 
complete dissociation of all β upon activation of Gα subunits by 0.5 mM of GTPS (5A: 
8.6 ± 1.6 %, n=15 versus 5A + GTPS: 4.6 ± 0.9, n=9, P<0.05, two-way ANOVA, 
Bonferroni‟s post-test; Figure 6.5). This reduction was qualitatively similar to that seen in 
the presence of GRK2ct, and also was specific to NaV1.1-5A variants (Figure 6.6). This 
suggests that the reduction of %INaP induced by the sequestration of Gβ subunits 
associated with GRK2ct, could be overridden by extensive, non-specific loss of Gβ 
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subunit activity (as with Gαt), and restored by complete activation of Gαβ subunits (as 
with GTPS), and indicates there may be competing regulation of INaP by different subsets 
of G proteins. 
Together these data suggest that a subset of specific Gβ subunits, and potentially Gα 
subunits, differentially modulate NaV1.1-5A persistent currents. 
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Figure 6.5 NaV1.1 splice variant mean percentage persistent currents in the presence 
of G-protein modulators. NaV1.1-5N persistent currents were unaffected by G-protein 
subunit modulation (right). Sequestration of subsets of Gβ by GRK2ct and complete Gβ 
activation by GTPS significantly reduced NaV1.1-5A persistent currents. In the presence 
of Gαt these effects were eradicated implying that a subset of specific G protein subunits 
differentially regulate NaV1.1-5A derived persistent currents. *P<0.05, two-way ANOVA, 
Bonferroni‟s post test.  
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6.4 Other effects of Gβ subunit sequestrants on macroscopic NaV1.1 currents. 
The original hypothesis, supported by preliminary experiments and work from other groups 
suggested a role for G-protein β subunits in regulating the amount of persistent currents 
produced by heterologously expressed NaV1.1 channels. Only a small change was 
observed, induced by a single sequestrant, however, in the course of experiments several 
other effects of G-protein sequestrants were seen, and as these have not been described 
elsewhere they are briefly summarised here. The previous constructs were designed to 
analyse INaP and no earlier reports indicate that Gβ subunits modify transient NaV1.1 
gating. Only parameters that were affected will be discussed for conciseness. Specific 
changes due to GTPS are considered separately in section 6.5. 
6.4 Other effects 1: GRK3ct and GRK5ct shift NaV1.1-5A voltage dependence of 
activation to more depolarized potentials  
To examine if attenuating the levels of intrinsic Gβ subunits NaV1.1 splice variant channel 
activation, current protocols and analyses previously described were applied. Unless 
otherwise stated statistical tests accounted for both the affect of splicing and Gβ 
modulation on NaV1.1 activation. As shown in Figure 6.6 A, GRK5ct caused a significant 
5.1 ± 0.4 mV depolarizing shift in NaV1.1-5A mean (±SEM) half-maximal activation (V50act 
5A: -18.8 ± 0.9 mV, n=15; 5A + GRK5: -13.4 ± 1.3 mV, n=8; P<0.05, two-way ANOVA, 
Bonferroni‟s post-test; Figure 6.6 A). GRK5ct had little effect on 5N-containing channels, 
demonstrating a comparable midpoint to α subunits expressed alone: -18.7 ± 1.6 mV (n=10; 
5N: -18.8 ± 0.8 mV, n=18), suggesting the effect of GRK5ct was specific to NaV1.1-5A 
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activation (5A + GRK5ct versus 5N + GRK5ct P <0.05; Bonferroni‟s post-test; Figure 6.6 
C).  
GRK3ct caused a significant mean (±SEM) 3.7 ± 0.7 mV rightward shift in NaV1.1-5A 
half-maximal activation (5A + GRK3ct: -14.8 ± 1.6 mV, n=7; P<0.05, Bonferroni‟s post-
test; Figure 6.6B). GRK3ct caused a similar mean (±SEM) 2.6 ± 0.0 mV non-significant 
shift in NaV1.1-5N activation (5N + GRK3ct: -16.2 ± 0.8 mV; n=10), implying that 
GRK3ct may have a general effect on NaV1.1 activation. In support, the mean V50 values of 
each variant with GRK3ct were not statistically different (Bonferroni‟s post-test; Figure 6.6 
B). Since GRK5ct effected activation but does not interact with Gβ, changes in INaT 
gating caused by GRK3ct and GRK2ct could not be attributed to G-protein interactions. 
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Figure 6.6 GRK3ct and GRK5ct shift NaV1.1-5A voltage dependence of activation in a 
rightward direction.  A. Mean (±SEM) V50 of activation of NaV1.1-5A + GRK5ct 
activation was shifted to more depolarized potentials compared to NaV1.1-5A and NaV1.1-
5N + GRK5ct. B. Mean (±SEM) midpoint of NaV1.1-5A activation was shifted in a 
rightward direction in the presence of GRK3ct. *P<0.05, two-way ANOVA, Bonferroni‟s 
post-tests. 
6.4 Other effects 2: The voltage-dependence of inactivation for both NaV1.1 splice 
variants is altered in the presence of GRK2ct 
Unless otherwise stated statistical analyses considered both the affect of splicing and Gβ 
modulation on NaV1.1 inactivation. Applying a two-way ANOVA with Bonferroni‟s post-
tests reveals that only GRK2ct affected NaV1.1 channel inactivation. As shown in Figures 
6.7 A&C, in the presence of GRK2ct NaV1.1-5N demonstrated a significant -5.5 ± 0.8 mV 
hyperpolarizing shift in mean (±SEM) V50 inactivation (5N: -53.1 ± 1.3 mV, n=11 versus 
5N + GRK2ct: -58.7 ± 2.1 mV, n=9; P<0.05).  5A-containing channels demonstrated a 
B A 
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similar, lesser ~3 mV, midpoint shift (5A: -54.2 ± 1.1 mV, n=14 versus 5A + GRK2ct: -
56.8 ± 1.9 mV, n=9; Figure 6.7 B&C); whereby significantly fewer channels were available 
at -70 mV (P<0.001; two-way ANOVA; Bonferroni‟s post-test; Figure 6.7 B&C).  
Compared to control cells GRK2ct significantly increased the slope factor of NaV1.1-5A, 
but not NaV1.1-5N channel inactivation by 2.6 ± 0.2 mV/e-fold change (5A versus 5A + 
GRK2ct P<0.01, two-way ANOVA, Bonferroni‟s post-test). Using the same mathematical 
analysis, however, slope factors of both α subunits in the presence of GRK2ct were not 
significantly different (Figure 6.7 C), suggesting that the reduction in voltage sensitivity of 
inactivation may not be specific to NaV1.1-5A. 
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Figure 6.7 GRK2ct altered the voltage dependence of NaV1.1 splice variant 
inactivation   A. Shows that GRK2ct shifts NaV1.1-5N activation curve to the left. Voltage 
protocol as in inset B. Significantly fewer channels were available at -70 mV in cells co-
transfected NaV1.1-5A and GRK2ct. ***P<0.0001, two-way ANOVA, Bonferroni‟s post 
test C. The average V50 for activation for NaV1.1-5N+GRK2ct was shifted to more 
hyperpolarized potentials compared to NaV1.1-5N but not NaV1.1-5A+GRK2ct. Compared 
to control cells GRK2ct significantly increased the mean slope factor of NaV1.1-5A. 
**P<0.01, *P<0.05, two-way ANOVA, Bonferroni‟s post test. 
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6.4 Other effects 3: C-terminal fragments of GRK3 and GRK5 slow NaV1.1 splice variant 
recovery from inactivation  
GRK5ct introduced a significant overall variation in NaV1.1-5N recovery from inactivation 
(P=0.02, two-way ANOVA; Figure 6.8 A); consequently, experiments using GRK2ct and 
GRK3ct were uninformative.  However, through an unknown mechanism the recovery of 
inactivation over a range of time intervals was significantly slowed for both channel 
isoforms in the presence of GRK3ct (5A versus 5A GRK3ct, n=5; P=0.04; 5N versus 5N 
GRK3ct, n=7, P=0.04; two-way ANOVA). NaV1.1-5A was particularly sensitive to 
GRK3ct action, as its time-course of recovery from inactivation was significantly slowed 
compared to NaV1.1-5N channels in the same condition (5A GRK3ct versus 5N GRK3ct, 
P=0.0009; two-way ANOVA; Figure 6.8 B). 
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Figure 6.8 (previous page) GRK c-terminal fragments slow the recovery from 
inactivation of NaV1.1 splice variants. A. NaV1.1-5N channels were more available for 
activation than NaV1.1-5N+GRK5ct channels for time points between 2 and 20 ms after 
prolonged depolarisations. *P<0.02, two-way ANOVA. B. Both splice variant channels 
recovery from inactivation were slowed in the presence of GRK3ct. NaV1.1-5A in the 
presence of GRK3ct were more gradual to recover compared to NaV1.15N channels in the 
same conditions.. *P=0.4, ***P=0.0009, two-way ANOVA. Currents were evoked using 
the protocol depicted at the bottom. 
 
In summary, the sequestration of distinct subsets of Gβ, by GRK2ct differentially affected 
the persistent current derived from NaV1.1-5A and NaV1.1-5N. Sequestering all Gβ 
subunits via Gαt had no affect on any parameter (INaP or INaT) for either variant. The c-
terminals of GRK proteins also modulated gating and recovery from inactivation but 
through unknown mechanisms. Channel current densities, the kinetics of activation and 
inactivation of NaV1.1 splice variants were largely unaffected.  
6.5 Stimulation of G-proteins 
 
In the following sections GTPγS was used to probe the effects of global activation of G-
proteins on macroscopic currents produced by NaV1.1 splice variants. As shown in section 
6.3 GTPγS had a similar effect on persistent currents as GRK2ct, these sections summarise 
the effects of GTPγS on other parameters. 
6.5 GTPγS 1: The effect of GTPγS Gα subunit activation on NaV1.1 splice variant 
transient currents 
G-protein stimulation did not change NaV1.1-5A INaT gating at higher temperatures. 
Experiments were performed in average temperatures ranging from 34 – 37oC and cells 
were dialyzed with 0.5 mM GTPS.  There were no significant changes in the mean 
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(±SEM) V50 of activation or inactivation or steepness of the Boltzmann curves fitted for 
both parameters, in cells transfected with NaV1.1-5A, in the presence or absence of GTPS 
(5A versus 5A + GTPS, P>0.05, two-way ANOVA, Bonferroni post test; Figure 6.9 A). In 
contrast, GTPS subtly affected both the voltage dependence of NaV1.1-5N activation and 
inactivation. For example, compared to control cells transfected with NaV1.1-5N  the mean 
(±SEM) V50 activation was shifted 2.8 ± 0.0 mV in a hyperpolarizing direction, with 
significantly more channels opened at -20 mV (P<0.001) and -10 mV (5N, n=15 versus 5N 
+ GTPS, n=13; P<0.01, two way ANOVA with Bonferroni‟s post test, Figures 6.9 A&B). 
At physiological temperatures, G-protein activation increased the voltage sensitivity of 
NaV1.1-5N but not NaV1.1-5A channels (mean ±SEM k: 5N versus 5N + GTPS P<0.05, 
two way ANOVA with Bonferroni‟s post test; Figure 6.9 B).  GTPS did not effect the rise 
time to peak over the voltage range (5A versus 5A + GTPS, P=0.8; 5N versus 5N + 
GTPS, P=0.9, two way ANOVA with Bonferroni‟s post test). 
In cells dialyzed with GTPS the mean (±SEM) NaV1.1-5N V50 inactivation was shifted 3.2 
± 0.2 mV in a negative direction compared to control cells. Significantly fewer number of 
channels were available at -50 mV (P<0.001) and -40 mV (5N, n=11 versus 5N + GTPS, 
n=14; P<0.05, two way ANOVA Bonferroni‟s post test, Figure 6.9 C). There was no 
change, however, in the voltage sensitivity of NaV1.1-5N inactivation (mean ±SEM k: 5N 
versus 5N + GTPS, P>0.05, two way ANOVA, with Bonferroni‟s post test).  Over the 
voltage range shown in Figure 6.9 D, the stimulation of G-proteins did significantly 
increase the rate of inactivation for both channels (5A, n=14 versus 5A + GTPS, n=11, P= 
0.0006; 5N, n=18 versus 5N + GTPS, n=13, P<0.0001, two-way ANOVA), which was not 
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altered by splicing (5A + GTPS versus 5N + GTPS, P=0.4, two-way ANOVA). Lastly, 
G-protein activation did not alter either splice variants recovery from inactivation compared 
to control conditions at any time interval (±SEM normalized current: 5A versus 5A + 
GTPS, n=5, P=0.8; 5N versus 5N + GTPS, n=6, P=0.9, two-way ANOVA).  
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Figure 6.9 GTPS regulation of NaV1.1 splice variant gating at physiological 
temperatures. A. At -20 mV and -10 mV the voltage dependence of NaV1.1-5N activation 
was shifted to more hyperpolarized potentials in cells dialyzed with GTPS. ***P=0.001, 
**P=0.01, two way ANOVA, Bonferroni‟s post test. B. GTPS did not alter the mean 
midpoint of NaV1.1 splice activation but increased the voltage sensitivity of NaV1.1-5N 
channels. *P<0.05, two way ANOVA, Bonferroni‟s post test. C. GTPS exerted subtle 
effects on NaV1.1-5N inactivation, and shifted the voltage dependence at -50 mV and -40 
mV in a leftward direction. ***P<0.001, *P<0.05, two-way ANOVA, Bonferroni‟s post 
test D. In the presence of GTPS the rate of inactivation (decay) was significantly 
A B 
C D 
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accelerated for a range of test potentials for both splice variants. ***P<0.0001, two-way 
ANOVA, Bonferroni‟s post test. 
6 .5 GTPγS 2: GTPS upregulated NaV1.1 persistent currents at RT 
Previous reports of GTPS regulation of VGSCs have shown effects on INaP (Ostman et 
al., 2008). However no change was seen here and this may be due to elevated temperatures, 
as previous reports used RT recordings. To confirm whether GTPS exerted effects on INaP 
from either splice variant at lower temperatures, experiments were repeated at RT. 
As shown in Figure 6.10 A, GTPS dramatically upregulated persistent currents from both 
NaV1.1 splice variants at RT. This effect was seen for both splice variants and was 
significantly greater than the increase produced at physiological temperatures. %INaP from 
NaV1.1-5A channels was greater at RT compared to physiological temperatures (37 versus 
RT, 5A + GTPS: 4.6 ± 0.9 %, n= 9; 16.2 ± 3.8 %, n=11, P<0.05 two way ANOVA). INaP 
from NaV1.1-5N had a slightly larger increase at RT compared to physiological 
temperatures (37 versus RT, 5N + GTPS: 3.6 ± 0.5 %, n=14; 29.0 ± 6.0, n=6, P<0.001; 
two way ANOVA with Bonferroni‟s post test, Figure 6.10). At RT, in cells dialyzed with 
GTPS NaV1.1-5A exhibited a large range of %INaP: approximately 20% cells producing 
over 30% INaP; a percentage not seen in untreated cells, but another ~40 % possessed less 
than 5% INaP.  Consequently, on comparison of both splice variants in the presence of 
GTPS NaV1.1-5N demonstrated a non-significant increase in proportional persistent 
current compared to NaV1.1-5A (P>0.05, Mann-Whitney).  
As expected in the presence of GTPS the increase in stability of the non-inactivating 
current was reflected in the significant decrease in the rate of current decay over the voltage 
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range for both 5A and 5N-containing channels at RT  (RT versus 37, P<0.001; two –way 
ANOVA, Bonferroni‟s post-tests, Figure 6.10 C). 
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Figure 6.10 GTPS significantly upregulated NaV1.1 splice variant persistent currents 
A. Raw traces demonstrating the dramatic increase in persistent currents at RT (bottom) 
compared to recordings at 37
o
C (top) of both channels isoforms in the presence of GTPS. 
B. Mean ±SEM %INaP NaV1.1 currents were significantly increased in cells dialyzed with 
GTPS compared to control conditions. *P<0.05, **P=0.001, two-way ANOVA, 
Bonferroni‟s post-test. C. The rate of current decay was significantly slowed at lower 
temperatures for both splice variants in the presence of GTPS over a voltage range. 
***P=0.0001, two-way ANOVA, Bonferroni‟s post-test. 
A B 
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6.5 GTPγS 3: GTPS does not activate endogenous voltage or ligand gated ion channels 
in HEK 293 cells 
Since there was a dramatic increase in persistent currents it was important to establish that 
GTPS did not stimulate intrinsic HEK 293 voltage and/or ligand-gated ion channels at 
lower temperatures. Endogenous currents were evoked and normalized using methods 
previously described in the methods. Recordings were performed using CsCl-based internal 
solutions containing 0.5 mM GTPS at RT. In the presence of GTPS negligible inward and 
outward currents peaking at +60 mV were observed (mean ±SEM = -4.3 ± 8.8 pA/pF; n = 
5; Figure 6.11). At -10 mV GTPS did not activate any substantial currents that would 
affect the calculation of %INaP; for example, mean (±SEM) current density was 0.6 ± 5.0 
pA/pF (n=5). This implies that persistent currents were derived from transfected sodium 
channels. 
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Figure 6.11. At RT negligible currents were observed from whole-cell patch clamp 
recordings of untransfected HEK 293 cells in the presence of GTPS. 
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6.5 GTPγS 4: NaV1.1-5N is sensitive to changes in temperature under GTPS 
modulation 
NaV1.1 current density was not affected by splicing in G-protein activated conditions 
indiscriminate of temperature (interaction of all factors, P=0.2; two-way ANOVA). At 
biological temperatures significantly more NaV1.1-5N channels were available at voltages 
between -20 mV and 0 mV (P<0.01, for noted voltages, two–way ANOVA, Bonferroni‟s 
post-tests). When considering both splicing and temperature, mean (±SEM)  NaV1.1-5N 
half maximal activation at ~ 37
o
C  is significantly 5.8 ± 0.4 mV more hyperpolarized 
compared to channels recorded at RT  (P<0.05, two–way ANOVA, Bonferroni‟s post-tests, 
Figure 6.12 A).  Allowing for the same conditions, temperature did not significantly change 
the mean (±SEM) steepness of the conductance curves for either NaV1.1-5A or NaV1.1-5N 
(Two–way ANOVA, Bonferroni‟s post-tests, Figure 6.12 B).  
As expected the time-course of activation, was accelerated for both channels at higher 
temperatures and the activation kinetics of NaV1.1-5N displaying a greater sensitivity to 
temperature in the presence of GTPS.  For example, between voltages -20 mV and + 20 
mV, mean (±SEM) rise time is significantly reduced at higher temperatures (P<0.001 for 
each voltage step; two–way ANOVA, Bonferroni‟s post-tests, Figure 6.12 C). NaV1.1-5A 
was less affected by the increase of temperature under the same conditions. Its time-course 
of activation was significantly accelerated at more hyperpolarized potentials, that is, -20 
mV to 0 mV, but not significantly effected at more depolarized potentials (P <0.05, for all 
three noted voltages; two–way ANOVA, Bonferroni‟s post-tests, Figure 6.12 C).  
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Figure 6.12 The effect of lower temperatures on the activation of NaV1.1 splice 
variants A. Shows the activation of NaV1.1-5N in the presence of GTPγS at higher 
temperatures is shifted to the left. B. Gα stimulation at higher temperatures shifts the 
average ±SEM V50 activation of NaV1.1-5N to more hyperpolarized potentials compared to 
RT recordings. C. Over a voltage range the kinetics of NaV1.1-5N activation was 
significantly slowed at RT in cells dialyzed with GTPS. Bonferroni‟s post-tests revealed 
that only at more hyperpolarised potentials the kinetics of NaV1.1-5A activation was 
affected by temperature in the presence of GTPS. *P<0.05, ***P<0.001, two-way 
ANOVA Bonferroni‟s post-test. 
 
6.5 GTPγS 5: At elevated temperatures GTPS shifts the voltage dependence of 
inactivation in a leftward direction 
The voltage dependence of inactivation for both splice variants was shifted in a 
hyperpolarized direction at biological temperatures. For both splice variants significantly 
more channels were unavailable between -50 mV and -30 mV at 37
o
C (P<0.01, for the 
voltage range, significant differences are not shown on Figure 6.13 A but notable voltages 
are marked by an asterisk for clarity). When considering individual channels, an increase in 
temperature caused a significant leftward shift 6.2 ± 0.7 mV in the mean V50 inactivation of 
NaV1.1-5A (P= 0.04, 2-tailed t-test; whereas when considering both variants using a two-
A B C 
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way ANOVA this was not significant; Figure 6.13 B). The voltage-sensitivity of NaV1.1-
5A to inactivation was not significantly effected by temperature (mean ±SEM k; P= 0.10, 
2-tailed t-test; Figure 6.13 B).   Although as previously mentioned temperature did change 
NaV1.1-5N inactivation properties at less negative potentials but this did not significantly 
shift the mean (±SEM) V50 of inactivation (P=0.08, 2-tailed t-test). However higher 
temperatures did significantly decrease the slope factor by 6.6 ± 2.8 mV/e-fold change (P= 
0.01, 2-tailed t-test; Figure 6.13 B).  
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Figure 6.13  GTPS changes the voltage dependence of NaV1.1 splice variant 
inactivation at RT A. Conductance curves show that for both splice variants significantly 
more channels were available between -50 mV and -30 mV at RT *P<0.01, two-way 
ANOVA, Bonferroni‟s post test B. The mean ±SEM V50 inactivation of NaV1.1-5A was 
shifted to more depolarized potentials by GTPS at RT. The mean ±SEM slope factors of 
NaV1.1-5N was increased in the presence of GTPS at lower temperatures. P<0.05, two-
way ANOVA, Bonferroni‟s post test. 
 
A B 
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At 37
o
C using CsCl based internal solutions the macroscopic currents from both variants 
were largely indistinguishable in the presence of GTPS. Simply lowering the temperature 
had a distinct effect on the two variants, mainly stabilizing the non-inactivated states of 
both channels, which supports similar reports involving other VGSCs (Ostman et al., 
2008). In summary, these data reveal that NaV1.1 splice variants are differentially 
modulated by different Gαβ subunits and their response to G-protein activation is 
dependent on temperature. Therefore investigating what second-messenger cascades target 
these channel variants may be a new path to understanding regulation of these channels and 
possibly the seizures associated with them. 
6.6 Discussion 
The positive findings of this chapter were: 
1. HEK 293 cells express a wide range of G-protein subunit genes. 
2. The persistent current of NaV1.1-5A is differentiately regulated by distinct subsets 
of Gβ proteins.  
3. Temperature markedly alters the properties of NaV1.1 splice variant behaviour after 
GTPγS stimulation.  
6.6.1 HEK 293 cells express a diverse range of G-protein subunit genes 
The HEK 293 cells used in the present study were shown to express a wide range of G-
protein subunits that are coupled to a variety of GPCRs (Shaw et al., 2002). Although 
preliminary, this study aimed to provide a „snapshot‟ expression profile rather than a 
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detailed examination. Two neuronal specific G-protein α subunits, GNAO and GNAZ were 
not found. All β subunits were highly expressed but two olfactory and gustatory γ subunits 
were undetected.  
6.6.2 NaV1.1 splice variant persistent currents are differentially modulated by β subunits 
This study is the first to show that a subset of specific Gβ subunits, and possibly Gα 
subunits, differentially modulate INaP from VGSC splice variants, specifically NaV1.1-5A. 
It is unknown which Gβ subunits GRK2ct selectively sequesters, and in turn, which Gβ 
specifically reduce NaV1.1-5A persistent currents. Since Gβ subunits bind to the 
intracellular side of the channel and the amino acid differences between the splice variants 
are extracellular, the Gβ may be interacting with different conformations of NaV1.1. In 
vivo, this sub-set of Gβ subunits would act to attenuate GABAergic neuron excitability. 
Compared to their voltage-gated calcium and potassium channel counterparts there is 
surprisingly little known about the GPCR regulation of VGSCs. INaT and INaP derived 
from a mixed population of NaV1.1 and NaV1.6 channels in striatal-cholinergic interneurons 
were attenuated after administration of a D2 dopamine receptor agonist (Maurice et al., 
2004). D2 receptors are coupled to Gαo and dialysis of purified GRK2ct, and therefore 
sequestration of Gβ, also attenuated INaT. The authors determined that PKC inhibition 
reduced transient currents and therefore continued to investigate kinase regulation of 
%INaP. Unfortunately, the affects of GRK2ct on persistent currents were not determined. 
However, a reduction in sodium currents via D2 receptors, and possibly Gαo associated Gβ 
subunits, diminished these cells autonomous discharge and consequently their pacemaker 
activity (Maurice et al., 2004).  It is possible that this mechanism also exists in cells that 
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predominantly express NaV1.1 (Yu et al., 2006). 
There are few reports demonstrating the differential modulation of G-proteins on ion 
channel splice variants. However, research suggests that this G-protein selective regulation 
on N-type calcium channels may have therapeutic implications for pain suffers. 
Neurotransmitter release from several neuronal types is reduced by inhibitory Gβ subunits 
acting directly on N-type calcium channels (Gray et al., 2007). In vivo c-terminal N-type 
calcium channel exon 37 splice variants, e37a and e37b, are differentially modulated by 
two mechanisms, which result from divergent pathways downstream of PTX sensitive G-
proteins (Raingo et al., 2007). Exon 37a and e37b containing channels are regulated by a 
Gβ subunit, in a voltage dependant but tyrosine kinase independent mechanism. CaV2.2-
e37b, however, can also be modulated by a mechanism that is independent of Gβ subunits 
and voltage but is regulated by a tyrosine kinase activated downstream of G-protein 
stimulation (Gray et al., 2007).  An N-type calcium subtype, CaV2.2 containing e37a 
channels are upregulated on the presynaptic nerve terminals of C-fiber nociceptors. CaV2.2 
channels containing the alternative exon, e37b are universally expressed in nervous system. 
Andrade et al. (2010) engineered a mouse whereby e37b replaced e37a in CaV2.2 channels 
expressed by DRG nociceptors.  Morphine binds to μ-opioid-Gi/o coupled receptors and by 
comparing the behavioural responses to noxious stimuli of wild-type and CaV2.2 exon 37 
mutant mice the authors discovered that morphine exerts its selective analgesia effects by 
indirectly inhibiting CaV2.2[e37a] and not CaV2.2[e37b] channels. Similar modulatory 
mechanisms could exist to control NaV1.1 activity; for example, particular NaV1.1 isoforms 
may be upregulated in inhibitory interneurons sub-types. This may be possible because 
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several SCN1A exons are alternatively spliced. If these splice variants do differentially 
respond to AEDs in vivo, cell-specific responses to drugs could be exploited for epilepsy 
treatment.  
6.6.3 Future studies to determine the true effects of G-protein acting on NaV1.1 splice 
variants 
To prevent co-transfecting HEK 293 cells with numerous G-protein subunit combinations, 
Gβ sequesterants were used. Although a significant decrease in NaV1.1-5A %INaP was 
observed in the presence of GRK2ct, INaP throughout the study was very variable this may 
result may have been a false positive. Moreover, although control experiments confirmed 
that GRKct fragments did sequester Gβ the non-specific effects of the control fragment, 
GRK5ct on INaT raises questions about whether the effects of GRK2ct on INaP were due to 
selectively sequestering Gβ subunits. Additionally, since Gβ subunits have dramatic 
effects on both potassium and calcium channels if there was a strong interaction between 
NaV1.1 and Gβ it would be predicted to be obvious; especially as the research tools used in 
this study are the gold standard for revealing G-protein interactions. In the Mantegazza et 
al. (2005) report, co-expression of Gβ2γ3 produced substantial persistent currents 
compared to this study, but that work was carried out at RT. In addition it may be that 
constitutively active G-proteins did not yield high concentrations of Gβ to exert equal 
effects. This may be reflected by GTPS shifting the equilibrium to full G-protein 
dissociation, causing the same reduction in INaP by perhaps increasing the number of free 
cytosolic Gβ. Unfortunately it cannot be concluded that GTPS acted via Gβ or via other 
G-protein cascades. In future, both NaV1.1 splice variants would be co-expressed with 
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Gβ2γ3 to determine INaP is differentially modulated by Gβ and whether this interaction is 
conserved at physiological temperatures.  
GPCRs that are likely to be expressed in inhibitory interneurons, for instance, GABAB, 
cannabinoid, dopaminergic receptors (Stephens 2009), could be co-expressed with NaV1.1 
in HEK cells.  The responses of each NaV1.1 splice variant to GPCR agonists could be 
assessed using whole-cell voltage patch clamp. To test if the effect of the neurotransmitter 
results from Gβ direct interactions Gβ dimers known to associate with specific GPCRs 
could be purified using affinity chromatography (Dascal et al., 2001). The purified proteins 
would be applied to the bath solution and using the „inside out‟ configuration the effects of 
Gβ on sodium currents could be assessed. If the latter mimicked the effects of macroscopic 
currents responding to agonist administration this would imply a direct interaction between 
Gβ and NaV1.1, rather an indirect downstream protein interaction.  Investigations could be 
moved into chicken neurons, whereby preliminary experiments would give some insights 
into which GPCRs to manipulate. In addition, siRNA could be used to knock down specific 
Gα genes and NaV1.1 splice variants to determine their potential synergistic effect on 
neuronal excitability.  
6.6.4 Non-specific effects of GRKct may be due to modulation of the Gαq pathway 
The non-specific effects of GRK5ct, and therefore possibly GRK2ct and GRK3ct, acting on 
INaT are hard to explain. One possibility is that the amino acid chains could fold into a 
tertiary structure that mimics a region of an endogenous protein that interacts with VGSCs. 
Alternatively the c-terminal tails of GRKs interact with a variety of proteins. For instance, 
both GRK5ct and GRK2ct bind to calmodulin but not GRK3ct. Since GRK3ct and GRK5ct 
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modulated two biophysical parameters of NaV1.1 splice variants in a comparable manner 
this could mean that they are acting through a similar mechanism compared to GRK2ct. 
Therefore, non-specific effects may not be due to changes in calmodulin channel 
regulation. However, all three c-terminal fragments do contain lipid binding domains. 
GRK2ct, GR3ct and GRK5ct interact with Phosphatidylinositol 4,5-bisphosphate (PIP2) 
PIP2 acts as a second messenger within the Gq activation pathway (Penela et al., 2003). 
PIP2 modulates numerous ion channels, including inward rectifier potassium channels, non-
voltage-gated sodium channels, purinergic receptors, AMPA and NMDA receptors 
(Logothetis et al., 2010). These protein fragments may be manipulating a different GPCR 
pathway. However, one review states that VGSCs are insensitive to PIP2 but fails to cite 
any references (Hilgemann et al., 2001). Thus, there may be a disruption in the availability 
of PIP2 within the pathway. This may lead to knock-on effects downstream altering NaV1.1 
behaviour. Attempts were made to investigate the effects of Gαq signalling on NaV1.1 
splice variants. As previously described, preliminary experiments involving PTX were 
going to be repeated with the Gαq inhibitor YM-254890. However, Asellas 
Pharmaceuticals has stopped supplying this bacterial toxin (Takasaki et al., 2004). 
Alternatively the Gαq „selective‟ activator, Pasteurella multocida toxin (Calbiochem) could 
have been used but these experiments were abandoned because this agent also activates Gαi 
subunits (Orth et al., 2008)  
6.6.5 The effects of GTPS is dependant on temperature 
The inactivation properties of both NaV1.1 splice variants in G-protein activated conditions 
were dramatically different at varying temperatures. CsCl-GTPS up-regulation of sodium 
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persistent currents at RT has been observed for endogenous rat DRG NaV1.9 channels and 
enteric neurons (Baker et al., 2003; Rugiero et al., 2003; Ostman et al., 2008). However, 
using same concentration of GTPS in this study, Ma and colleagues showed no increase in 
NaV1.2-6A INaP expressed in either in CHO or HEK cells. The intracellular solutions in 
these studies were fluoride free (Ma et al., 1994, Ma et al., 1997). These conflicting results 
may be due to differences in VGSC sub-type and/or cell backgrounds. In this study at RT 
the rate of current decay for both NaV1.1 isoforms was significantly slowed compared to 
control conditions but at elevated temperatures this was reversed. Thus, perhaps in vitro 
after G-protein activation, channels undergo a complex conformation change. At RT, 
during a slowed kinetic state, G-protein activation stabilizes inactivation and therefore 
recordings reflect an intermediate state. During this intermediate state the voltage 
sensitivity of NaV1.1-5N and NaV1.1-5A channels decrease although NaV1.1-5A channels 
to a lesser extent. Interestingly, in experiments performed at RT involving rat superior 
cervical ganglion neurons, the gating charges of TTX-sensitive VGSCs were disrupted by 
GTPS; although this was not predicted to increase INaP (Hernández-Ochoa et al., 2007). 
Nonetheless, at elevated temperatures, the kinetics of the conformational change might be 
accelerated and macroscopic currents may mirror the true physiological effect of G-protein 
modulation on NaV1.1.   
In the HEK cells used in this study, which as demonstrated by the mRNA data have a wide-
ranging G-protein subunit background, GTPS activated G-protein signalling pathways 
selectively increased the voltage sensitivity of NaV1.1-5N activation. Subtle effects were 
also observed in the voltage dependency of NaV1.1-5N gating. Therefore, it is possible that 
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global G-protein regulation of VGSCs may finely tune the excitability of neurons through 
changing the biophysical properties of splice variants of VGSCs. Concerning NaV1.1 splice 
variants this may be developmentally co-ordinated with changes in GPCR expression. For 
instance; Nova2 may also control the splicing of several GPCRs expressed in GABAergic 
neurons, including GABAB receptors (Li et al., 2007). GPCRs manipulation of NaV1.1 
activity may be disrupted during epilepsy, thus future treatments that influence these 
regulatory pathways could be developed. However, because of the flaws in experimental 
tools, these data only hint that NaV1.1 splice variants are differentially modulated by G-
proteins. Further studies are needed to untangle the true biological effect of Gαβ on 
NaV1.1. 
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Chapter 7: An investigation into the VGSC β subunit regulation 
of NaV1.1 splice variants 
7.1 Hypothesis and aims 
Hypothesis: VGSC β subunits proteins have been shown to be important for regulating 
sodium channel properties in various heterologous systems. It was hypothesized that 
distinctive pairs of β subunits will differentially modify NaV1.1 splice variant channel 
behaviour. 
Background and experimental aims: Early in development, when alternative splicing is 
thought to favour exon 5N, a large proportion of sodium channel α subunits are not 
associated with β subunits (Scheinman et al., 1989). In adult brain, however, α subunits are 
associated with two β subunits, including one of either β1- or β3- and one of either β2 or β4 
(Isom 2001; Ulbricht 2005). Moreover, in experimental epilepsy models and/or following 
seizures, when exon 5N is upregulated, several sodium channel genes including those that 
code for NaV1.1, β1, β2, and β3 are transiently down-regulated (Ellerkmann et al., 2003; 
Gastaldi et al., 1998; Gorter et al., 2006). It is possible that β subunits may modulate each 
splice variant α subunit differently. Moreover, β subunits have been shown not only to alter 
channel gating but also to change channel localization. The aim of this section was to 
investigate whether β subunits had similar effects on the biophysical properties and 
trafficking of both splice variants of SCN1A.  
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7.2 Biophysics 1: β1b, β2 subunits attenuate the peak current densities of NaV1.1 splice 
variants 
To determine the functional impact of β subunits on the splice variants, NaV1.1-5N and 
NaV1.1-5A were co-expressed with β2 paired with one of three related β subunits: β1, its 
splice variant β1b or β3. All experiments in these sections were carried out in average 
temperatures ranging from 35-37
o
C and used CsCl solutions. Figure 7.1 A shows raw traces 
of sodium currents from both splice variants co-expressed with β1,β2 (top panel) or  β1b,β2 
(bottom panel). No currents were recorded from NaV1.1 channels co-transfected with β3,β2 
(data not shown). 
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Figure 7.1 Peak current densities of splice variants is reduced in the presence of β1b, 
β2 A. Raw traces of NaV1.1 splice variants co-expressed with β1,β2 (top) and β1b, β2 
(bottom). Sweeps were elicited by the protocol in the inset. B. Mean peak (±SEM) current 
densities of splice variants co-expressed with denoted β subunits. Co-expression of β1b, β2 
significantly reduced the peak current density of NaV1.1 splice variants. *P<0.05, two-way 
ANOVA, Bonferroni‟s post-test. β1,β2 subunits had no significant effect on this parameter. 
P=>0.05, two-way ANOVA, Bonferroni‟s post-test. 
 
In the presence of β1, β2 the mean peak current densities of 5A and 5N-containing channels 
were not significantly altered (Figure 7.1 B; 5A: -97.1 ± 20.9 pA/pF, n=14 versus 5A + 
A 
B 
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β1,β2: -57.4 ± 9.2 pA/pF, n=12, 5N: -100.9 ± 20.8 pA/pF, n=18 versus 5N + β1,β2 : -92.8 ± 
23.3 pA/pF; n=7; two-way ANOVA, Bonferroni‟s post-test). However, co-expression of 
β1b, β2 significantly reduced the mean peak current density of both NaV1.1-5A and 
NaV1.1-5N (by 75.9 ± 17.8 pA/pF n=7 and 67.1 ± 15.3 pA/pF n=10 respectively), 
compared to those observed for α subunits alone (P<0.05; two-way ANOVA, Bonferroni‟s 
post test, Figure 7.1 B).  This indicates that these specific pairs of β subunits do not 
differentially regulate the NaV1.1 α subunit splice variants.  
Individual comparisons of NaV1.1-5A or NaV1.1-5N co-expressed with either β subunit 
pair, show that β1b,β2 significantly attenuates mean peak current densities compared to 
β1,β2. For instance, β1b,β2 caused a decrease in mean NaV1.1-5A current density of 36.2 ± 
6.1 pA/pF  compared to values obtained with β1,β2 (P<0.01, Mann-Whitney). A similar 
mean (±SEM) reduction was observed for NaV1.1-5N under the same conditions (59.0 ± 
17.8 pA/pF; P<0.05; Mann-Whitney). These data indicate that the two β1 splice variants 
have different effects on NaV1.1 current densities when matched with β2.  
7.2 Electrophysiology 2: The gating of NaV1.1 splice variants was largely unaffected by β 
subunit pairs 
When conductances were normalised to compare voltage dependence of macroscopic 
gating, multiple two-way ANOVA with Bonferroni‟s post-tests revealed no significant 
differences between the cells transfected with NaV1.1-5A, in the absence/presence of β 
subunit pairs, at any voltage step (5A vs 5A β1,β2, n=12, P=0.5; 5A vs 5A β1b,β2, n=7, 
P=0.06; two-way ANOVA, Figure 7.2 A). Moreover, the different α subunit splice variants 
also showed similar voltage dependence of activation in the presence of  β subunits (5A 
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β1,β2 vs 5N β1,β2, n=7, P=0.07; 5A β1b,β2 vs 5N β1b,β2, n=10, P=0.2; two-way ANOVA, 
Figure 7.2 A).  
In the presence of β1,β2 subunits some subtle variations in activation were observed for 
NaV1.1-5N channels (n=7, P=0.01, two-way ANOVA). Whereas β1b splice variant had 
little effect on this parameter compared to currents mediated by NaV1.1-5N α subunits with 
or without β1,β2 subunits (5N vs 5N β1b,β2, n=10, P=0.2; 5N β1,β2 vs 5N β1b,β2, P=0.6; 
two-way ANOVA). Finally, in all conditions, depicted in Figure 7.2 B there were no 
significant differences the mean (±SEM) inactivation V50 values and slope factors (V50act 
and k: P=>0.05 two-way ANOVA, Bonferroni‟s post-tests). The rate of NaV1.1-5A current 
decay was significantly slowed in the presence of β1b,β2 not β1,β2 subunits (5A vs 5A 
β1,β2, n=12, P=0.8; 5A vs 5A β1b,β2, n=7, P<0.0001; two-way ANOVA, Figure 7.2 A).  
Moreover this slowing was specific to 5A-containing channels (5N β1b,β2 vs 5A β1b,β2, 
P=0.0005, two-way ANOVA; Figure 7.2 C). 
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Figure 7.2 The effect of β1 splice variants paired with β2 on NaV1.1-5A and NaV1.1-5N 
gating  A. Conductance curves of both splice variants in the presence and absence of 
denoted β subunits. Currents were evoked from the protocol in the inset. Deviations in the 
voltage dependence of inactivation of NaV1.1-5N but not NaV1.1-5A channels were 
introduced by β subunits. B. No significant changes the mean ± SEM midpoints and slope 
factors were detected for either variant in all conditions. C. The rate of current decay of 
NaV1.1 channels isoforms over depolarizing steps in the presence and absence of indicated 
β subunits. NaV1.1-5A kinetics of activation was significantly slowed in the presence of 
β1bβ2 compared to 5A α subunit currents. ***P<0.0001, two-way ANOVA. 
 
Figure 7.3 A shows the relationship between prepulse potential and current available at the 
test pulse for 5A and 5N-containing channels co-expressed with the denoted β subunits. 
There was no difference in the fraction of current available at each voltage step for NaV1.1-
A 
B C 
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5A channels in the absence or presence of β subunits (5A versus 5A β1,β2, n=8, P=0.1; 5A 
versus 5A β1b,β2, n=3, P=0.5, two-way ANOVAs). However, in the presence of β subunits 
there were significant variations in the steady-state inactivation for NaV1.1-5N (5N versus 
5N β1,β2, n=8, P=0.03; 5N versus 5N β1b,β2, n=4, P=0.04, two-way ANOVA),  although 
these subtle changes were not affected by splicing (5A β1,β2 versus 5N β1,β2, P=0.2; 5A 
β1b,β2 versus 5N β1b,β2, P=0.5, two-way ANOVA). Although in all conditions, depicted 
in Figure 7.3 B there were no significant differences the mean (±SEM) inactivation V50 
values and slope factors, (V50inact and k: P>0.05 two-way ANOVA, Bonferroni‟s post-tests).  
Collectively these data suggest that neither β1 nor β1b when paired with β2 significantly 
alters the voltage dependence of NaV1.1 splice variant activation and inactivation.   
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Figure 7.3 β subunits do not regulate the voltage dependence of NaV1.1 splice variant 
inactivation The voltage dependence of inactivation of maximal peak transient currents 
show subtle variations in NaV1.1-5N inactivation in the presence of β subunits (A) but no 
significant differences were detected between the mean (±SEM) slope factor for both 
variants in all conditions (B). Currents were evoked by the protocol depicted in the inset. 
7.2 Electrophysiology 3: The rate of NaV1.1-5A and 5N fast inactivation is slowed in the 
presence of β1b, β2  
In all conditions the non-inactivating, persistent component of transient NaV1.1 splice 
variant sodium currents were comparable (%INaP P>0.05, two-way ANOVA with 
A 
B 
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Bonferroni‟s post-test).  β1b,β2 significantly slowed tau of NaV1.1-5A and NaV1.1-5N 
inactivation compared to channels in the presense or absence of β1,β2 subunits over a range 
of potentials (5A β1b,β2 versus 5A or 5A β1,β2 P<0.0001; 5N β1b,β2 versus 5N or 5N 
β1,β2 P<0.05 two-way ANOVA; Figures 7.4 A&B). In the presence of β1,β2 the rate of 
current decay was similar to rates calculated for NaV1.1 α subunits alone (5A versus 5A 
β1,β2, P=0.2; 5N versus 5N β1,β2, P=0.7; two-way ANOVA; Figures 7.4 A&B)  This 
implies that slowing of NaV1.1 current decay is specific to β1b,β2.  
In the presence of β1,β2 NaV1.1-5N current decay was significantly slowed compared to 
NaV1.1-5A channels (5A β1,β2 versus 5N β1,β2, P=0.02, two-way ANOVA; Figure 7.4 C). 
In contrast β1b,β2 did not differently modify the rate of fast inactivation from the two 
splice variants (5A βb1,β2 versus 5N β1b,β2, P=0.6, two-way ANOVA; Figure 7.4 D). The 
similarity between the splice variants is emphasized by the divergent slowing of NaV1.1 α 
subunit inactivation at 0mV – a potential likely to evoke maximal current activation (Figure 
7.4 D).  
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Figure 7.4 β subunit modulation of NaV1.1 splice variant rate of current decay. β1b,β2 
significantly slows the NaV1.1 splice variant rate of inactivation at maximal current 
activation for NaV1.1-5A channels in the presence or absence of β1,β2 subunits (A) and 
compared to NaV1.1-5N channels expressed alone (B) ***P<0.001; *P<0.05, two-way 
ANOVA. β1,β2 differentially modulates NaV1.1 splice variants rate of decay 
Semilogarithmic plot of the fast time constants derived from ﬁts of one exponential to the 
decay of the current over a range of test potentials show that in the presence of β1,β2 (C) 
but not β1b,β2 (D) NaV1.1-5N rate of current decay is significantly slowed compared to 
NaV1.1-5A channels. *P=0.02, two-way ANOVA. 
7.3 Immunocytochemistry: β subunits do not retain NaV1.1 splice variant α subunits 
within the secretory pathway 
The most striking effect of β subunit regulation on the biophysics of heterologously-
expressed sodium channels was a pronounced reduction in current density. There are two 
possible mechanisms behind this effect: firstly, β subunits could directly interact with the 
A 
C 
B 
D 
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channels at the cell surface attenuating their conductance. The second possibility is that the 
β subunits may sequester the α subunits within the secretory pathway preventing them from 
reaching the cell surface. It has been well established that accessory subunits can act as a 
chaperone protein for α subunits (Cusdin et al., 2007).  To determine whether the β subunit 
pairs altered the subcellular localisation of NaV1.1 α subunits, HEK 293 cells were 
transfected with the appropriate DNAs and fixed in 4% PFA and stained with anti-NaV1.1 
antibodies followed by TRITC conjugated secondary antibody. This sodium channel 
primary antibody is raised against amino acids within the first intracellular loop of the α 
subunit. However, a high level of background staining was detected in untransfected HEK 
cells using this antibody (Figure 7.5). This may represent unspecific binding of the 
antibody to non-VGSC proteins expressed by HEKs or, less likely, the expression of 
endogenous VGSCs in the HEKs, which did not produce currents. Therefore, in following 
immunocytochemisty experiments CHO cells were used.  Subsequent imaging was 
performed by Elin Reeves, an MSc student under my supervision.  
 
Figure 7.5 HEK 293 cells were unsuitable for immunocytochemistry studies 
Untransfected HEK 293 cells were fixed in 4% PFA and  labelled with anti-NaV1.1 
antibodies raised in rabbit (against amino acids with the first intracellular loop) and 
detected with TRITC conjugated secondary antibodies. Cells were visualised at x40 
magnification. A high level of background staining was detected. Scale bar: 20 µM.  
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To assess the background fluorescence of CHO cells untransfected cells were fixed and 
stained with TRITC conjugated secondary antibodies, with or without prior labelling with 
of anti-NaV1.1 antibodies raised against amino acids within the third intracellular loop.  
Different primary antibodies were used to prevent potential unspecific binding detected by 
the previous antibody. No signal was detected in either condition (Figure 7.6 A). Cells were 
transfected with NaV1.1 splice variants and α subunits were detected using the same 
indirect immunofluorescence microscopy method. NaV1.1 α subunits were present in the 
plasma membrane indicated by a faint rim of fluorescence circling the perimeter of each 
cell (Figure 7.6 B). Positive staining also validated this primary antibody. 
5A 5N 
Untransfected Untransfected 
- 1o
 
Figure 7.6 A. Untransfected CHO cells were fixed in 4% PFA and labelled with (left) or 
without (right) anti-NaV1.1 antibody raised in rabbit and detected with TRITC conjugated 
secondary antibodies. Primary (left) and secondary (right, -1
o
) antibodies demonstrated no 
unspecific binding B. CHO cells were co-transfected with NaV1.1 splice variants as 
indicated and fixed in 4% PFA. Cells were stained with anti-NaV1.1 antibody raised in 
rabbit followed by TRITC conjugated secondary antibodies. Primary antibodies were raised 
A 
B 
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against amino acids within the third intracellular loop. Both NaV1.1 splice variants were 
detected at the cell membrane (right & left). Cells were visualised at x63 magnification. 
Scale bar: 5 μM. 
 
To test whether β subunits altered trafficking CHO cells were co-transfected with NaV1.1 
splice variants and with either β1,β2; β1b,β2 or β3,β2 subunit pairs. Immunocyctochemistry 
was performed as described previously. GFP indicates the presence not the localization of β 
subunits (Figure 7.7 right panels). In all conditions, staining showed NaV1.1 splice variants 
were transported to the cell membrane (Figures 7.7 A – F). In the presence of β1b,β2 
NaV.1-5N appeared to have accumulated in endosomes and lysosomes, as numerous stained 
vesicles surrounded the perinuclear region (Figure 7.7 D), but this pattern of staining was 
inconsistent in these conditions. These results suggest that the reduction in current density 
by β1b,β2 and possibly β2,β3, was through subunit interactions at the cell surface rather 
than persistent retention within intracellular organelles. 
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Figure 7.7 β subunit pairs do not prevent the trafficking of α subunits to the cell 
membrane A-F. CHO cells were co-transfected with NaV1.1 splice variants and indicated 
subunits. Cells were fixed in 4% PFA and labelled with anti-NaV1.1 antibody raised in 
rabbit and detected with TRITC conjugated secondary antibodies. GFP (green 
fluorescence) indicates successful co-transfection with β subunits, but not their localization 
(right panels). Trafficking to the cell surface is confirmed by faint red fluoresce at the cell 
periphery in all images. Cells were visualised at x63 magnification. Scale bar: 5 μM. 
 
7.4 Discussion 
The main findings of this chapter were: 
1. β1b,β2 and possibily β3,β2 decreases the current density of NaV1.1 splice variants. 
2. Current density is not reduced by β subunit retention of NaV1.1 splice variant α 
B 
C 
D 
E 
F 
A 
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subunits. 
7.4.1 β1b, β2 reduced current density and slowed the kinetics of NaV1.1 splice variants 
The presence of both β1 splice variants and β2 did not alter the voltage dependency of 
NaV1.1 gating. However β1b,β2 and β3,β2 did reduce the current density of NaV1.1 sodium 
currents. The immunocytochemistry data implies that this was not due to β subunit-
dependent intracellular retention of α subunits, and therefore β subunit pairs may inhibit 
NaV1.1 conduction at the cell surface. No currents were recorded from cells expressing 
NaV1.1 and β3,β2 subunits. Within 48 hours of NaV1.1 with β3,β2 transfection the cells 
started to necrose and lift from the coverslips. Consequently the cells may have not had 
sufficient time to manufacture NaV1.1 channels, particularly if the metabolism of the cells 
was impaired. The IRES vector may have been toxic to the cells as the transfection 
efficiency of the vector during immunocytochemistry experiments was poor ~5 % (personal 
estimation). Indeed, in preliminary experiments the same outcome was observed for cells 
transfected with β1b,β2, but a reduction in plasmid DNA concentration improved cell 
viability. Nevertheless, indirect immunofluorescence did detect NaV1.1-5A and NaV1.1-5N 
expression in the presence of β3,β2 48 hours after transfection. The toxicity of the β3,β2 
IRES vector could be tested by transfecting SCN2B and SCN3B in separate plasmids. IRES 
vectors have been developed to ensure that reporter and experimental genes are co-
transfected within the same cells. However, there is strong evidence that separate plasmids 
transfected together are incorporated into the same cells (Groot-Kormelink et al., 2002).  
The few functional studies investigating the effects of β1b on VGSCs are in contrast to 
these data and showed that β1b increased the current density of both NaV1.2 and NaV1.5 
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channels (Qin et al., 2003; Watanabe et al., 2008). However, in both studies β2 was not 
present and suggests that β2 may exert a dominant effect over β1b. This could be 
investigating by transfecting different ratios of β1b vs β2 with NaV1.1 splice variants to 
determine if a sequential increase of β2 subunits correlated with a decrease NaV1.1 current 
density. β1b may interact uniquely with β2 and α subunits through its c-terminal region 
because the extracellular Ig domains of β1 and β1b are identical but their c-terminal regions 
are less than 17% conserved.  
It is surprising that β subunit expression did not decrease NaV1.1 currents by retaining α 
subunits within the secretory pathway. Mutation of an intracellular β1 polar tyrosine 
residue 181 to a glutamate reduced NaV1.2 channel expression in a heterologous cell line 
(McEwen et al., 2004), and plasma membrane expression of sodium channels was 
decreased in SCN2B null mice (Chen et al., 2002). The analogous residue at 181 in β1b is a 
non-polar proline; it would be interesting to mutagenize this residue to a tyrosine to analyze 
whether α subunit expression increased.  
β1b,β2 also slowed the rate of current decay of both NaV1.1 isoforms in the presence and 
absence of β1,β2. This was not observed for NaV1.2 or NaV1.5 channels (Qin et al., 2003; 
Watanabe et al., 2008). However, NaV1.5 channels were co-expressed with β1b in CHO 
cells and the internal solution used was CsF (Watanabe et al., 2008); two variables that 
alter the inactivation of VGSCs (Watanabe et al., 2008). Similarly for NaV1.2, β1b channels 
were expressed in Xenopus oocytes (Qin et al., 2003). β1b,β2 specifically slowed the 
kinetics of activation of NaV1.1-5A but because the currents were small, the signal-to-noise 
ratio was high, and this may have affected curve fitting and data analysis.  Therefore, a 
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greater number of experiments would have to be performed to verify this result. In the 
presence of β1,β2 the rate of inactivation of NaV1.1-5N channels was significantly slowed 
and therefore the up-regulation of one NaV1.1 splice variant may help to finely tune the 
excitability of neurons.   
7.4.2 β subunits may change AED efficacy  
These data suggest that while different β subunit pairs do have different effects on NaV1.1 
currents they do not dramatically distinguish between SCN1A exon 5 splice variants.  
However, β subunit modulation of channel recovery from inactivation was not assessed. 
Further experiments would reveal if this parameter is changed by the presence of specific β 
subunits, including pairs containing β4 subunits. Additionally, these experiments could 
measure whether the actions of AEDs on NaV1.1 splice variant currents may be sensitive to 
changes in β subunit pairs. A recent study involving SCN1B null mice demonstrated that β 
subunits can selectively change the responses of AEDs.  Compared to control neurons 
carbamazepine significantly shifted the voltage dependency INaP derived from mutant 
dentate granule cells in a hyperpolarized direction. The authors concluded that in a β1 
absent background carbamazepine would paradoxically encourage neuronal firing (Uebachs 
et al., 2010). However, Scheinmann et al. (1989) were the first to report that CNS VGSCs 
without β subunits are present in the developing rodent brain. The authors surmised that 
these were intracellular intermediates in the assembly of mature VGSCs and β subunits 
may help to stabilize the pore at the cell membrane (Alcaraz et al., 1997). There is no direct 
evidence to suggest that NaV1.1 α-only channels, in vivo, serve as functional channels. 
However, it is a strong possibility because β subunits, not NaV1.1 α subunits, are 
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persistently down-regulated in experimental models of epilepsy. Although β subunit data is 
conflicting and may rely on brain region and animal model (Ellerkmann et al., Gastaldi et 
al., Gorter et al., 2006). There are no reports to suggest that β1b,β2 subunits are subjected 
to the same down-regulation or even if this pair exists in vivo. However, if β1b,β2 subunits 
are sequestered during ictal activity this may act as a protective mechanism because an 
increased NaV1.1 α subunit only current would enhance inhibition.  This may explain why 
some AEDs can exacerbate seizures in GEFS+ patients. Future immunoblotting analysis 
and could help ascertain the relative changes in membrane β subunit and NaV1.1 splice 
variant α subunit expression and in chicken models of epilepsy. Selectively knocking down 
NaV1.1 splice variants and β subunits genes in neurons may reveal important but previously 
unrecognized targets and accidental modulators for AEDs. 
7.4.3 Overall conclusion and directions for future research 
The main aim of this work was to try and provide a mechanistic explanation for the 
association between rs3812718 and AED dosage found in the Tate et al., studies (2005, 
2006). Combining molecular information with genotyping may improve patient drug 
selection, predict side effects and avoid seizure aggravation. However, from these results 
the initial assumption, that epilepsy patients with a greater percentage of exon 5N require 
lowered drug dosages, may be inaccurate. Based on these data a reasonable hypothesis is 
that patients that favour the inclusion of exon 5N may experience a greater perturbation in 
inhibition after AED administration. Therefore a lower dosage requirement may simply 
reflect drug intolerance. Additionally, as demonstrated by the NaV1.1-R1648H family and 
the biophysical data presented in this study (Chapter 4), a change in splicing and a mutation 
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in SCN1A does not predict patient phenotype or drug responsiveness. One may ask how 
effective is genotyping in treating GEFS+ syndromes? Future association studies are 
needed whereby a genetic causality has to be confirmed and if positive these patients would 
be separated from individuals with non-genetic etiologies. Concerning GEFS+, in patients 
with a genetic epilepsy all known GEFS+ genes would have to be screened to assess 
possible multiple-genetic inheritance and cohorts would be needed to be selected whereby 
individuals suffered with GEFS+ rather than including individuals other epilepsy 
syndromes. Lastly precise clinical notes are essential as drug intolerance could be easily 
eliminated. Moreover, the hypothesis that a loss/dysfunction of NaV1.1 is the causality of 
GEFS+ may be inaccurate as findings in rodents may not translate to humans. This would 
be of importance to determine for further study.  
This study highlights the difficulties of heterologous expression studies and the need for 
more consistent methodologies to be used in the field with regards to solutions and cell 
models. This was especially important with regards to G-protein regulation of these 
channels. These results hints of a possible Gβγ differential regulation of NaV1.1 splice 
variant derived INaP, but further characterization of this modulation would be relevant. The 
selected β subunit pairs affected the gating of each splice variant similarly; however the 
recovery from inactivation was not assessed and future studies are needed to determine 
their affect on this parameter. Co-expression with additional β subunit pairs would be of 
importance to assess the broader impact of auxiliary subunit regulation. 
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